
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>rare-ex101_6.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
rare-ex101_6.htm
</title>
</head>
<!-- NG Converter v4.0.5.11 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.1</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:20.26%;margin-right:19.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LICENSE AND COLLABORATION<font style="letter-spacing:-0.35pt;"> </font>AGREEMENT</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;margin-left:20.26%;margin-right:19.01%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">BY AND<font style="letter-spacing:-0.05pt;"> </font>BETWEEN</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:20.27%;margin-right:19.01%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TAKEDA PHARMACEUTICAL COMPANY<font style="letter-spacing:-0.3pt;"> </font>LIMITED AND</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:26.47%;margin-right:25.21%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ULTRAGENYX PHARMACEUTICAL<font style="letter-spacing:-0.3pt;"> </font>INC. JUNE 6,<font style="letter-spacing:-0.05pt;"> </font>2016</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:20.27%;margin-right:19.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:22.45%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LICENSE AND COLLABORATION<font style="letter-spacing:-2.2pt;"> </font>AGREEMENT</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.43%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">This<font style="letter-spacing:1.25pt;"> </font>License<font style="letter-spacing:1.2pt;"> </font>and<font style="letter-spacing:1.3pt;"> </font>Collaboration<font style="letter-spacing:1.25pt;"> </font>Agreement<font style="letter-spacing:1.05pt;"> </font><font style="font-weight:normal;">(this</font><font style="letter-spacing:1.05pt;font-weight:normal;"> </font><font style="font-weight:normal;">&#8220;</font><font style="text-decoration:underline;font-weight:normal;">Agreement</font><font style="font-weight:normal;">&#8221;)</font><font style="letter-spacing:0.95pt;font-weight:normal;"> </font><font style="font-weight:normal;">is</font><font style="letter-spacing:1.05pt;font-weight:normal;"> </font><font style="font-weight:normal;">made</font><font style="letter-spacing:1.05pt;font-weight:normal;"> </font><font style="font-weight:normal;">as</font><font style="letter-spacing:1pt;font-weight:normal;"> </font><font style="font-weight:normal;">of</font><font style="letter-spacing:0.95pt;font-weight:normal;"> </font><font style="font-weight:normal;">the</font><font style="letter-spacing:1.1pt;font-weight:normal;"> </font><font style="font-weight:normal;">6th day</font><font style="letter-spacing:0.7pt;font-weight:normal;"> </font><font style="font-weight:normal;">of</font><font style="letter-spacing:0.8pt;font-weight:normal;"> </font><font style="font-weight:normal;">June,</font><font style="letter-spacing:0.8pt;font-weight:normal;"> </font><font style="font-weight:normal;">2016</font><font style="letter-spacing:0.85pt;font-weight:normal;"> </font><font style="font-weight:normal;">(the</font><font style="letter-spacing:0.9pt;font-weight:normal;"> </font><font style="font-weight:normal;">&#8220;</font><font style="text-decoration:underline;font-weight:normal;">Execution</font><font style="text-decoration:underline;letter-spacing:0.9pt;font-weight:normal;"> </font><font style="text-decoration:underline;font-weight:normal;">Date</font><font style="font-weight:normal;">&#8221;)</font><font style="letter-spacing:0.8pt;font-weight:normal;"> </font><font style="font-weight:normal;">by</font><font style="letter-spacing:0.7pt;font-weight:normal;"> </font><font style="font-weight:normal;">and</font><font style="letter-spacing:0.95pt;font-weight:normal;"> </font><font style="font-weight:normal;">between</font><font style="letter-spacing:1.05pt;font-weight:normal;"> </font>Takeda<font style="letter-spacing:1.2pt;"> </font>Pharmaceutical<font style="letter-spacing:1.2pt;"> </font>Company Limited<font style="font-weight:normal;">, a company incorporated under the laws of Japan having its principal place of</font><font style="letter-spacing:1.3pt;font-weight:normal;"> </font><font style="font-weight:normal;">business at 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, Japan (&#8220;</font><font style="text-decoration:underline;font-weight:normal;">Takeda</font><font style="font-weight:normal;">&#8221;), and </font>Ultragenyx Pharmaceutical Inc.<font style="font-weight:normal;">, a company incorporated under the laws of California, having its</font><font style="letter-spacing:2.35pt;font-weight:normal;"> </font><font style="font-weight:normal;">principal place of business at 60 Leveroni Court, Novato, CA 94949, United States</font><font style="letter-spacing:0.05pt;font-weight:normal;"> </font><font style="font-weight:normal;">(&#8220;</font><font style="text-decoration:underline;font-weight:normal;">Ultragenyx</font><font style="font-weight:normal;">&#8221;). Ultragenyx and Takeda are sometimes referred to herein individually as a &#8220;</font><font style="text-decoration:underline;font-weight:normal;">Party</font><font style="font-weight:normal;">&#8221;</font><font style="letter-spacing:0.75pt;font-weight:normal;"> </font><font style="font-weight:normal;">and collectively as the</font><font style="letter-spacing:-0.3pt;font-weight:normal;"> </font><font style="font-weight:normal;">&#8220;</font><font style="text-decoration:underline;font-weight:normal;">Parties</font><font style="font-weight:normal;">.&#8221;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RECITALS</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.43%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS<font style="font-weight:normal;">, Takeda has developed certain compounds and products</font><font style="letter-spacing:2.75pt;font-weight:normal;"> </font><font style="font-weight:normal;">potentially applicable to rare genetic disease</font><font style="letter-spacing:-0.4pt;font-weight:normal;"> </font><font style="font-weight:normal;">indications;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.43%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS<font style="font-weight:normal;">, Ultragenyx is a pharmaceutical company with significant experience</font><font style="letter-spacing:0.75pt;font-weight:normal;"> </font><font style="font-weight:normal;">with the development of products for rare genetic disease indications;</font><font style="letter-spacing:-0.5pt;font-weight:normal;"> </font><font style="font-weight:normal;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.43%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS<font style="font-weight:normal;">,</font><font style="letter-spacing:1.55pt;font-weight:normal;"> </font><font style="font-weight:normal;">Ultragenyx</font><font style="letter-spacing:1.7pt;font-weight:normal;"> </font><font style="font-weight:normal;">and</font><font style="letter-spacing:1.55pt;font-weight:normal;"> </font><font style="font-weight:normal;">Takeda</font><font style="letter-spacing:1.5pt;font-weight:normal;"> </font><font style="font-weight:normal;">desire</font><font style="letter-spacing:1.5pt;font-weight:normal;"> </font><font style="font-weight:normal;">to</font><font style="letter-spacing:1.6pt;font-weight:normal;"> </font><font style="font-weight:normal;">establish</font><font style="letter-spacing:1.55pt;font-weight:normal;"> </font><font style="font-weight:normal;">a</font><font style="letter-spacing:1.5pt;font-weight:normal;"> </font><font style="font-weight:normal;">collaboration</font><font style="letter-spacing:1.65pt;font-weight:normal;"> </font><font style="font-weight:normal;">for</font><font style="letter-spacing:1.45pt;font-weight:normal;"> </font><font style="font-weight:normal;">the</font><font style="letter-spacing:1.5pt;font-weight:normal;"> </font><font style="font-weight:normal;">further development and commercialization of certain products potentially applicable to rare</font><font style="letter-spacing:0.45pt;font-weight:normal;"> </font><font style="font-weight:normal;">genetic disease and other</font><font style="letter-spacing:-0.1pt;font-weight:normal;"> </font><font style="font-weight:normal;">indications.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.43%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE<font style="font-weight:normal;">, in consideration of the foregoing and the mutual agreements</font><font style="letter-spacing:2.3pt;font-weight:normal;"> </font><font style="font-weight:normal;">set forth below, and other good and valuable consideration, the receipt and sufficiency of which</font><font style="letter-spacing:2.8pt;font-weight:normal;"> </font><font style="font-weight:normal;">are hereby acknowledged, the Parties agree as</font><font style="letter-spacing:-0.45pt;font-weight:normal;"> </font><font style="font-weight:normal;">follows:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark0"></a><a name="_bookmark1"></a><a name="_bookmark1"></a>ARTICLE 1&nbsp;&nbsp;<font style="font-weight:normal;">&#8211;</font><font style="font-weight:normal;letter-spacing:0.05pt;"> </font>DEFINITIONS</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Development Plans</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">4.3(b).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] License Negotiation Period</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">5.1(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Option</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">5.1(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.4<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Option Term</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">5.1(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.5<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Patent Prosecution</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">12.3(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark2"></a>1.6<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Compound</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.7<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Product</font><font style="font-size:10.5pt;">&#8221; means any pharmaceutical product that contains a [***] Compound, including</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">forms,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">presentations,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">strengths,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">doses</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">formulations</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">(including</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">method</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of delivery).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.8<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Research Plan</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">6.3(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.9<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Accounting</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Standards</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">mean</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">GAAP</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">IFRS</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of Takeda.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.10<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Affiliate</font><font style="font-size:10.5pt;">&#8221; means, with respect to a particular Party, a person, corporation, partnership,</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">or other</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">entity</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">controls,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">controlled</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">common</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">control</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the purposes of this definition, the word &#8220;control&#8221; (including, with correlative meaning, the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">terms &#8220;controlled</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">&#8220;under</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">common</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">control</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with&#8221;)</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">actual</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">power,</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">directly</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">or indirectly through one or more intermediaries, to direct or cause the direction of the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">management and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">policies</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">entity,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">ownership</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">fifty</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">percent</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">(50%)</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">more</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the voting stock of such entity, or by contract or</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">otherwise.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.11<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in the</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">preamble.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.12<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Alliance Manager</font><font style="font-size:10.5pt;">&#8221; means the person appointed by each Party from within</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">their respective organization to coordinate and facilitate the communication, interaction</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">and cooperation of the Parties pursuant to this</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.13<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Applicable Laws</font><font style="font-size:10.5pt;">&#8221; means all applicable statutes, ordinances, regulations, rules, or</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">orders of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">kind</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">whatsoever</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Governmental</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Authority,</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">U.S.</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Food,</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Drug</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">and Cosmetic</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Act,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(21</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">U.S.C.</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">&#167;301</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">et</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">seq.)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">FFDCA</font><font style="font-size:10.5pt;">&#8221;),</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Prescription</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Drug</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Marketing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Act,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the Generic Drug Enforcement Act of 1992 (21 U.S.C. &#167;335a et seq.), U.S. Patent Act (35 U.S.C.</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">&#167;1 et seq.), Federal Civil False Claims Act (31 U.S.C. &#167;3729 et seq.), and the Anti-Kickback</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Statute (42</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">U.S.C.</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">&#167;1320a-7b</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">et</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">seq.),</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">amended</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">time,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">together</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">rules, regulations, and compliance guidance promulgated</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">thereunder.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.14<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Bankruptcy Laws</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">15.6(b).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.15<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Bayh-Doyle</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Act</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Trademark</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Law</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Amendments</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Act</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">1980,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">as amended,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">codified</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">35</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">U.S.C.</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">&#167;&#167;</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">200-212,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">well</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">regulations</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">promulgated</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">pursuant thereto, including 37 C.F.R. Part 401, and any successor statutes or</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">regulations.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.16<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] License Agreement</font><font style="font-size:10.5pt;">&#8221; means the License Agreement by and between</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Ultragenyx and [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.17<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Breaching Party</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">15.2(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.18<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Bulk Drug Product</font><font style="font-size:10.5pt;">&#8221; means a Product that has been Manufactured into a</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">final pharmaceutical product, including drug substance (e.g., tablets or granules) for administration</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to humans</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Laws,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Packaged</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Clinical Trials or for</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Commercialization.</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.19<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Business Day</font><font style="font-size:10.5pt;">&#8221; means a day other than Saturday, Sunday or any other day on</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">which commercial</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">banks</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">located</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">State</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">New</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">York,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">U.S.,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Japan,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">authorized</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">obligated by Applicable Laws to</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">close.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.20<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Calendar Quarter</font><font style="font-size:10.5pt;">&#8221; means the respective periods of three (3) consecutive&nbsp;&nbsp;calendar months ending on March 31, June 30, September 30 and December 31; provided, however,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">that</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:27pt;"></font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Quarter</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">extend</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">end</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the first</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Quarter</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">thereafter;</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">last</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Quarter</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">shall end upon the expiration or termination of this</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.21<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Calendar Year</font><font style="font-size:10.5pt;">&#8221; means the twelve-month period ending on December 31;</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">provided however, that (a) the first Calendar Year of the Term, shall begin on the Effective Date and</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">end on</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">December</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">31,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">2016;</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">last</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Year</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">end</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of expiration or termination of this</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.22<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Candidate Product</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">6.2(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Change</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">of</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Control</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of Ultragenyx means if: (a) any Third Party acquires directly or indirectly the beneficial ownership of any voting security of Ultragenyx, or if the percentage ownership of such person or entity in the voting securities of Ultragenyx is increased through stock redemption, cancellation or other recapitalization, and immediately after such&nbsp;&nbsp;acquisition or increase such Third Party is, directly or indirectly, the beneficial owner of voting securities representing more than fifty percent (50%) of the total voting power of all of the then- outstanding voting securities of Ultragenyx; (b) the consummation of a merger, consolidation, recapitalization, or reorganization of Ultragenyx, other than any such transaction, which would result in stockholders or equity holders of Ultragenyx, or an Affiliate of Ultragenyx, immediately prior to such transaction owning at least fifty percent (50%) of the outstanding securities of the surviving entity (or its parent entity) immediately following such transaction;&nbsp;&nbsp;(c) the stockholders or equity holders of Ultragenyx approve a plan of complete liquidation of Ultragenyx, or an agreement for the sale or disposition by Ultragenyx of all or a substantial portion of Ultragenyx&#8217;s assets, other than pursuant to the transaction as described above or to an Affiliate; or (d) the sale or other transfer to a Third Party of all or substantially all of Ultragenyx&#8217;s assets which relate to this Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.24<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Claim</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">17.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.25<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Clinical</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Trial</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">human</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">clinical</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">study</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">trial</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">in the Licensed Field in the Territory, including Phase I Trials, Phase II Trials, Phase III Trials</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">and Phase IV</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Trials.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Collaboration Activities</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">2.2(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.27<font style="margin-left:45pt;"></font><font style="text-decoration:underline;font-size:10.5pt;">&#8220;Collaboration Term</font><font style="font-size:10.5pt;">&#8221; means (a) with respect to [***] Products, twenty-four (24) months from</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">[***] Products, five (5) years from the Effective Date, unless, in case of each of the foregoing clauses (a) or (b), (i) extended by</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">mutual agreement of the Parties, or (ii) terminated earlier in accordance with the terms of</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">this</font></p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agreement;<font style="letter-spacing:1.95pt;"> </font>provided<font style="letter-spacing:1.9pt;"> </font>that<font style="letter-spacing:1.95pt;"> </font>if<font style="letter-spacing:1.9pt;"> </font>at<font style="letter-spacing:1.95pt;"> </font>the<font style="letter-spacing:1.9pt;"> </font>expiration<font style="letter-spacing:1.9pt;"> </font>of<font style="letter-spacing:1.85pt;"> </font>the<font style="letter-spacing:1.85pt;"> </font>foregoing<font style="letter-spacing:1.8pt;"> </font>period,<font style="letter-spacing:2pt;"> </font>an<font style="letter-spacing:1.9pt;"> </font>Option<font style="letter-spacing:1.95pt;"> </font>Negotiation Period is then ongoing, the Collaboration Term with respect to such Option Product<font style="letter-spacing:1.05pt;"> </font>will automatically extend until the earlier of (A) expiration of such Option Negotiation Period or<font style="letter-spacing:2.4pt;"> </font>(B) execution of the applicable Option Product License<font style="letter-spacing:-0.5pt;"> </font>Agreement.</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.28<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Combination Product</font><font style="font-size:10.5pt;">&#8221; means a Product that is comprised of or contains a Compound</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">as an active ingredient together with one (1) or more other active ingredients and is sold by a</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Party, or</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">sublicensees,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">fixed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">dose</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">separate</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">doses</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">(1) product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.29<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;">&#8221; means all activities undertaken in support of the</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">promotion, marketing, sale and distribution (including importing, exporting, transporting, customs</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">clearance, warehousing,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">invoicing,</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">handling</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">delivering</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">customers)</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the applicable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Manufacturing</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">commercial</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">sale,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">sales</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">force</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">efforts, detailing, advertising, marketing, the creation and approval of Promotional Materials, sales</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and distribution, pricing, customer and government contracting, and medical affairs,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">including medical education, medical information, clinical science liaison activities, health economics</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">and outcomes research, publications and investigator initiated research studies.</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Commercialize</font><font style="font-size:10.5pt;">&#8221; means to engage in Commercialization</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">activities.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.30<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Commercialization Plan</font><font style="font-size:10.5pt;">&#8221; means, as applicable, (a) a plan prepared by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx pursuant</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">5.3</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">containing</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">overview</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">general</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">strategy</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">high-level</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">budget for the promoting and marketing of the Licensed Products in the Ultragenyx Field in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the Territory or (b) a plan prepared by Takeda pursuant to Section 5.3 containing an overview of</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">the general strategy for the promoting and marketing of the Licensed [***] Product in the </font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Takeda Field in the</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.31<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Commercially Reasonable Efforts</font><font style="font-size:10.5pt;">&#8221; means with respect to the efforts to be expended,</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">or considerations to be undertaken, by a Party or its Affiliates with respect to any objective,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">activity or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">undertaken</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Compounds</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Products, the commercially reasonable efforts, expertise, and resources commonly used by such Party for</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">a product</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">owned</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">exclusive</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">territory,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">which,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">as compared</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">similar</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">market</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">potential,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">similar</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">stage</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">development</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or product</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">life,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">involves</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">similar</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">risks,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">measured</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">based</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">facts</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">circumstances at the time such efforts are due, taking into account issues of: efficacy and safety,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the competitiveness</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">alternative</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">products</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">sold</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Parties,</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">profile</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">(including Labeling), the proprietary protection and regulatory exclusivity, the expected and actual profitability and return on investment, and all other similar relevant</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">factors.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.32<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">2.3(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.33<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Common</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Stock</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Purchase</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">common</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">stock</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">purchase</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">agreement entered into on even date hereof by and between Ultragenyx and Takeda (or one of its</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Affiliates) providing for Takeda&#8217;s (or one of its Affiliate&#8217;s) purchase of common stock of</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.34<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Competing</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.35<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Compound,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Analog</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Compound,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">[***] Compound, Candidate Product or Ultragenyx Pipeline Compound, as</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.36<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Confidential Information</font><font style="font-size:10.5pt;">&#8221; means all non-public or proprietary Information disclosed</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">by a Party to the other Party under this Agreement, which may include ideas,</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">inventions, discoveries, concepts, compounds, compositions, formulations, formulas, practices,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">procedures, processes, methods, knowledge, know-how, trade secrets, technology, inventories,</font><font style="font-size:10.5pt;letter-spacing:-0.95pt;"> </font><font style="font-size:10.5pt;">machines, techniques, development and commercialization plans and related information,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">designs, drawings, computer programs, skill, experience, documents, apparatus, results, clinical</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">and regulatory strategies, regulatory documentation, information and submissions pertaining to,</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">or made in association with, filings with any Regulatory Authority, data,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">including pharmacological, toxicological and clinical data, analytical and quality control</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">data, manufacturing data and descriptions, Patent and legal data, market data, financial data</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or descriptions,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">devices,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">assays,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">chemical</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">formulations,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">specifications,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">material,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">samples and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">samples,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">physical,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">chemical</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">biological</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">materials</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">compounds,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">like, without</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">regard</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">foregoing</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">marked</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">&#8220;confidential&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">&#8220;proprietary,&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or disclosed in oral, written, graphic, or electronic form. Confidential Information shall include:</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">(a) the terms and conditions of this Agreement; and (b) Confidential Information disclosed by</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">either Party pursuant to the Confidentiality</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.37<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Confidentiality Agreement</font><font style="font-size:10.5pt;">&#8221; means the Mutual Confidential Disclosure Agreement dated March 13, 2015 by and between Takeda Pharmaceuticals International, Inc. and</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Inc.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.38<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Control</font><font style="font-size:10.5pt;">&#8221; means, with respect to any Information, Patent, trademark or other</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">intellectual property right, ownership or possession by a Party, including its Affiliates, of the ability</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">(without taking</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">account</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">this Agreement)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">access,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Information,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">trademark</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or other intellectual property right without violating the terms of any agreement or other arrangement</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">with,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">necessitating</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">consent</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party would</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">access,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or sublicense.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.39<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Cover</font><font style="font-size:10.5pt;">&#8221;, &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Covering</font><font style="font-size:10.5pt;">&#8221; or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Covered</font><font style="font-size:10.5pt;">&#8221; means, with respect to a product, technology,</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">process or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">method,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">that,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">absence</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">ownership</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Valid</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Claim,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the practice</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Exploitation</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">product,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">technology,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">process</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">method</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">would</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">infringe</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">such Valid</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Claim</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">(or,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Valid</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Claim</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">yet</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">issued,</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">would</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">infringe</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Valid Claim if it were to</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">issue).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.40<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Cure Period</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">15.2(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.41<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Data Package</font><font style="font-size:10.5pt;">&#8221; means the Final [***] Data Package, Final Phase II Data Package or</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Final Phase III Data Package, as</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">applicable.</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.42<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Development</font><font style="font-size:10.5pt;">&#8221; means all non-clinical and clinical drug development activities,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">including toxicology, pharmacology, and other non-clinical efforts, statistical analysis, the performance</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">of Clinical</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Trials,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Manufacturing</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Clinical Trials, or other activities necessary to obtain or maintain, Regulatory Approval of the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">applicable Products.</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">&#8220;Development&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">exclude</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">activities.</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">When</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">used</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">verb, &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Develop</font><font style="font-size:10.5pt;">&#8221; means to engage in Development</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">activities.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.43<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Disclosing Party</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">14.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.44<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">16.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Effective</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Date</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">becomes</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">effective,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">determined</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">in accordance with Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">18.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.46<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">EMA</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">European</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Medicines</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Agency</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">successor</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">agency</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">authority having substantially the same</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">function.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.47<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">EU</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">European</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Union</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">member</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">states</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">during the Term.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.48<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Execution Date</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in the</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">preamble.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.49<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exercised Countries</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">8.2(c).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.50<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exercised Product License Agreement</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">8.2(d).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.51<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exercised Products</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">8.2(c).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.52<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Expert</font><font style="font-size:10.5pt;">&#8221; means a disinterested, conflict-of-interest-free individual who is neutral</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">and independent of both Parties and all of their respective Affiliates and sublicensees and who,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">with respect to a dispute concerning a financial, commercial, scientific or regulatory matter,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">possesses appropriate expertise to resolve such dispute. Neither the Expert (nor any of the Expert&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">current or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">former</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">employers)</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">time,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Knowledge</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Parties,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">an employee,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">officer,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">director</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">previous</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">five</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(5)</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">years,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">consultant</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">contractor</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of either Party or any of its</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">Affiliates.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.53<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exploit</font><font style="font-size:10.5pt;">&#8221; or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exploitation</font><font style="font-size:10.5pt;">&#8221; means to research, import, Manufacture, have</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Manufactured, export distribute, use, have used, sell, have sold, or offer for sale, including to</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Develop, Commercialize, register, modify, enhance, improve or otherwise dispose</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">of.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.54<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">FDA</font><font style="font-size:10.5pt;">&#8221; means the U.S. Food and Drug Administration, or any successor agency</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">thereto.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.55<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Final</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">[***]</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Data</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Package</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">agree</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall provide</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">give</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">access</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">conclusion</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">contemplated</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the Initial [***] Development Plan for a given Licensed [***] Product as it relates to the Takeda</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Field, but</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">include</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">minimum</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">validated</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">reproducible</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">tables,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">listings</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">graphs, (b) all adverse event listings, safety narratives, CMC data and information, and</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">applicable</font></p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regulatory<font style="letter-spacing:2.1pt;"> </font>Documentation,<font style="letter-spacing:2.2pt;"> </font>(c)<font style="letter-spacing:2.3pt;"> </font>preclinical<font style="letter-spacing:2.2pt;"> </font>study<font style="letter-spacing:2.05pt;"> </font>results<font style="letter-spacing:2.2pt;"> </font>and<font style="letter-spacing:2.45pt;"> </font>final,<font style="letter-spacing:2.2pt;"> </font>if<font style="letter-spacing:2.2pt;"> </font>possible,<font style="letter-spacing:2.15pt;"> </font>or<font style="letter-spacing:2.15pt;"> </font>preliminary toxicology<font style="letter-spacing:2.45pt;"> </font>and<font style="letter-spacing:2.65pt;"> </font>pharmacology<font style="letter-spacing:2.45pt;"> </font>reports,<font style="letter-spacing:2.65pt;"> </font>and<font style="letter-spacing:2.65pt;"> </font>(d)<font style="letter-spacing:2.75pt;"> </font>a<font style="letter-spacing:2.65pt;"> </font>preliminary<font style="letter-spacing:2.5pt;"> </font>Phase<font style="letter-spacing:2.75pt;"> </font>I<font style="letter-spacing:2.55pt;"> </font>report<font style="letter-spacing:2.65pt;"> </font>and<font style="letter-spacing:2.65pt;"> </font>all<font style="letter-spacing:2.6pt;"> </font>Phase<font style="letter-spacing:2.65pt;"> </font>I clinical<font style="letter-spacing:-0.2pt;"> </font>data.</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.56<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Final Phase II Data Package</font><font style="font-size:10.5pt;">&#8221; means on a Product-by-Product basis, all Information</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the Parties agree that Ultragenyx shall provide to or give access to Takeda at the conclusion of</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">a Phase II Clinical Trial and after database lock, but which will include at a minimum (a)</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">validated and reproducible tables, listings and graphs, (b) all adverse event listings, safety narratives,</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">CMC data and information, and applicable Regulatory Documentation, (c) final, if possible,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">or preliminary</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">toxicology</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">pharmacology</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">reports,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">(d)</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Phase</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">I</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">report</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Phase</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">I clinical data, and (e) a preliminary Phase II report and all Phase II clinical</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">data.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.57<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Final Phase III Data Package</font><font style="font-size:10.5pt;">&#8221; means, on a Product-by-Product basis, all Information</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the Parties agree that Ultragenyx shall provide to or give access to Takeda at the conclusion of</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">a Phase III Clinical Trial and after database lock, but which will include at a minimum</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">(a) validated</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">reproducible</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">tables,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">listings</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">graphs,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">adverse</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">listings,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">material safety narratives, CMC data and information, and applicable Regulatory Documentation, </font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">(c) final, if possible, or preliminary toxicology and pharmacology reports, (d) the Phase I final</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">report and all Phase I clinical data to the extent not previously provided to Takeda, (e) the Phase II</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">final report</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Phase</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">II</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">clinical</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">previously</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(f)</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the preliminary Phase III report and all Phase III clinical</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">data.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.58<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Finished Product</font><font style="font-size:10.5pt;">&#8221; means Bulk Drug Product that has been Packaged into a form</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">suitable for use in Clinical Trials or for Commercial purposes (i.e., bottles or blisters), including</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">samples, in accordance with Applicable</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">Laws.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.59<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">First Commercial Sale</font><font style="font-size:10.5pt;">&#8221; means, on a country-by-country basis, the first sale of a</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Product under this Agreement by a Party, its Affiliates or its sublicensees to an end user or prescriber</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for use, consumption or resale of the Product in a country in the applicable territory in the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">applicable field where Regulatory Approval of the Product has been obtained and where the sale results in</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a recordable</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Net</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Sale.</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Sale</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Affiliate</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">a sublicensee</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">constitute</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">First</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Commercial</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Sale</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">unless</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Affiliate</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">sublicensee</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">end</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">user</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Product.</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Also,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">sale</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agreement by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">sublicensees</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">jurisdiction</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">where</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">that Product has not yet been attained shall not constitute a First Commercial Sale under</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">this Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.60<font style="margin-left:45pt;"></font><font style="text-decoration:underline;font-size:10.5pt;">Force</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Majeure</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">beyond</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">control</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">affected</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Party including: embargoes; war or acts of war, including terrorism; insurrections, riots, or civil</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">unrest; strikes, lockouts or other labor disturbances; epidemics, fire, floods, earthquakes or other acts</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">of nature; or acts, omissions or delays in acting by any governmental authority (including </font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">the refusal</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">competent</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">government</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">agencies</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">issue</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Approvals</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to reasons other than the affected Party&#8217;s negligence or willful misconduct or&nbsp;&nbsp;any other</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">cause within</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">control</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">affected</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party),</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">failure</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">plant</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">machinery</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">(provided that such failure could not have been prevented by the exercise of skill, diligence, and</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">prudence</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that would be reasonably and ordinarily expected from a skilled and experienced person<font style="letter-spacing:1.5pt;"> </font>engaged in the same type of undertaking under the same or similar<font style="letter-spacing:-0.65pt;"> </font>circumstances).</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.61<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">FTE</font><font style="font-size:10.5pt;">&#8221; means eighteen hundred (1800) hours of work per full Calendar Year</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(or equivalent</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">pro-rata</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">portion</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">thereof</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">less</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">twelve</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(12)</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">months)</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">devoted</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in support of the Development of the applicable Products in accordance with the Research Plans</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or the Manufacturing of a Product or the provision of Research Support (but excluding, for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">clarity, time spent travelling to and attending meetings under this Agreement and scientific and</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">medical conferences), that is carried out by one or more qualified scientific or technical employees</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">or contract</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">personnel</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">hours</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">measured</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">with Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">normal</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">allocation</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">practices.</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">avoidance</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">doubt,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">FTE</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">applies</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to employees of a Party, and does not apply to contractors of</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Takeda.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.62<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">FTE</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Cost</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">means,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">period,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">FTE</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Rate</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">multiplied</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">number</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">FTEs</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">in such</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">period.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.63<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">FTE Rate</font><font style="font-size:10.5pt;">&#8221; means a rate of [***] per FTE per Calendar Year (pro-rated for the period beginning on the Effective</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Date and ending at the end of the first Calendar Year) for personnel engaged in</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Development activities.</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Such</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">rate</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">adjusted</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">annually,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">annual</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">adjustment</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">effective</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of January</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">1</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">calendar</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">year</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">(with</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">annual</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">adjustment</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">January 1,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">2018)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">correspond</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">total</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">percentage</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">change</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Consumer</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Price</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Index</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">All Urban</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Consumers</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">(CPI-U)</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">U.S.</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">City</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Average,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">1982-84</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">=</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">100,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">calculated</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">U.S. Bureau of Labor Statistics over the twelve (12)-month period preceding each such January</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.64<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">GAAP</font><font style="font-size:10.5pt;">&#8221; means generally accepted accounting principles current in the</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">U.S.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.65<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Generic Competition Percentage</font><font style="font-size:10.5pt;">&#8221; means, with respect to any Product in a given</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">country in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">applicable),</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">units</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Generic</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Product(s)</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such Product, sold in the aggregate in such country divided by the sum of: (a) all units of the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product sold</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">country,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">units</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Generic</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Product(s)</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">sold</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">aggregate</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such country,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">where,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">case,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">number</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">units</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Generic</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">sold shall</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">based</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">average</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">monthly</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">IMS</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">IMS-equivalent</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">IMS</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">are not</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">available).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.66<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Generic Product</font><font style="font-size:10.5pt;">&#8221; means, on a Product-by-Product and country-by-country basis,</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">any pharmaceutical product sold by a Third Party, other than as a sublicensee to this Agreement</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">that:</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) contains the same active ingredients as the applicable Product, in the same dosage form<font style="letter-spacing:0.3pt;"> </font>(e.g., oral)<font style="letter-spacing:1.3pt;"> </font>as<font style="letter-spacing:1.3pt;"> </font>the<font style="letter-spacing:1.3pt;"> </font>applicable<font style="letter-spacing:1.3pt;"> </font>Product;<font style="letter-spacing:1.45pt;"> </font>or<font style="letter-spacing:1.3pt;"> </font>(b)<font style="letter-spacing:1.25pt;"> </font>is<font style="letter-spacing:1.35pt;"> </font>A/B<font style="letter-spacing:1.2pt;"> </font>Rated<font style="letter-spacing:1.3pt;"> </font>with<font style="letter-spacing:1.35pt;"> </font>respect<font style="letter-spacing:1.35pt;"> </font>to<font style="letter-spacing:1.35pt;"> </font>such<font style="letter-spacing:1.15pt;"> </font>Product<font style="letter-spacing:1.35pt;"> </font>or<font style="letter-spacing:1.25pt;"> </font>otherwise approved by the Regulatory Authority in such country as a substitutable generic for<font style="letter-spacing:2.5pt;"> </font>such Product; or (c) is approved in the applicable field by a Regulatory Authority pursuant to an<font style="letter-spacing:1.6pt;"> </font>NDA filed<font style="letter-spacing:1.95pt;"> </font>by<font style="letter-spacing:1.75pt;"> </font>a<font style="letter-spacing:1.95pt;"> </font>Third<font style="letter-spacing:1.95pt;"> </font>Party<font style="letter-spacing:1.75pt;"> </font>under<font style="letter-spacing:1.95pt;"> </font>Section<font style="letter-spacing:2pt;"> </font>505(b)(2)<font style="letter-spacing:2.3pt;"> </font>or<font style="letter-spacing:1.95pt;"> </font>505(j)(2)<font style="letter-spacing:2pt;"> </font>of<font style="letter-spacing:1.95pt;"> </font>the<font style="letter-spacing:1.95pt;"> </font>FFDCA<font style="letter-spacing:2pt;"> </font>(or<font style="letter-spacing:1.95pt;"> </font>an<font style="letter-spacing:2pt;"> </font>equivalent Regulatory<font style="letter-spacing:1.1pt;"> </font>Approval<font style="letter-spacing:1.25pt;"> </font>Application<font style="letter-spacing:1.25pt;"> </font>filed<font style="letter-spacing:1.2pt;"> </font>outside<font style="letter-spacing:1.2pt;"> </font>the<font style="letter-spacing:1.2pt;"> </font>U.S.),<font style="letter-spacing:1.35pt;"> </font>contains<font style="letter-spacing:1.25pt;"> </font>the<font style="letter-spacing:1.3pt;"> </font>active<font style="letter-spacing:1.2pt;"> </font>ingredients<font style="letter-spacing:1.25pt;"> </font>in<font style="letter-spacing:1.35pt;"> </font>the Product,<font style="letter-spacing:1.15pt;"> </font>and<font style="letter-spacing:1.1pt;"> </font>relies<font style="letter-spacing:1.15pt;"> </font>on<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>finding<font style="letter-spacing:1pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>safety<font style="letter-spacing:0.85pt;"> </font>and/or<font style="letter-spacing:1.1pt;"> </font>effectiveness<font style="letter-spacing:1.15pt;"> </font>in<font style="letter-spacing:1.15pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>Regulatory<font style="letter-spacing:0.85pt;"> </font>Approval<font style="letter-spacing:1.15pt;"> </font>of the Product. For the purposes of this definition, &#8220;A/B Rated&#8221; means, inside the<font style="letter-spacing:2.6pt;"> </font>U.S., &#8220;therapeutically&nbsp;&nbsp; equivalent&#8221;&nbsp;&nbsp; as&nbsp;&nbsp;&nbsp;&nbsp;determined&nbsp;&nbsp; by&nbsp;&nbsp; the&nbsp;&nbsp; FDA,&nbsp;&nbsp; applying&nbsp;&nbsp; the&nbsp;&nbsp; definition&nbsp;&nbsp;&nbsp;&nbsp; <font style="letter-spacing:2.4pt;"> </font>of</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;therapeutically equivalent&#8221; set forth in the preface to the then-current edition of the<font style="letter-spacing:-0.5pt;"> </font>FDA publication<font style="letter-spacing:1.6pt;"> </font>&#8220;Approved<font style="letter-spacing:1.65pt;"> </font>Drug<font style="letter-spacing:1.4pt;"> </font>Products<font style="letter-spacing:1.6pt;"> </font>With<font style="letter-spacing:1.55pt;"> </font>Therapeutic<font style="letter-spacing:1.5pt;"> </font>Equivalence<font style="letter-spacing:1.5pt;"> </font>Evaluations<font style="letter-spacing:1.55pt;"> </font>and,<font style="letter-spacing:1.55pt;"> </font>outside the U.S., such equivalent determination by the applicable Regulatory Authorities as is<font style="letter-spacing:2.35pt;"> </font>necessary to permit pharmacists or other individuals authorized to dispense pharmaceuticals<font style="letter-spacing:2.65pt;"> </font>under Applicable Law to substitute one product for another product in the absence of<font style="letter-spacing:1.25pt;"> </font>specific instruction from a physician or other authorized prescriber under Applicable<font style="letter-spacing:-0.65pt;"> </font>Law.&#8221;</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.67<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Good Clinical Practices</font><font style="font-size:10.5pt;">&#8221;, &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">GCP</font><font style="font-size:10.5pt;">&#8221; or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">cGCP</font><font style="font-size:10.5pt;">&#8221; means the then-current standards,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">practices and procedures promulgated or endorsed by the FDA as set forth in the guidelines adopted by the International Conference on Harmonization (&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">ICH</font><font style="font-size:10.5pt;">&#8221;), titled &#8220;Guidance for Industry E6</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Good Clinical Practice: Consolidated Guidance,&#8221; (or any successor document) including</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">related regulatory requirements imposed by the FDA and comparable regulatory standards, practices</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">and procedures</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">promulgated</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">EMA,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">PMDA</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the Territory, as they may be updated from time to</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">time.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.68<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Good Laboratory Practices</font><font style="font-size:10.5pt;">&#8221;, &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">GLP</font><font style="font-size:10.5pt;">&#8221;, or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">cGLP</font><font style="font-size:10.5pt;">&#8221; means the then-current</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">standards, practices</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">procedures</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">promulgated</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">endorsed</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">FDA</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">21</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">C.F.R.</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Part</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">58 (or any successor statute or regulation), including related regulatory requirements imposed by</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">the FDA and comparable regulatory standards, practices and procedures promulgated by the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">EMA, PMDA</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">they</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">updated</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">from time to time, including applicable guidelines promulgated under the</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">ICH.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.69<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Good Manufacturing Practices</font><font style="font-size:10.5pt;">&#8221;, &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">GMP</font><font style="font-size:10.5pt;">&#8221;, or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">cGMP</font><font style="font-size:10.5pt;">&#8221; means the then-current</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">good manufacturing</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">practices</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">FDA,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">FFDCA,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">amended,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the regulations promulgated thereunder, for the manufacture and testing of pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">materials, and comparable Applicable Law related to the manufacture and testing of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">pharmaceutical materials</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">jurisdictions</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">outside</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">U.S.,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">quality</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">guideline</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">promulgated</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the ICH designated ICH Q7A, titled &#8220;Q7A Good Manufacturing Practice Guidance for</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Active Pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Ingredients&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">regulations</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">promulgated</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">thereunder,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">they may be updated from time to</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">time.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.70<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Governmental Authority</font><font style="font-size:10.5pt;">&#8221; means any multi-national, federal, state, local, municipal</font><font style="font-size:10.5pt;letter-spacing:-1.35pt;"> </font><font style="font-size:10.5pt;">or other government authority of any nature (including any governmental division,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">subdivision, department, agency, bureau, branch, office, commission, council, court or other</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">tribunal).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.71<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Hatch-Waxman</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Act</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Drug</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Price</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Competition</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Restoration Act, 21 U.S.C. 355, as</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">amended</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.72<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">House Mark</font><font style="font-size:10.5pt;">&#8221; means the trademark that a Party uses to identify its</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">commercial operations.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.73<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">HSR Act</font><font style="font-size:10.5pt;">&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976,</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">as amended, and the rules promulgated</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">thereunder.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.74<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">HSR Conditions</font><font style="font-size:10.5pt;">&#8221; means the following conditions, collectively: (a) the waiting</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">period under</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Act</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">expired</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">earlier</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">terminated;</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">injunction</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(whether</font></p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">temporary, preliminary or permanent) prohibiting consummation of the transaction<font style="letter-spacing:1pt;"> </font>contemplated by this Agreement or any material portion hereof shall be in effect; (c) no judicial<font style="letter-spacing:1.95pt;"> </font>or administrative proceeding opposing consummation of all or any part of this Agreement shall<font style="letter-spacing:2.55pt;"> </font>be pending; and (d) no requirements or conditions shall have been imposed by the United<font style="letter-spacing:2.7pt;"> </font>States Department of Justice or Federal Trade Commission (as applicable) in&nbsp;&nbsp;connection&nbsp;&nbsp;with<font style="letter-spacing:-0.95pt;"> </font>the filings by the Parties under the HSR Act, other than requirements or conditions that<font style="letter-spacing:1.15pt;"> </font>are satisfactory to the Party on whom such requirements or conditions are<font style="letter-spacing:-0.6pt;"> </font>imposed.</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.75<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">HSR</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Filing</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">filings</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">United</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">States</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Federal</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Trade</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Commission</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the Antitrust Division of the United States Department of Justice of a Notification and Report</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Form for Certain Mergers and Acquisitions (as that term is defined in the HSR Act) with respect to</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">the subject matter of this Agreement, together with all required documentary attachments</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">thereto.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.76<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">IFRS</font><font style="font-size:10.5pt;">&#8221; means the International Financial Reporting Standards as promulgated by</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">the International Standards Accounting Board and as they may be updated for time to</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">time.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.77<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">IND</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Investigational</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">New</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Drug</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">application</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">defined</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">FFDCA,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">as amended, and applicable regulations promulgated hereunder by the FDA, or a clinical</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">trial authorization application for a product filed with a Regulatory Authority in any other</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">regulatory jurisdiction</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">outside</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">U.S.,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">commence</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">clinical testing of a pharmaceutical product in humans in such</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">jurisdiction.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.78<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">IND Date</font><font style="font-size:10.5pt;">&#8221; means the date on which ownership of Product INDs is transferred or a</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">right of reference is granted pursuant to Section 9.2(a)(i), in the case of transfers or grants</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx, or pursuant to Section 9.2(b)(i), in the case of transfers to</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Takeda..</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.79<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Indemnifying Party</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">17.3(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.80<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Indemnitee</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">17.3(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.81<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Information</font><font style="font-size:10.5pt;">&#8221; means information, Inventions, discoveries, compounds,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">compositions, formulations, formulas, practices, procedures, processes, methods, knowledge, trade</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">secrets, technology, techniques, designs, drawings, correspondence, computer programs,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">documents, apparatus, results, strategies, regulatory documentation, information and submissions</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">pertaining to,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">association</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">with,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">filings</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">office,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">data, including</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">pharmacological,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">toxicological,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">non-clinical</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">clinical</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">data,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">analytical</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">quality control data, manufacturing data and descriptions, market data, financial data or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">descriptions, devices, assays, chemical formulations, specifications, material, product samples and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">other samples,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">physical,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">chemical</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">biological</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">materials</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">compounds,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">like,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">written, electronic, oral or other tangible or intangible form, now known or hereafter developed,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">whether or not</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">patentable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark3"></a>1.82<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Initial [***] Development Plan</font><font style="font-size:10.5pt;">&#8221; means the plan (including timeline and budget)</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">covering preliminary</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">completed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">(to</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">extent expressly</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">plan)</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">attached</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hereto<font style="letter-spacing:1.85pt;"> </font>as<font style="letter-spacing:1.85pt;"> </font>Exhibit<font style="letter-spacing:1.9pt;"> </font>1.82,<font style="letter-spacing:1.85pt;"> </font>as<font style="letter-spacing:1.85pt;"> </font>such<font style="letter-spacing:1.8pt;"> </font>plan<font style="letter-spacing:1.8pt;"> </font>may<font style="letter-spacing:1.6pt;"> </font>be<font style="letter-spacing:1.9pt;"> </font>amended<font style="letter-spacing:1.85pt;"> </font>from<font style="letter-spacing:1.85pt;"> </font>time<font style="letter-spacing:1.8pt;"> </font>to<font style="letter-spacing:1.85pt;"> </font>time<font style="letter-spacing:1.8pt;"> </font>pursuant<font style="letter-spacing:1.85pt;"> </font>to<font style="letter-spacing:1.85pt;"> </font>Section 2.1(a)(v).</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.83<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Inventions</font><font style="font-size:10.5pt;">&#8221; means any and all inventions, discoveries and developments, whether or</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">not patentable, made, conceived or reduced to practice in the course of performance of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">this Agreement,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">made,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">conceived</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">reduced</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">practice</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">by,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda, Ultragenyx, the Parties jointly, or any Affiliate of the</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">same.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.84<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint Know-How</font><font style="font-size:10.5pt;">&#8221; means all Information included in the Joint</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Inventions.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.85<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint Intellectual Property</font><font style="font-size:10.5pt;">&#8221; means, collectively, Joint Know-How and Joint</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Patents.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.86<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint Invention</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">12.1(b).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.87<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint Patents</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">12.3(c).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.88<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint Research Committee</font><font style="font-size:10.5pt;">&#8221; or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">JRC</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">2.2(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.89<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint Steering Committee</font><font style="font-size:10.5pt;">&#8221; or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">JSC</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">2.1(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.90<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Knowledge</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">means,</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">applied</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">deemed</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">have knowledge</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">particular</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">fact</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">person</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Knowledge Group knew of such fact or other</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">matter.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark4"></a>1.91<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Knowledge Group</font><font style="font-size:10.5pt;">&#8221; means, with respect to each Party, the individuals holding</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the positions listed on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit 1.91</font><font style="font-size:10.5pt;">; provided that if one or more of the individuals listed on</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Exhibit</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.191<font style="letter-spacing:0.65pt;"> </font>no<font style="letter-spacing:0.65pt;"> </font>longer<font style="letter-spacing:0.6pt;"> </font>holds<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>same<font style="letter-spacing:0.6pt;"> </font>position<font style="letter-spacing:0.65pt;"> </font>or<font style="letter-spacing:0.6pt;"> </font>title<font style="letter-spacing:0.6pt;"> </font>set<font style="letter-spacing:0.65pt;"> </font>forth<font style="letter-spacing:0.65pt;"> </font>opposite<font style="letter-spacing:0.6pt;"> </font>his/her<font style="letter-spacing:0.9pt;"> </font>name,<font style="letter-spacing:0.6pt;"> </font>(a)<font style="letter-spacing:0.6pt;"> </font>such<font style="letter-spacing:0.6pt;"> </font>person shall<font style="letter-spacing:0.75pt;"> </font>continue<font style="letter-spacing:0.7pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>be<font style="letter-spacing:0.7pt;"> </font>considered<font style="letter-spacing:0.75pt;"> </font>part<font style="letter-spacing:0.75pt;"> </font>of<font style="letter-spacing:0.7pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>Knowledge<font style="letter-spacing:0.7pt;"> </font>Group,<font style="letter-spacing:0.85pt;"> </font>and<font style="letter-spacing:0.75pt;"> </font>(b)<font style="letter-spacing:0.7pt;"> </font>his/her<font style="letter-spacing:0.7pt;"> </font>replacement<font style="letter-spacing:0.8pt;"> </font>shall also be considered part of the Knowledge<font style="letter-spacing:-0.4pt;"> </font>Group.</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.92<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Labeling</font><font style="font-size:10.5pt;">&#8221; means the healthcare professional information or patient information used</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">in the Territory that is part of the Product Regulatory Approval including the package</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">insert, medication guides, company core safety information (CCSI) and company core data</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">sheet (CCDS).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.93<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Lead Regulatory Party</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">9.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark5"></a>1.94<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">[***]</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Compound</font><font style="font-weight:bold;font-size:10.5pt;">&#8221;</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">[***] as further described on, and with the chemical structure set forth in, </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit 1.94</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.95<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed [***] Know-How</font><font style="font-size:10.5pt;">&#8221; means Information related to the (a) Licensed</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">[***] Compound, Controlled by Takeda as of the Execution Date or during the Term, and/or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(b) Licensed Analog Compound specified in the Agreement Controlled by Takeda as of</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">the Execution Date, in each case including data, reports, and materials related to preclinical</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">studies, regulatory</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">filings/correspondence,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">chemistry,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">manufacturing</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">controls</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reasonably useful for the Exploitation of a Licensed [***] Compound or a Licensed<font style="letter-spacing:-1.1pt;"> </font>Analog Compound.</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.96<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed [***] Patent</font><font style="font-size:10.5pt;">&#8221; means the Patent that is Controlled by Takeda as of the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Execution Date</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">identified</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.168</font><font style="font-size:10.5pt;">,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">by Takeda during the Term that claim priority to such</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Patent.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.97<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">[***]</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">contains</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Licensed [***] Compound, including all forms, presentations, strengths, doses and formulations</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">(including any method of</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">delivery).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.98<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">[***]</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Technology</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Know- How.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark6"></a>1.99<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed Analog Compounds</font><font style="font-size:10.5pt;">&#8221; means (a) the compounds with the chemical</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">structures listed</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.99</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">structures</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">defined</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">by [***]</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">where</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">approved</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">JSC</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">2.1(a)(iii))</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">[***], that are disclosed in the Licensed [***]</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Patent and that are developed pursuant to, and as specified in, a mutually agreed research </font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">plan conducted by Ultragenyx involving modifications to such structures. </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit 1.99 </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">be updated from time to time to include those chemical structures described in the</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">foregoing subclause</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">(b).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.100<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed Analog Product</font><font style="font-size:10.5pt;">&#8221; means any pharmaceutical product that contains a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Licensed Analog Compound, including all forms, presentations, strengths, doses and</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">formulations (including any method of</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">delivery).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.101<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed Field</font><font style="font-size:10.5pt;">&#8221; means [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.102<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed Option Product</font><font style="font-size:10.5pt;">&#8221; means any Option Product for which the Parties</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">have executed an Option Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.103<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed Product</font><font style="font-size:10.5pt;">&#8221; means the Licensed [***] Products and Licensed Analog Products,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">as applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark7"></a>1.104<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed Product Improvement</font><font style="font-size:10.5pt;">&#8221; means any Invention related to the Licensed</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">[***] Compound, Licensed Analog Compounds, or Licensed Products made (a) solely by, or on</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">behalf of,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">sublicensees</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or its</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Agreement.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">clarity,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">employees</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or sublicensees, or their respective agents or independent contractors receiving consideration</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">from Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">sublicensees</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">course</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">conducting</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">this Agreement,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">considered</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">&#8220;solely</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">1.104,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii) neither Takeda nor any of its Affiliates shall, under any circumstances under this<font style="letter-spacing:2.05pt;"> </font>Agreement, be considered an agent or independent contractor of Ultragenyx or any of its Affiliates<font style="letter-spacing:0.1pt;"> </font>or sublicensees for purposes of this Section<font style="letter-spacing:-0.2pt;"> </font>1.104.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.105<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Improvement</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Cover</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Product Improvements that do not claim priority (in accordance with Section 1.129) to the Licensed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">[***] Patent.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.106<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Licensed Product Royalty Term</font><font style="font-size:10.5pt;">&#8221; means, on a country-by-country and Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">Product- by-Licensed Product basis, the period commencing on the First Commercial Sale of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such Licensed Product in such country in the Territory and ending upon the later of (a) ten (10)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">years after First Commercial Sale of such Licensed Product in such country, (b) the expiration in</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">such country</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">last</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Valid</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Claim</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Covers</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">composition,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or method of making or using, such Licensed Product, or (c) the expiration of the</font><font style="font-size:10.5pt;letter-spacing:-1.05pt;"> </font><font style="font-size:10.5pt;">applicable Regulatory Exclusivity of a Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.107<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Listed Compounds</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">6.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.108<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Loss</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">17.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.109<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Marketing Authorization Application</font><font style="font-size:10.5pt;">&#8221; or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">MAA</font><font style="font-size:10.5pt;">&#8221; means an application for</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Regulatory Approval (but excluding Pricing Approval) in any particular jurisdiction other than the</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">U.S.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.110<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Manufacture</font><font style="font-size:10.5pt;">&#8221; means all activities related to the manufacturing of a Finished Product</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or Bulk</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Drug</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">manufacture</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">ingredient</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">used</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">therein,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Development or</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">packaging,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">in-process</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">testing,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">validation, release of Product or any component or ingredient thereof, quality assurance activities related</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">to manufacturing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">release</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">ongoing</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">stability</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">tests,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Packaging</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Bulk</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Drug</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Product into Finished Product and regulatory activities related to any of the</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">foregoing.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.111<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">NDA</font><font style="font-size:10.5pt;">&#8221; means a New Drug Application or supplemental New Drug Application</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as contemplated by Section 505(b) of the FFDCA, as amended, and the regulations</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">promulgated thereunder,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">submitted</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">FDA</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Part</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">314</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Title</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">21</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">U.S.</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Code</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Federal Regulations, including any amendments</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">thereto.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.112<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Net Sales</font><font style="font-size:10.5pt;">&#8221; means, with respect to any Product and calculated in accordance</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">with Accounting</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Standards</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">consistently</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">applied</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">across</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">gross</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">revenue</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">recognized</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a Party, its Affiliates and sublicensees for sales of such Product to Third Parties, less the</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">following deductions, to the extent such deductions are paid, incurred or otherwise taken, reasonable</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">and customary, provided to Third Parties, and actually allowed with respect to such</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">sales:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">cash,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">trade</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">quantity</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">discounts,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">charge-back</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">payments,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">rebates actually</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">trade</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">customers,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">managed</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">health</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">care</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">organizations,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">benefit managers, group purchasing organizations and national, state, or local government;</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">credits, rebates or allowances actually allowed upon prompt payment or</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">on account of claims, damaged goods, rejections or returns of such Product, including in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">connection with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">recalls,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">actual</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">amount</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">write-offs</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">bad</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">debt</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(not</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">exceed</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">percent (1%)) (provided that an amount subsequently recovered will be treated as Net</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Sales)</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">inventory management fees and costs of freight, carrier insurance, and</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">other transportation charges directly related to the distribution of such Product;</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">taxes, duties or other governmental charges (including (i) any tax such as a</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">value added</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">similar</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">tax,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">taxes</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">based</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">income,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">payments</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the Pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Medical</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Device</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agency</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">(&#8220;</font><font style="font-style:italic;font-size:10.5pt;">Kiko</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">based</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">19</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">22</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">&#8220;Act</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on Pharmaceuticals and Medical Devices Agency (Act No.192 of 2002)&#8221;) directly levied on</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or measured by the billing amount for such Product, as adjusted for rebates and</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">refunds.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, amounts received or invoiced by a Party, its Affiliates<font style="letter-spacing:0.15pt;"> </font>or sublicensees<font style="letter-spacing:0.8pt;"> </font>for<font style="letter-spacing:0.55pt;"> </font>the<font style="letter-spacing:0.7pt;"> </font>sale<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.6pt;"> </font>such<font style="letter-spacing:0.6pt;"> </font>Product<font style="letter-spacing:0.65pt;"> </font>among<font style="letter-spacing:0.7pt;"> </font>a<font style="letter-spacing:0.7pt;"> </font>Party,<font style="letter-spacing:0.75pt;"> </font>its<font style="letter-spacing:0.65pt;"> </font>Affiliates<font style="letter-spacing:0.7pt;"> </font>or<font style="letter-spacing:0.6pt;"> </font>sublicensees<font style="letter-spacing:0.85pt;"> </font>for<font style="letter-spacing:0.7pt;"> </font>resale shall<font style="letter-spacing:1.95pt;"> </font>not<font style="letter-spacing:2pt;"> </font>be<font style="letter-spacing:1.9pt;"> </font>included<font style="letter-spacing:1.95pt;"> </font>in<font style="letter-spacing:2pt;"> </font>the<font style="letter-spacing:1.95pt;"> </font>computation<font style="letter-spacing:1.95pt;"> </font>of<font style="letter-spacing:1.9pt;"> </font>Net<font style="letter-spacing:2.1pt;"> </font>Sales<font style="letter-spacing:1.95pt;"> </font>hereunder.<font style="letter-spacing:2.05pt;"> </font>In<font style="letter-spacing:1.95pt;"> </font>any<font style="letter-spacing:1.85pt;"> </font>event,<font style="letter-spacing:2pt;"> </font>any<font style="letter-spacing:1.7pt;"> </font>amounts received or invoiced by a Party, its Affiliates and sublicensees shall be accounted for only<font style="letter-spacing:0.75pt;"> </font>once. For<font style="letter-spacing:0.7pt;"> </font>purposes<font style="letter-spacing:0.75pt;"> </font>of<font style="letter-spacing:0.7pt;"> </font>determining<font style="letter-spacing:0.65pt;"> </font>Net<font style="letter-spacing:0.8pt;"> </font>Sales,<font style="letter-spacing:0.75pt;"> </font>a<font style="letter-spacing:0.7pt;"> </font>Product<font style="letter-spacing:0.8pt;"> </font>shall<font style="letter-spacing:0.75pt;"> </font>be<font style="letter-spacing:0.7pt;"> </font>deemed<font style="letter-spacing:0.75pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>be<font style="letter-spacing:0.85pt;"> </font>sold<font style="letter-spacing:0.8pt;"> </font>when<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>revenue generated from such sale is recognized in accordance with the Accounting Standards. Each<font style="letter-spacing:-0.45pt;"> </font>Party shall record such Net Sales as the &#8220;principal&#8221; and not the &#8220;agent&#8221; as defined under<font style="letter-spacing:0.55pt;"> </font>the Accounting Standards. For clarity, a particular deduction may only be accounted for once in<font style="letter-spacing:1.15pt;"> </font>the calculation of Net Sales and no deductions may be made for the annual fee on prescription<font style="letter-spacing:1.85pt;"> </font>drug manufacturers imposed by the Patient Protection and Affordable Care Act, Pub. <font style="letter-spacing:-0.15pt;">L. </font>No.<font style="letter-spacing:1.25pt;"> </font>111-148 (as amended). Net Sales shall exclude any samples of a Product transferred or disposed of at<font style="letter-spacing:2.8pt;"> </font>no cost for promotional, Development or educational<font style="letter-spacing:-0.4pt;"> </font>purposes.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Net Sales of any Combination<font style="letter-spacing:-0.45pt;"> </font>Product:</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">for which the Product(s) and other active ingredient(s) of</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">such Combination</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">sold</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">separately</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">sublicensees,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in such</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">country,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">then</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Net</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Sales</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Combination</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">country</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">calculated by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">multiplying</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">actual</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Net</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Sales</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Combination</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">country</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">fraction A/(A+B), where A is the average Net Sales price of the Product as the only active</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">ingredient(s), as sold separately by a Party or any of its Affiliates or sublicensees in such country, and B is</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">the average</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">net</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">sales</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">(calculated</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">manner</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">analogous</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">manner</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Net</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Sales</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">are calculated</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">above)</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">price</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">active</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">ingredient(s)</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Combination</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Product as sold separately by a Party or any of its Affiliates or sublicensees in such</font><font style="font-size:10.5pt;letter-spacing:-0.9pt;"> </font><font style="font-size:10.5pt;">country;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(A)</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Combination</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">is/are sold</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">separately</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">sublicensees</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">country</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">(B)</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the other active ingredient(s) in the Combination Product is/are not sold separately by a Party or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any of its Affiliates or sublicensees in such country, then Net Sales for such Combination Product</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">in such country shall be calculated by multiplying actual Net Sales of such Combination Product</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">in such country by the fraction A/D, where A is the average Net Sales price of the Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Product as the only active ingredient(s), as sold separately by a Party or any of its Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or sublicensees in such country, and D is the average Net Sales price of the Combination Product</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as sold separately by a Party or any of its Affiliates or sublicensees in such country;</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">for which neither clause (i) nor clause (ii) above is applicable, the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Parties shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">determine</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Net</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Sales</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Combination</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">country</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">mutual</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">agreement</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">based<font style="letter-spacing:1.05pt;"> </font>on<font style="letter-spacing:1.05pt;"> </font>the<font style="letter-spacing:1.05pt;"> </font>relative<font style="letter-spacing:1.05pt;"> </font>contribution<font style="letter-spacing:1.1pt;"> </font>of<font style="letter-spacing:1.05pt;"> </font>the<font style="letter-spacing:1.05pt;"> </font>Licensed<font style="letter-spacing:1.05pt;"> </font>Product<font style="letter-spacing:1.1pt;"> </font>and<font style="letter-spacing:1.05pt;"> </font>the<font style="letter-spacing:1.05pt;"> </font>other<font style="letter-spacing:0.9pt;"> </font>active<font style="letter-spacing:1pt;"> </font>ingredient(s)<font style="letter-spacing:1.05pt;"> </font>in the Combination<font style="letter-spacing:-0.05pt;"> </font>Product.</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.113<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Neutral Expert</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">16.3(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.114<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Non-breaching Party</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">15.2(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.115<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Notice Date</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">16.3(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.116<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Negotiation Period</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">6.12(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.117<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Notice</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">6.12(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.118<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product</font><font style="font-size:10.5pt;">&#8221; means (a) a Candidate Product selected pursuant to Section 6.10 or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">(b) a [***] Product, as</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark8"></a>1.119<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product Improvements</font><font style="font-size:10.5pt;">&#8221; means any Invention related to a [***] Product or</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">another Research Product made (a) solely by, or on behalf of, Ultragenyx or its Affiliates or</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">sublicensees under this Agreement, or (b) solely by Takeda or its Affiliates under this Agreement. For</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">clarity,</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) employees of Ultragenyx or its Affiliates or sublicensees, or their respective agents<font style="letter-spacing:1.65pt;"> </font>or independent contractors receiving consideration from Ultragenyx or its Affiliates or<font style="letter-spacing:1.5pt;"> </font>sublicensees in the course of conducting activities under this Agreement, shall be considered &#8220;solely by, or<font style="letter-spacing:2.35pt;"> </font>on behalf<font style="letter-spacing:0.85pt;"> </font>of&#8221;<font style="letter-spacing:0.85pt;"> </font>pursuant<font style="letter-spacing:0.9pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>this<font style="letter-spacing:0.9pt;"> </font>Section<font style="letter-spacing:1pt;"> </font>1.119,<font style="letter-spacing:0.75pt;"> </font>and<font style="letter-spacing:0.85pt;"> </font>(ii)<font style="letter-spacing:0.7pt;"> </font>neither<font style="letter-spacing:0.85pt;"> </font>Takeda<font style="letter-spacing:0.85pt;"> </font>nor<font style="letter-spacing:0.85pt;"> </font>any<font style="letter-spacing:0.65pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>its<font style="letter-spacing:0.9pt;"> </font>Affiliates<font style="letter-spacing:0.9pt;"> </font>shall, under any circumstances under this Agreement, be considered an agent or independent<font style="letter-spacing:-0.05pt;"> </font>contractor of Ultragenyx or any of its Affiliates or sublicensees for purposes of this Section<font style="letter-spacing:-0.65pt;"> </font>1.119.</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.120<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product Improvement Patents</font><font style="font-size:10.5pt;">&#8221; means Patents Covering Option</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Product Improvements.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.121<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product Key Terms</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">6.10(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.122<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product Know-How</font><font style="font-size:10.5pt;">&#8221; means all Information Controlled by Takeda as of</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">the Execution Date and during the Term that is necessary or reasonably useful for, as applicable,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">(a) Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">evaluate</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">exercise</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Exploit an</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">performed</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">its Affiliates or sublicensees under the Option Product Research</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Plan.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.123<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product License Agreement</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">6.12(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.124<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Execution Date and during the Term that are necessary or reasonably useful for the Exploitation of</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">the Option Product(s) in the Ultragenyx Field in the</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.125<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product Research Plan</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">6.10(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.126<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product Technology</font><font style="font-size:10.5pt;">&#8221; means the Option Product Patents and Option</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Product Know-How.</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.127<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Packaging</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">preparation</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Bulk</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Drug</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">into Finished Product, including application of the approved Labeling. &#8220;Packaged&#8221; means that</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Bulk Drug Product has been subject to complete</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Packaging.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.128<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Party</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in the</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">preamble.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark9"></a>1.129<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;">&#8221; means all patents, including any utility or design patent, and all</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">applications thereof, including any provisional application, whether in the Territory or any other</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">jurisdiction; any other patent or patent application claiming priority to (a) any such specified patent or</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">patent application</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">application</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">specified</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">patent application claim priority; and (c) all divisionals, continuations, continuations</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">in-part, registrations, reissues, re-examinations, renewals, supplemental protection certificates,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">or extensions of (a) or</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">(b).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.130<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Patent Term Extension</font><font style="font-size:10.5pt;">&#8221; means any term extensions, supplementary</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">protection certificates and equivalents thereof offering Patent protection beyond the initial term with</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">respect to any issued</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Patents.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.131<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Person</font><font style="font-size:10.5pt;">&#8221; means an individual, sole proprietorship, partnership, limited</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">partnership, limited</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">liability</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">partnership,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">corporation,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">limited</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">liability</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">company,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">business</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">trust,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">joint</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">stock company, trust, incorporated association, joint venture or similar entity or </font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">organization, including a government or political subdivision, department or agency of a</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">government.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.132<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Phase I Trial</font><font style="font-size:10.5pt;">&#8221; means a clinical trial of a Product with the endpoint of determining</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">initial tolerance, safety, pharmacokinetic or pharmacodynamic information in single dose,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">single ascending dose, multiple dose and/or multiple ascending dose</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">regimens.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.133<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Phase II Trial</font><font style="font-size:10.5pt;">&#8221; means a clinical trial of a Product on patients, including</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">possibly pharmacokinetic,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">pharmacodynamic</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">dose-ranging</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">studies,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">principal</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">purposes</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">which are</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">preliminary</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">determination</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">safe</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">intended</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to obtain sufficient information about such product&#8217;s efficacy or dose-response information</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to permit the design of further clinical</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">trials.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.134<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Phase</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">III</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Trial</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">pivotal</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">clinical</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">trial</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">sufficient</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">number</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of patients,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">trial</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">designed</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">establish</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">safe</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">efficacious</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">its intended use; (b) define warnings, precautions and adverse reactions that are associated with</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">the product in the dosage range to be prescribed; and (c) pivotal to support submission of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">a Regulatory Approval Application for such</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.135<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Phase</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">IV</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Trial</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">clinical</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">trial</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">pharmacokinetic</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">studies, which</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">trial</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">order</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">obtain</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">indication;</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">(b) either</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">mandatory</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">conducted</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">indication,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">conducted</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">voluntarily</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">enhance</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">marketing</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or scientific</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">knowledge</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">(e.g.,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">providing</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">drug</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">profile,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">outcomes</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">research, safety data or marketing support information, or supporting expansion of product</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">labeling).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.136<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">PMDA</font><font style="font-size:10.5pt;">&#8221; means Japan&#8217;s Pharmaceuticals and Medical Devices Agency and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">any successor agency(ies) or authority having substantially the same</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">function.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark10"></a>1.137<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Preexisting Third Party IP</font><font style="font-size:10.5pt;">&#8221; means those intellectual property rights owned or</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">controlled by Third Parties as of the Execution Date that are necessary or reasonably useful for</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the Exploitation of Licensed Products and which are set forth in </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.137</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.138<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Pricing Approval</font><font style="font-size:10.5pt;">&#8221; means governmental approval, agreement, determination or</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">decision establishing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">prices</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">can</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">charged</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and/or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">reimbursed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">jurisdiction</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">where the applicable Governmental Authority or Regulatory Authority approves or determines</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">the pricing of pharmaceutical</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">products.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.139<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="font-size:10.5pt;">&#8221; means any Licensed [***] Product, Licensed Analog Product, Licensed</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Option Product or Ultragenyx Pipeline Product, as applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.140<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Complaint</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">data,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">come</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">attention</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">its Affiliates or its sub-licensees, concerning any dissatisfaction regarding a Product of such a</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">nature and magnitude that it is required under Applicable Laws to be collected, maintained and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">reported to a Regulatory Authority, including reports of actual or suspected product</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">tampering, contamination, mislabeling or inclusion of improper</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">ingredients.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark11"></a>1.141<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">IND</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">IND</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">filed</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">in existence as of the Effective Date or filed with the FDA during the Term, including</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">any supplements or amendments thereto. The Product INDs as of the Execution Date are set forth</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit 1.141</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.142<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Product Liabilities</font><font style="font-size:10.5pt;">&#8221; means all losses, damages, fees, costs and other liabilities</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">incurred by</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Affiliate</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">sublicensee</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">resulting</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">relating</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">a Compound and/or a Product in a human (including in Clinical Trials and/or pursuant</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">to Commercialization) in the Territory, other than any losses, damages, fees, costs and</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">other liabilities</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">result</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s,</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Affiliates&#8217;</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">sublicensee&#8217;s</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">negligence,</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">willful misconduct</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">representations</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">warranties</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">hereunder.</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the avoidance of doubt, Product Liabilities include, reasonable attorneys&#8217; and experts&#8217; fees and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">costs relating</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">potential</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">against</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Affiliate,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">sublicensee</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">all losses, damages, fees, costs. Product Liabilities shall not include liabilities&nbsp;&nbsp;associated</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">with recalls and/or the voluntary or involuntary withdrawal of the Compound and/or a</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.143<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Promotional</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Materials</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">written,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">printed,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">graphic,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">electronic,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">audio</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">video presentations of information, including journal advertisements, sales visual aids,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">formulary binders, reprints, direct mail, direct-to-consumer advertising, disease awareness</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">materials, internet</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">postings,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">broadcast</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">advertisements</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">sales</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">reminder</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">aides</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(for</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">example,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">note</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">pads, pens and other such items, if appropriate) intended for use or used by or on behalf of a Party,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">its Affiliates or its sublicensees in connection with the Commercialization of a Product in</font><font style="font-size:10.5pt;letter-spacing:-0.9pt;"> </font><font style="font-size:10.5pt;">the Territory.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.144<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Product Regulatory Approval</font><font style="font-size:10.5pt;">&#8221; means any Regulatory Documentation filed in</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the Territory</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Field,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">existence</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the Effective Date or filed with the applicable Regulatory Authority during the Term, including</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any supplements or amendments</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">thereto.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.145<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Product Trademarks</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">5.5(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.146<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">PVA</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">9.8(a)(i).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.147<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Receiving Party</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">14.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.148<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Regulatory Approval</font><font style="font-size:10.5pt;">&#8221; means any approval or authorization, including</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Pricing Approvals, of any Regulatory Authority that is necessary for the Manufacture, use,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">storage, import, transport and/or sale of a Product in accordance with Applicable</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Laws.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.149<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Regulatory Approval Application</font><font style="font-size:10.5pt;">&#8221; means an NDA or BLA, or any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">corresponding application for Regulatory Approval in the Territory, including: (a) with respect to the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">European Union, an MAA filed with the EMA pursuant to the Centralized Approval Procedure or with</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the applicable Regulatory Authority of a country in Europe with respect to the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">decentralized procedure,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">mutual</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">recognition</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">national</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">approval</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">procedure;</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">MAA</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">filed</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">with the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">PMDA,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">including,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">case,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">supplements,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">amendments,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">variations,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">extensions</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and renewals</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">thereof.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.150<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Regulatory Authority</font><font style="font-size:10.5pt;">&#8221; means any applicable Governmental Authority involved</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">in granting Regulatory Approval in a country or jurisdiction in the Territory, including in the</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">U.S., the FDA and any other applicable Governmental Authority in the U.S. having jurisdiction over</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">a Product;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">EU,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">EMA</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">competent</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Government</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">EU;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Japan,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the PMDA; and any other applicable Governmental Authority having jurisdiction over a</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.151<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Regulatory Documentation</font><font style="font-size:10.5pt;">&#8221; means, with respect to each Research Product or</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Licensed Product,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">all:</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Materials,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">contained</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">therein</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">supporting documents</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">created</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">for,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">submitted</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">received</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">governmental</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">agency</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">or Regulatory Authority relating to such Regulatory Materials; and (b) other documentation</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">or Information</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">useful</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">order</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Exploit such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">registrations</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">licenses, regulatory drug lists, advertising and promotion documents shared with Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Authorities, adverse event files, complaint files and Manufacturing</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">records.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.152<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Regulatory Exclusivity</font><font style="font-size:10.5pt;">&#8221; means any exclusive marketing rights or data protection </font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">or other</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">exclusivity</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">conferred</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">a country or jurisdiction in the Territory, other than a Patent right, including orphan</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">drug exclusivity,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">pediatric</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">exclusivity,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">conferred</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">U.S.</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Hatch</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Waxman</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Act,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in the EU under Directive 2001/83/EC, as amended, and Regulation (EC) No. 1901/2006,</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">as amended,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Biologics</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Price</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Competition</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Act</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Patient</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Protection</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">&amp; Affordable Care Act, or rights similar thereto in other countries or regulatory jurisdictions in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the Territory.</font></p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.153<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Regulatory Materials</font><font style="font-size:10.5pt;">&#8221; means, with respect to each Product, all</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">documentation, correspondence, submissions and notifications submitted to or received from a</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Regulatory Authority that are necessary or reasonably useful in order to Exploit such Product in</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">the applicable field in the Territory. For the avoidance of doubt, Regulatory Materials shall</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">include, with respect to each Product, all INDs, Regulatory Approval Applications,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Regulatory Approvals,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Pricing</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Approvals</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">amendments</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">supplements</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">foregoing,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">as well as the contents of any minutes from meetings (whether in person or by audio conference</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">or videoconference) with a Regulatory</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Authority.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.154<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Representative Expert</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">16.3(b).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.155<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Research Materials</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">6.6(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.156<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Research Plan</font><font style="font-size:10.5pt;">&#8221; means a [***] Research Plan or Option Product Research Plan,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">as applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.157<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Research Product</font><font style="font-size:10.5pt;">&#8221; means a [***] Product, Candidate Product or Option Product,</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">as applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.158<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Research Support</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">7.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.159<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Senior</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Officer</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Head</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">&amp;</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">his</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">her</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">designee,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">in the</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Chief</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Executive</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Officer</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">his</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">her</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">designee,</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of Ultragenyx.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.160<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda [***] License</font><font style="font-size:10.5pt;">&#8221; means the licenses granted to Takeda in Section</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">3.2.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.161<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Field</font><font style="font-size:10.5pt;">&#8221; means [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.162<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Indemnitee</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">17.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.163<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Option</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">8.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.164<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Option Field</font><font style="font-size:10.5pt;">&#8221; means all human indications other than the Takeda Field</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">for Licensed [***] Products, and all human indications for Licensed Analog Products,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Licensed Option Products and Ultragenyx Pipeline</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Products.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.165<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Option Negotiation Period</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">8.2(d).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.166<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Option Notice</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">8.2(c).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.167<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Option Term</font><font style="font-size:10.5pt;">&#8221; means the period beginning on the Effective Date and ending</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">on the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">earlier</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">[***] Product, Licensed Analog Product, Licensed Option Product, or Ultragenyx Pipeline Product,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">as</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the case may be: (i) [***] after Takeda&#8217;s receipt of the applicable<font style="letter-spacing:2.55pt;"> </font>Final Phase<font style="letter-spacing:1.9pt;"> </font>II<font style="letter-spacing:1.65pt;"> </font>Data<font style="letter-spacing:1.8pt;"> </font>Package<font style="letter-spacing:1.8pt;"> </font>for<font style="letter-spacing:1.8pt;"> </font>the<font style="letter-spacing:1.8pt;"> </font>applicable<font style="letter-spacing:1.95pt;"> </font>Licensed<font style="letter-spacing:1.85pt;"> </font>[***]<font style="letter-spacing:1.85pt;"> </font>Product,<font style="letter-spacing:2pt;"> </font>Licensed<font style="letter-spacing:1.85pt;"> </font>Analog<font style="letter-spacing:1.75pt;"> </font>Product<font style="letter-spacing:1.85pt;"> </font>or Licensed Option Product, (ii) [***] after Takeda&#8217;s receipt of the<font style="letter-spacing:2.2pt;"> </font>Final Phase II Data Package (or Final Phase III Data Package in the case of [***]) for the<font style="letter-spacing:1pt;"> </font>applicable Ultragenyx<font style="letter-spacing:0.7pt;"> </font>Pipeline<font style="letter-spacing:0.65pt;"> </font>Product<font style="letter-spacing:0.6pt;"> </font>(other<font style="letter-spacing:0.65pt;"> </font>than<font style="letter-spacing:0.65pt;"> </font>[***])<font style="letter-spacing:0.65pt;"> </font>and<font style="letter-spacing:0.7pt;"> </font>(iii)<font style="letter-spacing:0.55pt;"> </font>[***]<font style="letter-spacing:0.65pt;"> </font>after<font style="letter-spacing:0.6pt;"> </font>Takeda&#8217;s<font style="letter-spacing:0.65pt;"> </font>receipt<font style="letter-spacing:0.6pt;"> </font>of the Final Phase II Data Package for [***]. Notwithstanding the foregoing, (a) in the event of<font style="letter-spacing:0.15pt;"> </font>a [***]<font style="letter-spacing:1.3pt;"> </font>of<font style="letter-spacing:1.25pt;"> </font>Ultragenyx<font style="letter-spacing:1.4pt;"> </font>[***],<font style="letter-spacing:2.5pt;"> </font>the<font style="letter-spacing:2.5pt;"> </font>Takeda<font style="letter-spacing:2.45pt;"> </font>Option<font style="letter-spacing:2.5pt;"> </font>Term<font style="letter-spacing:2.5pt;"> </font>will<font style="letter-spacing:2.55pt;"> </font>expire<font style="letter-spacing:2.45pt;"> </font>with<font style="letter-spacing:2.5pt;"> </font>respect<font style="letter-spacing:2.55pt;"> </font>to<font style="letter-spacing:2.55pt;"> </font>all<font style="letter-spacing:2.55pt;"> </font>applicable<font style="letter-spacing:2.5pt;"> </font>products<font style="letter-spacing:2.55pt;"> </font>(i.e.,<font style="letter-spacing:2.5pt;"> </font>any Licensed [***] Product, Licensed Analog Product, Licensed Option Product, or<font style="letter-spacing:2pt;"> </font>Ultragenyx Pipeline Product) [***]; and (b) in<font style="letter-spacing:1.3pt;"> </font>the event of a [***] of Ultragenyx at any time [***],<font style="letter-spacing:1.4pt;"> </font>the<font style="letter-spacing:1.4pt;"> </font>Takeda<font style="letter-spacing:1.4pt;"> </font>Option<font style="letter-spacing:1.45pt;"> </font>Term<font style="letter-spacing:1.4pt;"> </font>will<font style="letter-spacing:1.45pt;"> </font>expire with respect to all applicable products (i.e., any Licensed [***] Product, Licensed Analog<font style="letter-spacing:0.9pt;"> </font>Product, Licensed<font style="letter-spacing:0.95pt;"> </font>Option<font style="letter-spacing:1pt;"> </font>Product,<font style="letter-spacing:1pt;"> </font>or<font style="letter-spacing:0.95pt;"> </font>Ultragenyx<font style="letter-spacing:1.1pt;"> </font>Pipeline<font style="letter-spacing:1.1pt;"> </font>Product)<font style="letter-spacing:1pt;"> </font>[***]<font style="letter-spacing:1pt;"> </font>after<font style="letter-spacing:0.95pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>closing<font style="letter-spacing:0.85pt;"> </font>of such [***].</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark12"></a>1.168<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">claims</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">priority</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(in accordance with Section 1.129) to the Licensed [***] Patent during the Term, and the</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Pipeline</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Improvement</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates.</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of the Execution Date are set forth on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.168</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.169<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Product Infringement</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">12.6(b)(i).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.170<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda ROFN Territory</font><font style="font-size:10.5pt;">&#8221; means</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Japan.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.171<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Royalty Term</font><font style="font-size:10.5pt;">&#8221; means, on a country-by-country and Exercised</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product-by- Exercised Product basis, the period commencing on the First Commercial Sale of such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Exercised Product in a country in the Takeda Territory by Takeda, its Affiliates, or sublicensees that</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">occurs after Takeda&#8217;s exercise of the Takeda Option and ending upon the later of (a) ten (10) years</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">after First Commercial Sale of such Exercised Product, (b) the expiration of the last Valid Claim</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">that Covers the composition, or method of making or using, such Exercised Product and issued</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">from the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">following,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">particular</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Product:</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">(ii) Option Product Patent that Covers a Licensed Option Product that is subject to an active</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Option Product License Agreement or (iii) Ultragenyx Pipeline Patent that Covers an</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Pipeline Product, or (c) the expiration of the applicable Regulatory Exclusivity for</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">such Exercised</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.172<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Territory</font><font style="font-size:10.5pt;">&#8221; means, (i) with respect to Licensed Products and Licensed</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Option Products, Japan and Asia and (ii) with respect Ultragenyx Pipeline Products,</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Japan.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.173<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Tax Conditions</font><font style="font-size:10.5pt;">&#8221; means, with respect to the premium being paid by Takeda</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx under the Common Stock Purchase Agreement, Ultragenyx&#8217;s confirmation of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">receipt of the tax residence certificate (IRS Form 6166) from the U.S. Internal Revenue</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Service specified</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">11.11(c)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">appropriate</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">submission</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">certificate</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">forms and information with the Osaka Regional Taxation</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Bureau.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.174<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Term</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">15.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.175<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Terminated Product</font><font style="font-size:10.5pt;">&#8221; means any: (a) Option Product for which an Option</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product License</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">executed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Negotiation</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Period</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">accordance with Section 6.12(a); (b) Research Product terminated pursuant to Section 6.7(d) or 18.5;</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">(c) Licensed</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">reverts</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Section 4.3(f); or (d) Licensed Product or Research Product terminated pursuant to Section 15.2, 15.4</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">or 15.5.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.176<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;">&#8221; means worldwide.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.177<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Third</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Party</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Person</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">their</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">respective Affiliates.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.178<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx [***] Know-How</font><font style="font-size:10.5pt;">&#8221; means all Information related to the Licensed</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">[***] Compound Controlled by Ultragenyx during the</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Term.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.179<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx [***] License</font><font style="font-size:10.5pt;">&#8221; means the licenses granted to Ultragenyx in Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">3.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.180<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx [***] Patents</font><font style="font-size:10.5pt;">&#8221; means all Patents Controlled by Ultragenyx or its Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">as of the Execution Date or during the Term that are necessary or reasonably useful for</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">the Exploitation</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Analog</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Licensed Field in the Territory, but expressly excluding any Licensed Product Improvement Patents.</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">The Ultragenyx [***] Patents as of the Execution Date are set forth on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.188</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.181<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">[***]</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Technology</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">[***] Know-How.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.182<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Field</font><font style="font-size:10.5pt;">&#8221; means the Licensed Field, excluding the Takeda</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Field.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.183<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx In-License Agreement</font><font style="font-size:10.5pt;">&#8221; means [***] and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">(g)</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">any other applicable agreement between Ultragenyx (or its Affiliates) and a Third Party under</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">which Takeda is granted a sublicense or other right under this</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.184<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Indemnitee</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">17.2.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.185<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Know-How</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Information</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the Term that is necessary or reasonably useful to Exploit a Compound or a Product in the</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Licensed Field.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.186<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Intellectual Property</font><font style="font-size:10.5pt;">&#8221; means, collectively, Ultragenyx Know-How</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Patents.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.187<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Option</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">6.11.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark13"></a>1.188<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Patents</font><font style="font-size:10.5pt;">&#8221; means all Ultragenyx [***] Patents, Licensed Product</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Improvement Patents Controlled by Ultragenyx or its Affiliates, Option Product Improvement</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Patents Controlled by Ultragenyx or its Affiliates and Ultragenyx Pipeline Patents. The</font><font style="font-size:10.5pt;letter-spacing:-1.1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Patents as of the Execution Date are set forth on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.188</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.189<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Pipeline Compound</font><font style="font-size:10.5pt;">&#8221; means the active ingredient in an Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Pipeline Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark14"></a>1.190<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Pipeline Improvements</font><font style="font-size:10.5pt;">&#8221; means any Invention related to an</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">by,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">sublicensees under this Agreement or (b) solely by Ultragenyx or its Affiliates under this Agreement.</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">For clarity,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">employees</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">sublicensees,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">their</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">respective</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">agents</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or independent contractors receiving consideration from Takeda or its Affiliates or sublicensees</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">in the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">course</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">conducting</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">considered</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">&#8220;solely</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">by,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">on behalf</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">1.190,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">neither</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">nor</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Affiliates shall,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">circumstances</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">considered</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">agent</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">independent contractor of Takeda or any of its Affiliates or sublicensees for purposes of this Section</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">1.190.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark15"></a>1.191<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Pipeline Improvement Patents</font><font style="font-size:10.5pt;">&#8221; means Patents that Cover</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Pipeline Improvements.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.192<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Pipeline Patents</font><font style="font-size:10.5pt;">&#8221; means all Patents Controlled by Ultragenyx as of</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">the Execution Date and during the Term that: (a) claim the composition of matter of, or the</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">method of making or using an Ultragenyx Pipeline Product; or (b) are otherwise necessary or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">reasonably useful to Exploit an Ultragenyx Pipeline Product in the Licensed Field. The Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Pipeline Patents for the Takeda Territory as of the Execution Date are set forth on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.188</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark16"></a>1.193<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Pipeline Products</font><font style="font-size:10.5pt;">&#8221; means all products that have entered into Clinical</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Trials and are Controlled by Ultragenyx or its Affiliates during the Collaboration Term and</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">that Ultragenyx or its Affiliates have rights to Commercialize in the Takeda ROFN</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Territory, [***].</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">purposes</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">this Section 1.193, &#8220;Controlled&#8221; shall not include [***]</font></p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***].</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.194<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Product Infringement</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">12.6(b)(i).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark17"></a>1.195<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">UX[***]</font><font style="font-size:10.5pt;">&#8221; means the compound having Ultragenyx reference number UX[***] as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">further described on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.195</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.196<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">UX[***]</font><font style="font-size:10.5pt;">&#8221; means the compound having Ultragenyx reference number UX[***] as</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">further described on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.195</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.197<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">UX[***]</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">compound</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">having</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">reference</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">number</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">UX[***]</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">further described on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.195</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.198<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">UX[***]</font><font style="font-size:10.5pt;">&#8221; means the compound having Ultragenyx reference number UX[***] as</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">further described on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.195</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.199<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">UX[***]</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">compound</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">having</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">reference</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">number</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">UX[***]</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">further described on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.195</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.200<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Valid</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Claim</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">means</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">issued</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">unexpired</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">included</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the Takeda Patents, the Ultragenyx Patents or the Joint Patents, to the extent such claim has not</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">been revoked, held invalid or unenforceable by a patent office, court or other governmental agency</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of competent</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">jurisdiction</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">order,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">further</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">appeal</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">can</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">taken,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">which claim has not been disclaimed, denied or admitted to be invalid or unenforceable through</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">reissue, re-examination or</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">disclaimer.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.201<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Validation Research Plan</font><font style="font-size:10.5pt;">&#8221; has the meaning set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">6.2(b).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:26.03%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark18"></a>ARTICLE 2&nbsp;&nbsp;&#8211; OVERVIEW;<font style="letter-spacing:-0.55pt;"> </font>MANAGEMENT</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">Joint Steering Committee for Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Products.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark19"></a>(a)<font style="margin-left:45pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Formation and Purpose</font><font style="font-size:10.5pt;">. Within thirty (30) days after the Effective Date,</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">the Parties</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">promptly</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">establish</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">convene</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Steering</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Steering</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;">&#8221; or &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">JSC</font><font style="font-size:10.5pt;">&#8221;) in accordance with Section 2.3(c)(i) that will direct and oversee</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">activities relating to the Licensed Products under this Agreement. The JSC shall consist of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">representatives and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">operate</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">procedures</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">2.3.</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">Except</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">provided herein, the role of the Joint Steering Committee shall</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">be:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.86%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:45pt;"></font><font style="font-size:10.5pt;">to encourage and facilitate ongoing communication and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">cooperation between</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Exploitation</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the Licensed Field;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to serve as a forum for sharing discoveries and exchanging data and</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">results generated by each Party relating to additional compounds Covered by the Licensed [***]</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">Patent;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark20"></a>(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to evaluate and approve the inclusion as Licensed Analog Compounds of additional</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">compounds</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Covered</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">do</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">meet</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the definition of Licensed Analog Compounds [***];</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark21"></a>(iv)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to evaluate and approve the exclusion from the definition of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Licensed Analog</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Compounds</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">compounds</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Covered</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">[***];</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark22"></a>(v)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to review and discuss [***] Development Plans and any</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">proposed amendments or revisions to the [***] Development</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Plans;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vi)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to review and discuss Commercialization Plans including the review</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and discussion of any amendments to such Commercialization</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Plans;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to review and discuss Licensed Product regulatory issues, including</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">those raised</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">joint</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">regulatory</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">affairs</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">working</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">group</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">established</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">2.1(a)(viii) and Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">9.4(a);</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(viii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">establish</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">working</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">groups</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">subcommittees,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">needed</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to further</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">purposes</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">relating</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">mutually</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">agreed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the Parties in</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">writing;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:15.29%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ix)<font style="margin-left:117pt;"></font><font style="font-size:10.5pt;">to resolve any disputes referred to the JSC;</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:15.29%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(x)<font style="margin-left:117pt;"></font><font style="font-size:10.5pt;">to approve or decide such other matters as provided in this</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.71%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark23"></a><font style="font-size:10.5pt;font-weight:bold;">JSC Decisions; Final Decision</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Authority.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">The JSC will make good faith efforts to make all decisions by</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">consensus. Except as set forth in Section 2.1(b)(ii), actions to be taken by the Joint Steering Committee</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">shall be</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">taken</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">unanimous</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">vote,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">representatives</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">collectively</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">having one</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">(1)</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">vote.</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Steering</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">fails</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">reach</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">unanimous</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">matter before</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">excess</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">fifteen</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(15)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">presented</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">JSC</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">writing,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">submit</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">resolution</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Senior</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Officers</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">attempted</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">resolution</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">negotiation</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">thirty</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(30)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such notice is received by the Senior</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Officers.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark24"></a>(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">If the Senior Officers of the Parties are unable to resolve such</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">dispute within</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">thirty</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">(30)</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">day</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">period,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">dispute</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">resolved</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">follows. For the avoidance of doubt, the right of a Party to make final decisions with respect to any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">issue</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shall not otherwise diminish or eliminate such Party&#8217;s obligations under this<font style="letter-spacing:0.5pt;"> </font>Agreement, including its obligation to exercise Commercially Reasonable Efforts where required<font style="letter-spacing:-0.45pt;"> </font>herein.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(A)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Subject to Sections 2.1(b)(ii)(D) and 2.1(b)(ii)(E) and</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">provided that such decision does not result in an increase in the scope of work or costs associated</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">with the performance of any activities by Takeda under this Agreement, Ultragenyx will have</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">final decision</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">over</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">[***];</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(B)<font style="margin-left:171pt;"></font><font style="font-size:10.5pt;">Takeda will have final decision making authority over</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(C)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Takeda will have final decision making authority over</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark25"></a>(D)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">exercises</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Option Term</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">co-Development</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">co-Commercialization</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the Takeda Field in the Territory, Takeda will have final decision making authority over</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark26"></a>(E)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">does</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">exercise</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">[***] Option Term for the co-Development and co-Commercialization of Licensed [***] Products</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">in the</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">continue</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">making authority over [***],</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">continue</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">over [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(F)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Takeda shall have final decision making authority over</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">[***];</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(G)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall have final decision making authority</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">over [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Neither Party shall have the final decision making authority for any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">other matter under the purview of the JSC and not covered by subsections (A)-(G), and the status</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">quo shall persist with respect to such matter if the Parties are unable to agree. For clarity, the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Parties anticipate</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">governed</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">separate committees</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">established</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">applicable Option Product License Agreement or Exercised Product License Agreement,</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">respectively.</font></p>
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Discontinuation of JSC. </font><font style="font-size:10.5pt;">Upon the second (2<sup style="font-size:85%; vertical-align:top">nd</sup>) anniversary of the Effective Date or any time thereafter, Ultragenyx shall have the right, upon written notice to Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font></p>
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:9.71%;margin-right:1.24%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">discontinue<font style="letter-spacing:0.95pt;"> </font>its<font style="letter-spacing:1pt;"> </font>participation<font style="letter-spacing:1pt;"> </font>in<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:0.95pt;"> </font>JSC.<font style="letter-spacing:2.05pt;"> </font>Once<font style="letter-spacing:0.95pt;"> </font>Ultragenyx<font style="letter-spacing:1.15pt;"> </font>has<font style="letter-spacing:1pt;"> </font>provided<font style="letter-spacing:1.05pt;"> </font>such<font style="letter-spacing:1pt;"> </font>notice<font style="letter-spacing:0.95pt;"> </font>to<font style="letter-spacing:1.1pt;"> </font>Takeda, the JSC shall have no further obligations under this Agreement and, thereafter, Takeda shall<font style="letter-spacing:0.15pt;"> </font>have final decision making authority with respect to the topics that were otherwise determined by<font style="letter-spacing:1.2pt;"> </font>the JSC, subject to the other terms and conditions of this<font style="letter-spacing:-0.5pt;"> </font>Agreement.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2.2</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Joint Research Committee for Collaboration</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Activities</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark27"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Formation and Purpose</font><font style="font-size:10.5pt;">. Within thirty (30) days after the Effective Date, the Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">promptly</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">establish</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">convene</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Research</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;">&#8221;</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">JRC</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">2.3(c)(i)</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">overall</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">coordination</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">and oversight of the Collaboration Activities.&nbsp;&nbsp;The JRC shall consist of representatives and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">operate by the procedures in accordance with Section 2.3. Except as otherwise provided herein, the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Joint Research Committee shall be responsible for supporting the [***] in assessing, prioritizing, and advancing Takeda&#8217;s rare genetic disease</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">products, including the following specific activities (collectively, &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Collaboration</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Activities</font><font style="font-size:10.5pt;">&#8221;):</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">review and approve the Validation Research Plan and any amendments thereto;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.15%;margin-right:1.24%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">review and approve the Option Product Research Plans and any amendments thereto;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">review and approve any amendments to the [***] Research Plan;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">evaluate and prioritize [***];</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-right:1.24%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(v)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">support the overall direction of Candidate Product and Option Product strategy;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vi)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">identify, define, and support collaborations with key experts and investigators and other third parties in support of the prioritized Candidate Products, Option Products and related indications;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.15%;margin-right:1.24%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">identify and implement opportunities [***];</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.15%;margin-right:1.24%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(viii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">determine the [***]; and</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.15%;margin-right:1.24%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ix)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">oversee and manage the secondee program provided for in Section 2.6.</font></p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Termination of Responsibilities. </font><font style="font-size:10.5pt;">Upon execution of an Option Product</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">License Agreement for an Option Product, the JRC will no longer have any responsibility&nbsp;&nbsp;over</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">or decision making authority relating to such Option</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-right:1.03%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.71%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">JRC Decisions; Final Decision</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Authority</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">JRC</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">efforts</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">decisions</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">consensus Except</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">2.2(c)(ii),</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">actions</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">taken</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Committee shall</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">taken</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">unanimous</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">vote,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">representatives</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">collectively having one (1) vote. If the Joint Research Committee fails to reach unanimous agreement on</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">a matter</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">excess</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">fifteen</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">(15)</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">first presented to the JRC in writing, either Party may submit such matter for resolution to the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Senior Officers of the Parties for attempted resolution by good faith negotiation within thirty (30)</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">days after such notice is received among the Senior</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Officers.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark28"></a>(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">If the Senior Officers of the Parties are unable to resolve such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">dispute within such thirty (30) day period, such dispute shall be resolved during the Collaboration</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Term as follows. For the avoidance of doubt, the right of a Party to make final decisions with </font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">respect to any issue shall not otherwise diminish or eliminate such Party&#8217;s obligations under</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">this Agreement, including its obligation to exercise Commercially Reasonable Efforts where</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">required herein.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(A)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Ultragenyx will have final decision making authority</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">over [***];</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.24%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(B)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">The Parties must mutually agree on the scope of</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Research Support</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Takeda.</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">unable</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">unanimously</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">agree</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the scope of the Research Support to be provided, then no Research Support shall be</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">provided;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(C)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Takeda will have final decision making authority over</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">[***];</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.07%;margin-right:1.03%;text-indent:22.31%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(D)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Neither Party shall have the final decision making authority for any</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">purview</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">JRC</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">covered</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">subsections</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(A)-(C),</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and the status quo shall persist with respect to such matter if the Parties are unable to agree.</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">For clarity,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">anticipate</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">governed</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">separate committee and final decision making authority to be established pursuant to the</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">Option Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2.3</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark29"></a><font style="font-size:10.5pt;font-weight:bold;">Committee Membership and</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Procedures</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark30"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Membership. </font><font style="font-size:10.5pt;">Takeda and Ultragenyx shall each designate an equal number</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of representatives to serve on the JSC and the JRC (each, a &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;">&#8221;) by written notices to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the other Party. Promptly after the Effective Date, each Party shall designate three</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(3)</font></p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">representatives for the JSC and three (3) representatives for the JRC. Each Committee may<font style="letter-spacing:1.8pt;"> </font>elect to<font style="letter-spacing:1.65pt;"> </font>vary<font style="letter-spacing:1.4pt;"> </font>the<font style="letter-spacing:1.75pt;"> </font>number<font style="letter-spacing:1.7pt;"> </font>of<font style="letter-spacing:1.6pt;"> </font>representatives<font style="letter-spacing:1.65pt;"> </font>from<font style="letter-spacing:1.8pt;"> </font>time<font style="letter-spacing:1.6pt;"> </font>to<font style="letter-spacing:1.65pt;"> </font>time<font style="letter-spacing:1.6pt;"> </font>during<font style="letter-spacing:1.5pt;"> </font>the<font style="letter-spacing:1.75pt;"> </font>Term;<font style="letter-spacing:1.7pt;"> </font>provided<font style="letter-spacing:1.6pt;"> </font>that<font style="letter-spacing:1.65pt;"> </font>each Committee shall maintain an equal number of representatives from each Party.<font style="letter-spacing:2.5pt;"> </font>Each representative shall have the appropriate level of experience in the subject area of <font style="letter-spacing:1.3pt;"> </font>the Committee, and at least one (1) representative shall have sufficient seniority within<font style="letter-spacing:2.5pt;"> </font>the applicable Party&#8217;s organization to have the necessary decision-making authority in order for<font style="letter-spacing:1.85pt;"> </font>the Committee to fulfill its responsibilities. Either Party may designate substitutes for its<font style="letter-spacing:0.55pt;"> </font>Committee representatives if one (1) or more of such Party&#8217;s designated representatives is unable to<font style="letter-spacing:2.95pt;"> </font>be present at a meeting. From time to time each Party may replace its Committee representatives<font style="letter-spacing:-0.5pt;"> </font>by written notice to the other Party specifying the prior representative(s) and their<font style="letter-spacing:-0.75pt;"> </font>replacement(s).</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:85pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Chairperson</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">two</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">chairpersons,</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">designated</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">by each</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Parties.</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">chairpersons</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">calling</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">convening</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">meetings, but</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">special</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">over</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">members</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Committee,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">no additional voting rights. The chairpersons (or their designates) shall jointly: (i) prepare</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and circulate an agenda reasonably in advance of each upcoming meeting; and (ii) prepare and</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">issue minutes of each Committee meeting within thirty (30) days thereafter. Such minutes shall not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be finalized</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">until</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">representative</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">reviews</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">approves</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">minutes</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">writing; provided that any minutes shall be deemed approved unless a member of such Committee</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">objects to the accuracy of such minutes within fifteen (15) days after the circulation of the</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">minutes.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.71%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Meetings</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark31"></a>(i)<font style="margin-left:119pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Committee</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Meetings.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">meet</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">least</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">once</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">each Calendar Quarter. Additional meetings of the Committees may be held with the consent of</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">each Party (such consent not to be unreasonably withheld, conditioned or delayed), as required</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">under this</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agreement.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">dispute</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">referred</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Committee,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">meeting</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">held within</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">five</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">(5)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Business</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Days</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">referral</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Committee,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">soon</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">reasonably possible.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-weight:bold;font-size:10.5pt;">General Requirements. </font><font style="font-size:10.5pt;">Meetings of a Committee shall be effective</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">only if a majority of representatives of each Party are present or participating. Other than the</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">initial meeting,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">held</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">person,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">meet</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(A)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">person</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">either Party&#8217;s facilities or at such locations as the Parties may otherwise agree; or (B) by audio or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">video teleconference. Additional non-members of a Committee having relevant experience may</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">from time</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">invited</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">participate</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">meeting,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">participants shall have no voting rights or powers. Non-member participants who are not employees of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a Party or its Affiliates shall only be allowed to attend if: (i) the other Party&#8217;s representatives</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">have consented to the attendance (such consent not to be unreasonably withheld, conditioned</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or delayed); and (ii) such non-member participant is subject to confidentiality and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">non-use obligations at least as restrictive as those set forth in this Agreement. Each Party shall</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">be responsible for all of its own expenses incurred in connection with participating in</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">the Committees</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">travel</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">associated</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">initial</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">alliance</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">kick-off meeting.</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">All</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">incurred</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">furtherance</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">meeting,</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">as expenses associated with off-site meetings, shall be shared equally by the</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Parties.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Alliance Managers</font><font style="font-size:10.5pt;">.&nbsp;&nbsp;Promptly following the Effective Date, each Party shall </font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">designate in writing an Alliance Manager to serve as the primary point of contact for the Parties</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">regarding all collaboration and transition activities contemplated under this Agreement. Each</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Alliance Manager</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">facilitate</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">communication</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">coordination</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Parties&#8217;</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">this Agreement relating to the Products and shall plan the Committee meetings. The</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Alliance Managers shall be allowed to attend Committee meetings as non-voting</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">observers.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;">. The Parties agree that, in voting on matters as described in this ARTICLE </font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">2, it shall be conclusively presumed that unless otherwise explicitly stated, each voting member </font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of a Committee has the authority and approval of such member&#8217;s respective senior management</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in casting</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">his</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">her</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">vote.</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Committee</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">powers</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">assigned</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">expressly</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in this</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">2</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">elsewhere</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">power</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">amend, modify or waive compliance with this</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark32"></a>2.6<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Takeda Secondee. </font><font style="font-size:10.5pt;">Takeda shall have the right, at its own expense, to place </font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">one employee of Takeda or its Affiliates, who is reasonably acceptable to Ultragenyx, as a</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">secondee with</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Collaboration</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Term;</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">secondee</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall enter into a confidentiality agreement with Ultragenyx prior to placement. Takeda may, one</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or more</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">times</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Collaboration</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">substitute</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">employee</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">another</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">employee</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of Takeda or its</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Affiliates.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark33"></a>ARTICLE 3&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>LICENSES FOR [***] AND<font style="letter-spacing:-0.1pt;"> </font>ANALOGS</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark34"></a>3.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Licenses from Takeda to Ultragenyx. </font><font style="font-size:10.5pt;">Subject to the terms and conditions of</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">this Agreement, Takeda hereby grants to Ultragenyx in the Territory during the</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Term:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark35"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">an exclusive (even as to Takeda and its Affiliates, subject to the retention of</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">rights to conduct activities under the [***] Development Plan) license, with the right to grant</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">sublicenses solely</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">3.3,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Technology,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product Improvements</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Improvement</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Patents Controlled by Takeda or its Affiliates, and Joint Intellectual Property to Exploit the Licensed</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">[***] Products in the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Field;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:81pt;"></font><font style="font-size:10.5pt;">a co-exclusive license, without the right to grant sublicenses, under the</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Licensed</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***] Technology, Licensed Product Improvements Controlled by Takeda or its<font style="letter-spacing:1.65pt;"> </font>Affiliates, Licensed Product Improvement Patents Controlled by Takeda or its Affiliates, and<font style="letter-spacing:0.4pt;"> </font>Joint Intellectual Property to conduct activities under the [***] Development Plan in the Takeda Field<font style="letter-spacing:-0.2pt;"> </font>in the Territory;<font style="letter-spacing:-0.4pt;"> </font>and</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark36"></a>(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">exclusive</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(even</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Affiliates)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">license,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to grant</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">sublicenses</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">3.3,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Technology, Licensed Product Improvements Controlled by Takeda or its Affiliates, Licensed</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Product Improvement Patents Controlled by Takeda or its Affiliates, and Joint Intellectual Property</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">to Exploit the Licensed Analog Compounds and Licensed Analog Products in the Licensed Field</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">in the Territory; provided, however, that, notwithstanding the licenses granted in this </font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Section 3.1(c),</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">not,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(i)</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">directly<font style="letter-spacing:1.1pt;"> </font>or<font style="letter-spacing:1.3pt;"> </font>indirectly<font style="letter-spacing:1pt;"> </font>Exploit<font style="letter-spacing:1.4pt;"> </font>any<font style="letter-spacing:1.1pt;"> </font>Licensed<font style="letter-spacing:1.3pt;"> </font>Analog<font style="letter-spacing:1.25pt;"> </font>Product<font style="letter-spacing:1.4pt;"> </font>in<font style="letter-spacing:1.4pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>Takeda<font style="letter-spacing:1.3pt;"> </font>Field<font style="letter-spacing:1.35pt;"> </font>or<font style="letter-spacing:1.3pt;"> </font>(ii)<font style="letter-spacing:1.35pt;"> </font>license, authorize,<font style="letter-spacing:1.85pt;"> </font>appoint,<font style="letter-spacing:1.85pt;"> </font>or<font style="letter-spacing:1.8pt;"> </font>otherwise<font style="letter-spacing:1.8pt;"> </font>enable<font style="letter-spacing:1.8pt;"> </font>any<font style="letter-spacing:1.6pt;"> </font>Third<font style="letter-spacing:1.85pt;"> </font>Party<font style="letter-spacing:1.45pt;"> </font>to,<font style="letter-spacing:1.85pt;"> </font>directly<font style="letter-spacing:1.6pt;"> </font>or<font style="letter-spacing:1.8pt;"> </font>indirectly,<font style="letter-spacing:1.85pt;"> </font>Exploit<font style="letter-spacing:1.85pt;"> </font>any Licensed Analog Product in the Takeda<font style="letter-spacing:-0.5pt;"> </font>Field.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark37"></a>3.2<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Licenses from Ultragenyx to Takeda. </font><font style="font-size:10.5pt;">Subject to the terms and conditions of</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">this Agreement, Ultragenyx hereby grants to Takeda in the Territory during the</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">Term:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark38"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">exclusive</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(even</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">retention</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of rights</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Plan)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">license,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">grant sublicenses under multiple tiers solely in accordance with Section 3.3, under the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">[***] Technology</font><font style="font-weight:bold;font-size:10.5pt;">, </font><font style="font-size:10.5pt;">Licensed Product Improvements Controlled by Ultragenyx or its</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Affiliates, Licensed Product Improvement Patents Controlled by Ultragenyx or its Affiliates, and</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">Joint Intellectual Property to (i) Exploit the Licensed [***] Products in the Takeda Field in</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">the Territory,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Exploit</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">structures</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Covered</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">with respect to Licensed Analog Compounds, in the Takeda Field in the</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">a co-exclusive license, without the right to grant sublicenses,&nbsp;&nbsp;under</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Technology</font><font style="font-weight:bold;font-size:10.5pt;">,</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Improvements</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">its Affiliates, Licensed Product Improvement Patents Controlled by Ultragenyx or its Affiliates,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">and Joint Intellectual Property to conduct activities under the [***] Development Plan in</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx Field in the Territory and to perform the activities under the [***] Development</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">Plan.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark39"></a>3.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Sublicensing</font><font style="font-size:10.5pt;">. Each Party shall have the right to grant sublicenses, through multiple</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">tiers, of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Sections</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">3.1(a)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">3.1(c)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">(in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx) and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">3.2(a)</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">(in</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Takeda),</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Parties;</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">provided, however</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">5.2,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">rights granted to it under (i) Section 3.1(a) to a Third Party without the prior written consent of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Takeda (not to be unreasonably withheld, conditioned or delayed) or (ii) Section 3.1(c) in the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Takeda Field</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">3.2(a) to a Third Party without the prior written consent of Ultragenyx (not to be </font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">unreasonably withheld,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">conditioned</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">delayed).</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">refer</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">subordinate</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">this Agreement</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">agree</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">writing,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">must be consistent in all material respects with the terms and conditions of this Agreement.</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Upon termination</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">shall continue</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">transferred</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Party shall continue and be transferred to Ultragenyx; provided that such sublicenses comply with</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the requirements of this Section 3.3. Each Party shall remain responsible for the performance of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">this Agreement and the performance of its sublicensees hereunder.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.4<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">No Implied Licenses</font><font style="font-size:10.5pt;">. No license or other right is or shall be created or granted</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">hereunder by</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">implication,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">estoppel,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">otherwise.</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">All</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">licenses</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">as expressly</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Agreement.</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">All</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">expressly</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">this Agreement are reserved by the Party and may not be used by the other Party for any</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">purpose.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:19.65%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE 4&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>LICENSED PRODUCT<font style="letter-spacing:-0.15pt;"> </font>DEVELOPMENT</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Overview of Product Development</font><font style="font-size:10.5pt;">. The Parties desire and intend to collaborate</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">with respect to the Development of the Licensed Product in the Licensed Field in the Territory, to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the extent set forth in this Agreement. Takeda&#8217;s Development of the Licensed [***] Products in</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the Takeda</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Field</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Analog</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">conducted</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">manner consistent with the [***] Development Plans and using Commercially Reasonable</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">Efforts.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.2</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Transition and Exchange of Know-How</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Transition from Takeda to Ultragenyx. </font><font style="font-size:10.5pt;">As soon as practicable after</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">the Effective</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Date,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">cooperate</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">act</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">support</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">transition</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the Licensed [***] Product from Takeda to Ultragenyx in the Ultragenyx Field and, solely</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">for purposes</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">performance</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">4.3(a)(ii),</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Takeda Field,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">consideration</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">payable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">transition</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the extent appropriate, assignment of Regulatory Materials and Regulatory Approvals covering</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the Licensed [***] Product in the Ultragenyx Field and, solely for purposes of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s performance</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">4.3(a)(ii),</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Field,</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx, (ii) sharing of the Licensed [***] Know-How with Ultragenyx to the extent</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">necessary or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">useful</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Analog</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Products for and implementation of the Initial [***] Development Plan, and (iii) transferring to</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx, at no cost to Ultragenyx, those biological materials or chemical compounds related to</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">the Licensed</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Execution</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">for Ultragenyx to perform the activities allocated to it under the Initial [***] Development</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Plan. Takeda will also use Commercially Reasonable Efforts, at Ultragenyx&#8217;s sole cost and expense,</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">to assign</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">existing</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">agreements</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or reasonably</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">useful</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Exploitation</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the Territory.</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Within</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">forty-five</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">(45)</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">invoice</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">reflecting</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the costs and expenses of such assignment or sublicense, Ultragenyx shall pay the invoiced</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">amounts to</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Takeda.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Know-How Sharing by Ultragenyx. </font><font style="font-size:10.5pt;">Ultragenyx shall provide to</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Takeda, promptly after the Effective Date and during the Term upon Ultragenyx Know-How</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">being obtained or generated by Ultragenyx, at no additional cost or expense to Takeda, all</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such Ultragenyx Know-How as is necessary or reasonably useful to enable Takeda: (a) to perform</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">its obligations</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Agreement;</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Exploit</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Field, and (c) to Exploit any structures Covered by the Licensed [***] Patent, other than with respect</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to Licensed Analog Compounds, in the Takeda Field in the</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.3</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Development</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Activities</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark40"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Throughout the Term, Ultragenyx will use Commercially Reasonable Efforts</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">to</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="letter-spacing:1.15pt;"> </font>Exploit<font style="letter-spacing:1.25pt;"> </font>a<font style="letter-spacing:1.15pt;"> </font>Licensed<font style="letter-spacing:1.15pt;"> </font>[***]<font style="letter-spacing:1.2pt;"> </font>Product<font style="letter-spacing:1.3pt;"> </font>or<font style="letter-spacing:1.25pt;"> </font>Licensed<font style="letter-spacing:1.25pt;"> </font>Analog<font style="letter-spacing:1.1pt;"> </font>Product<font style="letter-spacing:1.3pt;"> </font>in<font style="letter-spacing:1.2pt;"> </font>the<font style="letter-spacing:1.15pt;"> </font>Ultragenyx<font style="letter-spacing:1.3pt;"> </font>Field<font style="letter-spacing:1.2pt;"> </font>in<font style="letter-spacing:1.2pt;"> </font>the Territory and&nbsp;&nbsp;(ii) complete Development&nbsp;&nbsp;activities&nbsp;&nbsp;for a&nbsp;&nbsp;Licensed [***]&nbsp;&nbsp;Product&nbsp;&nbsp;in&nbsp;&nbsp;the<font style="letter-spacing:2.35pt;"> </font>Takeda</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Field,<font style="letter-spacing:1.55pt;"> </font>in<font style="letter-spacing:1.55pt;"> </font>each<font style="letter-spacing:1.55pt;"> </font>case<font style="letter-spacing:1.5pt;"> </font>at<font style="letter-spacing:1.55pt;"> </font>Ultragenyx&#8217;s<font style="letter-spacing:1.5pt;"> </font>sole<font style="letter-spacing:1.55pt;"> </font>expense<font style="letter-spacing:1.6pt;"> </font>and<font style="letter-spacing:1.55pt;"> </font>pursuant<font style="letter-spacing:1.55pt;"> </font>to<font style="letter-spacing:1.85pt;"> </font>the<font style="letter-spacing:1.65pt;"> </font>Initial<font style="letter-spacing:1.55pt;"> </font>[***]<font style="letter-spacing:1.55pt;"> </font>Development Plan.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark41"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If the Parties mutually agree to conduct other Development activities with</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">respect to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Initial</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Plan,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">then</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the Parties shall prepare a plan (including timeline and budget) covering the Development</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">activities to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">completed,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">completing</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">activities,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">responsible for the associated costs (together with the Initial [***] Development Plan, the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***]</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Development</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Plans</font><font style="font-size:10.5pt;">&#8221;).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark42"></a>(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If Ultragenyx elects to pursue Development of a Licensed Analog</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Product, Ultragenyx will use Commercially Reasonable Efforts to Exploit such Licensed Analog</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Product in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">expense</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">[***] Development Plan for such Licensed Analog Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">At Ultragenyx&#8217;s sole expense, Takeda, using Commercially Reasonable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Efforts, will (i) conduct initial manufacturing process development and scale-up activities for</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the Licensed</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Initial</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the agreed</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">budget</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">contained</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">therein,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">work</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">transfer</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">[***] Know-How as necessary or reasonably useful for Development and for the purposes</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of completing Regulatory Applications, initiating Clinical Trials and for </font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">transitioning manufacturing activities to Ultragenyx, and (iii) conduct such other Development</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">and Manufacturing activities as may be mutually agreed by the</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">Parties.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">scientific manner</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">compliance</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">respects</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Laws,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">including,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">GCP, GLP, and</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">GMP.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark43"></a>(f)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If Ultragenyx breaches its obligations under Section 4.3(a) or 4.3(c) or</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">is otherwise no longer actively conducting Development of a Licensed [***] Compound</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">and Licensed [***] Product in any indication in the Ultragenyx Field, then [***] of the date Ultragenyx stopped actively conducting such Development,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx [***] License for the Licensed [***] Compound and Licensed [***] Product</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">shall terminate and, [***] of such event, such license shall revert to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Takeda and the terms of Section 15.7(c) shall apply with respect to such Compound and</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Product; provided, that, upon the reversion of rights to Takeda, Takeda shall not develop such Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in the Ultragenyx Field except in accordance with Takeda&#8217;s exercise of the Takeda Option or</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">right of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">negotiation</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">8.</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">If,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">effective</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">reversion, Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">determines</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">wishes</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx Field, Ultragenyx may provide written notice to Takeda. Following receipt of</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">such notice, Takeda and Ultragenyx will negotiate in good faith such license agreement for a period</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">of [***] thereafter, which period may be extended by mutual agreement. Any</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">resulting license</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">exercise</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">first negotiation pursuant to ARTICLE</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">8.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Neither Party may Develop Licensed [***] Products in the Ultragenyx Field</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">except as</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Plan.</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">discretion</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Develop Licensed [***] Products in the Takeda</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Field.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.4</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark44"></a><font style="font-size:10.5pt;font-weight:bold;">Clinical Trial Registry</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall be responsible for registering any Clinical Trial</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">performed pursuant</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Plans</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">appropriate</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">clinical</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">trial</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">registry</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">(e.g., clinicaltrials.gov) and posting the results of such Clinical Trials as required by Applicable</font><font style="font-size:10.5pt;letter-spacing:-0.85pt;"> </font><font style="font-size:10.5pt;">Laws.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The posting of any results to a clinical trial registry in accordance&nbsp;&nbsp;with</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">this Section 4.4 shall be considered a &#8220;publication&#8221; and subject to the Parties&#8217; obligations set forth</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in Section 14.9.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark45"></a>4.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Records; Disclosure of Data and Results. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In </font><font style="font-size:10.5pt;">conformity with standard</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">pharmaceutical industry</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">practices</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">conditions</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">prepare</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and maintain,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">prepared</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">maintained,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">accurate</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">records, accounts, notes, reports and data with respect to activities conducted pursuant to the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">[***] Development</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Plans</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">minimum</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">three</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">(3)</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">years</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">end</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Year</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">to which they pertain (or such longer period as may be required by Applicable Laws) and, upon</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">the other</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">request,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">send</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">legible</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">copies</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(in</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">English</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">electronic format)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">aforesaid</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">already</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">provided,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">throughout</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the Term and for a minimum of twelve (12) months following the Term. Upon reasonable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">advance notice, at the request of the JSC, each Party agrees to make its employees and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">consultants reasonably</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">available</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">their</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">respective</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">places</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">employment</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">consult</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">on issues arising in connection with the [***] Development Plans. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In </font><font style="font-size:10.5pt;">accordance with the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">reporting format</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">schedule</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">approved</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">JSC,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">promptly</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">fully</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">disclose</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the other Party in writing all data, including preclinical data, Clinical Trial data, formulation </font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">data and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">manufacturing</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">data,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">generated</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">in the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Field.</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Without</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">limiting</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">foregoing:</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">keep</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">regularly and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">fully</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">informed</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">reporting</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">JSC</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">quarterly</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of Licensed</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">and sublicensees,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">status</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Clinical</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Trials,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Regulatory Materials</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Field in the Territory; (b) on at least an annual basis (but in any event, no later than December</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">1 of each Calendar Year), each Party, as applicable, shall submit to the JSC proposed updates</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and amendments, as appropriate, to the [***] Development Plans; and (c) Takeda shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">keep Ultragenyx regularly informed by reporting to the JSC on a quarterly basis regarding</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the Development of Licensed Products in the Takeda Field by Takeda, its&nbsp;&nbsp;Affiliates and sublicensees, including information regarding the status of any Clinical Trials, filing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Materials</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the Takeda Field in the</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE 5<font style="font-weight:normal;">&#8211; </font>[***] CO-DEVELOPMENT AND<font style="letter-spacing:-0.25pt;"> </font>CO-COMMERCIALIZATION</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark46"></a>5.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Co-Development and Co-Commercialization Negotiation for Takeda</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Field</font><font style="font-size:10.5pt;">.</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark47"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">As</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">soon</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">practicable,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">later</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">[***],</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">deliver</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Final [***]</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Data</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Package</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Product.</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the deadline</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">delivery</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Final</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Data</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Package</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">earlier</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Final</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Data</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Package</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***]</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Option</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Term</font><font style="font-size:10.5pt;">&#8221;),</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx will have the right to exercise an exclusive option to co-Develop and co-Commercialize</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the Licensed [***] Products in the Takeda Field in the Territory (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Option</font><font style="font-size:10.5pt;">&#8221;). Upon exercise</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of the [***] Option prior to the expiration of the [***] Option Term, the Parties will negotiate in</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">good faith, for a period of up to [***] (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] License</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Negotiation</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Period</font><font style="font-size:10.5pt;">&#8221;),</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">relating</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">co-Development</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">co-Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Licensed [***]</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(other</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">decision making authority of the Parties, which will be as set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">2.1(b)(ii)(D)).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If Ultragenyx exercises the [***] Option within the [***] Option Term&nbsp;&nbsp;and</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">the Parties reach agreement regarding the co-Development and co-Commercialization of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the Licensed [***] Product in the Takeda Field within the [***] License Negotiation Period,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such agreement,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">needed</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">modification</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">[***] License,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">entered</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">their</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">designated</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Affiliates.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall provide that, if Ultragenyx terminates the Development of Licensed [***] Products in</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx Field, then Ultragenyx shall have the right to terminate such co-Development and co- Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">providing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">with the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">notice:</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">time of termination, [***], and (ii) if the Licensed [***] Product is being Commercialized</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">at the time of termination, [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If Ultragenyx exercises the [***] Option within the [***] Option Term&nbsp;&nbsp;and</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">the Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">fail</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">reach</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">co-Development</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">co-Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Negotiation</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Period,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">then Takeda and Ultragenyx shall have the right to submit their proposed terms for such</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;letter-spacing:0.1pt;">co-</font><font style="font-size:10.5pt;"> Development and co-Commercialization of the Licensed [***] Products in the Takeda Field in</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the Territory</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">binding</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">arbitration</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">16.3;</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">provided,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">however,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">rights regarding</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">2.1(b)(ii)(D) will not be subject to modification in such</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">arbitration.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark48"></a>5.2<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Takeda Right of First Negotiation for the Ultragenyx Field.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Notwithstanding Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">sublicense</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">3.3,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">does</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">enter into an agreement with any Third Party for the co-Development and/or</font><font style="font-size:10.5pt;letter-spacing:-1pt;"> </font><font style="font-size:10.5pt;">co-Commercialization (including co-promotion) of the Licensed Product in the Ultragenyx Field except in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">accordance with the terms of this Section 5.2. If Ultragenyx intends to co-Develop and/or</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">co-Commercialize (including co-promote) with a Third Party a Licensed Product in the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Field, Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">intent</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">[***] after receipt of such notice, Takeda will have a right of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">first negotiation to enter into a definitive agreement with Ultragenyx for such co-Development</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and/or co-Commercialization</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">(including</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">co-promotion).</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">If</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">fail</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">enter</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">definitive</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">agreement<font style="letter-spacing:1.15pt;"> </font>prior<font style="letter-spacing:1.1pt;"> </font>to<font style="letter-spacing:1.15pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>expiration<font style="letter-spacing:1.1pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>[***],<font style="letter-spacing:1.1pt;"> </font>Ultragenyx<font style="letter-spacing:1.2pt;"> </font>will have the right to enter into a definitive agreement with a Third Party (including via<font style="letter-spacing:0.2pt;"> </font>sublicensing as set forth in Section 3.3) for the co-Development and/or co-Commercialization (including<font style="letter-spacing:0.1pt;"> </font>co- promotion)<font style="letter-spacing:1.05pt;"> </font>of<font style="letter-spacing:1.05pt;"> </font>the<font style="letter-spacing:1.15pt;"> </font>Licensed<font style="letter-spacing:1.05pt;"> </font>Product<font style="letter-spacing:1.1pt;"> </font>in<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.05pt;"> </font>Ultragenyx<font style="letter-spacing:1.3pt;"> </font>Field;<font style="letter-spacing:1.1pt;"> </font>provided,<font style="letter-spacing:1.05pt;"> </font>that,<font style="letter-spacing:1.1pt;"> </font>[***], Ultragenyx shall<font style="letter-spacing:1.3pt;"> </font>not enter into such a definitive agreement with a Third Party on terms, when viewed as a whole,<font style="letter-spacing:0.5pt;"> </font>that are less favorable to Ultragenyx than the terms last offered to Ultragenyx by<font style="letter-spacing:-0.95pt;"> </font>Takeda.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark49"></a>5.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Commercialization Plans. </font><font style="font-size:10.5pt;">Each Party shall submit a Commercialization Plan to the</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">JSC for</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">discussion</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">less</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">anticipated</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">obtaining Regulatory Approval for a Licensed Product. Thereafter, each Party shall provide a copy of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the then-current</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">JSC</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">least</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">once</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Year</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the Licensed Product Royalty Term and Takeda Royalty Term, as</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.4</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Commercialization Activities.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Ultragenyx Commercialization</font><font style="font-size:10.5pt;">. Ultragenyx shall use Commercially</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">Reasonable Efforts to Commercialize the Licensed Product in the Ultragenyx Field in the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Territory throughout</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Term.</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">Subject</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">modifications</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">based</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">agreements</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">reached</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to Sections 5.1 and 5.2, Ultragenyx&#8217;s Commercially Reasonable Efforts requirements and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the provisions of Section 2.1(b), Ultragenyx has sole discretion relating to all aspects of</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the Commercialization</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Territory.</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">As</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">between the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Parties,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">bear</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">incurred</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">connection</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">all such Commercialization activities. On an annual basis, and no later than March 1 of</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">each Calendar Year following the First Commercial Sale of a Licensed Product in the&nbsp;&nbsp;Ultragenyx Field</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">present</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">detailed</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">report</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">JSC summarizing Ultragenyx&#8217;s overall Commercialization activities undertaken during the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">previous Calendar Year with respect to the Licensed Products in the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Field.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Takeda Commercialization</font><font style="font-size:10.5pt;">. Subject to any modifications based on</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">agreements reached</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Sections</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">5.1</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">5.2</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">provisions</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">2.1(b),</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">sole discretion relating to the Commercialization of Licensed [***] Products in the Takeda Field in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the Territory.</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">As</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">between</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Parties,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">bear</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">incurred</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in connection with all such Commercialization</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">activities.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.5</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Trademarks</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark50"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Ownership. </font><font style="font-size:10.5pt;">Each Party shall own, throughout the world, each Product</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">trademark that it develops for a Product in its Field in the Territory (each a &#8220;Product Trademark&#8221;).</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">All goodwill</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">attributable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Trademark</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">generated</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a Product bearing such mark shall inure to the benefit of such</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Party.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Use. </font><font style="font-size:10.5pt;">Neither Party shall be obligated to use the other Party&#8217;s Product</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Trademark or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">House</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Marks</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Law</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">requirement. Neither</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">thereafter,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">adopt,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">register</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">trademark,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">trade</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">name,<font style="letter-spacing:0.85pt;"> </font>brand<font style="letter-spacing:0.85pt;"> </font>name,<font style="letter-spacing:0.85pt;"> </font>symbol<font style="letter-spacing:0.9pt;"> </font>or<font style="letter-spacing:0.85pt;"> </font>logo<font style="letter-spacing:0.85pt;"> </font>that<font style="letter-spacing:0.85pt;"> </font>is<font style="letter-spacing:1pt;"> </font>identical,<font style="letter-spacing:0.9pt;"> </font>or<font style="letter-spacing:0.95pt;"> </font>confusingly<font style="letter-spacing:0.65pt;"> </font>similar,<font style="letter-spacing:0.85pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>other<font style="letter-spacing:0.9pt;"> </font>Party&#8217;s Product<font style="letter-spacing:-0.2pt;"> </font>Trademarks.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Filing; Maintenance. </font><font style="font-size:10.5pt;">Each Party shall solely be responsible for, and shall</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">solely bear all costs associated with maintenance and enforcement of, such Party&#8217;s Product</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">Trademark.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:24.09%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE 6&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>RESEARCH COLLABORATION</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark51"></a>6.1 <font style="font-weight:bold;">Research Collaboration Generally</font>. The Parties will conduct research of Takeda&#8217;s<font style="letter-spacing:0.1pt;"> </font>[***] Compound and Candidate Products as set forth in this Agreement. As further described<font style="letter-spacing:1pt;"> </font>below, the Candidate Products will be selected from the Takeda-Controlled compounds listed on<font style="letter-spacing:0.1pt;"> </font><font style="text-decoration:underline;">Exhibit</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">6.1</font><font style="text-decoration:underline;margin-left:29pt;"></font>attached<font style="letter-spacing:0.75pt;"> </font>hereto,<font style="letter-spacing:0.85pt;"> </font>as<font style="letter-spacing:0.9pt;"> </font>may<font style="letter-spacing:0.65pt;"> </font>be<font style="letter-spacing:0.85pt;"> </font>amended<font style="letter-spacing:0.85pt;"> </font>from<font style="letter-spacing:0.9pt;"> </font>time<font style="letter-spacing:0.75pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>time<font style="letter-spacing:0.75pt;"> </font>by<font style="letter-spacing:0.65pt;"> </font>Takeda<font style="letter-spacing:0.7pt;"> </font>in<font style="letter-spacing:0.9pt;"> </font>its<font style="letter-spacing:0.75pt;"> </font>sole<font style="letter-spacing:0.75pt;"> </font>discretion<font style="letter-spacing:0.75pt;"> </font>(the &#8220;<font style="text-decoration:underline;">Listed</font><font style="text-decoration:underline;letter-spacing:-0.05pt;"> </font><font style="text-decoration:underline;">Compounds</font>&#8221;).</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.2</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><font style="text-decoration:underline;"></font><font style="font-weight:bold;">Nomination of Candidate Products and Validation</font><font style="letter-spacing:0.2pt;font-weight:bold;"> </font><font style="font-weight:bold;">Research</font>.</p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark52"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Nomination</font><font style="font-size:10.5pt;">. Either Party may nominate compounds from the Listed</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Compounds for consideration and approval by the JRC as candidate products under this Agreement</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">(upon such approval, each such Listed Compound shall thereafter be a &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Candidate Product</font><font style="font-size:10.5pt;">&#8221;). The</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">JRC may select up to five (5) Candidate Products for validation pursuant to Section 6.2(b) at any</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">one time.</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> five (5)</font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">selected</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">time,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">neither</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">may nominate</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Listed</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">considered</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">unless</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and until</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">determine,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">completion</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">research</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the applicable</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Validation</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Plan,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">nominated</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">an Option Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark53"></a>(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Validation Research Plan</font><font style="font-size:10.5pt;">. Takeda will design, with input from Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">a research plan and budget for the initial validation for each Candidate Product (each,</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">a &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Validation</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Research</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;">&#8221;),</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Validation</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">intended</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">sufficiently include the activities required to provide information and data necessary for the JRC </font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to determine</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">nominate</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Product.</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Validation Research</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">submitted</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">JRC</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">approval</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">(for</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">final decision-making authority in accordance with Section 2(c)(ii)(C)) and will be funded by</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Takeda and performed by or on behalf of Takeda, in Takeda&#8217;s sole</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">discretion.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.3</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><font style="text-decoration:underline;"></font><font style="font-weight:bold;">[***] Research Plan and Transition</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark54"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">During</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Collaboration</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">will use Commercially Reasonable Efforts to Exploit the [***] Products, at Ultragenyx&#8217;s sole</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">expense, pursuant</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">initial</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">research</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">plan</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">budget</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">attached</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">hereto</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">6.3(a) </font><font style="font-size:10.5pt;">(the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">[***] Research Plan</font><font style="font-size:10.5pt;">&#8221;). Pursuant to the [***] Research Plan and in accordance with</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the associated budget, at Ultragenyx&#8217;s sole expense, Takeda will use Commercially</font><font style="font-size:10.5pt;letter-spacing:-1.1pt;"> </font><font style="font-size:10.5pt;">Reasonable Efforts to conduct initial Manufacturing process development and scale-up of the [***]</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Products, as</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">agreed</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Parties.</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">clarity,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">there</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">Validation</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">[***] Products.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">During the Collaboration Term with respect to the [***] Products, the Parties</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">shall cooperate</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">act</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">support</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">transition</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">useful</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to perform</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Plan,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">transition</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Know-How</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">with respect to the [***] Products. [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">6.4</font><font style="text-decoration:underline;margin-left:47pt;"></font><font style="font-weight:bold;">Option Product Research Plan</font>. During the Collaboration Term with respect to<font style="letter-spacing:1.9pt;"> </font>each Option Product for which there is an agreed Option Product Research Plan, Ultragenyx will<font style="letter-spacing:2.1pt;"> </font>use Commercially Reasonable Efforts to Exploit each Option Product in accordance with<font style="letter-spacing:1.25pt;"> </font>the applicable Option Product Research<font style="letter-spacing:-0.1pt;"> </font>Plan.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.5</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><a name="_bookmark55"></a><font style="text-decoration:underline;"></font><font style="font-weight:bold;">Limited Licenses During the Collaboration</font><font style="letter-spacing:0.05pt;font-weight:bold;"> </font><font style="font-weight:bold;">Term</font>.</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark56"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">License to</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark57"></a>(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Upon</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">selection</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">JRC and as of the Effective Date with respect to [***] Products, Takeda hereby grants to Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">a limited, co-exclusive (with Takeda and its Affiliates), non-transferable,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">non-sublicensable, royalty-free license under the Option Product Technology, Option Product</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Improvements Controlled by Takeda or its Affiliates, Option Product Improvement Patents Controlled</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">by Takeda</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Intellectual</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Property</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Exploit</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in accordance with the activities to be performed by Ultragenyx under the Option Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Research Plan.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">foregoing</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">6.5(a)(i)</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">continue</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Option Product-by-Option Product basis until the earlier of (A) execution of an Option Product</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">License Agreement, (B) failure by the Parties to enter into an Option Product License Agreement by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the expiration</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Negotiation</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Period,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(C)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the Collaboration</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Terminated</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">all rights to such Option Product will revert to Takeda in accordance with Section 15.7(c);</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">provided that, if in the case of (C), an Option Negotiation Period is then ongoing, the Collaboration</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Term with</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">automatically</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">extend</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">until</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">earlier</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(1)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">expiration of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Negotiation</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Period</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">(2)</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">execution</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">License Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">License to Takeda</font><font style="font-size:10.5pt;">. During the Collaboration Term, with respect to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">each Research Product, Ultragenyx hereby grants to Takeda a limited, non-exclusive,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">non- transferable, non-sublicensable, royalty-free license, under all Ultragenyx Intellectual</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">Property, Option</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Improvements</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Intellectual</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Property</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">use in the Licensed Field in the Territory solely to perform its obligations under each Research</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Plan and to the extent necessary or reasonably useful for Takeda to evaluate a Candidate</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">No</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Implied</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Licenses</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">No</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">created</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">granted hereunder</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Collaboration</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">implication,</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estoppel,<font style="letter-spacing:1.6pt;"> </font>or<font style="letter-spacing:1.55pt;"> </font>otherwise.<font style="letter-spacing:0.5pt;"> </font>All<font style="letter-spacing:1.6pt;"> </font>rights<font style="letter-spacing:1.65pt;"> </font>not<font style="letter-spacing:1.75pt;"> </font>expressly<font style="letter-spacing:1.45pt;"> </font>granted<font style="letter-spacing:1.55pt;"> </font>by<font style="letter-spacing:1.45pt;"> </font>a<font style="letter-spacing:1.55pt;"> </font>Party<font style="letter-spacing:1.45pt;"> </font>under<font style="letter-spacing:1.55pt;"> </font>this<font style="letter-spacing:1.6pt;"> </font>Agreement<font style="letter-spacing:1.6pt;"> </font>are reserved by such Party and may not be used by the other Party for any<font style="letter-spacing:-0.7pt;"> </font>purpose.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.6</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><font style="text-decoration:underline;"></font><font style="font-weight:bold;">Research Materials Transfer</font>.</p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark58"></a><a name="_bookmark59"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;"><a name="_bookmark59"></a>In order to facilitate the activities contemplated by this Agreement, Takeda</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">shall transfer to Ultragenyx, at no cost to Ultragenyx (i) those quantities of [***] Compound</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Controlled by</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Execution</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">perform</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">activities allocated to it under the [***] Research Plan and (ii) reasonable quantities of biological</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">materials or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">chemical</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">compounds</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">becomes</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">an Option Product for Development of such Option Product (collectively, the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Research</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Materials</font><font style="font-size:10.5pt;">&#8221;) by Ultragenyx in furtherance of the applicable Research Plans. Such transfer shall be pursuant</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">to a mutually agreed upon Research Materials transfer plan and schedule (including, as necessary,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a separate agreement with respect to such transfer which the Parties shall enter as soon</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">as practicable</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">(A)</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">foregoing</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">clause</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">(B)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a Candidate Product becomes an Option Product in the case of the foregoing clause (ii)). </font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Except as otherwise provided for under this Agreement, all such Research Materials will remain the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">sole property</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">used</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">furtherance</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">conducted</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">accordance with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Plans,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">used</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">delivered</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">benefit</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any Third</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">(except</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">subcontractors</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">furtherance</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Plans),</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">without</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">prior written consent of Takeda, and will be used in compliance with Applicable Law. </font><font style="font-size:10.5pt;letter-spacing:0.1pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Research Materials supplied under this Agreement must be used with prudence and appropriate caution</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">in any experimental work because not all of their characteristics may be known.&nbsp;&nbsp;Takeda</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">will provide</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">most</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">current</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">safety</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">sheet</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Materials</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">upon transfer of any Research</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Materials.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark60"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Except as expressly set forth in this Agreement, THE RESEARCH</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">MATERIALS ARE</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">PROVIDED</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">&#8220;AS</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">IS&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">AND</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">WITHOUT</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">ANY</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">REPRESENTATION</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">OR</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">WARRANTY, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTY</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">OF MERCHANTABILITY OR OF FITNESS FOR ANY PARTICULAR PURPOSE OR</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">ANY WARRANTY THAT THE USE OF THE RESEARCH MATERIALS WILL NOT INFRINGE OR VIOLATE ANY PATENT OR OTHER PROPRIETARY RIGHTS OF ANY</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">THIRD PARTY.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.7</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><font style="text-decoration:underline;"></font><font style="font-weight:bold;">General Terms Applicable to Research Plans and Research</font><font style="letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-weight:bold;">Activities</font>.</p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Annual Review of Research Plans</font><font style="font-size:10.5pt;">. On an annual basis, the Parties, through</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the JRC, shall review, and as necessary, update and amend the then-current Research </font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Plans, provided that either Party may at any time between annual updates recommend updates</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or amendments of the then-current plans and associated budget for consideration by the</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">JRC.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Performance Obligations</font><font style="font-size:10.5pt;">. With respect to each Research Plan, Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and Takeda shall each use Commercially Reasonable Efforts to execute and perform the</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">activities assigned to it and cooperate with the other Party in the performance of such activities. </font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Each Party</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">assigned</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">scientific manner</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">compliance</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">respects</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Law,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">applicable</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">national and international (e.g., ICH, GCP, GLP, and GMP) guidelines. If a Research<font style="letter-spacing:0.2pt;"> </font>Plan provides<font style="letter-spacing:1.1pt;"> </font>for<font style="letter-spacing:1.05pt;"> </font>Clinical<font style="letter-spacing:1.15pt;"> </font>Trials,<font style="letter-spacing:1.2pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>sponsor<font style="letter-spacing:1.1pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>such<font style="letter-spacing:0.95pt;"> </font>trial<font style="letter-spacing:1.1pt;"> </font>shall<font style="letter-spacing:1.15pt;"> </font>register<font style="letter-spacing:1.1pt;"> </font>and<font style="letter-spacing:1.1pt;"> </font>post<font style="letter-spacing:1.3pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>results<font style="letter-spacing:1.15pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>such trial.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Records; Disclosure of Data and Results</font><font style="font-size:10.5pt;">. Each Party shall prepare </font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and maintain,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">prepared</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">maintained,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">accurate</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">records, accounts,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">notes,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">reports</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">conducted</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Research Plan in conformity with Applicable Law and standard pharmaceutical industry</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">practices; provided</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">records</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">maintained</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">less</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">three</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">(3)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">years</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">following the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Year</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">records</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">pertain</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">longer</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">by Applicable Laws). Upon the other Party&#8217;s written request, the Party receiving such</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">written request shall send legible copies of the aforesaid to the other Party throughout the Term</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">with respect to such Research Product and for a minimum of twelve (12) months following</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">such Term. Upon reasonable advance notice, at the request of the JRC, each Party agrees to make</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">its employees and consultants reasonably available at their respective places of employment</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to consult with the other Party on issues arising in connection with each Research Plan.</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">In accordance with the reporting format and schedule approved by the JRC, each Party</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">shall promptly</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">disclose</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">writing</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">data,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">preclinical</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">data,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">clinical</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">trial data</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">(if</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">any),</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">formulation</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Manufacturing</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">data,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">generated</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party with respect to a Research Product in the Licensed Field in the</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark61"></a>(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Termination of Research Plan</font><font style="font-size:10.5pt;">. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In </font><font style="font-size:10.5pt;">the event the activities under a Research</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Plan are</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">terminated</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">reason,</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">research</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">thereunder</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">cease</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Option Product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">deemed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Terminated</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Product.</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">All</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Terminated</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Products shall revert to Takeda pursuant to Section 15.7(c). For clarity, such termination shall</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">not terminate the Collaboration Term for any other purpose under this</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.8</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><font style="text-decoration:underline;"></font><font style="font-weight:bold;">Research Program</font><font style="letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-weight:bold;">Expenses.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Nomination Evaluation</font><font style="font-size:10.5pt;">. Each Party shall be responsible for its own FTEs and any</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">expenses,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">case,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">incurred</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">nomination,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">evaluation</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and selection of Candidate Products in accordance with Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">6.2(a).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">[***] Research Plan</font><font style="font-size:10.5pt;">. Ultragenyx shall reimburse Takeda for Takeda&#8217;s FTE</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Costs and</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">out-of-pocket</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">expenses,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">case,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">incurred</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">furtherance</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the completion of those activities assigned to it under the [***] Research Plan and in accordance</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">with the applicable budget, subject to a maximum reimbursement obligation of [***] of such budget or such greater amount as Ultragenyx may approve in</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">advance.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Validation Research Plan</font><font style="font-size:10.5pt;">. Takeda shall be responsible for its own FTEs and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any Third Party expenses incurred by Takeda with respect to a Validation Research</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">Plan.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Option Product Research Plan. </font><font style="font-size:10.5pt;">Ultragenyx shall reimburse Takeda </font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for Takeda&#8217;s FTE Costs and out-of-pocket Third Party expenses, in each case, incurred by Takeda</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">in furtherance of the completion of those activities assigned to it under an Option Product</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Research Plan and in accordance with the applicable budget, subject to a maximum</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">reimbursement</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">obligation of [***] of such budget or such greater amount<font style="letter-spacing:2.65pt;"> </font>as Ultragenyx may approve in<font style="letter-spacing:-0.4pt;"> </font>advance.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">6.9</font><font style="text-decoration:underline;margin-left:47pt;"></font><font style="font-weight:bold;">Invoices</font>. Within forty-five (45) days after the end of each Calendar Quarter, Takeda<font style="letter-spacing:2.85pt;"> </font>will provide a written report and invoice to Ultragenyx setting forth in reasonable detail its FTEs<font style="letter-spacing:1.2pt;"> </font>and its<font style="letter-spacing:2.3pt;"> </font>Third<font style="letter-spacing:2.1pt;"> </font>Party<font style="letter-spacing:2.05pt;"> </font>expenses<font style="letter-spacing:2.25pt;"> </font>recorded<font style="letter-spacing:2.25pt;"> </font>in<font style="letter-spacing:2.3pt;"> </font>furtherance<font style="letter-spacing:2.3pt;"> </font>the<font style="letter-spacing:2.25pt;"> </font>[***]<font style="letter-spacing:2.2pt;"> </font>Research<font style="letter-spacing:2.25pt;"> </font>Plan<font style="letter-spacing:2.4pt;"> </font>and<font style="letter-spacing:2.25pt;"> </font>Option<font style="letter-spacing:2.15pt;"> </font>Product Research Plans. Within sixty (60) days after the receipt of such invoice, Ultragenyx shall pay<font style="letter-spacing:-0.75pt;"> </font>the undisputed<font style="letter-spacing:0.95pt;"> </font>portion<font style="letter-spacing:1pt;"> </font>of<font style="letter-spacing:0.95pt;"> </font>any<font style="letter-spacing:0.95pt;"> </font>such<font style="letter-spacing:1.1pt;"> </font>invoice.<font style="letter-spacing:2.2pt;"> </font>For<font style="letter-spacing:1.1pt;"> </font>clarity,<font style="letter-spacing:1pt;"> </font>making<font style="letter-spacing:0.85pt;"> </font>such<font style="letter-spacing:1.1pt;"> </font>a<font style="letter-spacing:0.95pt;"> </font>payment<font style="letter-spacing:1pt;"> </font>does<font style="letter-spacing:1pt;"> </font>not<font style="letter-spacing:1pt;"> </font>preempt Ultragenyx&#8217;s audit rights under Section 11.12, which remain in full force and effect.<font style="letter-spacing:1.1pt;"> </font>If Ultragenyx in good faith identifies items in an invoice which are disputed, Ultragenyx will<font style="letter-spacing:0.5pt;"> </font>notify Takeda<font style="letter-spacing:1.2pt;"> </font>in<font style="letter-spacing:1.4pt;"> </font>writing,<font style="letter-spacing:1.25pt;"> </font>noting<font style="letter-spacing:1.1pt;"> </font>its<font style="letter-spacing:1.25pt;"> </font>objection<font style="letter-spacing:1.25pt;"> </font>to<font style="letter-spacing:1.25pt;"> </font>the<font style="letter-spacing:1.2pt;"> </font>disputed<font style="letter-spacing:1.2pt;"> </font>item(s)<font style="letter-spacing:1.2pt;"> </font>with<font style="letter-spacing:1.25pt;"> </font>specificity,<font style="letter-spacing:1.25pt;"> </font>within<font style="letter-spacing:1.25pt;"> </font>ten<font style="letter-spacing:1.35pt;"> </font>(10) business days of receipt of the invoice. Takeda will respond to such written notification<font style="letter-spacing:1.5pt;"> </font>within ten (10) days of receipt of the disputed notification. Thereafter, the Parties shall negotiate <font style="letter-spacing:1.85pt;"> </font>in good faith to resolve the dispute with either Takeda supplying Ultragenyx<font style="letter-spacing:2.3pt;"> </font>documentation justifying<font style="letter-spacing:1.35pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>charge<font style="letter-spacing:1.4pt;"> </font>or<font style="letter-spacing:1.55pt;"> </font>reducing<font style="letter-spacing:1.25pt;"> </font>or<font style="letter-spacing:1.45pt;"> </font>deleting<font style="letter-spacing:1.25pt;"> </font>the<font style="letter-spacing:1.45pt;"> </font>disputed<font style="letter-spacing:1.35pt;"> </font>amount.<font style="letter-spacing:2.8pt;"> </font>Any<font style="letter-spacing:1.25pt;"> </font>dispute<font style="letter-spacing:1.35pt;"> </font>over<font style="letter-spacing:1.3pt;"> </font>invoiced amounts due that cannot be resolved by direct good faith negotiation between the Parties shall<font style="letter-spacing:1.65pt;"> </font>be resolved<font style="letter-spacing:2pt;"> </font>in<font style="letter-spacing:2.05pt;"> </font>accordance<font style="letter-spacing:2.1pt;"> </font>with<font style="letter-spacing:2.15pt;"> </font>ARTICLE<font style="letter-spacing:2pt;"> </font>16<font style="letter-spacing:2.05pt;"> </font>(Dispute<font style="letter-spacing:2pt;"> </font>Resolution)<font style="letter-spacing:2pt;"> </font>of<font style="letter-spacing:1.85pt;"> </font>this<font style="letter-spacing:1.9pt;"> </font>Agreement;<font style="letter-spacing:2.05pt;"> </font>provided further,<font style="letter-spacing:2.55pt;"> </font>if<font style="letter-spacing:2.65pt;"> </font>the<font style="letter-spacing:2.55pt;"> </font>Dispute<font style="letter-spacing:2.6pt;"> </font>is<font style="letter-spacing:2.6pt;"> </font>not<font style="letter-spacing:2.6pt;"> </font>resolved<font style="letter-spacing:2.55pt;"> </font>pursuant<font style="letter-spacing:2.7pt;"> </font>to<font style="letter-spacing:2.6pt;"> </font>Section<font style="letter-spacing:2.8pt;"> </font>16.2,<font style="letter-spacing:2.55pt;"> </font>the<font style="letter-spacing:2.55pt;"> </font>Parties<font style="letter-spacing:2.55pt;"> </font>agree<font style="letter-spacing:2.6pt;"> </font>that<font style="letter-spacing:2.55pt;"> </font>such Dispute shall be resolved pursuant to Section 16.3.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.10</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><a name="_bookmark62"></a><font style="text-decoration:underline;"></font><font style="font-weight:bold;">Option</font><font style="letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-weight:bold;">Products.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark63"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">At any time during the Collaboration Term after the completion of</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">research activities under a Validation Research Plan, either Ultragenyx or Takeda may, through the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;letter-spacing:0.1pt;">JRC,</font><font style="font-size:10.5pt;"> nominate</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">selection</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">JRC</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">promptly consider</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">request.</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">In</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">order</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">become</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">JRC must</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">agree</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">(by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">mutual</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Parties&#8217;</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">representatives</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">JRC)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">selection of the Candidate Product as an Option Product, (ii) a research plan, and budget that identifies</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the research</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">development</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">performed</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">paid</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">entirely</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx (each, an &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product Research Plan</font><font style="font-size:10.5pt;">&#8221;), and (iii) key terms, including</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the territory,</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">field</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">use,</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">development</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">commercial</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">responsibilities</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">financial</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">(the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Key</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Terms</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">serve</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Agreement. For clarity, the Option Product Research Plan for [***] Products is the [***] Research</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Plan.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark64"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The [***] Products are designated as Option Products as of the Effective Date.</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">The Option Product Key Terms for [***] Products are attached hereto as </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">6.10(b)</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark65"></a><font style="text-decoration:underline;">6.11</font><font style="text-decoration:underline;margin-left:47pt;"></font><font style="font-weight:bold;">The</font><font style="font-weight:bold;letter-spacing:2.25pt;"> </font><font style="font-weight:bold;">Ultragenyx</font><font style="font-weight:bold;letter-spacing:2.3pt;"> </font><font style="font-weight:bold;">Option.</font><font style="font-weight:bold;letter-spacing:1.7pt;"> </font>Takeda<font style="letter-spacing:1.85pt;"> </font>hereby<font style="letter-spacing:1.8pt;"> </font>grants<font style="letter-spacing:1.95pt;"> </font>to<font style="letter-spacing:2pt;"> </font>Ultragenyx,<font style="letter-spacing:1.9pt;"> </font>during<font style="letter-spacing:1.9pt;"> </font>the<font style="letter-spacing:1.9pt;"> </font>applicable Collaboration Term, the exclusive option to obtain, on a product-by-product basis, an exclusive license,<font style="letter-spacing:2.3pt;"> </font>with<font style="letter-spacing:2.35pt;"> </font>the<font style="letter-spacing:2.4pt;"> </font>right<font style="letter-spacing:2.35pt;"> </font>to<font style="letter-spacing:2.3pt;"> </font>grant<font style="letter-spacing:2.35pt;"> </font>sublicenses<font style="letter-spacing:2.35pt;"> </font>through<font style="letter-spacing:2.3pt;"> </font>multiple<font style="letter-spacing:2.3pt;"> </font>tiers,<font style="letter-spacing:2.4pt;"> </font>under<font style="letter-spacing:2.3pt;"> </font>the<font style="letter-spacing:2.3pt;"> </font>Option<font style="letter-spacing:2.7pt;"> </font>Product Technology and Joint Intellectual Property to Exploit (a) the [***] Products and (b) up to five<font style="letter-spacing:1.95pt;"> </font>(5) other<font style="letter-spacing:0.75pt;"> </font>Option<font style="letter-spacing:0.85pt;"> </font>Products<font style="letter-spacing:0.85pt;"> </font>in<font style="letter-spacing:0.7pt;"> </font>the<font style="letter-spacing:0.9pt;"> </font>Licensed<font style="letter-spacing:0.8pt;"> </font>Field<font style="letter-spacing:0.8pt;"> </font>in<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.8pt;"> </font>Territory<font style="letter-spacing:0.75pt;"> </font>(the<font style="letter-spacing:0.9pt;"> </font>&#8220;<font style="text-decoration:underline;">Ultragenyx</font><font style="text-decoration:underline;letter-spacing:0.95pt;"> </font><font style="text-decoration:underline;">Option</font>&#8221;),<font style="letter-spacing:0.8pt;"> </font>subject to the terms and conditions set forth in this Agreement including ARTICLE<font style="letter-spacing:-0.2pt;"> </font>8.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;text-decoration:underline;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.12</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;"><font style="text-decoration:underline;"></font><font style="font-weight:bold;">Exercising the</font><font style="letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-weight:bold;">Option</font>.</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark66"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">At any time during the Collaboration Term, Ultragenyx may exercise</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">notifying</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">writing</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">intent</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to exercise the Option with respect to a specific Option Product and negotiate the terms of a</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">license agreement</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Notice</font><font style="font-size:10.5pt;">&#8221;).</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">During</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">beginning</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">effective</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of each</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Notice</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">ending</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">[***] thereafter,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">extended by</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">mutual</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Negotiation</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Period</font><font style="font-size:10.5pt;">&#8221;),</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">faith negotiations with the intent to agree upon license terms and conclude a definitive</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">license agreement (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Option Product License Agreement</font><font style="font-size:10.5pt;">&#8221;) in accordance with the applicable</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Option Product Key Terms and other terms that reflect the expected commercial opportunity</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and development</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">stage</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product.</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">will include provisions to address approvals of any Governmental Authority which&nbsp;&nbsp;are</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">required before effectiveness of such Option Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">cannot</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">conclude</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the Option Negotiation Period, Takeda and Ultragenyx shall each have the right to submit the</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Option Product Key Terms and other terms for a final decision regarding the terms&nbsp;&nbsp;of&nbsp;&nbsp;the</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Option Product License Agreement pursuant to binding arbitration under Section 16.3. All rights to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">any Option Product for which the Parties do not enter into an Option Product License</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">Agreement shall revert to Takeda and such Option Product shall be deemed a Terminated Product subject</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">15.7(c).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:23.84%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE 7&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>TAKEDA RESEARCH<font style="letter-spacing:-0.15pt;"> </font>SUPPORT</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark67"></a>7.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Research Support. </font><font style="font-size:10.5pt;">During the Collaboration Term and upon mutual agreement of</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the Parties, Takeda may provide research support as set forth in this Section 7.1</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Research</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Support</font><font style="font-size:10.5pt;">&#8221;) to Ultragenyx, at Ultragenyx&#8217;s sole cost. Such Research Support shall be related to</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the development</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(in</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">case,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Products)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or Licensed Option Products (in each case, in connection with an Option Product License Agreement), and shall include medicinal chemistry, testing of compounds in disease</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">animal models, drug formulation and clinical development support. If Ultragenyx and Takeda agree</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">that Takeda should provide such Research Support, the confidentiality obligations, access&nbsp;&nbsp;to premises,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">details</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">personnel</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">providing</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Support</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx shall be addressed in a separate agreement between the Parties and such</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">personnel.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Expenses and Invoices. </font><font style="font-size:10.5pt;">Ultragenyx shall reimburse Takeda for Takeda&#8217;s FTE Costs and out-of-pocket Third Party expenses, in each case, incurred by Takeda for the provision of</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">the Research Support and in accordance with the applicable budget, subject to a</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">maximum reimbursement</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">obligation</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">of [***]</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">budget</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">greater amount as Ultragenyx may approve in advance. Within forty-five (45) days after the end of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">each Calendar Quarter, Takeda will provide a written report and invoice to Ultragenyx setting forth</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">in reasonable</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">detail</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">FTEs</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">recorded</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Support. Within</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">sixty</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">(60)</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">invoice,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">undisputed portion of any such invoice. For clarity, making such a payment does not preempt</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s audit</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">11.12,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">remain</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">full</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">force</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">effect.</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">good faith identifies items in an invoice which are disputed, Ultragenyx will notify Takeda in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">writing,</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">noting<font style="letter-spacing:1.85pt;"> </font>its<font style="letter-spacing:1.95pt;"> </font>objection<font style="letter-spacing:1.95pt;"> </font>to<font style="letter-spacing:2pt;"> </font>the<font style="letter-spacing:1.9pt;"> </font>disputed<font style="letter-spacing:1.95pt;"> </font>item(s)<font style="letter-spacing:1.9pt;"> </font>with<font style="letter-spacing:2pt;"> </font>specificity,<font style="letter-spacing:2.05pt;"> </font>within<font style="letter-spacing:1.95pt;"> </font>ten<font style="letter-spacing:2.2pt;"> </font>(10)<font style="letter-spacing:1.9pt;"> </font>business<font style="letter-spacing:2pt;"> </font>days<font style="letter-spacing:1.95pt;"> </font>of receipt<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.8pt;"> </font>the<font style="letter-spacing:0.8pt;"> </font>invoice.<font style="letter-spacing:1.75pt;"> </font>Takeda<font style="letter-spacing:0.8pt;"> </font>will<font style="letter-spacing:0.85pt;"> </font>respond<font style="letter-spacing:0.85pt;"> </font>to<font style="letter-spacing:0.85pt;"> </font>such<font style="letter-spacing:0.8pt;"> </font>written<font style="letter-spacing:0.8pt;"> </font>notification<font style="letter-spacing:0.8pt;"> </font>within<font style="letter-spacing:0.8pt;"> </font>ten<font style="letter-spacing:0.8pt;"> </font>(10)<font style="letter-spacing:0.75pt;"> </font>days<font style="letter-spacing:0.85pt;"> </font>of receipt of the disputed notification. Thereafter, the Parties shall negotiate in good faith to<font style="letter-spacing:-0.5pt;"> </font>resolve the<font style="letter-spacing:2.3pt;"> </font>dispute<font style="letter-spacing:2.3pt;"> </font>with<font style="letter-spacing:2.35pt;"> </font>either<font style="letter-spacing:2.4pt;"> </font>Takeda<font style="letter-spacing:2.4pt;"> </font>supplying<font style="letter-spacing:2.25pt;"> </font>Ultragenyx<font style="letter-spacing:2.5pt;"> </font>documentation<font style="letter-spacing:2.3pt;"> </font>justifying<font style="letter-spacing:2.2pt;"> </font>the<font style="letter-spacing:2.3pt;"> </font>charge<font style="letter-spacing:2.25pt;"> </font>or reducing or deleting the disputed amount. Any dispute over invoiced amounts due that cannot<font style="letter-spacing:0.05pt;"> </font>be resolved by direct good faith negotiation between the Parties shall be resolved in <font style="letter-spacing:1.85pt;"> </font>accordance with<font style="letter-spacing:1.35pt;"> </font>ARTICLE<font style="letter-spacing:1.3pt;"> </font>16<font style="letter-spacing:1.35pt;"> </font>(Dispute<font style="letter-spacing:1.25pt;"> </font>Resolution)<font style="letter-spacing:1.3pt;"> </font>of<font style="letter-spacing:1.25pt;"> </font>this<font style="letter-spacing:1.2pt;"> </font>Agreement;<font style="letter-spacing:1.35pt;"> </font>provided<font style="letter-spacing:1.3pt;"> </font>further,<font style="letter-spacing:1.3pt;"> </font>if<font style="letter-spacing:1.3pt;"> </font>the<font style="letter-spacing:1.3pt;"> </font>Dispute<font style="letter-spacing:1.25pt;"> </font>is not<font style="letter-spacing:2.6pt;"> </font>resolved<font style="letter-spacing:2.55pt;"> </font>pursuant<font style="letter-spacing:2.6pt;"> </font>to<font style="letter-spacing:2.6pt;"> </font>Section<font style="letter-spacing:2.65pt;"> </font>16.2,<font style="letter-spacing:2.55pt;"> </font>the<font style="letter-spacing:2.55pt;"> </font>Parties<font style="letter-spacing:2.55pt;"> </font>agree<font style="letter-spacing:2.5pt;"> </font>that<font style="letter-spacing:2.6pt;"> </font>such<font style="letter-spacing:2.5pt;"> </font>dispute<font style="letter-spacing:2.55pt;"> </font>shall<font style="letter-spacing:2.55pt;"> </font>be<font style="letter-spacing:2.5pt;"> </font>resolved pursuant to Section<font style="letter-spacing:-0.2pt;"> </font>16.3.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Patent Ownership. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">If </font><font style="font-size:10.5pt;">Research Support is provided pursuant to Section 7.1 related to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">an Ultragenyx Pipeline Product (other than an Exercised Product), then, notwithstanding</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Section</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.1<font style="letter-spacing:0.75pt;"> </font>or<font style="letter-spacing:0.7pt;"> </font>any<font style="letter-spacing:0.5pt;"> </font>other<font style="letter-spacing:0.7pt;"> </font>separate<font style="letter-spacing:0.7pt;"> </font>written<font style="letter-spacing:0.75pt;"> </font>agreement<font style="letter-spacing:0.75pt;"> </font>between<font style="letter-spacing:0.75pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>Parties<font style="letter-spacing:1pt;"> </font>with<font style="letter-spacing:0.8pt;"> </font>respect<font style="letter-spacing:0.8pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>such<font style="letter-spacing:0.7pt;"> </font>Research Support,<font style="letter-spacing:1.2pt;"> </font>as<font style="letter-spacing:1.2pt;"> </font>between<font style="letter-spacing:1.2pt;"> </font>the<font style="letter-spacing:1.15pt;"> </font>Parties<font style="letter-spacing:1.15pt;"> </font>and<font style="letter-spacing:1.2pt;"> </font>regardless<font style="letter-spacing:1.2pt;"> </font>of<font style="letter-spacing:1.25pt;"> </font>inventorship,<font style="letter-spacing:1.2pt;"> </font>Ultragenyx<font style="letter-spacing:1.3pt;"> </font>shall<font style="letter-spacing:1.1pt;"> </font>own<font style="letter-spacing:1.15pt;"> </font>all<font style="letter-spacing:1.2pt;"> </font>right, title and interest in and to any Patents related to such Ultragenyx Pipeline Product (other than<font style="letter-spacing:1.4pt;"> </font>an Exercised Product in the Exercised Countries) that arise out of such Research Support.<font style="letter-spacing:2.2pt;"> </font>For purposes of clarity, following the execution of an Option Product License Agreement<font style="letter-spacing:2.2pt;"> </font>or Exercised Product License Agreement, the terms of such license agreement shall govern<font style="letter-spacing:1.25pt;"> </font>the handling<font style="letter-spacing:1.25pt;"> </font>of<font style="letter-spacing:1.45pt;"> </font>activities<font style="letter-spacing:1.35pt;"> </font>of<font style="letter-spacing:1.45pt;"> </font>the<font style="letter-spacing:1.5pt;"> </font>type<font style="letter-spacing:1.4pt;"> </font>covered<font style="letter-spacing:1.45pt;"> </font>by<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.45pt;"> </font>definition<font style="letter-spacing:1.35pt;"> </font>of<font style="letter-spacing:1.45pt;"> </font>Research<font style="letter-spacing:1.6pt;"> </font>Support<font style="letter-spacing:1.4pt;"> </font>related<font style="letter-spacing:1.45pt;"> </font>to<font style="letter-spacing:1.4pt;"> </font>the Product(s) that are the subject of the applicable license<font style="letter-spacing:-0.6pt;"> </font>agreement.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:25.1%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark68"></a>ARTICLE 8&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>TAKEDA&#8217;S LICENSE<font style="letter-spacing:-0.15pt;"> </font>OPTION</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark69"></a>8.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">The License Option. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In </font><font style="font-size:10.5pt;">partial consideration for the premium paid by Takeda</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx under the Common Stock Purchase Agreement, Ultragenyx hereby grants to</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">Takeda during the applicable Takeda Option Term, the exclusive option to obtain (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Option</font><font style="font-size:10.5pt;">&#8221;), on a product-by-product and country-by-country basis, an exclusive license (even as</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx and its Affiliates) to (a) any or all of the Licensed Products in the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Field,</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="letter-spacing:2.45pt;"> </font>any<font style="letter-spacing:2.4pt;"> </font>or<font style="letter-spacing:2.6pt;"> </font>all<font style="letter-spacing:2.65pt;"> </font>Licensed<font style="letter-spacing:2.6pt;"> </font>Option<font style="letter-spacing:2.55pt;"> </font>Products<font style="letter-spacing:2.7pt;"> </font>in<font style="letter-spacing:2.55pt;"> </font>the<font style="letter-spacing:2.7pt;"> </font>Licensed<font style="letter-spacing:2.6pt;"> </font>Field,<font style="letter-spacing:2.6pt;"> </font>and<font style="letter-spacing:2.5pt;"> </font>(c)<font style="letter-spacing:2.45pt;"> </font>one<font style="letter-spacing:2.6pt;"> </font>(1)<font style="letter-spacing:2.45pt;"> </font>Ultragenyx Pipeline<font style="letter-spacing:0.6pt;"> </font>Product<font style="letter-spacing:0.65pt;"> </font>in<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>Licensed<font style="letter-spacing:0.7pt;"> </font>Field,<font style="letter-spacing:0.65pt;"> </font>in<font style="letter-spacing:0.75pt;"> </font>each<font style="letter-spacing:0.65pt;"> </font>case<font style="letter-spacing:0.6pt;"> </font>in<font style="letter-spacing:0.8pt;"> </font>any<font style="letter-spacing:0.65pt;"> </font>or<font style="letter-spacing:0.7pt;"> </font>all<font style="letter-spacing:0.65pt;"> </font>of<font style="letter-spacing:0.7pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>countries<font style="letter-spacing:0.65pt;"> </font>in<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>Takeda Territory.<font style="letter-spacing:1.1pt;"> </font>For<font style="letter-spacing:0.5pt;"> </font>clarity,<font style="letter-spacing:0.5pt;"> </font>if<font style="letter-spacing:0.6pt;"> </font>Takeda<font style="letter-spacing:0.45pt;"> </font>elects<font style="letter-spacing:0.55pt;"> </font>not<font style="letter-spacing:0.55pt;"> </font>to<font style="letter-spacing:0.55pt;"> </font>exercise<font style="letter-spacing:0.5pt;"> </font>the<font style="letter-spacing:0.5pt;"> </font>Takeda<font style="letter-spacing:0.45pt;"> </font>Option<font style="letter-spacing:0.55pt;"> </font>with<font style="letter-spacing:0.55pt;"> </font>respect<font style="letter-spacing:0.55pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>(i)<font style="letter-spacing:0.5pt;"> </font>any Licensed [***] Product, Licensed Analog Product, Licensed Option Product, or<font style="letter-spacing:2.05pt;"> </font>Ultragenyx Pipeline Product, or (ii) any country in the Takeda Territory, as the case may be, prior to<font style="letter-spacing:0.45pt;"> </font>the expiration<font style="letter-spacing:2.2pt;"> </font>of<font style="letter-spacing:2.15pt;"> </font>the<font style="letter-spacing:2.15pt;"> </font>Takeda<font style="letter-spacing:2.15pt;"> </font>Option<font style="letter-spacing:2.2pt;"> </font>Term<font style="letter-spacing:2.2pt;"> </font>with<font style="letter-spacing:2.2pt;"> </font>respect<font style="letter-spacing:2.2pt;"> </font>to<font style="letter-spacing:2.2pt;"> </font>such<font style="letter-spacing:2.15pt;"> </font>Product<font style="letter-spacing:2.45pt;"> </font>and/or<font style="letter-spacing:2.2pt;"> </font>such<font style="letter-spacing:2.15pt;"> </font>country,<font style="letter-spacing:2.2pt;"> </font>as applicable, then Takeda shall no longer have any rights under the Takeda Option with respect<font style="letter-spacing:2.85pt;"> </font>to such Product and/or such country, as<font style="letter-spacing:-0.35pt;"> </font>applicable.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.44%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8.2</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Exercising the License</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Option</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark70"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Preparation and Delivery of the Data Packages</font><font style="font-size:10.5pt;">. Ultragenyx shall prepare</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and deliver</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">soon</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">practicable</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">completion</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Clinical Trials (a) the Final Phase II Data Package for each Licensed [***] Product, Licensed</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Analog Product, Licensed Option Product and Ultragenyx Pipeline Product (other than [***]) and</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">(b) the Final Phase III Data Package for</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Takeda Review of Research Data Package</font><font style="font-size:10.5pt;">. Following Takeda&#8217;s receipt of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">the applicable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Data</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Package</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">8.2(a)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Option Term,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">review</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">assess</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Data</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Package</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">determine</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">submit</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the Takeda Option Notice. During this review period, upon Takeda&#8217;s&nbsp;&nbsp;reasonable </font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">request, Ultragenyx shall promptly make available to Takeda: (i) its employees, consultants</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">and independent contractors (subject to the availability of any independent contractors)</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">who performed the activities on behalf of Ultragenyx, including the preparation of the Data</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Package; and (ii) any additional Information under Ultragenyx&#8217;s possession and Control related to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the applicable products that is reasonably useful in evaluating the Data</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Package.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark71"></a>(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Takeda Option Exercise Mechanics</font><font style="font-size:10.5pt;">. Takeda may exercise the Takeda</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Option for one or more Licensed [***] Products, one or more Licensed Analog Products, one or</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">more Licensed Option Products, and one Ultragenyx Pipeline Product on a country-by-country basis</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">in the Takeda Territory at any time during the applicable Takeda Option Term by providing</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">written notice to Ultragenyx (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Option Notice</font><font style="font-size:10.5pt;">&#8221;) identifying the applicable</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Products (&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exercised</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Products</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">countries</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">(&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exercised</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Countries</font><font style="font-size:10.5pt;">&#8221;);</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">provided,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">however,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Takeda may</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">exercise</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">once</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(i.e.,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the Takeda</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">exercised</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">particular</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">fewer</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">all applicable</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">countries,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">then</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">countries</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">added</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">exercises</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the Takeda Option with respect to that particular Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Product).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.44%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark72"></a>(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">During</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">beginning</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">effective</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Option Notice and ending [***], which period may be extended by</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">mutual agreement (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Option Negotiation Period</font><font style="font-size:10.5pt;">&#8221;), the Parties will conduct good</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">faith negotiations to conclude a definitive license agreement (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Exercised Product</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">License</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;">&#8221;). Such Exercised Product License Agreement shall include the</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">following:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the Exercised</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Countries,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">which,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">conflict,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">supersede</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">[***] License and Takeda [***] License and the terms of any Option Product License</font><font style="font-size:10.5pt;letter-spacing:-0.9pt;"> </font><font style="font-size:10.5pt;">Agreement: Ultragenyx hereby grants to Takeda an exclusive license (even as to Ultragenyx and</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">its Affiliates), with the right to grant sublicenses through multiple tiers, under the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Intellectual</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Property</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Intellectual</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Property,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Exploit</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(where</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Product)</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Field (where such Exercised Product is a Licensed Option Product or Ultragenyx Pipeline Product)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in the Exercised</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Countries;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">financial terms in ARTICLE 11 (and related definitions) applicable</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">to Exercised Products (and no other consideration payable by</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Takeda);</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">provisions to address approvals of any Governmental Authority which</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">are required before effectiveness of the Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Agreement;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">provisions to address the prosecution, enforcement and defense of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Patents that cover Exercised Products similar to those contained in ARTICLE</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">12;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.16%;margin-right:7.02%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(v)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">the right for Takeda to terminate for convenience upon [***] written notice;</font></p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.88%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vi)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">lieu</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">material breach or insolvency, receive rights on the basis set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">15.7(a)(ii)(B);</font></p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vii)</font><font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">provisions</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Royalty</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">each Exercised</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Country,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">non-exclusive,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">fully-paid</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">up and irrevocable license under the Ultragenyx Intellectual Property with respect to such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Exercised Product</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Country</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">(for</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">are Licensed Products) and in the Licensed Field (for Exercised Products that are Option Products</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or Ultragenyx Products);</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;"> </font><font style="font-size:10.5pt;font-family:Calibri;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;font-family:Calibri;"> </font><font style="font-size:10.5pt;font-family:Calibri;">18.</font></p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(viii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">to the extent applicable, Miscellaneous provisions as contained in</font></p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">cannot</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">conclude</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">during the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Negotiation</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Period,</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to submit</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">(other</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">those</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">specified</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Section 8.2(d)) of the Exercised Product License Agreement pursuant to binding arbitration </font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">under Section</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">16.3.</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">clarity,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">8.2(d)</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">must</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">included</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the Exercised Product License Agreement and are not subject to arbitration and Ultragenyx shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be required</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">enter</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">those</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the Takeda Option is exercised pursuant to Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">8.2(c).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Takeda Right of First Negotiation on Ultragenyx Pipeline Products. </font><font style="font-size:10.5pt;">As</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">additional consideration for the premium being paid by Takeda to Ultragenyx under the Common</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Stock Purchase Agreement, and notwithstanding anything to the contrary contained in this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Agreement, if,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">during the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">[***] period</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Option Term,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">intends</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">(all</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">subset</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">rights)</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">transfer</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">any Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">ROFN</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">will provide</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">intent</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">[***] after receipt of such notice, Takeda will have a right of first negotiation to enter into</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a definitive</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">subset</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">rights)</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">other transfer in the Takeda ROFN Territory. If the Parties fail to enter into a&nbsp;&nbsp;definitive</font><font style="font-size:10.5pt;letter-spacing:-1.15pt;"> </font><font style="font-size:10.5pt;">agreement prior to the expiration of the [***] period, Ultragenyx will have the</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">right to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">enter</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">definitive</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">subset</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">all rights) or other transfer of such Ultragenyx Pipeline Product in the Takeda ROFN</font><font style="font-size:10.5pt;letter-spacing:-0.9pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.4<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Transition of Responsibilities After Exercise of the Takeda Option</font><font style="font-size:10.5pt;">. Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">shall, in</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">transition</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">plan</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Agreement, transfer to Takeda all activities and responsibilities related to the Exercised Products in</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the Exercised Countries. The Parties shall exercise Commercially Reasonable Efforts to </font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">complete the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">transfer</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">transition</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">plan.</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Any</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">dispute</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">between</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">regarding the transition shall be resolved as set forth in the Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Development and Commercialization After Exercise of the Takeda Option</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">After exercise of the Takeda Option, Takeda will use Commercially Reasonable Efforts to Exploit</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">the Exercised</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Countries</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">cost</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">and expense; provided, however, notwithstanding the above, Takeda&#8217;s financial commitment</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">toward global</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Products will be in accordance with the terms set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">8.6.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark73"></a>8.6<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Cost Sharing for Development Activities in Takeda Territory</font><font style="font-size:10.5pt;">. After exercise of</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the Takeda Option with respect to a Licensed Option Product and/or an Ultragenyx Pipeline</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">Product:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">share</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">future</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">global</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such Licensed Option Product or Ultragenyx Pipeline Product, as applicable, including costs</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">for Clinical Trials and clinical drug supply and chemistry, manufacturing and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">controls-related activities in accordance with mutually agreed upon Development plans, budgets and cost</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">sharing structures; provided that Takeda shall only be required to share global Development costs</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">where the Development activities are necessary or reasonably useful to support the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Development, Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">which case</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">contribute</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">[***].</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">clarity,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to share</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">future</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">global</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">where</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">activities, including Clinical Trials, are not necessary and are not used to support the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Development,</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regulatory Approval and Commercialization of such product in the Takeda Territory;<font style="letter-spacing:-0.75pt;"> </font>and</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, Takeda shall be solely responsible for</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">all Development</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">where</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">specifically</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">for Regulatory Approval of a Licensed Option Product or Ultragenyx Pipeline Product,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">as applicable, in the Takeda Territory. If such Development activities are also necessary</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">or reasonably</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">useful</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or Ultragenyx Pipeline Product, as applicable, outside the Takeda Territory, the Parties</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">will negotiate in good faith to agree upon an equitable sharing of costs for such</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Development activities.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:33.53%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE 9&nbsp;&nbsp;<font style="font-weight:normal;">&#8211;</font><font style="font-weight:normal;letter-spacing:0.1pt;"> </font>REGULATORY</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark74"></a>9.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Lead Regulatory Party</font><font style="font-size:10.5pt;">.&nbsp;&nbsp;Primary regulatory responsibility under this Agreement</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">shall be</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">assigned</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Lead</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Regulatory</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Party</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">this Section 9.1.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall be the Lead Regulatory Party for all Licensed Products</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">until expiration</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Term.</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Following</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or not</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">exercised</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">for Licensed [***] Products in the Takeda Field unless otherwise agreed by the Parties, and</font><font style="font-size:10.5pt;letter-spacing:-1.05pt;"> </font><font style="font-size:10.5pt;">(ii) Ultragenyx shall be the Lead Regulatory Party for Licensed [***] Products in the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Field and shall be the Lead Regulatory Party for Licensed Analog Products in the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">Field.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall be the Lead Regulatory Party for all Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Pipeline Products in the Territory until expiration of the Takeda Option Term. Following the </font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">expiration of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">for all Ultragenyx Pipeline Products for which the Parties have not entered into an Exercised</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">Product License Agreement. For clarity, at all times Ultragenyx shall be the Lead Regulatory Party </font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">for all Ultragenyx Pipeline Products outside of the Takeda Territory. If Takeda exercises the</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Takeda Option with respect to an Exercised Product, the Exercised Product License Agreement</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">shall provide that Takeda shall be the Lead Regulatory Party for such Exercised Product in</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the Licensed Field in the Takeda</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The Parties will agree as to which Party shall be the Lead Regulatory Party for</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">the [***]</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Collaboration</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Term; provided, however, that Takeda shall be the Lead Regulatory Party (i) if the Parties are unable</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to agree,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">provides</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">exercise the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">(iii)</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">planned</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Scientific Advice with the Dutch Medicines Evaluation Board and US Orphan Drug Designation</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">follow-up (as needed) for [***]. Ultragenyx shall be the Lead Regulatory</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Party for</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">entered</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">License Agreement and Takeda shall be the Lead Regulatory Party for each Option Product for which</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the Parties have not entered into an Option Product License</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">In</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">foregoing,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">entering</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">License Agreement or Exercised Product License Agreement, it is understood that the terms of</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">such Option</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">govern</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">with respect to such Option Product covered by such Option Product License Agreement or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Exercised Product covered by such Exercised Product License Agreement, as</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">applicable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;text-indent:0%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9.2<font style="margin-left:36pt;"></font><font style="font-size:10.5pt;font-weight:bold;">Initial Transfer of Data and Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Materials</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.69%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-weight:bold;font-size:10.5pt;">Transfer to</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Ultragenyx</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark75"></a>(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">As</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">soon</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">practicable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Date,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">later than sixty (60) days after the Effective Date, Takeda shall timely transfer to Ultragenyx copies</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">of</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(A) all Regulatory Materials (in electronic or other format) in its possession related to the use<font style="letter-spacing:2.85pt;"> </font>of the<font style="letter-spacing:2pt;"> </font>Licensed<font style="letter-spacing:1.85pt;"> </font>[***]<font style="letter-spacing:1.9pt;"> </font>Products<font style="letter-spacing:2.05pt;"> </font>in<font style="letter-spacing:1.95pt;"> </font>the<font style="letter-spacing:1.9pt;"> </font>Ultragenyx<font style="letter-spacing:2.05pt;"> </font>Field<font style="letter-spacing:1.95pt;"> </font>(and,<font style="letter-spacing:1.9pt;"> </font>solely<font style="letter-spacing:1.65pt;"> </font>for<font style="letter-spacing:1.85pt;"> </font>purposes<font style="letter-spacing:1.9pt;"> </font>of<font style="letter-spacing:1.85pt;"> </font>Ultragenyx&#8217;s performance of its obligations under Section 4.3(a)(ii), in the Takeda Field) and (B) the briefing book, FDA meeting minutes, Takeda meeting minutes, and FDA correspondence associated with  [***], the US Orphan Drug Designation Request and subsequent regulatory correspondence, and the briefing book and correspondence for Scientific Advice with the Dutch Medicines Evaluation Board,  in each case for the [***] Products in<font style="letter-spacing:2.2pt;"> </font>the Licensed<font style="letter-spacing:1.2pt;"> </font>Field<font style="letter-spacing:1.1pt;"> </font>and<font style="letter-spacing:1.3pt;"> </font>existing<font style="letter-spacing:1pt;"> </font>as<font style="letter-spacing:1.25pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>such<font style="letter-spacing:1.2pt;"> </font>date<font style="letter-spacing:1.1pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>transfer.<font style="letter-spacing:2.45pt;"> </font>Following<font style="letter-spacing:1.15pt;"> </font>each<font style="letter-spacing:1.25pt;"> </font>such<font style="letter-spacing:1.1pt;"> </font>transfer<font style="letter-spacing:1.25pt;"> </font>and<font style="letter-spacing:1.1pt;"> </font>at<font style="letter-spacing:1.25pt;"> </font>a time to be mutually agreed by the Parties, the Parties shall take all steps necessary (a)<font style="letter-spacing:1.2pt;"> </font>for Ultragenyx to own or have the right of reference to the INDs and Regulatory<font style="letter-spacing:0.75pt;"> </font>Approvals necessary to conduct Development of the Licensed [***] Product in the Ultragenyx Field and<font style="letter-spacing:0.05pt;"> </font>(b) for Takeda to own or have the right of reference to the INDs and Regulatory<font style="letter-spacing:2.45pt;"> </font>Approvals necessary to conduct Development of the Licensed [***] Product in the Takeda<font style="letter-spacing:-0.55pt;"> </font>Field.</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Within sixty (60) days after the Effective Date, Takeda shall</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">make available</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">separate</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">copies</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">(in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">electronic</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">format)</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">study</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">reports</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> from all non-clinical trials and Clinical Trials in the Territory</font><font style="font-size:10.5pt;">, in each case, whether completed as of the Effective Date or then in-progress, that are Controlled by Takeda (to the extent </font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">not previously</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx),</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">reports</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">become</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">available</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the extent that they relate to the use of the Licensed [***] Products for the</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.69%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Transfer to</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Takeda</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark76"></a>(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">As soon as practicable after the effective date of an Exercised</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Product License Agreement for a given Exercised Product, but in any event no later than sixty (60)</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">days after such date, Ultragenyx shall timely transfer to Takeda copies of all Regulatory Materials</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">(in electronic or other format) in its possession related to the use of the Exercised Product in</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the Exercised Countries and which support the Product INDs, the Product Regulatory Approvals</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and associated</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">correspondence,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">existing</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">transfer.</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Promptly</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">transfer, Ultragenyx shall take all steps necessary to transfer ownership of all such Product INDs</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and Product Regulatory Approvals in the Takeda Territory to Takeda, including, if</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">submitting to the PMDA a letter or other necessary documentation (with a copy to Takeda) notifying</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">PMDA</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">transfer</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">ownership.</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">From</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">IND</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Date, and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">previously</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">disclosed,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">shall,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates to,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">without</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">compensation,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">disclose</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">available</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">whatever</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">form Takeda</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">request,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Materials</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Controlled</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">related to the use of an Exercised Product in the Exercised</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Countries.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Within sixty (60) days after the Parties enter into an Exercised</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Product License</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">given</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">available</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Takeda separate copies (in electronic or other format) of the study reports from all non-clinical trials</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">and Clinical Trials in the Territory, in each case, whether completed as of the Effective Date, that</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">are Controlled</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">(to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">previously</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Takeda),</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">reports become available to Ultragenyx, and to the extent that they relate to the use of the</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Exercised Products in the Exercised</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Countries.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9.3</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Preparation of Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Materials</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">After</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">(or,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">IND</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Date),</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Regulatory Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">responsibility,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">exercise</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Commercially</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Reasonable Efforts,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">prepare,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">obtain,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">maintain,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Materials,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the Product INDs, the Product Regulatory Approvals, and other submissions, and to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">conduct communications with the FDA, for the relevant Products in the applicable indication in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the Territory</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">portion</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">thereof,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the Effective Date until expiration of the [***] Option Term, during which time Takeda shall hold</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the IND</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">(i.e.,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Party)</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">receive</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">reference</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">from Takeda. Except with respect to Licensed [***] Products from the Effective Date until expiration</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">of the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">INDs</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Approvals</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">generated</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the Effective</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Date,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">supplements</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">amendments</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">those</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">INDs</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Product Regulatory Approvals in existence as of the Effective Date, with respect to such Products in</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font></p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applicable indication in the Territory or applicable portion thereof under this Agreement shall<font style="letter-spacing:0.6pt;"> </font>be owned<font style="letter-spacing:0.8pt;"> </font>by,<font style="letter-spacing:0.9pt;"> </font>and<font style="letter-spacing:0.8pt;"> </font>shall<font style="letter-spacing:0.85pt;"> </font>be<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.8pt;"> </font>sole<font style="letter-spacing:0.8pt;"> </font>property<font style="letter-spacing:0.7pt;"> </font>and<font style="letter-spacing:0.9pt;"> </font>held<font style="letter-spacing:0.8pt;"> </font>in<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.8pt;"> </font>name<font style="letter-spacing:0.8pt;"> </font>of,<font style="letter-spacing:1.25pt;"> </font>Lead<font style="letter-spacing:1.05pt;"> </font>Regulatory<font style="letter-spacing:0.55pt;"> </font>Party<font style="letter-spacing:0.7pt;"> </font>or<font style="letter-spacing:0.75pt;"> </font>its designee.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Other</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the Scientific Advice Briefing Book for the [***] Products which has been prepared as of the Execution Date but not yet been submitted, the Lead Regulatory Party shall provide the other Party with an opportunity to review and comment on all material Regulatory Materials submitted by the Lead Regulatory Party to a Regulatory Authority after the Effective Date, in each case reasonably in advance of when the Lead Regulatory Party intends</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">to submit such Regulatory Materials to the applicable Regulatory Authority. The other Party</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">shall provide</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">comments</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">[***],</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">mutually agreed to by the Parties. The Lead Regulatory Party shall consider in good faith any</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">such comments</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party.</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">a copy in electronic form of all material Regulatory Materials filed with the Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Authority related to the use of the relevant</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Products.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.78%;margin-right:1.03%;text-indent:6.91%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:18pt;"></font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">notify</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">less</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> [***]</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">request</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">meeting</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">substantive</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">telephone</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">conference</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">call</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a Regulatory Authority with respect to any Product IND or Product Regulatory Approval.</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Upon the other Party&#8217;s request, the Lead Regulatory Party shall request that the FDA or</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">other Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">permit</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">least [***]</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">employees</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">attend</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">such meeting</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">conference</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">call.</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">To</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">FDA</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Authority, the other Party shall have the right to participate in any such meeting or conference call.</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">The foregoing</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">apply</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">meetings</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">conferences</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">initiated</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the Lead Regulatory Party or by a Regulatory Authority. The Lead Regulatory Party shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">promptly furnish the other Party with copies of all substantive correspondence related to the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">relevant Product</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">had</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Authority,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">contact</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">reports concerning substantive conversations or minutes from any substantive meetings with</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">a Regulatory Authority related to such</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, Takeda, in consultation with Ultragenyx, shall</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">be responsible for the preparation of any components of Regulatory Materials to be filed</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx that relate to the Manufacture of a Licensed Product or Option Product. Takeda</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">shall use Commercially Reasonable Efforts to prepare such components in a timely manner</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and provide such components to Ultragenyx with sufficient time for Ultragenyx to review</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">and comment on such components; provided, however, that Takeda may use an</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">alternative arrangement</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">(such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">drug</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">master</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">file)</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">preserve</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">confidentiality</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">components</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to the extent required by any Third Party agreements or, in Takeda&#8217;s reasonable discretion,</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">if otherwise necessary to protect Takeda confidential information and such alternative</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">arrangement is</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">permissible</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Laws;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">provided,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">further,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">requests additional</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Licensed Product</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">treated</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">confidential</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">alternative</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">arrangement (such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">drug</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">master</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">file),</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">consider</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">request.</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">that Ultragenyx elects to Manufacture a Licensed Product or Option Product, Ultragenyx shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">notify Takeda of such election and, to the extent covered by the license rights granted in Sections</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">3.1(a)</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and 3.1(c) (for Licensed Products) or Section 6.5(a) (for Option Products), Takeda <font style="letter-spacing:0.65pt;"> </font>shall promptly<font style="letter-spacing:0.75pt;"> </font>transfer<font style="letter-spacing:0.95pt;"> </font>to<font style="letter-spacing:1pt;"> </font>Ultragenyx<font style="letter-spacing:1.1pt;"> </font>or<font style="letter-spacing:0.95pt;"> </font>its<font style="letter-spacing:1.15pt;"> </font>Third<font style="letter-spacing:0.95pt;"> </font>Party<font style="letter-spacing:0.9pt;"> </font>designee<font style="letter-spacing:1pt;"> </font>all<font style="letter-spacing:1.05pt;"> </font>Regulatory<font style="letter-spacing:0.85pt;"> </font>Materials,<font style="letter-spacing:1pt;"> </font>processes and<font style="letter-spacing:1.5pt;"> </font>technical<font style="letter-spacing:1.5pt;"> </font>information<font style="letter-spacing:1.55pt;"> </font>Controlled<font style="letter-spacing:1.45pt;"> </font>by<font style="letter-spacing:1.1pt;"> </font>Takeda<font style="letter-spacing:1.55pt;"> </font>or<font style="letter-spacing:1.45pt;"> </font>its<font style="letter-spacing:1.5pt;"> </font>Affiliates<font style="letter-spacing:1.5pt;"> </font>that<font style="letter-spacing:1.45pt;"> </font>are<font style="letter-spacing:1.55pt;"> </font>reasonably<font style="letter-spacing:1.25pt;"> </font>necessary and<font style="letter-spacing:2.45pt;"> </font>useful<font style="letter-spacing:2.5pt;"> </font>for<font style="letter-spacing:2.5pt;"> </font>the<font style="letter-spacing:2.4pt;"> </font>Manufacture<font style="letter-spacing:2.4pt;"> </font>of<font style="letter-spacing:2.4pt;"> </font>such<font style="letter-spacing:2.5pt;"> </font>Licensed<font style="letter-spacing:2.45pt;"> </font>Product<font style="letter-spacing:2.45pt;"> </font>or<font style="letter-spacing:2.6pt;"> </font>Option<font style="letter-spacing:2.45pt;"> </font>Product,<font style="letter-spacing:2.5pt;"> </font>and<font style="letter-spacing:2.45pt;"> </font>thereafter Ultragenyx<font style="letter-spacing:1.05pt;"> </font>shall<font style="letter-spacing:0.95pt;"> </font>be<font style="letter-spacing:1pt;"> </font>responsible<font style="letter-spacing:0.9pt;"> </font>for<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.9pt;"> </font>preparation<font style="letter-spacing:0.9pt;"> </font>of<font style="letter-spacing:1pt;"> </font>any<font style="letter-spacing:0.7pt;"> </font>components<font style="letter-spacing:0.95pt;"> </font>of<font style="letter-spacing:0.9pt;"> </font>Regulatory<font style="letter-spacing:0.7pt;"> </font>Materials to be filed related to the Manufacture by Ultragenyx or its Third Party designee of such<font style="letter-spacing:1.9pt;"> </font>Licensed Product or Option<font style="letter-spacing:-0.25pt;"> </font>Product.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9.4</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Cooperation, Consultation and Review</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">cooperate</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">achieve</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">regulatory</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">objectives contemplated herein in a timely, accurate and responsive manner and shall assist the other</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party as reasonably requested in connection with the preparation and filing of Regulatory Materials</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">in the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Field,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">outside</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Territory.</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">establish</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">joint regulatory</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">working</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">group</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">manage</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">regulatory</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">issues.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">It</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the intention</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">joint</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">regulatory</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">working</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">group</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">meet</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">(in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">person</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">via teleconference) on an as-needed basis after the Effective Date and throughout the Term, but at</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">a minimum on a quarterly basis. The Parties agree and acknowledge that the activities</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Licensed Analog Products in the Licensed Field and the activities of Takeda with respect to (A)</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Licensed [***] Products in the Takeda Field and (B) Licensed Products outside of the Licensed Field,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">shall be coordinated such that they are consistent with the overall objective of facilitating</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Regulatory Approvals.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The other Party shall assist the Lead Regulatory Party, as is reasonably</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">necessary, in order for the Lead Regulatory Party to obtain and maintain the Product INDs and the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Product Regulatory Approvals, including in connection with the preparation and filing of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Regulatory Materials necessary to maintain such Product INDs and Product Regulatory</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">Approvals.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Regulatory Costs and Expenses</font><font style="font-size:10.5pt;">. Each Party shall bear its own costs and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">expenses incurred related to the preparation, maintenance, formatting and filing of the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Regulatory Materials.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.6<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Rights of Reference to Regulatory Materials</font><font style="font-size:10.5pt;">. Each Party hereby grants to the</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">other Party</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">reference</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Materials,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">relied</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">support</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of such Regulatory Materials, solely for the purpose of seeking, obtaining and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">maintaining Regulatory</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Approvals</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">consistent</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">roles</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">this Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.7<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Labeling Information Exchange/Labeling Agreement</font><font style="font-size:10.5pt;">. The Parties shall cooperate</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to develop methods and/or procedures for sharing information related to Labeling. Specific</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">details regarding the management of Labeling information, including CCDS will be delineated in</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a separate Labeling agreement that shall be agreed upon by the</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Parties.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9.8</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Adverse Event Reporting and Safety Data</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Exchange</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;text-indent:7.42%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;font-weight:bold;">Safety Information Exchange; Pharmacovigilance</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Agreement</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark77"></a>(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">The Parties shall cooperate to develop methods and/or procedures</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">for sharing information relating to the clinical experiences in accordance with safety</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">reporting requirements</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">respective</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Authorities</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">comply with Applicable Laws. Specific details regarding the management of safety </font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">information including</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">adverse</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">events</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">reports</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the Products will be delineated in a separate global pharmacovigilance agreement (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">PVA</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">that shall be agreed to by the Parties as soon as reasonably practicable, but in any event not later than [***] of the Effective Date. The Lead Regulatory Party shall</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">be responsible for the compliance and filing of all required safety reports to the</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Regulatory Authorities in the Territory, including annual safety reports, throughout the</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Term.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:17.11%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;">The PVA shall provide as</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">follows:</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.06%;margin-right:1.03%;text-indent:22.27%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(A)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Unless otherwise agreed by the Parties, the Lead</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Regulatory Party</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">global</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">safety</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">database</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">mirror</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">databases</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">be maintained by the other Party; provided, however, that Takeda shall maintain the global</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">safety database</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">global</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">safety database regarding Licensed Analog Products. For clarity, to the extent a Party is no</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">longer actively Developing or Commercializing a Licensed [***] Product, then the global</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">safety database shall be transferred to the Party that continues to actively Develop or</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Commercialize such Licensed [***]</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.06%;margin-right:1.03%;text-indent:22.27%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(B)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">Each Party shall timely report to the other Party all</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">clinical experiences, safety monitoring, and pharmacovigilance surveillance observed in the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Territory, which in all cases shall be (i) for clinical studies: as soon as practicable, [***]</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">commercial Products: [***]; exchange of information shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be on</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Council</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">International</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Organizations</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Medical</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Sciences</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Suspect</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Adverse</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Reaction Report Form (&#8220;CIOMS</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Form&#8221;).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.06%;margin-right:1.03%;text-indent:22.27%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(C)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">The other Party shall prepare and provide to the</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">Lead Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">timely</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">safety</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">updates</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">order</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to meet</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">safety</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">report</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">submission</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">requirements</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">INDs</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and the Product Regulatory</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Approvals.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Regulatory Reporting of Safety Information</font><font style="font-size:10.5pt;">.&nbsp;&nbsp;The Parties shall work </font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">together to achieve consensus with respect to safety issues related to the Products, including urgent</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">safety information, and to report said opinion to safety boards, investigators, and to</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">applicable Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Authorities.</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">In</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">that,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">medical</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">scientific</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">consultation, the Parties cannot achieve consensus with respect to safety issues to be reported to </font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">any applicable</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Authority,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Lead</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">making</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">authority with respect to the Products in the Licensed Field in the Territory.<font style="letter-spacing:0.2pt;"> </font>Notwithstanding anything to the contrary in this Agreement, either Party may report safety matters to a<font style="letter-spacing:-0.5pt;"> </font>Regulatory Authority<font style="letter-spacing:1.65pt;"> </font>that<font style="letter-spacing:1.9pt;"> </font>it<font style="letter-spacing:1.95pt;"> </font>reasonably<font style="letter-spacing:1.7pt;"> </font>determines<font style="letter-spacing:1.9pt;"> </font>are<font style="letter-spacing:1.9pt;"> </font>necessary<font style="letter-spacing:1.6pt;"> </font>to<font style="letter-spacing:2.05pt;"> </font>report<font style="letter-spacing:1.9pt;"> </font>prior<font style="letter-spacing:1.85pt;"> </font>to<font style="letter-spacing:2.05pt;"> </font>the<font style="letter-spacing:1.85pt;"> </font>conclusion<font style="letter-spacing:1.9pt;"> </font>of<font style="letter-spacing:1.85pt;"> </font>the dispute resolution<font style="letter-spacing:-0.3pt;"> </font>procedure.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.9<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Regulatory Authority Communications Received by a Party</font><font style="font-size:10.5pt;">. Each Party shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">inform the other Party in a timely manner, not to exceed [***], of the notification of</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">any action by, or notification or other information which it receives (directly or indirectly) from</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">any Regulatory Authority which: (i) raises any material concerns regarding the safety or efficacy of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a Product; (ii) indicates or suggests a potential material liability of either Party to Third Parties</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">in connection with a Product; (iii) is reasonably likely to lead to a recall or market withdrawal of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">a Product;</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">(iv)</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">relates</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">expedited</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">reports</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">adverse</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">events</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">or Product Complaints, and which may have a material impact on obtaining or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">maintaining Regulatory Approval or the continued Commercialization of a Product, as then conducted.</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">The other Party will fully cooperate with and assist such Party in complying with</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">regulatory obligations and communications, including by providing to such Party, in a timely manner after</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">a request, such information and documentation in the other Party&#8217;s possession as may be</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">necessary or helpful for the Party to prepare a response to an inquiry from a Regulatory Authority.</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Each Party will provide the other Party in a timely manner with a copy of all correspondence</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">received from a Regulatory Authority specifically regarding the matters referred to</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">above.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.10<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Audit</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">desires</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">inspection</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">audit</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s facility or a facility under contract with such Party with regard to a Product in the Territory,</font><font style="font-size:10.5pt;letter-spacing:3pt;"> </font><font style="font-size:10.5pt;">then the audited Party shall notify the other Party as soon as practicably possible after receipt of</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">such notification of such audit or inspection and provide copies of any materials provided to it by</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the applicable Regulatory Authority; provided, that the audited Party shall not be required to</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">notify the other Party of audits or inspections that are of a routine nature or that do not relate to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">a Product, except where such audits result in communications or actions of such</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Regulatory Authority</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">direct</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">impact</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product.</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">addition,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Authority conducts an unannounced inspection or audit of a Party&#8217;s facility or a facility under contract</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">with such Party with regard to a Product in the Territory, then the audited Party shall notify the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">other Party within [***] of commencement of such audit or inspection. The</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">audited Party shall cooperate, and shall use reasonable efforts to cause the contract facility to</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">cooperate, with such Regulatory Authority and the other Party during such inspection or audit.</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Following receipt of the inspection or audit observations of such Regulatory Authority (a copy of which</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the audited Party will immediately provide to the other Party), the audited Party will also provide</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">the other</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">copies</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">communications</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">received</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Authorities with respect to such facilities in a timely manner after receipt, to the extent such</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">written communications</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">relate</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">directly</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Manufacture</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">thereof,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">prepare</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the response to any such observations. The audited Party will provide the other Party with a copy</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of any proposed response to such communications and will consider in good faith&nbsp;&nbsp;such</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">other Party&#8217;s reasonable comments with respect to such proposed response. The audited Party </font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">agrees to conform its activities under this Agreement to any commitments made in such a</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">response.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark78"></a>9.11<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Recalls and Voluntary Withdrawals</font><font style="font-size:10.5pt;">. Each Party shall notify the other Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">promptly but</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">later</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">determination</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">event, incident, or circumstance has occurred that may result in the need for a recall, market</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">suspension, or market withdrawal of a Product under any MAA or Regulatory Approval for the Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">held by</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">filed</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Authorities</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">include</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">such notice the reasoning behind such determination, and any supporting facts. Such Party shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">have the sole right to make the final determination whether to voluntarily implement any such</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">recall, market</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">suspension,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">market</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">withdrawal</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Territory;</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">any implementation</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">recall,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">market</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">suspension,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">market</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">withdrawal,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">shall, to the extent practical, consult with the other Party and shall consider the other Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">comments in good faith. For all recalls, market suspensions or market withdrawals undertaken pursuant</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to this</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">9.11,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">execution</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">thereof,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">other Party</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">cooperate</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">recall</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">efforts.</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Subject</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">17,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Party shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">recall,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">market</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">suspension,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">market</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">withdrawal; provided that, the other Party shall be responsible for the costs of any recall, market</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">suspension, or market withdrawal with respect to a Product in the Territory to the extent such recall,</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">market suspension, or market withdrawal is attributable to the other Party&#8217;s breach of its</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">obligations hereunder or its negligence, recklessness or willful</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">misconduct.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE 10&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>MANUFACTURING AND SUPPLY</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1 <font style="font-weight:bold;">Supply Agreement</font>. The Parties shall enter into mutually agreeable supply agreements<font style="letter-spacing:0.3pt;"> </font>as soon as appropriate after the Effective Date covering the manufacture and research supply<font style="letter-spacing:0.1pt;"> </font>(other than as provided in Section 6.6), clinical supply or Commercial supply of Compounds<font style="letter-spacing:1.95pt;"> </font>or Products needed for Development or<font style="letter-spacing:-0.4pt;"> </font>Commercialization.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark80"></a><a name="_bookmark79"></a><a name="_bookmark79"></a>ARTICLE 11&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>PAYMENT</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark81"></a>11.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;"><a name="_bookmark81"></a>Licensed Product Development Milestones Payable to</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">forty-five</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(45)</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">days after the first achievement of each of the following milestones for each Licensed</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Product, calculated as follows:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">[***];</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">upon Regulatory Approval of [***];</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">upon both (A) Regulatory Approval of [***] and (B) Pricing Approval [***]</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">[***];</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;text-indent:15.26%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(v)<font style="margin-left:117pt;"></font><font style="font-size:10.5pt;">upon Regulatory Approval of [***]</font><font style="font-size:10.5pt;font-family:Calibri;">;</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;font-family:Calibri;"> </font><font style="font-size:10.5pt;font-family:Calibri;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vi)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">upon both (A) Regulatory Approval of [***] and (B) Pricing Approval [***]</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">11.1</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">payable</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">first achievement</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">amounts</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">for subsequent or repeated achievements of such milestone for the same Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11.2</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark82"></a><font style="font-size:10.5pt;font-weight:bold;">Licensed Product Sales Milestones Payable to</font><font style="font-size:10.5pt;letter-spacing:0.15pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Takeda</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">[***] after</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">achievement</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">milestones</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">aggregated</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">annual</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Net Sales of all Licensed Products, calculated as</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">follows:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">upon the Net Sales in the Territory of all Licensed Products made</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx, its Affiliates and Sublicensees in a given Calendar Year equaling or exceeding</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">[***];</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">upon the Net Sales in the Territory of all Licensed Products made</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx, its Affiliates and Sublicensees in a given Calendar Year equaling or exceeding</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">[***];</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">upon the Net Sales in the Territory of all Licensed Products made</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx, its Affiliates and Sublicensees in a given Calendar Year equaling or exceeding</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">11.2</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">payable</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">first achievement</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">aggregate</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">amounts</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be due for subsequent or repeated achievements of such milestone. If two or more milestone</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">events are achieved in the same Calendar Year, Ultragenyx shall pay to Takeda each milestone</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">payment corresponding to the respective milestone</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">event.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark83"></a>11.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Licensed Product Royalties Payable to Takeda. </font><font style="font-size:10.5pt;">Subject to Section 11.8 below,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and during</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Royalty</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a Licensed</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Product-by-Licensed</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">basis,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">running</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">incremental royalty rates, on Net Sales of each Licensed Product in the Territory in a Calendar</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">Year:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:3.48%;width:411.05pt;;">
<tr>
<td style="width:294.55pt;"></td>
<td style="width:116.5pt;"></td>
</tr>
<tr style="height:21.8pt;">
<td valign="top" >
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:78.8pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Sales in the<font style="letter-spacing:-0.35pt;"> </font>Territory</p></td>
<td valign="top" >
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:38.05pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Royalty<font style="letter-spacing:-0.15pt;"> </font>Rate</p></td>
</tr>
<tr style="height:39.5pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:8.04%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales less than<font style="letter-spacing:-0.25pt;"> $</font>[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:63.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:21.9pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.25pt;"> </font>or</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:3.48%;width:401.6pt;;">
<tr>
<td style="width:305.8pt;"></td>
<td style="width:95.8pt;"></td>
</tr>
<tr style="height:21.9pt;">
<td colspan="2" valign="top" >
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:11.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">equal to $[***] but less than $[***]</p></td>
</tr>
<tr style="height:39.6pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:10.1%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.3pt;"> </font>or equal to $[***] but less than $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:49.3pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:35.7pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:10.1%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.25pt;"> </font>or equal to $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:49.3pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11.4</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Exercised Product Milestones and Fees Payable to</font><font style="font-size:10.5pt;letter-spacing:0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Ultragenyx</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark84"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Pursuant</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall pay</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Approval</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">indication</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Japan</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">[***] if such product is an Exercised Product that has</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">not been terminated at the time of such Regulatory Approval. The milestone payment in this</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Section 11.4(a) shall be payable only upon the first achievement of such milestone for each</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such Exercised Product and no amounts shall be due for subsequent or repeated achievements of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such milestone for such Exercised Product. For clarity, the maximum aggregate amount payable </font><font style="font-size:10.5pt;letter-spacing:0.15pt;">by</font><font style="font-size:10.5pt;"> Takeda</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">11.4(a)</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">For all Ultragenyx Pipeline Products other than [***], during the Takeda Option Negotiation Period for such Ultragenyx Pipeline Products, the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Parties will negotiate in good faith (for inclusion in the applicable Exercised Product</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">License Agreement) commercially reasonable financial terms in addition to the royalties contemplated</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">in Section 11.6 (such as one or more of the following: option exercise fees, sales and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">development milestones, reimbursement for historical research and development costs allocable to Japan,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and milestones due to Third Party licensors) for such Ultragenyx Pipeline Products, taking</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">into consideration</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">factors</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">investment</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">collaboration</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">already made by Takeda, including the premium paid by Takeda to Ultragenyx under the Common</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Stock Purchase</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Agreement.</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">cannot</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">reach</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">commercially</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">reasonable financial terms during the Takeda Option Negotiation Period, either Takeda or Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">may seek a final decision regarding the commercially reasonable financial terms pursuant to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">binding arbitration as set forth in Section 16.3.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark85"></a>11.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Licensed Product Royalties Payable to Ultragenyx for the Exercised</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Countries</font><font style="font-size:10.5pt;">. Subject to Section 11.8 below, and during the applicable Licensed Product Royalty Term, pursuant</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx, on a Licensed Product-by-Licensed Product basis, a running royalty at the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">following incremental</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">rates,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">aggregate,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Net</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Sales</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Licensed Product in the Exercised Countries in a Calendar</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Year:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">exercised</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to Takeda&#8217;s receipt of the Final Phase II Data Package for such Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">Product:</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:3.48%;width:411.1pt;;">
<tr>
<td style="width:294.55pt;"></td>
<td style="width:116.55pt;"></td>
</tr>
<tr style="height:21.8pt;">
<td valign="top" >
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:51.2pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Sales in the Exercised<font style="letter-spacing:-0.3pt;"> </font>Countries</p></td>
<td valign="top" >
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:38.1pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Royalty<font style="letter-spacing:-0.15pt;"> </font>Rate</p></td>
</tr>
<tr style="height:39.5pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:8.04%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales less than<font style="letter-spacing:-0.25pt;"> </font>$[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:63.55pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:39.6pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:7.84%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.3pt;"> </font>or equal to $[***] but less than $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.55pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:39.6pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:7.84%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.3pt;"> </font>or equal to $[***] but less than $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.55pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:35.7pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:7.84%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.3pt;"> </font>or equal to $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.55pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If the Takeda Option for such Licensed Product is exercised by Takeda</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">after Takeda&#8217;s receipt of the Final Phase II Data Package for such Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Product:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:3.48%;width:411.05pt;;">
<tr>
<td style="width:294.55pt;"></td>
<td style="width:116.5pt;"></td>
</tr>
<tr style="height:21.8pt;">
<td valign="top" >
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:51.2pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Sales in the Exercised<font style="letter-spacing:-0.3pt;"> </font>Countries</p></td>
<td valign="top" >
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:38.05pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Royalty<font style="letter-spacing:-0.15pt;"> </font>Rate</p></td>
</tr>
<tr style="height:39.5pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:8.04%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales less than<font style="letter-spacing:-0.3pt;"> </font>$[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:39.6pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:7.84%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.3pt;"> </font>or equal to $[***] but less than $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:39.6pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:7.84%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.3pt;"> </font>or equal to $[***] but less than $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
<tr style="height:35.7pt;">
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:11.5pt;;margin-right:7.63%;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For that portion of annual Net Sales greater than<font style="letter-spacing:-0.2pt;"> </font>or equal to $[***]</p></td>
<td valign="top" >
<p style="margin-top:5pt;margin-bottom:0pt;margin-left:60.5pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]%</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark86"></a>11.6<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Licensed Option Product and Ultragenyx Pipeline Product Royalties Payable</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">to Ultragenyx for the Exercised Countries</font><font style="font-size:10.5pt;">. During the Takeda Option Negotiation Period for</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">a Licensed Option Product or Ultragenyx Pipeline Product, the Parties will negotiate in good</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">faith (for</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">inclusion</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Agreement)</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">tiered</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">rates</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">on annual Net Sales of such Licensed Option Product or Ultragenyx Pipeline Product to be paid</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by Takeda to Ultragenyx during the Takeda Royalty Term. If the Parties cannot reach agreement</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">on such tiered royalty rates during the Takeda Option Negotiation Period, either Takeda</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">seek</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">rates</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">binding</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">arbitration as set forth in Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">16.3.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark87"></a>11.7<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Royalty Reduction for Generic Product Entry in a Country</font><font style="font-size:10.5pt;">. On a Licensed</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Product- by-Licensed Product basis, the royalty rates set forth in Sections 11.3 and 11.5 for Net Sales of</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">a Product</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">country</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">reduced</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Quarter</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">during which the Generic Competition Percentage with respect to such Licensed Product in </font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">such country in such Calendar Quarter is greater than or equal to [***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11.8</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark88"></a><font style="font-size:10.5pt;font-weight:bold;">Payment for Third Party</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Licenses</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">paying</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">fees,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">royalties, and/or milestones, with respect to Third Party licenses entered into by such Party or its</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Affiliates prior to or on the Effective Date or during the Term, for intellectual property that is necessary</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or reasonably useful for the Exploitation of any Licensed Product. For such Third Party licenses</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to Preexisting Third Party IP, the paying Party will be entitled to deduct up to [***] of such amounts due to any such Third Party from royalties payable to the other Party hereunder</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">on such</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Product.</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">licenses</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">obtained</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">paying Party will be entitled to deduct [***] of such amounts due to any such Third</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Party from royalties payable to the other Party hereunder on such Licensed Product.</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Notwithstanding the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">foregoing,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">payable</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Quarter</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">a result</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">reduction</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">less</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">[***] of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">amount</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">would</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">be due.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall be responsible for paying all Third Party license fees,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">royalties, and/or milestones, with respect to Third Party licenses for intellectual property that is</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">necessary or reasonably useful for the Exploitation of any Ultragenyx Pipeline Product, where </font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such licenses</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">entered</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">unless</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">until</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">such Ultragenyx Pipeline Product is an Exercised Product, during the Term. Each Party will be responsible</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">paying</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">fees,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">royalties,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and/or</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">milestones,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to Third Party licenses for intellectual property that is necessary or reasonably useful for</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the Exploitation of any Ultragenyx Pipeline Product that is an Exercised Product entered into </font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">by such Party or its Affiliates on or after the date on which it becomes an Exercised Product.</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">For such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">licenses</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">obtained</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">entitled</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">deduct [***] of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">amounts</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">royalties</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">payable</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx on such Exercised Product. Notwithstanding the foregoing, in no event shall</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">the royalty</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">payable</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Quarter</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">result</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of this reduction be less than [***] of the amount that would otherwise be</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">due.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, for intellectual property held by a Third Party</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">that is necessary or reasonably useful for the Exploitation of any Exercised Products in both</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">the Exercised</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Countries</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">countries</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">coordinate</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">license negotiations with such Third Party for rights in both the Exercised Countries and other</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">countries in the</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark89"></a>11.9<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Manner of Royalty Payment. </font><font style="font-size:10.5pt;">Each Party will&nbsp;&nbsp;calculate and report royalty </font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">payments due</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">11.3</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">11.5,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Calendar Quarter. Each Party shall pay all royalty payments due under Section 11.3 or 11.5, as</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">applicable, within sixty (60) days after the end of each Calendar Quarter and shall include&nbsp;&nbsp;with</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">each payment</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">report</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">containing</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Quarter:</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">(a) the amount of gross sales (in U.S. dollars) of the Products in the Territory; (b) an</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">itemized calculation</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Net</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Sales</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">showing</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">deductions,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">provided for</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">definition</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">&#8220;Net</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Sales&#8221;;</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(c)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">calculation</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">sales;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="letter-spacing:0.45pt;"> </font>an<font style="letter-spacing:0.65pt;"> </font>accounting<font style="letter-spacing:0.4pt;"> </font>of<font style="letter-spacing:0.6pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>number<font style="letter-spacing:0.45pt;"> </font>of<font style="letter-spacing:0.5pt;"> </font>units<font style="letter-spacing:0.55pt;"> </font>and<font style="letter-spacing:0.5pt;"> </font>prices<font style="letter-spacing:0.55pt;"> </font>for<font style="letter-spacing:0.7pt;"> </font>the<font style="letter-spacing:0.5pt;"> </font>Products<font style="letter-spacing:0.55pt;"> </font>sold;<font style="letter-spacing:0.55pt;"> </font>and<font style="letter-spacing:0.55pt;"> </font>(e)<font style="letter-spacing:0.55pt;"> </font>application<font style="letter-spacing:0.5pt;"> </font>of</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the<font style="letter-spacing:1.8pt;"> </font>reductions,<font style="letter-spacing:1.85pt;"> </font>if<font style="letter-spacing:1.95pt;"> </font>any,<font style="letter-spacing:1.95pt;"> </font>made<font style="letter-spacing:1.75pt;"> </font>in<font style="letter-spacing:1.85pt;"> </font>accordance<font style="letter-spacing:1.9pt;"> </font>with<font style="letter-spacing:1.85pt;"> </font>the<font style="letter-spacing:1.8pt;"> </font>terms<font style="letter-spacing:1.85pt;"> </font>of<font style="letter-spacing:2pt;"> </font>Section<font style="letter-spacing:2pt;"> </font>11.7<font style="letter-spacing:1.85pt;"> </font>and<font style="letter-spacing:1.9pt;"> </font>11.8.<font style="letter-spacing:0.75pt;"> </font>Within twenty<font style="letter-spacing:1.2pt;"> </font>(20)<font style="letter-spacing:1.35pt;"> </font>Business<font style="letter-spacing:1.45pt;"> </font>Days<font style="letter-spacing:1.55pt;"> </font>after<font style="letter-spacing:1.4pt;"> </font>the<font style="letter-spacing:1.4pt;"> </font>end<font style="letter-spacing:1.3pt;"> </font>of<font style="letter-spacing:1.4pt;"> </font>each<font style="letter-spacing:1.4pt;"> </font>Calendar<font style="letter-spacing:1.4pt;"> </font>Quarter,<font style="letter-spacing:1.4pt;"> </font>each<font style="letter-spacing:1.4pt;"> </font>Party<font style="letter-spacing:1.2pt;"> </font>shall<font style="letter-spacing:1.3pt;"> </font>provide<font style="letter-spacing:1.4pt;"> </font>a preliminary report as described above for the most recent Calendar Quarter then ended.<font style="letter-spacing:2.8pt;"> </font>Each Party<font style="letter-spacing:1.7pt;"> </font>shall<font style="letter-spacing:1.95pt;"> </font>reasonably<font style="letter-spacing:1.7pt;"> </font>cooperate<font style="letter-spacing:1.95pt;"> </font>to<font style="letter-spacing:2pt;"> </font>reconcile<font style="letter-spacing:1.9pt;"> </font>any<font style="letter-spacing:1.85pt;"> </font>deviations<font style="letter-spacing:2pt;"> </font>and<font style="letter-spacing:1.95pt;"> </font>confirm<font style="letter-spacing:2pt;"> </font>the<font style="letter-spacing:1.95pt;"> </font>accuracy<font style="letter-spacing:1.7pt;"> </font>to<font style="letter-spacing:2pt;"> </font>the extent necessary under Applicable Laws, GAAP or<font style="letter-spacing:-0.65pt;"> </font>IFRS.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark90"></a>11.10<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Exchange</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Rate</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">rate</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">exchange</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">used</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">computing</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">amount</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">currency equivalent</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">U.S.</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Dollars</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">owed</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">equal</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">weighted average</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">exchange</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">rate,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">over</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Quarter,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">between</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">currency</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">origin and U.S. Dollars as reported by OANDA (www.oanda.com), or an equivalent resource as</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">agreed by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Parties,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">last</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Business</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Day</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Quarter</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Net Sales were</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">made.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11.11</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark91"></a><font style="font-size:10.5pt;font-weight:bold;">Taxes</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Cooperation and Coordination</font><font style="font-size:10.5pt;">. The Parties acknowledge and agree that it</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">is their mutual objective and intent to appropriately calculate, to the extent feasible and legal,</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">taxes payable with respect to their collaborative efforts under this Agreement and that they shall use</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">all commercially</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">efforts</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">cooperate</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">coordinate</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">achieve</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">such objective. Ultragenyx shall cooperate with Takeda in seeking any tax exemption or credits</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">that may be available to Takeda with respect to any research which Takeda or its affiliates perform</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">or fund under this Agreement, including any credits under section 45C of the U.S. Internal</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Revenue Code of 1986, as</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">amended.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Payment</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">of</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Tax</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">A</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">receiving</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">11 shall</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">taxes</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">levied</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">payment.</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">A</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">this ARTICLE 11 shall make a reasonable effort to obtain the lowest tax rate under Applicable</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Laws for taxes required to be deducted and withheld. If Applicable Laws require that&nbsp;&nbsp;taxes</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be deducted and withheld from a payment made pursuant to this ARTICLE 11, after a Party</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">making a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">makes</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">effort</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">obtain</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">lowest</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">tax</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">rate,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">remitting</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall:</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">(i) deduct</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">those</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">taxes</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">payment;</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">taxes</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">proper</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">taxing</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">authority;</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">(iii) send</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">evidence</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">obligation</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">together</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">proof</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">sixty</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(60) days following that<font style="letter-spacing:-0.3pt;"> </font>payment.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark92"></a>(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Tax Residence Certificate</font><font style="font-size:10.5pt;">. A Party receiving a payment pursuant to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">11</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">remitting</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">appropriate</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">certification</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">relevant</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">revenue authorities</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">tax</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">resident</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">jurisdiction,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">receiving</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">wishes</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to claim</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">benefits</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">income</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">tax</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">treaty</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">jurisdiction</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">party.</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Upon</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">receipt thereof, any deduction and withholding of taxes shall be made at the appropriate treaty tax</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">rate.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Assessment</font><font style="font-size:10.5pt;">. Either Party may, at its own expense, protest any</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">assessment, proposed assessment, or other claim by any Governmental Authority for any additional </font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">amount of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">taxes,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">interest</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">penalties</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">seek</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">refund</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">amounts</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">paid</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">do</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">so</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by Applicable Laws. The Parties shall cooperate with each other in any&nbsp;&nbsp;protest&nbsp;&nbsp;by</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">providing records</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">additional</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">pursue such</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">protest.</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark93"></a>(e)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Withholding</font><font style="font-size:10.5pt;">. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">If </font><font style="font-size:10.5pt;">a Party that owes a payment under this Agreement assigns</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">its rights and obligations to any Person and if, solely as a result of such&nbsp;&nbsp;assignment, </font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the withholding or deduction of tax required by Applicable Laws with respect to payments under</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">this Agreement is increased, then, subject to Section 11.11(f), any amount payable under</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">this Agreement</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">increased</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">take</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">account</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">withheld</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">deducted</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">taxes</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">be necessary so that, after making all required withholdings and deductions (including</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">withholdings and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">deductions</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">amounts</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">payable</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">11.11(e)),</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">payee</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">receives</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">amount equal</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">sum</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">would</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">received</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">had</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">increased</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">withholding</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">deduction</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">been made.</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">avoidance</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">doubt,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">payee</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">assigns</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and obligations under this Agreement, the payee shall not be entitled to any additional payments</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with respect to Taxes arising as a result of such payee's</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">assignment.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark94"></a>(f)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Credit. </font><font style="font-size:10.5pt;">To the extent a payee obtains any credit for Taxes for which it</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">has received a payment pursuant to Section 11.11(e) against any liability for tax in the year in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">which the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">taxable,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">preceding</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">years,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">succeeding</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">years</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">term</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">this Agreement, thereby reducing out-of-pocket tax payments by the Section 11.11(e)-payee in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">such year or years, calculated on a "with and without" basis, the Section 11.11(e)-payee </font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">shall promptly reimburse the Section 11.11(e)-payor an amount equal to its tax savings resulting</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">from such credit and the Section 11.11(e)-payee shall timely provide the Section 11.11(e)-payor</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">with reasonable evidence as may reasonably be requested to determine whether any amounts</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">are subject to reimbursement pursuant to this Section</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">11.11(f).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark95"></a>11.12<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Audit.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">accurate</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">records</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">sufficient</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">detail</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to permit</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">confirm</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">accuracy</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">calculation</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">payments under this Agreement. Upon reasonable prior notice, such records shall be available</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">during regular business hours for a period of three (3) years from the end of the Calendar Year to</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">which they pertain for examination at the expense of the requesting Party, and not more often than</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">once each</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Calendar</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Year,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">independent</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">certified</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">public</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">accountant</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">selected</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">requesting Party and reasonably acceptable to the other Party, for the sole purpose of verifying the</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">accuracy of</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">financial</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">reports</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">furnished</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Agreement.</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Any</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">such auditor</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">disclose</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Confidential</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Information,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such disclosure is necessary to verify the accuracy of the financial reports furnished by the other</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Party or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">amount</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">payments</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">thirty six (36) months. Any amounts shown to be owed but unpaid shall be paid within thirty (30)</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">days from</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">accountant&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">report,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">plus</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">interest</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">(as</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">11.13)</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">original</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">due date. Any amounts shown to have been overpaid shall be refunded within thirty (30) days</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">from the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">accountant&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">report.</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">requesting</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">bear</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">full</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">cost</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">audit</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">unless</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such audit</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">discloses</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">underpayment</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">more</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">five</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">percent</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">(5%)</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">amount due, in which case the other Party shall bear the full cost of such</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">audit.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark96"></a>11.13<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Manner</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">of</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Payment,</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Late</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Payment.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">All</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">payments</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be made in U.S. Dollars by wire transfer of immediately available funds into an account</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">designated by</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party.</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">does</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">receive</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">payment</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">sum</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">due date, simple interest shall thereafter accrue on the sum due to such Party until the&nbsp;&nbsp;date</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">of payment</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">per</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">annum</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">rate</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">percent</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">(1%)</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">over</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">then-current</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">prime</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">rate</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">quoted</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">by</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Citibank<font style="letter-spacing:1.2pt;"> </font>in<font style="letter-spacing:1.15pt;"> </font>New<font style="letter-spacing:1.2pt;"> </font>York<font style="letter-spacing:1.25pt;"> </font>City<font style="letter-spacing:0.85pt;"> </font>or<font style="letter-spacing:1.2pt;"> </font>the<font style="letter-spacing:1.2pt;"> </font>maximum<font style="letter-spacing:1.25pt;"> </font>rate<font style="letter-spacing:1.2pt;"> </font>allowable<font style="letter-spacing:1.2pt;"> </font>by<font style="letter-spacing:1.25pt;"> </font>Applicable<font style="letter-spacing:1.3pt;"> </font>Laws,<font style="letter-spacing:1.25pt;"> </font>whichever<font style="letter-spacing:1.2pt;"> </font>is lower.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.14<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Finance and Accounting Working Group</font><font style="font-size:10.5pt;">. The Parties shall cooperate with each</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">other to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">achieve</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">finance</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">accounting</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">objectives</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">contemplated</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">herein</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">timely,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">accurate</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and responsive manner. The Parties shall establish a finance and accounting working group</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to manage</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">financial</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">accounting</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">affairs</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">which,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">least</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">first twelve (12) months after the Effective Date, shall meet monthly unless otherwise agreed upon</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">by the</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Parties.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:18.37%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark97"></a><a name="_bookmark97"></a>ARTICLE 12&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>INTELLECTUAL PROPERTY<font style="letter-spacing:-0.15pt;"> </font>MATTERS</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark98"></a>12.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Ownership of Inventions</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Sole</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Ownership.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Subject</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">own any Inventions made solely by its own employees, agents, or independent contractors or</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">its Affiliate&#8217;s or sublicensees&#8217; employees, agents, or independent contractors in the course</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">of conducting its activities under this Agreement, together with all intellectual property</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">rights therein.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark99"></a>(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Joint Ownership</font><font style="font-size:10.5pt;">. The Parties shall jointly own any Inventions that are</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">made jointly</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">employees,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">agents,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">independent</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">contractors</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the course</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">performing</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">together</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">intellectual</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">property rights therein (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Inventions</font><font style="font-size:10.5pt;">&#8221;).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Inventorship. </font><font style="font-size:10.5pt;">For purposes of this Agreement, inventorship shall be</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">determined in accordance with U.S. patent laws.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.2</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Assignment Obligation and Disclosure of</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Inventions</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each Party shall cause all Persons who perform activities for such Party under</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">this Agreement to be under an obligation to assign (or, if such Party is unable to cause such Person</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">to agree to such assignment obligation despite such Party using commercially reasonable efforts</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">to negotiate such assignment obligation, provide a license under) their rights in any Information</font><font style="font-size:10.5pt;letter-spacing:-0.9pt;"> </font><font style="font-size:10.5pt;">and Inventions</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">resulting</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">therefrom</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">where</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Law</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">requires</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">otherwise and except in the case of governmental, not-for-profit and public institutions which </font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">have standard policies against such an assignment (in which case a suitable license, or right to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">obtain such a license, shall be</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">obtained).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Takeda will promptly disclose to Ultragenyx in writing, the</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">conception, discovery, development or making of any Joint Inventions and any Inventions</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Covering Ultragenyx Pipeline Improvements by Persons who perform activities for Takeda under</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">this Agreement.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx will promptly disclose to Takeda in writing the conception,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">discovery, development</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Inventions</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Inventions</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Covering</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Product Improvements, or Option Product</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Improvements.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each Party will promptly disclose to the other Party in writing, the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">conception, discovery, development or making of any Joint Inventions by Persons who perform activities</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">for it under this</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.3</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark100"></a><font style="font-size:10.5pt;font-weight:bold;">Prosecution of Patents.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark101"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Licensed </font><font style="font-size:10.5pt;">[***]</font><font style="font-weight:bold;font-size:10.5pt;"> Patents, Licensed Product Improvement Patents, and</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Joint Patents relating to Licensed Products. </font><font style="font-size:10.5pt;">Except as otherwise provided in this Section 12.3(a),</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">as between the Parties, Takeda shall have the sole right and authority to prepare, file, prosecute</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">and maintain the Licensed [***] Patent, Licensed Product Improvement Patents, and, where relating</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to Licensed</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">(collectively,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">&#8220;[***]</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Prosecution&#8221;)</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">worldwide basis (including the right to defend in patent office proceedings such as inter partes reviews,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">post grant reviews and oppositions).Takeda shall bear all costs of preparation, filing, prosecution</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">and maintenance</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Prosecution</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Territory.</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Provided</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">rights with respect to the applicable Licensed Product have not terminated, Takeda, upon</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s request,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">opportunity</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">review</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">comment</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">material communications from any patent authority in the Territory regarding the [***] Patent</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Prosecution and drafts of any material filings or responses to be made to such patent authorities in advance</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of submitting such filings or responses. Takeda shall consider Ultragenyx&#8217;s comments</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">regarding such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">communications</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">drafts</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">view</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">maximizing</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">protection and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">scope</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Field.</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the applicable Licensed Product have not terminated and Takeda determines in its sole discretion</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to abandon</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Improvement</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or, where relating to Licensed Products, Joint Patent that is being prosecuted or maintained</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">by Takeda</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Field,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">then</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">shall provide Ultragenyx with written notice of such determination within a period of time</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">reasonably necessary</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">allow</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">determine,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">discretion,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">interest</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Patent(s) (which notice by Takeda shall be given no later than sixty (60) days prior to the final deadline</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">for any pending action or response that may be due with respect to such Patent(s) with the</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">applicable patent authority). If Ultragenyx provides timely written notice expressing its interest</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">in continuing</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">support</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Patent(s),</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">pursue</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">or support</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">continued</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">prosecution</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">maintenance</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">reimbursement</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">out-of-pocket</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">costs,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">unpublished</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">patent applications</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">documents</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">permit</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">take such action to establish or preserve any such Patents. If Ultragenyx pursues the filing or</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">support of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">continues</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">pursue</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Field,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">it shall provide Takeda a reasonable opportunity to review and comment on</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">material communications</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">drafts</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of any</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">filings</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">responses</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">authorities</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">advance</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">submitting such filings or responses. Ultragenyx shall consider Takeda&#8217;s comments regarding</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such communications and drafts in good</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">faith.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.4%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark102"></a>(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Option Product Patents, Option Product Improvement Patents, and</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Joint Patents Relating to Research Products. </font><font style="font-size:10.5pt;">Except as otherwise provided in this Section </font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">12.3(b), as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">between</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Parties,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">prepare,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">file,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">prosecute and maintain the Option Product Patents, Option Product Improvement Patents and,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">where relating</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">worldwide</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(including</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">defend in</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">office</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">proceedings</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">inter</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">partes</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">reviews,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">post</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">reviews</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">oppositions). Takeda shall bear all costs of preparation, filing, prosecution and maintenance of Option</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Product Patents,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Improvement</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">where</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">relating</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Joint Patents</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Territory.</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">During</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Collaboration</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">request, shall provide Ultragenyx a reasonable opportunity to review and comment on</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">material communications from any patent authority in the Territory regarding Option Product</font><font style="font-size:10.5pt;letter-spacing:-0.95pt;"> </font><font style="font-size:10.5pt;">Patents, Option Product Improvement Patents and, where relating to Research Products, Joint Patents</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and drafts</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">filings</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">responses</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">authorities</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">advance</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of submitting such filings or responses. Takeda shall consider Ultragenyx&#8217;s comments</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">regarding such</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">communications</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">drafts</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">view</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">maximizing</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">protection and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">scope</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Field;</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">authority rests with Takeda. If, during the Collaboration Term, Takeda determines in its sole discretion</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to abandon</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Improvement</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and, where relating to Research Products, Joint Patent that is being prosecuted or maintained</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">by Takeda in the Territory, then Takeda shall provide Ultragenyx with written notice of</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">such determination within a period of time reasonably necessary to allow Ultragenyx to determine,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">discretion,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">interest</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Patent(s)</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(which</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">given</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">later than</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">sixty</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(60)</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">deadline</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">pending</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">response</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be due</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Patent(s)</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">authority).</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">provides timely</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">expressing</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">interest</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">continuing</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">support</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patent(s),</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">pursue</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">support</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">continued</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">prosecution</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">maintenance</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of such Patents and Takeda shall provide to Ultragenyx, subject to reimbursement of Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">out- of-pocket</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">costs,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">unpublished</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">applications</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">documents necessary to permit Ultragenyx to take such action to establish or preserve any such Patents.</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">If Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">pursues</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">support</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Patents,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">reasonable opportunity to review and comment on material communications from any patent authority in</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">the Territory regarding such Patents and drafts of any material filings or&nbsp;&nbsp;responses to be made</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">to such</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">authorities</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">advance</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">submitting</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">filings</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">responses.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">shall consider Takeda&#8217;s comments regarding such communications and drafts in good</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">faith. Notwithstanding the foregoing, following the execution of an Option Product License</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">Agreement and/or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">covering</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such license agreement(s) shall govern the handling of the preparation, filing, prosecution</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and maintenance of Patents covering the Option</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Product(s).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark103"></a>(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Ultragenyx Pipeline Patents, Ultragenyx Pipeline Improvement</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Patents, Ultragenyx</font><font style="font-size:10.5pt;"> [***]</font><font style="font-weight:bold;font-size:10.5pt;"> Patents and Joint Patents Related to Ultragenyx Pipeline Products</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Except as</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">12.3(c),</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">between</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Parties,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the sole right and authority to prepare, file, prosecute and maintain the Ultragenyx Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Patents, Ultragenyx Pipeline Improvement Patents, Ultragenyx [***] Patents and, where relating</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Products,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">included</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Inventions</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Joint</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;">&#8221;),</font></p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on a worldwide basis (including the right to defend in patent office proceedings such as<font style="letter-spacing:0.95pt;"> </font>inter partes reviews, post grant reviews and oppositions). Ultragenyx shall bear all costs <font style="letter-spacing:0.25pt;"> </font>of preparation, filing, prosecution and maintenance of Ultragenyx Pipeline Patents,<font style="letter-spacing:0.45pt;"> </font>Ultragenyx Pipeline Improvement Patents, Ultragenyx [***] Patents and, where relating to <font style="letter-spacing:0.2pt;"> </font>Ultragenyx Pipeline Products, Joint Patents in the Territory. During the Takeda Option Term, Ultragenyx, upon Takeda&#8217;s request, shall provide Takeda a reasonable opportunity to review and comment<font style="letter-spacing:-0.55pt;"> </font>on material communications from any patent authority in the Territory regarding<font style="letter-spacing:1.7pt;"> </font>Ultragenyx Pipeline Patents, Ultragenyx Pipeline Improvement Patents, Ultragenyx [***] Patents and,<font style="letter-spacing:2.25pt;"> </font>where relating to Ultragenyx Pipeline Products, Joint Patents and drafts of any material filings<font style="letter-spacing:0.75pt;"> </font>or responses to be made to such patent authorities in advance of submitting such filings<font style="letter-spacing:2.6pt;"> </font>or responses. Ultragenyx shall consider Takeda&#8217;s comments regarding such communications<font style="letter-spacing:0.25pt;"> </font>and drafts<font style="letter-spacing:0.65pt;"> </font>in<font style="letter-spacing:0.8pt;"> </font>good<font style="letter-spacing:0.75pt;"> </font>faith<font style="letter-spacing:0.65pt;"> </font>with<font style="letter-spacing:0.8pt;"> </font>a<font style="letter-spacing:0.6pt;"> </font>view<font style="letter-spacing:0.6pt;"> </font>to<font style="letter-spacing:0.75pt;"> </font>maximizing<font style="letter-spacing:0.55pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>Patent<font style="letter-spacing:0.65pt;"> </font>protection<font style="letter-spacing:0.65pt;"> </font>and<font style="letter-spacing:0.65pt;"> </font>scope<font style="letter-spacing:0.6pt;"> </font>in<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>Territory; provided that final decision making authority rests with Ultragenyx. During the Takeda<font style="letter-spacing:2.45pt;"> </font>Option Term, if Ultragenyx determines in its sole discretion to abandon or not maintain any<font style="letter-spacing:0.05pt;"> </font>Ultragenyx Pipeline<font style="letter-spacing:2.05pt;"> </font>Patent,<font style="letter-spacing:2.1pt;"> </font>Ultragenyx<font style="letter-spacing:2.2pt;"> </font>Pipeline<font style="letter-spacing:2.3pt;"> </font>Improvement<font style="letter-spacing:2.1pt;"> </font>Patent,<font style="letter-spacing:2.3pt;"> </font>Ultragenyx<font style="letter-spacing:2.3pt;"> </font>[***]<font style="letter-spacing:2.1pt;"> </font>Patent<font style="letter-spacing:2.2pt;"> </font>and,<font style="letter-spacing:2.1pt;"> </font>where relating<font style="letter-spacing:0.8pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>Ultragenyx<font style="letter-spacing:0.85pt;"> </font>Pipeline<font style="letter-spacing:0.7pt;"> </font>Products,<font style="letter-spacing:0.8pt;"> </font>Joint<font style="letter-spacing:0.8pt;"> </font>Patent<font style="letter-spacing:1pt;"> </font>that<font style="letter-spacing:0.75pt;"> </font>is<font style="letter-spacing:0.8pt;"> </font>being<font style="letter-spacing:0.65pt;"> </font>prosecuted<font style="letter-spacing:0.75pt;"> </font>or<font style="letter-spacing:0.7pt;"> </font>maintained<font style="letter-spacing:0.85pt;"> </font>by Ultragenyx in the Takeda Territory, then Ultragenyx shall provide Takeda with written notice<font style="letter-spacing:1.55pt;"> </font>of such<font style="letter-spacing:0.85pt;"> </font>determination<font style="letter-spacing:0.85pt;"> </font>within<font style="letter-spacing:0.85pt;"> </font>a<font style="letter-spacing:0.85pt;"> </font>period<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>time<font style="letter-spacing:0.85pt;"> </font>reasonably<font style="letter-spacing:0.65pt;"> </font>necessary<font style="letter-spacing:0.5pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>allow<font style="letter-spacing:1.25pt;"> </font>Takeda<font style="letter-spacing:0.85pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>determine, in its sole discretion, its interest in such Patent(s) (which notice by Ultragenyx shall be given<font style="letter-spacing:0.6pt;"> </font>no later than sixty (60) days prior to the final deadline for any pending action or response that<font style="letter-spacing:2.75pt;"> </font>may be<font style="letter-spacing:0.9pt;"> </font>due<font style="letter-spacing:0.9pt;"> </font>with<font style="letter-spacing:0.95pt;"> </font>respect<font style="letter-spacing:0.95pt;"> </font>to<font style="letter-spacing:0.95pt;"> </font>such<font style="letter-spacing:0.95pt;"> </font>Patent(s)<font style="letter-spacing:0.9pt;"> </font>with<font style="letter-spacing:0.95pt;"> </font>the<font style="letter-spacing:0.9pt;"> </font>applicable<font style="letter-spacing:0.9pt;"> </font>patent<font style="letter-spacing:0.95pt;"> </font>authority).<font style="letter-spacing:2.05pt;"> </font>If<font style="letter-spacing:1.15pt;"> </font>Takeda<font style="letter-spacing:0.95pt;"> </font>provides timely written notice expressing its interest in continuing to support such Patent(s), Takeda<font style="letter-spacing:1.55pt;"> </font>shall have<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>right<font style="letter-spacing:0.9pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>pursue<font style="letter-spacing:0.9pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>filing<font style="letter-spacing:0.8pt;"> </font>or<font style="letter-spacing:0.85pt;"> </font>support<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>continued<font style="letter-spacing:0.85pt;"> </font>prosecution<font style="letter-spacing:0.85pt;"> </font>or<font style="letter-spacing:0.95pt;"> </font>maintenance<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>such Patents<font style="letter-spacing:0.85pt;"> </font>and<font style="letter-spacing:0.85pt;"> </font>Ultragenyx<font style="letter-spacing:1pt;"> </font>shall<font style="letter-spacing:0.85pt;"> </font>provide<font style="letter-spacing:0.8pt;"> </font>to<font style="letter-spacing:0.95pt;"> </font>Takeda,<font style="letter-spacing:0.95pt;"> </font>subject<font style="letter-spacing:0.85pt;"> </font>to<font style="letter-spacing:0.85pt;"> </font>reimbursement<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.9pt;"> </font>Ultragenyx&#8217;s<font style="letter-spacing:0.9pt;"> </font>out- of-pocket<font style="letter-spacing:1.75pt;"> </font>costs,<font style="letter-spacing:1.65pt;"> </font>all<font style="letter-spacing:1.65pt;"> </font>unpublished<font style="letter-spacing:1.55pt;"> </font>patent<font style="letter-spacing:1.6pt;"> </font>applications<font style="letter-spacing:1.6pt;"> </font>and<font style="letter-spacing:1.6pt;"> </font>any<font style="letter-spacing:1.35pt;"> </font>other<font style="letter-spacing:1.55pt;"> </font>information<font style="letter-spacing:1.6pt;"> </font>and<font style="letter-spacing:1.6pt;"> </font>documents necessary to permit Takeda to take such action to establish or preserve any such Patents.<font style="letter-spacing:2.35pt;"> </font><font style="letter-spacing:-0.15pt;">If</font> Takeda pursues the filing or support of such Patents, it shall provide Ultragenyx a<font style="letter-spacing:2.35pt;"> </font>reasonable opportunity to review and comment on material communications from any patent authority in<font style="letter-spacing:0.1pt;"> </font>the Territory<font style="letter-spacing:1.25pt;"> </font>regarding<font style="letter-spacing:1.3pt;"> </font>such<font style="letter-spacing:1.45pt;"> </font>Patents<font style="letter-spacing:1.45pt;"> </font>and<font style="letter-spacing:1.45pt;"> </font>drafts<font style="letter-spacing:1.35pt;"> </font>of<font style="letter-spacing:1.45pt;"> </font>any<font style="letter-spacing:1.1pt;"> </font>material<font style="letter-spacing:1.45pt;"> </font>filings<font style="letter-spacing:1.45pt;"> </font>or<font style="letter-spacing:1.45pt;"> </font>responses<font style="letter-spacing:1.35pt;"> </font>to<font style="letter-spacing:1.4pt;"> </font>be<font style="letter-spacing:1.4pt;"> </font>made<font style="letter-spacing:1.4pt;"> </font>to such patent authorities in advance of submitting such filings or responses. Takeda shall<font style="letter-spacing:2.45pt;"> </font>consider Takeda&#8217;s comments regarding such communications and drafts in good faith.<font style="letter-spacing:1.95pt;"> </font>Notwithstanding the foregoing, following the execution of an Exercised Product License Agreement covering<font style="letter-spacing:2.9pt;"> </font>an Ultragenyx<font style="letter-spacing:1.2pt;"> </font>Pipeline<font style="letter-spacing:1.1pt;"> </font>Product,<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>terms<font style="letter-spacing:1.1pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>such<font style="letter-spacing:1.1pt;"> </font>license<font style="letter-spacing:1.2pt;"> </font>agreement<font style="letter-spacing:1.1pt;"> </font>shall<font style="letter-spacing:1.25pt;"> </font>govern<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.2pt;"> </font>handling<font style="letter-spacing:1pt;"> </font>of the preparation, filing, prosecution and maintenance of Patents covering such <font style="letter-spacing:0.2pt;"> </font>Ultragenyx Pipeline<font style="letter-spacing:-0.1pt;"> </font>Product.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Cooperation in Prosecution</font><font style="font-size:10.5pt;">. Each Party shall provide the other Party</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">all reasonable</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">assistance</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">cooperation</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">prosecution</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">efforts</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">above</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">this Section 12.3, including providing any necessary powers of attorney and executing any</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">other required</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">documents</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">instruments</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">prosecution,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">well</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">further</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">actions</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">forth below.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">The Parties shall respectively prepare, file, maintain and prosecute</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the Patents</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">12.3.</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">As</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">used</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">herein,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">&#8220;prosecution&#8221;</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">shall</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">include all communication and other interaction with any patent office or patent authority<font style="letter-spacing:1.7pt;"> </font>having jurisdiction over a patent application in connection with pre-grant<font style="letter-spacing:-0.55pt;"> </font>proceedings.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">All communications between the Parties relating to the preparation,</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">filing, prosecution</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">maintenance</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">12.3,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">copies</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">draft</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">documents</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">communications</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">received</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">sent</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">patent</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">offices</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or patenting</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">authorities</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patents,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">considered</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Confidential</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Information and subject to the confidentiality provisions of ARTICLE</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">14.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.4</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark104"></a><font style="font-size:10.5pt;font-weight:bold;">Patent Term Extensions in the</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Territory</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">discuss</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">approve</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">which,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">any,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">this Agreement</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">should</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">seek</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Extensions</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-weight:bold;font-size:10.5pt;">.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">are unable to reach agreement for which, if any, of such Patents the Parties should seek Patent</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Term Extension, the final decision shall rest with the Party who first receives Regulatory Approval</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">for the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Term applies for such Party&#8217;s territory. The Party with final decision-making authority shall act</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">with reasonable</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">promptness</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">light</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">stage</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">apply</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Term Extensions,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">decision.</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">does</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">apply</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">extension hereunder</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">cooperate</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">fully</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">filings</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">actions,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">including making available all required Regulatory Materials (including underlying data) and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Information and executing any required authorizations to apply for such Patent Term Extension. </font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">All expenses</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">incurred</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">connection</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Patent(s)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">for which</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">seeks</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Extensions</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">12.4</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">entirely</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">borne</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">by the Party applying for such Patent Term</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Extension.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Orange Book Listing</font><font style="font-size:10.5pt;">. The Party that is the NDA holder for the applicable Product</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">shall be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">listing</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">maintaining</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Orange</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Book</font><font style="font-weight:bold;font-size:10.5pt;">,</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">including payment of all costs and expenses related to such maintenance incurred after the Effective</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Date. The listing and maintaining Party shall provide the other Party with its planned&nbsp;&nbsp;listings</font><font style="font-size:10.5pt;letter-spacing:-1.1pt;"> </font><font style="font-size:10.5pt;">in advance of their submission with sufficient time for the other Party to review and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">provide comments.</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">listing</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">maintaining</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">consider</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">comments</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">faith. Upon request of the listing and maintaining Party, the other Party shall cooperate in the filing</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">of appropriate information with the FDA listing such Patents in the Orange</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Book.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.6</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark105"></a><font style="font-size:10.5pt;font-weight:bold;">Infringement of Patents by Third Parties</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Notification</font><font style="font-size:10.5pt;">. Each Party shall promptly notify the other Party in writing of</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">any existing, alleged or threatened infringement of the Licensed [***] Patents, Licensed</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Product Improvement Patents, Ultragenyx [***] Patents, Option Product Patents, Option</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Product Improvement Patents, Ultragenyx Pipeline Patents, Ultragenyx Pipeline Improvement</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Patents, and</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">becomes</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">aware,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">shall provide all Information in such Party&#8217;s possession or control demonstrating such</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">infringement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:7.84%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark106"></a>(b)<font style="margin-left:81pt;"></font><font style="font-size:10.5pt;font-weight:bold;">Infringement</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Action</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark107"></a>(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Takeda shall have the first right, but not the obligation, to bring</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">an appropriate</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">suit</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">against</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">engaged</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">existing,</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">alleged</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">or threatened</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">infringement</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Patents,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Patents,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Product Improvement Patents, Ultragenyx [***] Patents, Option Product Patents, and Option</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Product Improvement Patents, in each case where relating to Licensed Products or Research Products</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">(a &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Product Infringement</font><font style="font-size:10.5pt;">&#8221;), subject to Section 12.6(b)(ii) through 12.6(b)(iv); provided</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">that if</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Infringement</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">concerns</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">enforcement</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Valid</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Claim</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">against</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Third Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">making,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">using,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">selling,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">offering</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">sale,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">importing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Field, Takeda must receive Ultragenyx&#8217;s prior consent with respect to all strategic decisions</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">in connection with such Takeda Product Infringement, such consent not to be</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">unreasonably withheld,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">conditioned,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">delayed;</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">further</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Developing</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">or Commercializing</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Field,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">then</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">foregoing</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">right with</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Infringement</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">become</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">hereunder. Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">right,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">obligation,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">bring</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">appropriate</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">suit</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">other action against any Third Party engaged in any existing, alleged or&nbsp;&nbsp;threatened</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">infringement related</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Joint</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Patents,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Improvement Patents, in each case where relating to an Ultragenyx Pipeline Product (an &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Product</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Infringement</font><font style="font-size:10.5pt;">&#8221;), subject to Section 12.6(b)(ii) through 12.6(b)(iv).&nbsp;&nbsp;Notwithstanding</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the foregoing, following the execution of an Option Product License Agreement or </font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">Exercised Product License Agreement, the terms of such license agreement shall govern the handling of</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">the infringement actions relating to the Patents covering such Licensed Option Product or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Exercised Product, respectively, that is the subject of such license</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark108"></a>(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">The Parties shall discuss how to address each Takeda </font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">Product Infringement</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Infringement</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">enforce shall</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">consider</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">input</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">determining</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">how</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">proceed.</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">The Party with the first right to enforce shall notify the other Party of its election to take any action</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in accordance with Section 12.6(b)(i) within ten (10) Business Days before any time limit set</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">forth in an Applicable Laws or regulation, including the time limits set forth under the Hatch</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Waxman Act. In the event such Party does not so elect, it shall so notify the other Party in writing, and</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">the other Party shall have the right to commence a suit or take action to enforce the applicable</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Patent against such Third Party perpetrating such Takeda Product Infringement or Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Product Infringement, as applicable, in the applicable portion of the Territory at its own cost and</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">expense. If</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">elects</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">bring</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">suit</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">take</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">against</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">Infringement</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">or Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Infringement,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">then</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(at</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">expense)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">have the right, prior to commencement of the trial, suit or action, to join any such suit or</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">action.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark109"></a>(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Each Party shall provide to the Party enforcing any such rights under</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">this Section 12.6(b) reasonable assistance in such enforcement, at such enforcing Party&#8217;s request</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and expense,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">joining</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">party</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">plaintiff</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Laws</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">to pursue</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">action.</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">enforcing</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">keep</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">regularly</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">informed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the status</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">progress</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">enforcement</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">efforts</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">consider</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s comments</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">important</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">aspects</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">enforcement,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">determination</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">litigation strategy and filing of important papers to the competent</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">court.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark110"></a>(iv)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Subject to this Section 12.6(b)(iv), the enforcing Party shall be</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">solely responsible for all costs and expenses arising from a suit or action against a Takeda</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">Product Infringement or Ultragenyx Product Infringement, as applicable. For the avoidance of doubt,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the enforcing Party shall not be responsible for the other Party&#8217;s internal costs (e.g., FTEs)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">incurred as</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">result</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">cooperation</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">enforcement</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Section 12.6(b)(iii). The Party not bringing an action with respect to the Takeda Product Infringement</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or Ultragenyx Product Infringement, as applicable, under this Section 12.6(b) shall be entitled</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to separate</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">representation</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">counsel</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">own</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">choice</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">own</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">expense,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">but such Party shall at all times cooperate fully with the Party bringing such</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">action.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark111"></a>(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Settlement</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">enforcing</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">settle</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">claim,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">suit</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">has brought under this Section 12.6 without the prior written consent of the other Party; provided</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">that any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">settlement</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">does</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">negatively</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">impact</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">non-enforcing</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">interests</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in such non-enforcing Party&#8217;s territory or</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">field.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark112"></a>(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Allocation of Proceeds</font><font style="font-size:10.5pt;">. If either Party recovers monetary damages from</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">any Third Party in a suit or action brought under Sections 12.6(b), 12.6(c), or 12.8(b) or any</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">royalties from a license agreement with a Third Party related to any alleged Takeda Product</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Infringement or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Infringement,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">recovery</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">allocated</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the reimbursement of any expenses incurred by the Parties in such suit or action, and any remaining amounts shall be split as follows: (i) if such suit or action is initiated or defended by</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx, such</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">amounts</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">retained</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">suit</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">was</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">initiated</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">or defended by Takeda, such amounts shall be retained by</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">Takeda.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.7</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark113"></a><font style="font-size:10.5pt;font-weight:bold;">Infringement of Third Party Rights in the</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Territory</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark114"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Notice</font><font style="font-size:10.5pt;">. If any Licensed Product used or sold by either Party, its</font><font style="font-size:10.5pt;letter-spacing:-0.9pt;"> </font><font style="font-size:10.5pt;">Affiliates, licensees</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">sublicensees</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">becomes</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">assertion</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of infringement of a Patent granted in either Party&#8217;s field or territory, the Party first having notice</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">of the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">assertion</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">promptly</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">notify</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">agree</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">enter into an &#8220;identity of interest agreement&#8221; wherein such Parties agree to their&nbsp;&nbsp;shared,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">mutual interest</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">outcome</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">potential</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">dispute,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">thereafter,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">promptly</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">meet to consider the claim or assertion and the appropriate course of</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">action.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:7.84%;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:81pt;"></font><font style="font-size:10.5pt;font-weight:bold;">Defense</font><font style="font-size:10.5pt;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall have the first right, but not the obligation, to defend</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">any Third Party claim or assertion of infringement of a Patent described in Section 12.7(a) above</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx Pipeline Products, at Ultragenyx&#8217;s expense. If Ultragenyx does not </font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">commence actions</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">defend</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">thirty</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(30)</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">receives</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">thereof</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(or</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">within thirty (30) days after it should have given notice thereof to Takeda as required by</font><font style="font-size:10.5pt;letter-spacing:-0.95pt;"> </font><font style="font-size:10.5pt;">Section 12.7(a)), then, to the extent allowed by Applicable Laws, Takeda shall have the right, but not the obligation,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">control</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">defense</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">counsel</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">choice,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">expense. The non-defending Party shall reasonably cooperate with the Party conducting the defense of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the claim or assertion, including if required to conduct such defense, furnishing a power of</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">attorney.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">right,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">obligation,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">defend</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">any Third Party claim or assertion of infringement of a Patent described in Section 12.7(a) above</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">by Licensed [***] Products, Licensed Analog Products, Candidate Products or Option Products,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">at Takeda&#8217;s expense. If Takeda does not commence actions to defend such claim within thirty</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">(30) days</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">receives</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">thereof</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(or</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">thirty</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">(30)</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">should</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">given</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">notice thereof</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">12.7(a)),</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">then,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">allowed</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Applicable Laws, Ultragenyx shall have the right, but not the obligation, to control the defense of such</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">claim by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">counsel</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">choice,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">expense.</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">non-defending</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">reasonably cooperate with the Party conducting the defense of the claim or assertion, including if required</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">to conduct such defense, furnishing a power of</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">attorney.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, following the execution of an</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Option Product License Agreement or Exercised Product License Agreement, the terms of such</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">license agreement</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">govern</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">handling</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">defense</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">against</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">infringement</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product(s)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">are the subject of the applicable license</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Settlement; Licenses</font><font style="font-size:10.5pt;">. Neither Party shall enter into any settlement of any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">claim described in this Section 12.7 that negatively affects the other Party&#8217;s rights or interests</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">without such other Party&#8217;s written consent, which consent shall not be unreasonably</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">withheld, conditioned or delayed. Each Party shall have the right to decline to defend or to tender</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">defense of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">notice,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">fails</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to agree to a settlement that such Party proposes. In the event that it is determined by any court</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">of competent jurisdiction that the Exploitation of a Product in the Licensed Field in the</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Territory, conducted in accordance with the terms and conditions of this Agreement, infringes,</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">or the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">JSC</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">determines</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">likely</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">infringe,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">patent,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">copyright,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">trademark, data exclusivity right or trade secret right arising under Applicable Laws of any Third</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Party, Ultragenyx shall use Commercially Reasonable Efforts to: (i) procure a license from such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Third Party authorizing Ultragenyx to continue to conduct such activities; or (ii) modify such</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">activities so as to render it</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">non-infringing.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.8</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;font-weight:bold;">Patent Oppositions and Other</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Proceedings</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark115"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Third-Party Patent Rights</font><font style="font-size:10.5pt;">. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">If </font><font style="font-size:10.5pt;">either Party desires to bring an opposition,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">action for declaratory judgment, nullity action, interference, declaration for</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">non-infringement, reexamination</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">attack</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">validity,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">title</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">enforceability</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">owned</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or controlled by a Third Party and having one or more claims that covers a Product, or the use,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">sale, offer</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">sale</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">importation</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">(except</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">insofar</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">counterclaim</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or defense of, or accompanies a defense of, a Third Party&#8217;s claim or assertion of infringement</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">under Section</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">12.7,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">provisions</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">12.7</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">govern),</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">so notify</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">promptly</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">confer</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">determine</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">bring</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">such action</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">manner</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">settle</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">action.</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">exclusive</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">right, but</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">obligation,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">bring</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">own</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">expense</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">control</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the Territory with respect to Ultragenyx Pipeline Products. Takeda shall have the exclusive right,</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">but not</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">obligation,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">bring</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">own</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">expense</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">control</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">to Licensed [***] Products, Licensed Analog Products and Research Products in the Territory. If</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Party<font style="letter-spacing:1pt;"> </font>with<font style="letter-spacing:1.25pt;"> </font>the<font style="letter-spacing:1.2pt;"> </font>first<font style="letter-spacing:1.25pt;"> </font>right<font style="letter-spacing:1.45pt;"> </font>does<font style="letter-spacing:1.25pt;"> </font>not<font style="letter-spacing:1.25pt;"> </font>bring<font style="letter-spacing:1.15pt;"> </font>such<font style="letter-spacing:1.2pt;"> </font>an<font style="letter-spacing:1.25pt;"> </font>action,<font style="letter-spacing:1.25pt;"> </font>within<font style="letter-spacing:1.25pt;"> </font>ninety<font style="letter-spacing:0.85pt;"> </font>(90)<font style="letter-spacing:1.2pt;"> </font>days<font style="letter-spacing:1.25pt;"> </font>of<font style="letter-spacing:1.2pt;"> </font>notification thereof<font style="letter-spacing:0.85pt;"> </font>pursuant<font style="letter-spacing:0.9pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>this<font style="letter-spacing:0.85pt;"> </font>Section<font style="letter-spacing:0.95pt;"> </font>12.8(a)<font style="letter-spacing:0.85pt;"> </font>(or<font style="letter-spacing:0.9pt;"> </font>earlier,<font style="letter-spacing:0.85pt;"> </font>if<font style="letter-spacing:0.85pt;"> </font>required<font style="letter-spacing:0.85pt;"> </font>by<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>nature<font style="letter-spacing:0.8pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>proceeding), then the other Party shall have the right, but not the obligation, to bring, at its sole expense,<font style="letter-spacing:1.8pt;"> </font>such action. The Party not bringing an action under this Section 12.8(a) shall be entitled to<font style="letter-spacing:0.6pt;"> </font>separate representation in such proceeding by counsel of its own choice and at its own expense, and<font style="letter-spacing:1.7pt;"> </font>shall cooperate fully with the Party bringing such action. Any awards or amounts received in<font style="letter-spacing:0.2pt;"> </font>bringing any such action shall be first allocated to reimburse the initiating Party&#8217;s expenses in such<font style="letter-spacing:0.65pt;"> </font>action and any remaining amounts shall be retained by such<font style="letter-spacing:-0.75pt;"> </font>Party.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark116"></a>(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Parties&#8217; Patent Rights</font><font style="font-size:10.5pt;">. If any Licensed [***] Patents, Licensed</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Product Improvement Patent, Ultragenyx [***] Patents, Option Product Patent, Option</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Product Improvement</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Pipeline</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Improvement</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Patent,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or Joint</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Patent</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">becomes</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">proceeding</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">commenced</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the Territory in connection with an opposition, reexamination request, action for</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">declaratory judgment,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">nullity</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">action,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">interference</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">attack</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">validity,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">title</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">enforceability thereof</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">(except</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">insofar</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">counterclaim</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">defense</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">of,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">accompanies</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">a defense of, an action for infringement against a Third Party under Section 12.6, in which case</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the provisions of Section 12.6 shall govern), then the Party responsible for filing,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">preparing, prosecuting and maintaining such Patent as set forth in Section 12.3, shall control such defense</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">at its own cost and expense. The controlling Party shall permit the non-controlling Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to participate in the proceeding to the extent permissible under Applicable Laws, and to</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">be represented by its own counsel in such proceeding, at the non-controlling Party&#8217;s expense. If</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the controlling Party decides that it does not wish to defend against such action, then the other</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party shall have a backup right to assume defense of such Third-Party action at its own expense.</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Any awards or amounts received in defending any such Third-Party action shall be allocated</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">between the Parties as provided in Section</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">12.6(d).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark117"></a>ARTICLE 13&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>REPRESENTATIONS AND<font style="letter-spacing:-0.05pt;"> </font>WARRANTIES</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Mutual Representations, Warranties and Covenants</font><font style="font-size:10.5pt;">. Each of the Parties</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">hereby represents and warrants to the other Party as of the Execution Date and covenants</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">that:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Organization. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">It </font><font style="font-size:10.5pt;">is a corporation duly organized, validly existing, and in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">good standing</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">laws</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">jurisdiction</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">organization,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">requisite</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">power</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and authority, corporate or otherwise, to execute, deliver, and perform this</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Binding</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Agreement.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">This</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">legal</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">valid</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">obligation</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">binding upon such Party and enforceable in accordance with its terms, subject to the effects</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of bankruptcy, insolvency, or other laws of general application affecting the enforcement of</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">creditor rights, judicial principles affecting the availability of specific performance,&nbsp;&nbsp;and</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">general principles of equity (whether enforceability is considered a proceeding at law or</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">equity).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Authorization. </font><font style="font-size:10.5pt;">The execution, delivery, and performance of this Agreement</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">by such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">duly</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">authorized</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">corporate</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">do</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">conflict</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">with any agreement, instrument, or understanding, oral or written, to which it is a party or by which</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">it is</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">bound,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">nor</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">violate</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Laws</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">order,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">writ,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">judgment,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">injunction,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">decree,</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">determination,<font style="letter-spacing:1.25pt;"> </font>or<font style="letter-spacing:1.3pt;"> </font>award<font style="letter-spacing:1.3pt;"> </font>of<font style="letter-spacing:1.2pt;"> </font>any<font style="letter-spacing:1.1pt;"> </font>court<font style="letter-spacing:1.2pt;"> </font>or<font style="letter-spacing:1.3pt;"> </font>governmental<font style="letter-spacing:1.25pt;"> </font>body,<font style="letter-spacing:1.25pt;"> </font>or<font style="letter-spacing:1.2pt;"> </font>administrative<font style="letter-spacing:1.2pt;"> </font>or<font style="letter-spacing:1.3pt;"> </font>other<font style="letter-spacing:1.3pt;"> </font>agency presently in effect applicable to such<font style="letter-spacing:-0.45pt;"> </font>Party.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">No Further Approval. </font><font style="font-size:10.5pt;">Subject to Section 18.1, it is not aware&nbsp;&nbsp;of </font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">any government authorization, consent, approval, license, exemption of or filing or registration</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">with any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">court</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">governmental</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">department,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">commission,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">board,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">bureau,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">agency</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">instrumentality, domestic or foreign, under any Applicable Laws, currently in effect, necessary for, or</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">in connection</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">with,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">transactions</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">contemplated</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or instrument executed in connection herewith, or for the performance by it of its obligations</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">under this Agreement and such other agreements (save for Regulatory Approvals and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">similar authorizations from Regulatory Authorities necessary for the Exploitation of the Compounds</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">and the Products as contemplated</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">hereunder).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">No Inconsistent Obligations. </font><font style="font-size:10.5pt;">Neither Party is under any obligation, </font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">contractual or otherwise, to any Person that conflicts with or is inconsistent in any material respect with</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the terms</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">would</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">impede</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">diligent</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">fulfillment</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">its obligations</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">hereunder.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Transparency Reporting</font><font style="font-size:10.5pt;">. Each Party shall be responsible for tracking</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">and reporting transfers of value initiated and controlled by its and its Affiliates&#8217;</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">employees, independent contractors, and agents pursuant to the requirements of the marketing reporting</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">laws of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Government</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Authority</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">6002</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Patient</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Protection and Affordable Care Act, commonly referred to as the &#8220;Sunshine</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">Act.&#8221;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Neither Party nor any of its Affiliates has been debarred by the FDA, is subject</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">to any similar sanction of other Regulatory Authorities in the Territory, and neither Party nor any</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">of its Affiliates has used, or will engage, in any capacity, in connection with this Agreement or</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">any ancillary</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">agreements</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">(if</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">any),</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Person</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">who</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">debarred</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Regulatory Authority,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">conviction</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">described</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">306</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">FFDCA.</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Party shall inform the other in writing promptly if it or any Person engaged by such Party or any of</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">its Affiliates who is performing services under this Agreement or any ancillary agreements (if</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">any) is</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">debarred</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">conviction</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">described</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">306</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">FFDCA,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">any action,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">suit,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">claim,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">investigation</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">legal</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">administrative</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">proceeding</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">pending</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">such Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Knowledge,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">threatened,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">relating</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">debarment</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">conviction</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of its Affiliates or any such Person performing services hereunder or</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">thereunder.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.2<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Additional&nbsp;&nbsp; </font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:-0.05pt;">Representations,</font><font style="font-weight:bold;font-size:10.5pt;">&nbsp;&nbsp; </font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:-0.05pt;">Warranties</font><font style="font-weight:bold;font-size:10.5pt;">&nbsp;&nbsp; </font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.05pt;">and</font><font style="font-weight:bold;font-size:10.5pt;">&nbsp;&nbsp; </font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:-0.05pt;">Covenants</font><font style="font-weight:bold;font-size:10.5pt;">&nbsp;&nbsp; of&nbsp;&nbsp;</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:-0.05pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;">.</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;margin-left:47pt;">Takeda</font><font style="font-size:10.5pt;"> represents and warrants as of the Execution Date and covenants to Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">that:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Takeda has all rights necessary to grant the options and licenses under</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the Licensed</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Technology</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Technology</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">cross-reference</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">under Regulatory Materials, in each case, existing as of the Execution Date that it grants to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx in</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Agreement.</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">duration</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">not,</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Affiliates not to, grant to any Third Party rights in the Licensed Field or the Ultragenyx Field,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">as applicable, in the Territory that encumber, diminish or conflict with the rights granted</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx hereunder with respect to the Licensed [***] Technology, Option Product<font style="letter-spacing:0.25pt;"> </font>Technology, Joint Intellectual Property or Regulatory<font style="letter-spacing:-0.6pt;"> </font>Materials.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark118"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">1.168</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">represent</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Patents,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to Takeda&#8217;s Knowledge, the Compounds set forth in </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit 13.2(b) </font><font style="font-size:10.5pt;">represent all</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">structures Controlled</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">[***],</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:32pt;"></font><font style="font-size:10.5pt;">to Takeda&#8217;s Knowledge, the Compound set forth in </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit 1.94 </font><font style="font-size:10.5pt;">represents the sole</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">Licensed [***] Compound. Takeda (Y) is the sole and exclusive owner of the entire right, title and </font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">interest in the Takeda Patents, and (Z) to Takeda&#8217;s Knowledge, the sole and exclusive owner of the</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">entire right, title and interest in the Licensed [***] Compound and Licensed Analog Compounds, and</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">in each</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">cases</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(Y)</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">(Z),</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">free</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">encumbrance,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">lien,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">ownership</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Third Party.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Takeda&#8217;s Knowledge, there is no actual or threatened infringement</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">or misappropriation of the Licensed [***] Technology and Option Product Technology by </font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">any Person in the</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The Takeda Patents are being diligently prosecuted in the Territory in</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">accordance with Applicable Laws. To Takeda&#8217;s Knowledge, the Takeda Patents have been filed</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and maintained</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">properly</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">correctly</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">fees</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">paid</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">due date for</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">payment.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Takeda&#8217;s Knowledge, each of the Takeda Patents properly identifies each</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">and every</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">inventor</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">claims</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">thereof</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">determined</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Applicable</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Laws</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the jurisdiction in which such Takeda Patent is issued or such application is</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">pending.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To the extent permissible under Applicable Laws, all employees of Takeda or</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">its Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">performing</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">obligation</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to assign all right, title and interest in and to their Inventions and intellectual property rights</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">therein, to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Affiliate(s)</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">owner</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">thereof.</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">obligation</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to contribute to any remuneration of any inventor employed or previously employed by Takeda</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">or any of its Affiliates in respect of any such Inventions and intellectual property rights therein</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">that are</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">so</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">assigned</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Affiliate(s).</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">pay</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">remuneration</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">such inventors with respect to such Inventions and intellectual property rights</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">therein.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The Inventions claimed or disclosed by the Takeda Patents (i) were </font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">not conceived, discovered, developed, or otherwise made in connection with any research</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">activities funded, in whole or in part, by the federal government of the U.S. or any agency thereof, (ii)</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">are not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">&#8220;subject</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">invention&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">term</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">described</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">35</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">U.S.C.</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">201(f),</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(iii)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">not otherwise subject to the provisions of the Bayh-Dole</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Act.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(h)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Takeda&#8217;s Knowledge, there are no material claims, judgments, or</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">settlements against,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">amounts</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">thereto,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">owed</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Third Parties relating to the Regulatory Materials, Licensed [***] Technology or Option</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product Technology in the</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">No claim or litigation in the Territory has been brought or, to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s Knowledge, threatened by any Person alleging, and Takeda has no Knowledge of any</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">claim, whether or not asserted: (i) that any of the Takeda Patents is invalid or unenforceable, (ii) that</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">the Regulatory Materials, or the disclosing, copying, making, assigning, or licensing of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the Regulatory Materials, violates, infringes, or otherwise conflicts or interferes with, or</font><font style="font-size:10.5pt;letter-spacing:-1.05pt;"> </font><font style="font-size:10.5pt;">would violate,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">infringe,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">conflict</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">interfere</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">with,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">intellectual</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">property</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;letter-spacing:0.2pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">proprietary right</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Person;</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">(iii)</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Commercialization</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Licensed Products or Research Products, including any claims of Product</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Liability.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Takeda has no Knowledge of any material adverse information with respect to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the safety</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">efficacy</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">disclosed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx, and all such information that has been disclosed is true, correct, and complete in</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">all material</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">respects.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Takeda&#8217;s Knowledge, Takeda and its Affiliates have generated,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">prepared, maintained, and retained all material Regulatory Materials in the Licensed Field that are</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">required to be maintained or retained pursuant to and in accordance with GCP, GLP and other</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Applicable Laws,</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">true,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">correct</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">respects</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">what</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">it purports to be.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(l)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Takeda</font><font style="font-weight:bold;font-size:10.5pt;">, </font><font style="font-size:10.5pt;">without the prior written consent of Ultragenyx, during the Term, will</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">not solicit, induce, encourage, or participate in soliciting, inducing, or encouraging any employee</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">of Ultragenyx, or any of its Affiliates, to terminate his or her relationship with Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:-0.85pt;"> </font><font style="font-size:10.5pt;">or Ultragenyx&#8217;s Affiliate. An offer of employment to an employee of Ultragenyx by Takeda</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">which results directly from unsolicited responses to general advertisements for employment will not</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">be deemed to be in violation of this</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">provision.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(m)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">In performing its obligations under this Agreement, Takeda shall, and shall</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">cause its Affiliates to, comply with all Applicable Laws, including any applicable anti-corruption</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">or anti-bribery laws or regulation, of any Governmental Authority with jurisdiction over</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the activities performed by Takeda or its Affiliates in furtherance of such</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">obligations.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Additional Representations, Warranties and Covenants of Ultragenyx</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx represents and warrants as of the Execution Date and covenants to Takeda</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">that:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx and its Affiliates have provided or made available to Takeda prior</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">to the Execution Date, true, complete, and correct copies (as of the Execution Date) of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">all Ultragenyx In-License</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">Agreements.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">options</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">licenses under the Ultragenyx Intellectual Property and rights of cross-reference under</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Regulatory Materials, in each case, that it grants to Takeda in this Agreement. For the duration of the</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">Term, Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">not,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">grant</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the Takeda</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Territory,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">that encumber,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">diminish</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">conflict</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx Intellectual Property, Joint Intellectual Property or Regulatory</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Materials.</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The Patents set forth in </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit 1.188 </font><font style="font-size:10.5pt;">represent all&nbsp;&nbsp;Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Patents. Ultragenyx is the sole and exclusive owner of the entire right, title and interest in the</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Patents free of any encumbrance, lien, or claim of ownership by any Third</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">Party.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Ultragenyx&#8217;s Knowledge, there is no actual or threatened infringement</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">or misappropriation of the Ultragenyx Intellectual Property by any Person in the</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The Ultragenyx Patents are being diligently prosecuted in the Territory</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">in accordance with Applicable Laws and consistent with Ultragenyx&#8217;s current </font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">prosecution practices. To Ultragenyx&#8217;s Knowledge, the Ultragenyx Patents have been filed and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">maintained properly</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">correctly</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">fees</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">paid</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">for payment.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Ultragenyx&#8217;s Knowledge, each of the Ultragenyx Patents properly</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">identifies each and every inventor of the claims thereof as determined in accordance with Applicable</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Laws of the jurisdiction in which such Ultragenyx Patent is issued or such application is</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">pending.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To the extent permissible under Applicable Laws, all employees of Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">or its Affiliates performing activities under this Agreement shall be under an obligation to assign</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">all right,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">title</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">interest</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">their</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Inventions,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">intellectual</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">property</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">therein,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to Ultragenyx or its Affiliate(s) as the sole owner thereof. Takeda shall have no obligation</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to contribute to any remuneration of any inventor employed or previously employed by</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx or any of its Affiliates in respect of any such inventions, Information and discoveries</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">and intellectual property rights therein that are so assigned to Ultragenyx or its</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Affiliate(s). Ultragenyx will pay all such remuneration due to such inventors with respect to such</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Inventions and intellectual property rights</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">therein.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(h)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Ultragenyx&#8217;s Knowledge, the Inventions claimed or disclosed by</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx Patents (i) were not conceived, discovered, developed, or otherwise made</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">in connection with any research activities funded, in whole or in part, by the federal government</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">U.S.</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">agency</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">thereof,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">&#8220;subject</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">invention&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">term</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">described</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">35</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.3%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.C.</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;">Section 201(f), and (iii) are not otherwise subject to the provisions of the Bayh-Dole</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">Act.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">To Ultragenyx&#8217;s Knowledge, there are no material claims, judgments,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">or settlements against, or amounts with respect thereto, owed by Ultragenyx or any of its</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">Affiliates to any Third Parties relating to the Regulatory Materials or the Ultragenyx Intellectual</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">Property in the</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx has no Knowledge of any material adverse information with respect</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">to the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">safety</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">efficacy</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">disclosed</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and all such information that has been disclosed is true, correct, and complete in all material</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">respects.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">No claim or litigation in the Territory has been brought or, to</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s Knowledge, threatened by any Person alleging, and Ultragenyx has no Knowledge of any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">claim, whether</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">asserted:</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">that any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">invalid</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">unenforceable,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(ii) that the Regulatory Materials, the Ultragenyx Intellectual Property, or the disclosing,</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">copying,</font></p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">making, assigning, or licensing of the Regulatory Materials or the Ultragenyx<font style="letter-spacing:1.45pt;"> </font>Intellectual Property, violates, infringes, or otherwise conflicts or interferes with, or would violate,<font style="letter-spacing:0.4pt;"> </font>infringe, or otherwise conflict or interfere with, any intellectual property or proprietary right&nbsp;&nbsp;of<font style="letter-spacing:-0.75pt;"> </font>any Person; or (iii) related to the Development or Commercialization of the Products, including<font style="letter-spacing:2.7pt;"> </font>any claims of Product<font style="letter-spacing:-0.4pt;"> </font>Liability.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(l)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">In</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">performing</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">shall,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall cause its Affiliates to, comply with all Applicable Laws, including any applicable</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">anti-corruption or anti-bribery laws or regulation, of any Governmental Authority with jurisdiction over</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the activities performed by Ultragenyx or its Affiliates in furtherance of such</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">obligations.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(m)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-weight:bold;font-size:10.5pt;">, </font><font style="font-size:10.5pt;">without the prior written consent of Takeda, during the Term, will</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">not solicit, induce, encourage, or participate in soliciting, inducing, or encouraging any employee</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">of Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">terminate</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">his</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">her</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">relationship</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s Affiliate. An offer of employment to an employee of Takeda by Ultragenyx&nbsp;&nbsp;which</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">results directly from unsolicited responses to general advertisements for employment will not</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">be deemed to be in violation of this</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">provision.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(n)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">[***].</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(o)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx has provided Takeda with true and correct copies (as of the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Execution Date)</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">In-License</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Agreements</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">effect</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Execution</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Date.</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">None</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of Ultragenyx, its Affiliates and, to their Knowledge, any Third Party, is in breach of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">any Ultragenyx In-License Agreement and none of Ultragenyx, its Affiliates and, to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">their Knowledge, any other party to any Ultragenyx In-License Agreement has threatened </font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">to terminate, or has otherwise alleged any material breach under, such agreement and</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">each Ultragenyx In-License Agreement is in full force and effect in accordance with its</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">terms</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.4&nbsp;&nbsp;<font style="font-weight:bold;">No Other Representations or Warranties</font>.&nbsp;&nbsp; EXCEPT AS EXPRESSLY SET&nbsp;&nbsp;<font style="letter-spacing:2.35pt;"> </font>FORTH IN THIS ARTICLE 13, THE PARTIES MAKE NO REPRESENTATIONS OR<font style="letter-spacing:0.6pt;"> </font>WARRANTIES OF<font style="letter-spacing:1pt;"> </font>ANY<font style="letter-spacing:1.05pt;"> </font>KIND<font style="letter-spacing:1.05pt;"> </font>WHATSOEVER,<font style="letter-spacing:1.15pt;"> </font>EITHER<font style="letter-spacing:1.15pt;"> </font>EXPRESS<font style="letter-spacing:1.2pt;"> </font>OR<font style="letter-spacing:1.15pt;"> </font>IMPLIED,<font style="letter-spacing:1.2pt;"> </font>WRITTEN<font style="letter-spacing:1.05pt;"> </font>OR<font style="letter-spacing:1.25pt;"> </font>ORAL, EITHER<font style="letter-spacing:1.2pt;"> </font>IN<font style="letter-spacing:1.05pt;"> </font>FACT<font style="letter-spacing:1.05pt;"> </font>OR<font style="letter-spacing:1.2pt;"> </font>BY<font style="letter-spacing:1.05pt;"> </font>OPERATION<font style="letter-spacing:1pt;"> </font>OF<font style="letter-spacing:1.1pt;"> </font>LAW,<font style="letter-spacing:1.05pt;"> </font>BY<font style="letter-spacing:1.05pt;"> </font>STATUTE<font style="letter-spacing:1pt;"> </font>OR<font style="letter-spacing:1.1pt;"> </font>OTHERWISE,<font style="letter-spacing:1.05pt;"> </font>AND EACH PARTY SPECIFICALLY DISCLAIMS ANY OTHER WARRANTIES,<font style="letter-spacing:2.3pt;"> </font>INCLUDING ANY EXPRESS OR IMPLIED WARRANTY OF QUALITY,<font style="letter-spacing:1.9pt;"> </font>MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR WARRANTY OF<font style="letter-spacing:2.35pt;"> </font>NON-INFRINGEMENT OR AS TO THE VALIDITY OF ANY PATENTS <font style="letter-spacing:-0.15pt;">IN </font>THE<font style="letter-spacing:-0.15pt;"> </font>TERRITORY.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark119"></a>ARTICLE 14&nbsp;&nbsp;&#8211;<font style="letter-spacing:-1.2pt;"> </font>CONFIDENTIALITY</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark120"></a>14.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Nondisclosure.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">agrees</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">that,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">during</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">ten</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(10) years thereafter, a Party (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Receiving Party</font><font style="font-size:10.5pt;">&#8221;) receiving Confidential Information of the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">other Party (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Disclosing Party</font><font style="font-size:10.5pt;">&#8221;) shall (a) maintain in confidence such Confidential</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Information using</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">less</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">efforts</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Receiving</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">uses</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">confidence</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">own confidential or proprietary Information of similar kind and value, (b) not disclose</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">such</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential<font style="letter-spacing:1pt;"> </font>Information<font style="letter-spacing:0.85pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>any<font style="letter-spacing:0.5pt;"> </font>Third<font style="letter-spacing:0.85pt;"> </font>Party<font style="letter-spacing:0.5pt;"> </font>without<font style="letter-spacing:0.9pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>prior<font style="letter-spacing:0.85pt;"> </font>written<font style="letter-spacing:0.85pt;"> </font>consent<font style="letter-spacing:0.9pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>Disclosing Party, except for disclosures expressly permitted below, and (c) not use such<font style="letter-spacing:0.45pt;"> </font>Confidential Information for any purpose except those permitted by this Agreement (it being understood<font style="letter-spacing:1.55pt;"> </font>that this Section 14.1 shall not create or imply any rights or licenses not expressly granted under<font style="letter-spacing:2.85pt;"> </font>this Agreement). Notwithstanding anything to the contrary in the foregoing, the obligations of confidentiality and non-use with respect to any trade secret within such Confidential<font style="letter-spacing:1.7pt;"> </font>Information shall<font style="letter-spacing:1.85pt;"> </font>survive<font style="letter-spacing:1.8pt;"> </font>such<font style="letter-spacing:1.8pt;"> </font>ten<font style="letter-spacing:1.85pt;"> </font>(10)<font style="letter-spacing:1.9pt;"> </font>year<font style="letter-spacing:1.8pt;"> </font>period<font style="letter-spacing:1.8pt;"> </font>for<font style="letter-spacing:1.75pt;"> </font>so<font style="letter-spacing:1.85pt;"> </font>long<font style="letter-spacing:1.7pt;"> </font>as<font style="letter-spacing:1.85pt;"> </font>such<font style="letter-spacing:1.85pt;"> </font>Confidential<font style="letter-spacing:2pt;"> </font>Information<font style="letter-spacing:1.85pt;"> </font>remains protected as a trade secret under Applicable<font style="letter-spacing:-0.4pt;"> </font>Laws.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark121"></a>14.2<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Exceptions.&nbsp;&nbsp;</font><font style="font-size:10.5pt;">The obligations in Section 14.1 shall not apply with respect to any </font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">portion of the Confidential Information that the Receiving Party can show by competent</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">evidence:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">is publicly disclosed by the Disclosing Party, either before or after it is</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">disclosed to the Receiving Party</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">hereunder;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">is known to the Receiving Party or any of its Affiliates, without any obligation</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to keep it confidential or any restriction on its use, prior to disclosure by the Disclosing</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">Party;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">is subsequently disclosed to the Receiving Party or any of its Affiliates on a</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">non- confidential</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">that,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Receiving</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Knowledge,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">bound</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">a similar duty of confidentiality or restriction on its</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">use;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">now,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">hereafter</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">becomes,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">through</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">act</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">failure</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">act</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">part</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the Receiving</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">generally</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">known</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">available,</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">is disclosed to the Receiving</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Party;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">independently</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">discovered</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">developed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Receiving</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Party or any of its Affiliates without the use of or access to Confidential Information belonging to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the Disclosing Party;</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">or</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:7.84%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:81pt;"></font><font style="font-size:10.5pt;">is the subject of written permission to disclose provided by the Disclosing</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">Party.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark122"></a>14.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Authorized Disclosure. </font><font style="font-size:10.5pt;">The Receiving Party may disclose Confidential</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Information belonging</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Disclosing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">disclosure</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">reasonably</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in the following instances: filing or prosecuting Patents as permitted by this</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">Agreement;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">filing Regulatory Materials in order to obtain or maintain Regulatory</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">Approvals;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">prosecuting or defending litigation, including responding to a subpoena in a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Third Party</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">litigation;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.86%;margin-right:1.24%;text-indent:7.84%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:81pt;"></font><font style="font-size:10.5pt;">complying with Applicable Laws or regulations or court or administrative</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">orders;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">to its Affiliates, sublicensees or prospective sublicensees, subcontractors</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or prospective</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">subcontractors,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">payors,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">consultants,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">agents</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">advisors</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">&#8220;need-to-know&#8221;</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">basis</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in order for the Receiving Party to exercise its rights or fulfill its obligations under<font style="letter-spacing:2.4pt;"> </font>this Agreement,<font style="letter-spacing:1.55pt;"> </font>each<font style="letter-spacing:1.4pt;"> </font>of<font style="letter-spacing:1.35pt;"> </font>whom<font style="letter-spacing:1.45pt;"> </font>prior<font style="letter-spacing:1.4pt;"> </font>to<font style="letter-spacing:1.45pt;"> </font>disclosure<font style="letter-spacing:1.35pt;"> </font>must<font style="letter-spacing:1.45pt;"> </font>be<font style="letter-spacing:1.35pt;"> </font>bound<font style="letter-spacing:1.4pt;"> </font>by<font style="letter-spacing:1.3pt;"> </font>obligations<font style="letter-spacing:1.4pt;"> </font>of<font style="letter-spacing:1.5pt;"> </font>confidentiality and restrictions on use of such Confidential Information that are no less restrictive than those<font style="letter-spacing:1.2pt;"> </font>set forth in this ARTICLE 14; provided, however, that, in each of the above situations, <font style="letter-spacing:1.9pt;"> </font>the Receiving Party shall remain responsible for any failure by any Person who <font style="letter-spacing:1.6pt;"> </font>receives Confidential Information pursuant to this Section 14.3 to treat such Confidential Information<font style="letter-spacing:2.8pt;"> </font>as required under this ARTICLE<font style="letter-spacing:-0.25pt;"> </font>14.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If and whenever any Confidential Information is disclosed in accordance with</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">this Section</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">14.3,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">disclosure</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">cease</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Confidential Information</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">disclosure</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">results</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">public</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">disclosure</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">such information</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">(other</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Agreement).</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Notwithstanding</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">foregoing,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the event</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">disclosure</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Confidential</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Information pursuant to clauses (a) through (d) of this Section 14.3, it will, except where impracticable,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">give reasonable</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">advance</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">disclosure</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">less</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">same efforts to secure confidential treatment of such information as it would to protect its</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">own confidential</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">information</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">disclosure</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">jointly</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">severally</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">liable</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;letter-spacing:0.1pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">breach of this ARTICLE 14 by such</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Person.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark123"></a>14.4<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Terms of this Agreement. </font><font style="font-size:10.5pt;">The Parties acknowledge that this Agreement and all of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the respective terms of this Agreement shall be treated as Confidential Information of both</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">Parties.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark124"></a>14.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Publicity.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">joint</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">public</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">announcement</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">execution</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">this Agreement</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">form</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">attached</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">14.5</font><font style="font-size:10.5pt;">,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">issued</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">mutually agreed</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Parties.</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">agrees</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">issue</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">press</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">release</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">public statement disclosing other information relating to this Agreement or the</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">transactions contemplated hereby that contains information not previously publicly disclosed in</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">accordance with this Section 14.5 without the prior written consent of the other Party, not to be</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">unreasonably withheld, conditioned or</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">delayed.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark125"></a>14.6<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Securities Filings. </font><font style="font-size:10.5pt;">Notwithstanding anything to the contrary in this ARTICLE 14, in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the event either Party proposes to file with the Securities and Exchange Commission or the</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">securities regulators of any state or other jurisdiction a registration statement or any other</font><font style="font-size:10.5pt;letter-spacing:-0.95pt;"> </font><font style="font-size:10.5pt;">disclosure document</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">describes</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">refers</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">conditions</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">related agreements between the Parties, such Party shall notify the other Party of such intention and</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">shall provide</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">copy</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">relevant</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">portions</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">proposed</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">least</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">ten</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(10) Business</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Days</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">revisions</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">portions</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">proposed</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a reasonable</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">thereof),</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">exhibits</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">thereto</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">refer</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">other Party</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">conditions</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">agreements</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">between</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the Parties. The Party making such filing shall cooperate in good faith with the other Party to</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">obtain confidential</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">treatment</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">conditions</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">agreements between the Parties that the other Party requests to be kept confidential or otherwise</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">afforded confidential treatment, and shall only disclose Confidential Information that it is</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">reasonably advised by outside counsel is legally required to be disclosed. No such notice and provision of</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">a copy shall be required if the description of or reference to this Agreement or a related</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">agreement</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">between<font style="letter-spacing:1.7pt;"> </font>the<font style="letter-spacing:1.55pt;"> </font>Parties<font style="letter-spacing:1.7pt;"> </font>contained<font style="letter-spacing:1.55pt;"> </font>in<font style="letter-spacing:1.6pt;"> </font>the<font style="letter-spacing:1.7pt;"> </font>proposed<font style="letter-spacing:1.7pt;"> </font>filing<font style="letter-spacing:1.45pt;"> </font>has<font style="letter-spacing:1.7pt;"> </font>been<font style="letter-spacing:1.7pt;"> </font>included<font style="letter-spacing:1.6pt;"> </font>in<font style="letter-spacing:1.6pt;"> </font>any<font style="letter-spacing:1.35pt;"> </font>previous<font style="letter-spacing:1.6pt;"> </font>filing made by the either Party in accordance with this Section 14.6 or otherwise approved by the<font style="letter-spacing:2.3pt;"> </font>other Party.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark126"></a>14.7<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Relationship to Confidentiality Agreement. </font><font style="font-size:10.5pt;">As of the Effective Date, this</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Agreement supersedes the Confidentiality Agreement; provided however, that all &#8220;Confidential</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">Information&#8221; disclosed or received by the Parties thereunder shall be deemed Confidential</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Information hereunder and shall be subject to the terms and conditions of this</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark127"></a>14.8<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Equitable Relief. </font><font style="font-size:10.5pt;">Given the nature of the Confidential Information and the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">competitive damage that could result to a Party upon unauthorized disclosure, use or transfer of its Confidential Information to any Third Party, the Parties agree that monetary damages may not</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">be a sufficient remedy for any breach of this ARTICLE 14. In addition to all&nbsp;&nbsp;other&nbsp;&nbsp;remedies,</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">a Party shall be entitled to seek specific performance and injunctive and other equitable relief as</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">a remedy for any breach or threatened breach of this ARTICLE</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">14.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark128"></a>14.9<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Publications. </font><font style="font-size:10.5pt;">All publications relating to the use of the Compound and/or a Product</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">in the Licensed Field shall be prepared, presented and/or published in accordance</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">with pharmaceutical industry accepted guidelines including: (a) International Committee of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Medical Journal Editors (ICMJE) guidelines, (b) Uniform Requirements for Manuscripts Submitted</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">to Biomedical Journals: Writing and Editing for Biomedical Publication, (c)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Pharmaceutical Research and Manufacturers of America (PhRMA) guidelines, and (d) Principles on Conduct</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">of Clinical</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Trials.</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">publish</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">summaries</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">results</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Clinical Trials conducted by such Party with respect to the use of a Product in the Licensed Field after</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">the Effective Date; </font><font style="font-style:italic;font-size:10.5pt;">provided</font><font style="font-size:10.5pt;">, </font><font style="font-style:italic;font-size:10.5pt;">however, </font><font style="font-size:10.5pt;">that the other Party will have the right to review </font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">and comment on all proposed publications prior to submission of such publication. The</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">publishing Party shall provide the other Party at least sixty (60) days prior notice to review and comment</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">on the</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Clinical</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Trials</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">results,</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">non-clinical</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">study</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">results</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">published</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">purposes</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">of preparing any necessary Patent</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">filings.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.10<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Clinical Trial Transparency</font><font style="font-size:10.5pt;">. Both Parties agree to collaborate to maintain</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">compliance with all Applicable Laws related to clinical trial transparency, as well as any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">industry guidelines/codes of conduct, or other obligations that may apply to either the sponsor of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any clinical trial and/or the owner of any Regulatory Approval, all as relates to any Research</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Product or Licensed Product. The Parties shall cooperate to maintain clinical&nbsp;&nbsp;trial </font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">transparency consistent with each sponsor&#8217;s clinical trial registration, summary result, and data</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">sharing transparency policies and will support disclosure of Information as needed based on the needs</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">of the sponsors of the study or the Regulatory Approval holder with respect to&nbsp;&nbsp;any</font><font style="font-size:10.5pt;letter-spacing:-1pt;"> </font><font style="font-size:10.5pt;">Research Product or Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark129"></a>ARTICLE 15&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>TERM AND TERMINATION</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark130"></a>15.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Term</font><font style="font-size:10.5pt;">. This Agreement shall become effective as of the Effective Date&nbsp;&nbsp;and </font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">shall continue in full force and effect, unless earlier terminated pursuant to this ARTICLE 15, until</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">the later</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Collaboration</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Term,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Option Term,</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">(c)</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Royalty</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Licensed</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Products<font style="letter-spacing:1.15pt;"> </font>in<font style="letter-spacing:1.15pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>Territory,<font style="letter-spacing:1.1pt;"> </font>or<font style="letter-spacing:1.1pt;"> </font>(d)<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.2pt;"> </font>expiration<font style="letter-spacing:1.1pt;"> </font>of<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.1pt;"> </font>Takeda<font style="letter-spacing:1.05pt;"> </font>Royalty<font style="letter-spacing:0.85pt;"> </font>Term<font style="letter-spacing:1.15pt;"> </font>with<font style="letter-spacing:1.15pt;"> </font>respect<font style="letter-spacing:1.15pt;"> </font>to<font style="letter-spacing:1.45pt;"> </font>all Products the Takeda Territory (the<font style="letter-spacing:-0.5pt;"> </font>&#8220;<font style="text-decoration:underline;">Term</font>&#8221;).</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.2</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark131"></a><font style="font-size:10.5pt;font-weight:bold;">Termination for Material</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Breach</font><font style="font-size:10.5pt;">.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark132"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Either Party (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Non-breaching Party</font><font style="font-size:10.5pt;">&#8221;) may terminate this Agreement in</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">its entirety (except as otherwise provided in this Section 15.2(a)) if the other Party (the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Breaching</font><font style="font-size:10.5pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Party</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">materially</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">breached</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">cured within sixty (60) days after receipt of written notice of such breach by the Breaching Party</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">from the Non-Breaching Party (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Cure Period</font><font style="font-size:10.5pt;">&#8221;); provided, however, that, notwithstanding</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the foregoing,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">15.2(a)</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Compound-by-Compound and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product-by-Product</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">unless</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">materially</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">diminishes,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">materially frustrates,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">value</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Non-breaching</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">taken</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">whole,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">which case the Non-breaching Party may terminate this Agreement in its entirety. Any termination</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">of this Agreement with respect to a Compound or Product, or in its entirety, pursuant to this</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Section 15.2(a)</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">become</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">effective</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">end</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Cure</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Period,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">unless</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Breaching</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">has cured</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Cure</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Period.</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">either Party</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">terminate</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">entirety,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">as provided</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">15.2(a)</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">affected</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">way</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">waiver</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or failure to take action with respect to any previous breach under this</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark133"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If the Parties reasonably and in good faith disagree as to whether there has been</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a material</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">breach,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">was</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">material,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">disputes</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">whether there</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">material</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">contest</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">allegation</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">16. Notwithstanding</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">anything</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">contrary</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">contained</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">15.2(a),</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Cure</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Period</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">any Dispute</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">run</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">was</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">first</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Breaching</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">by the Non-Breaching Party through the resolution of such Dispute pursuant to ARTICLE 16, and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">it is understood and acknowledged that, during the pendency of a Dispute pursuant to this</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Section 15.2(b),</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">conditions</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">remain</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">effect,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Parties shall continue to perform all of their respective obligations under this</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, following the execution of an Option</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Product License Agreement or Exercised Product License Agreement, the terms of such</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">license agreement shall govern the handling of termination for material breach with respect to</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">the activities that are the subject of such license agreement (which shall be on the basis of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">this Section 15.2) and any termination of this Agreement shall not affect the existence of such</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Option Product License Agreement or Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.3</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark134"></a><font style="font-size:10.5pt;font-weight:bold;">Termination for Safety</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Reasons.</font></p></td>
<td valign="top" style="width:1.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">terminate</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Compound-by- Compound</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Product-by-Product</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">field</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">territory</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any time upon providing ninety (90) days prior written notice to the other Party (i) if</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">senior executives responsible for the terminating Party&#8217;s pharmacovigilance and clinical</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">science functions determine in good faith that the risk/benefit profile of the Compound or Product is</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">such that</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">cannot</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">continue</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Developed</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">administered</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">patients</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">safely;<font style="letter-spacing:0.65pt;"> </font>or<font style="letter-spacing:0.6pt;"> </font>(b)<font style="letter-spacing:0.55pt;"> </font>upon<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.7pt;"> </font>occurrence<font style="letter-spacing:0.6pt;"> </font>of<font style="letter-spacing:0.6pt;"> </font>serious<font style="letter-spacing:0.65pt;"> </font>adverse<font style="letter-spacing:0.55pt;"> </font>events<font style="letter-spacing:0.65pt;"> </font>related<font style="letter-spacing:0.6pt;"> </font>to<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>use<font style="letter-spacing:0.6pt;"> </font>of<font style="letter-spacing:0.6pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>Compound or Product that cause the terminating Party to conclude that the continued use of the<font style="letter-spacing:2.4pt;"> </font>Compound or<font style="letter-spacing:2.3pt;"> </font>Product<font style="letter-spacing:2.35pt;"> </font>by<font style="letter-spacing:2.05pt;"> </font>patients<font style="letter-spacing:2.45pt;"> </font>will<font style="letter-spacing:2.35pt;"> </font>result<font style="letter-spacing:2.35pt;"> </font>in<font style="letter-spacing:2.35pt;"> </font>patients<font style="letter-spacing:2.35pt;"> </font>being<font style="letter-spacing:2.2pt;"> </font>exposed<font style="letter-spacing:2.3pt;"> </font>to<font style="letter-spacing:2.35pt;"> </font>a<font style="letter-spacing:2.25pt;"> </font>product<font style="letter-spacing:2.35pt;"> </font>in<font style="letter-spacing:2.35pt;"> </font>which<font style="letter-spacing:2.3pt;"> </font>the<font style="letter-spacing:2.3pt;"> </font>risks outweigh the<font style="letter-spacing:-0.2pt;"> </font>benefits.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, following the execution of an Option</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Product License Agreement or Exercised Product License Agreement, the terms of such</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">license agreement shall govern the handling of termination for safety reasons with respect to</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the activities that are the subject of such license agreement (which shall be on the basis of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">this Section 15.3) and any termination of this Agreement shall not affect the existence of such</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Option Product License Agreement or Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.4</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark135"></a><font style="font-size:10.5pt;font-weight:bold;">Termination for</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Convenience</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Takeda shall have the right to terminate this Agreement with respect to </font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the Takeda Option for any or no reason upon ninety (90) days written</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">notice.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Provided</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">completed</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Licensed [***]</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Initial</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to Section 4.3(a), after the end of the Collaboration Term Ultragenyx shall have the right</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">to terminate this Agreement with respect to any or all Licensed Products in any or all countries</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">for which it has rights with respect to such Licensed Products for any or no reason upon ninety</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">(90) days written</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">notice.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, following the execution of an Option</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Product License Agreement or Exercised Product License Agreement, the terms of such</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">license agreement shall govern the handling of termination for convenience with respect to the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">activities that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(which</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">15.4) and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">affect</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">existence</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Product License Agreement or Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.5</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark136"></a><font style="font-size:10.5pt;font-weight:bold;">Termination for Patent Challenge</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">terminate</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">at any</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">providing</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s Affiliates,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">directly,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">indirectly</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">through</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">assistance</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">commences</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">any interference or opposition proceeding, challenges the validity or enforceability of, or opposes</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">any extension of or the grant of a supplementary protection certificate with respect to any</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Takeda Patent or any other Patent owned or controlled by Takeda that claims or discloses</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the composition of matter or the method of making or using a Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Takeda may terminate this Agreement with respect to all Candidate</font><font style="font-size:10.5pt;letter-spacing:-1pt;"> </font><font style="font-size:10.5pt;">Products and/or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">providing</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Ultragenyx, or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">directly,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">indirectly</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">through</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">assistance</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Third Party, commences any interference or opposition proceeding, challenges the validity</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">or enforceability of, or opposes any extension of or the grant of a supplementary</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">protection</font></p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">certificate<font style="letter-spacing:2.2pt;"> </font>with<font style="letter-spacing:2.25pt;"> </font>respect<font style="letter-spacing:2.25pt;"> </font>to<font style="letter-spacing:2.25pt;"> </font>any<font style="letter-spacing:2.15pt;"> </font>Takeda<font style="letter-spacing:2.2pt;"> </font>Patent<font style="letter-spacing:2.25pt;"> </font>or<font style="letter-spacing:2.3pt;"> </font>any<font style="letter-spacing:2pt;"> </font>other<font style="letter-spacing:2.2pt;"> </font>Patent<font style="letter-spacing:2.45pt;"> </font>Controlled<font style="letter-spacing:2.25pt;"> </font>by<font style="letter-spacing:2pt;"> </font>Takeda<font style="letter-spacing:2.2pt;"> </font>that claims<font style="letter-spacing:1.75pt;"> </font>or<font style="letter-spacing:1.7pt;"> </font>discloses<font style="letter-spacing:1.7pt;"> </font>the<font style="letter-spacing:1.8pt;"> </font>composition<font style="letter-spacing:1.75pt;"> </font>of<font style="letter-spacing:1.7pt;"> </font>matter<font style="letter-spacing:1.65pt;"> </font>or<font style="letter-spacing:1.7pt;"> </font>the<font style="letter-spacing:1.7pt;"> </font>method<font style="letter-spacing:1.7pt;"> </font>of<font style="letter-spacing:1.7pt;"> </font>making<font style="letter-spacing:1.7pt;"> </font>or<font style="letter-spacing:1.7pt;"> </font>using<font style="letter-spacing:1.75pt;"> </font>a<font style="letter-spacing:1.65pt;"> </font>Candidate Product and/or Option<font style="letter-spacing:-0.25pt;"> </font>Product.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Ultragenyx may terminate this Agreement with respect to an Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Pipeline Product</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">providing</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s Affiliates,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">directly,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">indirectly</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">through</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">assistance</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">commences</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">any interference or opposition proceeding, challenges the validity or enforceability of, or opposes</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">any extension of or the grant of a supplementary protection certificate with respect to any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx Patent or any other Patent Controlled by Ultragenyx that claims or discloses the composition</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">of matter or the method of making or using such Ultragenyx Pipeline</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, following the execution of an Option</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Product License Agreement or Exercised Product License Agreement, the terms of such</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">license agreement shall govern the handling of termination for patent challenge with respect to</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the activities</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">(which</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">this Section 15.5) and any termination of this Agreement shall not affect the existence of such</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Option Product License Agreement or Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.6</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark137"></a><font style="font-size:10.5pt;font-weight:bold;">Termination for Insolvency</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Either Party may terminate this Agreement in its entirety upon providing</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">written notice to the other Party on or after the time that such other Party makes a general assignment</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">for the benefit of creditors, files an insolvency petition in bankruptcy, petitions for or acquiesces</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">in the appointment of any receiver, trustee or similar officer to liquidate or conserve its business</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">substantial</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">part</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">assets,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">commences</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">laws</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">jurisdiction</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">proceeding involving its insolvency, bankruptcy, reorganization, adjustment of debt, dissolution,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">liquidation or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">similar</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">proceeding</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">release</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">financially</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">distressed</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">debtors,</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">becomes</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">a party to any proceeding or action of the type described above, and such proceeding or</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">action remains un-dismissed or un-stayed for a period of more than ninety (90)</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">days.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark138"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">All rights and licenses granted under or pursuant to this Agreement are, and</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">shall otherwise be deemed to be, for purposes of Section 365(n) of Title 11 of the United States</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Code and other similar laws in any other jurisdiction outside of the Territory (collectively,</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Bankruptcy Laws</font><font style="font-size:10.5pt;">&#8221;), licenses of rights to &#8220;intellectual property&#8221; as defined&nbsp;&nbsp;under</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">the Bankruptcy Laws. If a case is commenced during the Term by or against a Party</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">under Bankruptcy Laws then, unless and until this Agreement is rejected as provided pursuant to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">such Bankruptcy Laws, such Party (in any capacity, including debtor-in-possession) and its</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">successors and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">assigns</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">(including</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Title</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">11</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">trustee)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">perform</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Agreement intended to be performed by such Party. If a case is commenced during the Term by or against</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">a Party under the Bankruptcy Laws, this Agreement is rejected as provided for under</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the Bankruptcy Laws, and the non-bankrupt Party elects to retain its rights hereunder as provided</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">for under</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Bankruptcy</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Laws,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">then</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Bankruptcy</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Laws</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(in any capacity, including debtor-in-possession) and its successors and assigns (including a Title</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">11 trustee), shall provide to the non-bankrupt Party copies of all Patents and Information</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">necessary for</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">non-bankrupt</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">prosecute,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">maintain</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">enjoy</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">this</font></p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agreement. All rights, powers and remedies of the non-bankrupt Party as provided herein are<font style="letter-spacing:0.65pt;"> </font>in addition<font style="letter-spacing:1.95pt;"> </font>to<font style="letter-spacing:1.95pt;"> </font>and<font style="letter-spacing:1.9pt;"> </font>not<font style="letter-spacing:1.95pt;"> </font>in<font style="letter-spacing:1.8pt;"> </font>substitution<font style="letter-spacing:1.8pt;"> </font>for<font style="letter-spacing:1.85pt;"> </font>any<font style="letter-spacing:1.65pt;"> </font>and<font style="letter-spacing:1.9pt;"> </font>all<font style="letter-spacing:1.95pt;"> </font>other<font style="letter-spacing:1.85pt;"> </font>rights,<font style="letter-spacing:1.95pt;"> </font>powers<font style="letter-spacing:1.9pt;"> </font>and<font style="letter-spacing:1.9pt;"> </font>remedies<font style="letter-spacing:1.9pt;"> </font>now<font style="letter-spacing:1.9pt;"> </font>or hereafter existing at law or in equity (including the Bankruptcy Laws) in the event of<font style="letter-spacing:-0.55pt;"> </font>the commencement of a case by or against a Party under the Bankruptcy Laws. <font style="letter-spacing:-0.15pt;">In </font>particular, it is<font style="letter-spacing:-0.2pt;"> </font>the intention and understanding of the Parties to this Agreement that the rights granted to the<font style="letter-spacing:0.95pt;"> </font>Parties under this Section 15.6 are essential to the Parties&#8217; respective businesses and the<font style="letter-spacing:0.9pt;"> </font>Parties acknowledge that damages are not an adequate<font style="letter-spacing:-0.45pt;"> </font>remedy.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding the foregoing, following the execution of an Option</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">Product License Agreement or Exercised Product License Agreement, the terms of such</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">license agreement</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">govern</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">handling</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">insolvency</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">activities that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">(which</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">15.6) and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">affect</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">existence</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Product License Agreement or Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.7</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark139"></a><font style="font-size:10.5pt;font-weight:bold;">Effects of Termination</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark140"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Effects of Termination of Agreement in its</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Entirety</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">In the event of a termination of this Agreement in its entirety</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx pursuant to Section 15.2 (Breach) and 15.6 (Insolvency), Ultragenyx may elect</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">either of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">options</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(A)</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(B)</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">providing</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">election</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of termination:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:22.27%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark141"></a>(A)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">to effectuate actual termination of this Agreement in its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">entirety, in which case the following shall</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">apply:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(I)<font style="margin-left:227pt;"></font><font style="font-size:10.5pt;">all rights and licenses granted to</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx hereunder shall terminate immediately;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(II)<font style="margin-left:227pt;"></font><font style="font-size:10.5pt;">all rights and licenses granted by</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Ultragenyx hereunder</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">terminate</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">immediately</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">License,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">shall become</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">non-exclusive</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">intellectual</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">property</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">assigned</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the remainder of this Section 15.7(a)(i)(A), and which license shall apply to the Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">[***] Compound, Licensed Analog Compounds, Licensed Products and Research</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Products;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark142"></a>(III)<font style="margin-left:227pt;"></font><font style="font-size:10.5pt;">Ultragenyx, as soon as reasonably practical after</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the effective</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">termination,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">extent permitted under any applicable Third Party contract, (1) any Information, including copies of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">all Clinical Trial data and results, and the like developed by or for the benefit of Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">relating to a Licensed Product or Research Product, and (2) other documents to the extent relating to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the Licensed [***] Compounds, Licensed Analog Compounds, [***] Compounds, Candidate</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Products, Licensed Products or Research Products that are necessary for their Exploitation. </font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx will cooperate with Takeda to provide a transfer of such Information and documents at</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s expense.</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">At</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">request,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">assign</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">agreements</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to which Ultragenyx, or its Affiliate, and a Third Party are parties, and that govern the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Exploitation</font></p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">activities<font style="letter-spacing:0.8pt;"> </font>conducted<font style="letter-spacing:0.8pt;"> </font>in<font style="letter-spacing:0.85pt;"> </font>connection<font style="letter-spacing:0.8pt;"> </font>with<font style="letter-spacing:0.95pt;"> </font>such<font style="letter-spacing:0.8pt;"> </font>Compounds<font style="letter-spacing:0.85pt;"> </font>or<font style="letter-spacing:0.8pt;"> </font>Products<font style="letter-spacing:0.85pt;"> </font>prior<font style="letter-spacing:0.8pt;"> </font>to<font style="letter-spacing:0.85pt;"> </font>such<font style="letter-spacing:0.8pt;"> </font>termination, or,<font style="letter-spacing:1.15pt;"> </font>if<font style="letter-spacing:1.1pt;"> </font>such<font style="letter-spacing:1.1pt;"> </font>assignment<font style="letter-spacing:1.15pt;"> </font>is<font style="letter-spacing:1.25pt;"> </font>not<font style="letter-spacing:1.15pt;"> </font>permitted<font style="letter-spacing:1.1pt;"> </font>under<font style="letter-spacing:1.1pt;"> </font>the<font style="letter-spacing:1.2pt;"> </font>relevant<font style="letter-spacing:1.25pt;"> </font>agreement:<font style="letter-spacing:1.15pt;"> </font>(i)<font style="letter-spacing:1.2pt;"> </font>grant<font style="letter-spacing:1.15pt;"> </font>to<font style="letter-spacing:1.15pt;"> </font>Takeda<font style="letter-spacing:1.05pt;"> </font>other rights<font style="letter-spacing:0.85pt;"> </font>to<font style="letter-spacing:0.85pt;"> </font>provide<font style="letter-spacing:0.8pt;"> </font>to<font style="letter-spacing:0.85pt;"> </font>Takeda<font style="letter-spacing:0.8pt;"> </font>the<font style="letter-spacing:0.8pt;"> </font>benefit<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.8pt;"> </font>such<font style="letter-spacing:0.8pt;"> </font>non-assignable<font style="letter-spacing:0.8pt;"> </font>agreement,<font style="letter-spacing:0.8pt;"> </font>at<font style="letter-spacing:0.85pt;"> </font>Takeda&#8217;s<font style="letter-spacing:0.8pt;"> </font>expense, to the extent permitted under the terms of such non-assignable agreement; or (ii) to the extent<font style="letter-spacing:0.8pt;"> </font>not permitted<font style="letter-spacing:1.35pt;"> </font>under<font style="letter-spacing:1.45pt;"> </font>the<font style="letter-spacing:1.45pt;"> </font>terms<font style="letter-spacing:1.4pt;"> </font>of<font style="letter-spacing:1.3pt;"> </font>such<font style="letter-spacing:1.45pt;"> </font>non-assignable<font style="letter-spacing:1.35pt;"> </font>agreement,<font style="letter-spacing:1.45pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>Parties<font style="letter-spacing:1.35pt;"> </font>shall<font style="letter-spacing:1.35pt;"> </font>discuss<font style="letter-spacing:1.35pt;"> </font>in<font style="letter-spacing:1.5pt;"> </font>good faith<font style="letter-spacing:0.6pt;"> </font>an<font style="letter-spacing:0.6pt;"> </font>alternative<font style="letter-spacing:0.55pt;"> </font>solution<font style="letter-spacing:0.6pt;"> </font>to<font style="letter-spacing:0.6pt;"> </font>enable<font style="letter-spacing:0.55pt;"> </font>Takeda<font style="letter-spacing:0.55pt;"> </font>to<font style="letter-spacing:0.6pt;"> </font>receive,<font style="letter-spacing:0.7pt;"> </font>at<font style="letter-spacing:0.6pt;"> </font>Takeda&#8217;s<font style="letter-spacing:0.55pt;"> </font>expense,<font style="letter-spacing:0.55pt;"> </font>the<font style="letter-spacing:0.55pt;"> </font>benefit<font style="letter-spacing:0.6pt;"> </font>of<font style="letter-spacing:0.55pt;"> </font>the terms<font style="letter-spacing:0.8pt;"> </font>of<font style="letter-spacing:0.7pt;"> </font>such<font style="letter-spacing:0.7pt;"> </font>non-assignable<font style="letter-spacing:0.75pt;"> </font>agreement.<font style="letter-spacing:0.85pt;"> </font>In<font style="letter-spacing:0.75pt;"> </font>addition<font style="letter-spacing:0.75pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>actions<font style="letter-spacing:0.75pt;"> </font>contemplated<font style="letter-spacing:0.75pt;"> </font>in<font style="letter-spacing:0.8pt;"> </font>this<font style="letter-spacing:0.75pt;"> </font>Section 15.7(a)(i)(A)(III),<font style="letter-spacing:1.05pt;"> </font>Ultragenyx<font style="letter-spacing:1.15pt;"> </font>shall<font style="letter-spacing:1.1pt;"> </font>take<font style="letter-spacing:1pt;"> </font>such<font style="letter-spacing:1.05pt;"> </font>other<font style="letter-spacing:1.05pt;"> </font>actions<font style="letter-spacing:1.1pt;"> </font>and<font style="letter-spacing:1.05pt;"> </font>execute<font style="letter-spacing:1.05pt;"> </font>such<font style="letter-spacing:1.05pt;"> </font>other<font style="letter-spacing:1pt;"> </font>instruments, assignments<font style="letter-spacing:1pt;"> </font>and<font style="letter-spacing:0.85pt;"> </font>documents,<font style="letter-spacing:0.85pt;"> </font>at<font style="letter-spacing:0.9pt;"> </font>Takeda&#8217;s<font style="letter-spacing:0.95pt;"> </font>expense,<font style="letter-spacing:0.95pt;"> </font>as<font style="letter-spacing:0.9pt;"> </font>may<font style="letter-spacing:0.75pt;"> </font>be<font style="letter-spacing:0.95pt;"> </font>necessary<font style="letter-spacing:0.75pt;"> </font>to<font style="letter-spacing:1pt;"> </font>effect<font style="letter-spacing:0.9pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>transfer<font style="letter-spacing:0.95pt;"> </font>of rights to such Compound(s) and Product(s) hereunder to<font style="letter-spacing:-0.5pt;"> </font>Takeda;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(IV)<font style="margin-left:227pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall, at Takeda&#8217;s expense, transfer</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to Takeda any and all Regulatory Documentation related to a Licensed Product or</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Research Product,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">INDs</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Approvals</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s request, shall make available to Takeda any other relevant information reasonably related to</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">such Regulatory Documentation;</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(V)<font style="margin-left:227pt;"></font><font style="font-size:10.5pt;">effective on the date of termination, Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">for itself</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">hereby</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">assigns</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">assignment</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">can</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">only be made in the future hereby agrees to assign) to Takeda all right, title and interest in and to</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">any Licensed Product Improvements, Licensed Product Improvement Patents, Option</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Product Improvements, and Option Product Improvement Patents, in each case where Controlled</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx or its Affiliates. Ultragenyx will, at Takeda&#8217;s expense, execute and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">record assignments and other necessary documents consistent with such change in ownership;</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">or</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:21.86%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark143"></a>(B)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">in lieu of actual termination under (A) above, Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">may elect that all rights and licenses granted to Ultragenyx hereunder shall continue under</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">this Agreement</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">milestone</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">payments</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">become</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Ultragenyx with</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">shall be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">[***] and paid to Takeda in accordance with the payment provisions of this Agreement. This</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Section 15.7(a)(i)(B) may only be exercised</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">once.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">In</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">entirety</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Takeda pursuant to Section 15.2 (Breach) or 15.6 (Insolvency), Takeda may elect either of the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">following options (A) or (B) by providing written notice of its election with its notice of</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">termination:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:22.27%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark144"></a>(A)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">to effectuate actual termination of this Agreement in its</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">entirety, in which case the following shall</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">apply:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.86%;margin-right:1.03%;text-indent:37.11%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(I)<font style="margin-left:225pt;"></font><font style="font-size:10.5pt;">all rights and licenses granted to Takeda</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">hereunder shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">terminate</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">immediately,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">License,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">become non-exclusive</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">intellectual</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">property</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">assigned</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">remainder of</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">15.7(a)(ii)(A),</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">licenses</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">apply</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Compound, Licensed Analog Compounds, Licensed Products and Research</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">Products;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:39.39%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:5.57%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(II)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">licenses</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">hereunder</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shall terminate<font style="letter-spacing:-0.35pt;"> </font>immediately;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(III)<font style="margin-left:218pt;"></font><font style="font-size:10.5pt;">if not already completed and provided,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">report</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Product in</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Initial</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Plan</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Section 4.3(a);</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark145"></a>(IV)<font style="margin-left:218pt;"></font><font style="font-size:10.5pt;">Ultragenyx, as soon as reasonably practical after</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the effective</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">termination,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">extent permitted under any applicable Third Party contract, (1) any Information, including copies of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">all Clinical Trial data and results, and the like developed by or for the benefit of Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">relating to a Licensed Product or Research Product, and (2) other documents to the extent relating to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the Licensed [***] Compounds, Licensed Analog Compounds, [***] Compounds, Candidate</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">Products, Licensed Products or Research Products that are necessary for their Exploitation. </font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx will cooperate with Takeda to provide a transfer of such material Information and documents</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">at Ultragenyx&#8217;s expense. At Takeda&#8217;s request, Ultragenyx shall assign to Takeda any&nbsp;&nbsp;and</font><font style="font-size:10.5pt;letter-spacing:-1.1pt;"> </font><font style="font-size:10.5pt;">all Patents</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">agreements</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Affiliate,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">parties,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and that govern the Exploitation activities conducted in connection with such Compounds </font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or Products</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">termination,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">assignment</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">relevant agreement: (i) grant to Takeda other rights to provide to Takeda the benefit of such</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">non- assignable</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">agreement,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">expense,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such non-assignable agreement; or (ii) to the extent not permitted under the terms of such</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">non- assignable</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">agreement,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">discuss</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">alternative</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">solution</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">enable Takeda</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">receive,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">at</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">expense,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">benefit</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">non-assignable agreement. In addition to the actions contemplated in this Section 15.7(a)(ii)(A)(IV),</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">Ultragenyx shall take such other actions and execute such other instruments, assignments and documents,</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">at Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">expense,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">effect</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">transfer</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Compound(s) and Product(s) hereunder to Takeda;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(V)<font style="margin-left:218pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall, at its expense, transfer&nbsp;&nbsp;to</font><font style="font-size:10.5pt;letter-spacing:-1.15pt;"> </font><font style="font-size:10.5pt;">Takeda any and all Regulatory Documentation related to a Licensed Product or Research</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Product, including any Product INDs and Product Regulatory Approvals and, upon&nbsp;&nbsp;Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">request, shall make available to Takeda any other relevant information reasonably related to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">such Regulatory Documentation;</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:37.12%;font-size:12pt;font-family:Times New Roman;letter-spacing:0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(VI)<font style="margin-left:218pt;"></font><font style="font-size:10.5pt;">effective on the date of termination, Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">for itself</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">hereby</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">assigns</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">(and</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">assignment</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">can</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">only be made in the future hereby agrees to assign) to Takeda all right, title and interest in and to</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">any Licensed Product Improvements, Licensed Product Improvement Patents, Option</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Product Improvements, and Option Product Improvement Patents, in each case where Controlled</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx or its Affiliates. Ultragenyx will, at its expense, execute and record assignments</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and other necessary documents consistent with such change in ownership;</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">or</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:22.27%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark146"></a>(B)<font style="margin-left:168pt;"></font><font style="font-size:10.5pt;">in lieu of actual termination under (A) above, Takeda may</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">elect that all rights and licenses granted to Takeda hereunder shall continue under this Agreement</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">milestones</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">royalty</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">payments</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">become</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">to</font></p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any Exercised Product after such termination shall be reduced by fifty percent (50%) and paid<font style="letter-spacing:0.8pt;"> </font>to Ultragenyx in accordance with the payment provisions of this Agreement. This<font style="letter-spacing:0.75pt;"> </font>Section 15.7(a)(ii)(B) may only be exercised<font style="letter-spacing:-0.6pt;"> </font>once.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">For clarity, an Exercised Product License Agreement or an Option</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Product License Agreement shall include termination provisions similar to this Section 15.7(a) and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall otherwise govern the effects of termination of such agreement in its</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">entirety.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Effects of Termination of a Compound or Product for Safety Reasons. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the event</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">particular</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Product pursuant to Section 15.3 (for the avoidance of doubt, not a Terminated Product)</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">then:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">received</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">terminating</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">of the terminating Party with respect to the terminated Compound or Product shall cease and,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">with respect to the terminating Party only, this Agreement shall automatically be deemed to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">be amended</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">exclude</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">terminating</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">the terminated</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Compound</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">otherwise</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">survive</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">continue</font><font style="font-size:10.5pt;letter-spacing:2.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">effect</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the remaining Compounds and Products;</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">the non-terminating Party shall continue to have all rights and</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">obligations under this Agreement with respect to the terminated Compound or Product (including</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the obligation to make royalty, milestone and other payments to the terminating Party) unless it</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">also elects to terminate the particular Compound or Product pursuant to Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">15.3.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark147"></a>(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Effects of Termination with Respect to a Terminated Product. </font><font style="font-size:10.5pt;">In the event</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">of termination</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Terminated</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(but</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">any termination of this Agreement in its entirety)</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">then:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">all rights and licenses granted hereunder by either Party </font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">shall automatically</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">deemed</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">amended</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">exclude</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Terminated</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">but</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">otherwise survive and continue in effect for the remaining Compounds and</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Products;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">in the case of termination for convenience pursuant to Section 15.4, if</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">an Option Negotiation Period or Takeda Option Negotiation Period is then ongoing, the Term</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">with respect</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">automatically</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">extend until the earlier of (A) expiration of such Option Negotiation Period or Takeda</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Option Negotiation</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Period,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">applicable,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(B)</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">execution</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">License Agreement or Exercised Product License</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">Agreement;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">if the Terminated Product is a Licensed Product, if not already</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">completed and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">provided,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">complete</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">report</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Development</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">for the Licensed [***] Product in the Takeda Field as set forth in the Initial [***] Development Plan</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">in accordance with Section</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">4.3(a);</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark148"></a>(iv)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Ultragenyx, as soon as reasonably practical after the effective date of</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">such termination, shall provide to Takeda, as applicable and to the extent permitted under</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">any</font></p>
<p style="text-align:center;margin-top:7pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applicable<font style="letter-spacing:0.85pt;"> </font>Third<font style="letter-spacing:0.85pt;"> </font>Party<font style="letter-spacing:0.75pt;"> </font>contract,<font style="letter-spacing:0.9pt;"> </font>(A)<font style="letter-spacing:0.95pt;"> </font>any<font style="letter-spacing:0.75pt;"> </font>Information,<font style="letter-spacing:0.85pt;"> </font>including<font style="letter-spacing:0.8pt;"> </font>copies<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.95pt;"> </font>all<font style="letter-spacing:0.9pt;"> </font>Clinical<font style="letter-spacing:0.9pt;"> </font>Trial<font style="letter-spacing:0.85pt;"> </font>data and<font style="letter-spacing:0.85pt;"> </font>results,<font style="letter-spacing:0.9pt;"> </font>and<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>like<font style="letter-spacing:0.7pt;"> </font>developed<font style="letter-spacing:0.85pt;"> </font>by<font style="letter-spacing:0.5pt;"> </font>or<font style="letter-spacing:0.85pt;"> </font>for<font style="letter-spacing:0.85pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>benefit<font style="letter-spacing:0.9pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>Ultragenyx<font style="letter-spacing:1pt;"> </font>relating<font style="letter-spacing:0.75pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>a<font style="letter-spacing:1.2pt;"> </font>Terminated Product,<font style="letter-spacing:2.25pt;"> </font>and<font style="letter-spacing:2.2pt;"> </font>(B)<font style="letter-spacing:2.15pt;"> </font>other<font style="letter-spacing:2.25pt;"> </font>documents<font style="letter-spacing:2.2pt;"> </font>to<font style="letter-spacing:2.2pt;"> </font>the<font style="letter-spacing:2.25pt;"> </font>extent<font style="letter-spacing:2.05pt;"> </font>relating<font style="letter-spacing:2.1pt;"> </font>to<font style="letter-spacing:2.2pt;"> </font>the<font style="letter-spacing:2.25pt;"> </font>Terminated<font style="letter-spacing:2.15pt;"> </font>Products<font style="letter-spacing:2.3pt;"> </font>that<font style="letter-spacing:2.2pt;"> </font>are necessary for their Exploitation. Ultragenyx will cooperate with Takeda to provide a transfer<font style="letter-spacing:2.75pt;"> </font>of such material Information and documents. Ultragenyx shall assign to Takeda any and all<font style="letter-spacing:1.2pt;"> </font>Patents and<font style="letter-spacing:1.95pt;"> </font>agreements<font style="letter-spacing:2pt;"> </font>to<font style="letter-spacing:2pt;"> </font>which<font style="letter-spacing:1.95pt;"> </font>Ultragenyx,<font style="letter-spacing:1.95pt;"> </font>or<font style="letter-spacing:2.05pt;"> </font>its<font style="letter-spacing:1.95pt;"> </font>Affiliate,<font style="letter-spacing:1.95pt;"> </font>and<font style="letter-spacing:1.95pt;"> </font>a<font style="letter-spacing:1.9pt;"> </font>Third<font style="letter-spacing:1.95pt;"> </font>Party<font style="letter-spacing:1.85pt;"> </font>are<font style="letter-spacing:1.85pt;"> </font>parties,<font style="letter-spacing:1.95pt;"> </font>and<font style="letter-spacing:2.05pt;"> </font>that govern the Exploitation activities conducted in connection with a Terminated Product prior<font style="letter-spacing:2.5pt;"> </font>to such termination, or, if such assignment is not permitted under the relevant agreement: (1)<font style="letter-spacing:0.45pt;"> </font>grant to Takeda other rights to provide to Takeda the benefit of such non-assignable agreement to<font style="letter-spacing:2.9pt;"> </font>the extent<font style="letter-spacing:2.2pt;"> </font>permitted<font style="letter-spacing:2.2pt;"> </font>under<font style="letter-spacing:2.15pt;"> </font>the<font style="letter-spacing:2.15pt;"> </font>terms<font style="letter-spacing:2.25pt;"> </font>of<font style="letter-spacing:2.15pt;"> </font>such<font style="letter-spacing:2.35pt;"> </font>non-assignable<font style="letter-spacing:2.3pt;"> </font>agreement;<font style="letter-spacing:2.2pt;"> </font>or<font style="letter-spacing:2.25pt;"> </font>(2)<font style="letter-spacing:2.15pt;"> </font>to<font style="letter-spacing:2.2pt;"> </font>the<font style="letter-spacing:2.15pt;"> </font>extent<font style="letter-spacing:2.2pt;"> </font>not permitted<font style="letter-spacing:1.35pt;"> </font>under<font style="letter-spacing:1.45pt;"> </font>the<font style="letter-spacing:1.45pt;"> </font>terms<font style="letter-spacing:1.4pt;"> </font>of<font style="letter-spacing:1.3pt;"> </font>such<font style="letter-spacing:1.45pt;"> </font>non-assignable<font style="letter-spacing:1.35pt;"> </font>agreement,<font style="letter-spacing:1.45pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>Parties<font style="letter-spacing:1.35pt;"> </font>shall<font style="letter-spacing:1.35pt;"> </font>discuss<font style="letter-spacing:1.35pt;"> </font>in<font style="letter-spacing:1.5pt;"> </font>good faith an alternative solution to enable Takeda to receive the benefit of the terms of such<font style="letter-spacing:2.65pt;"> </font>non- assignable agreement. In addition to the actions contemplated in this Section 15.7(c)(iv), Ultragenyx shall take such other actions and execute such other instruments, assignments<font style="letter-spacing:0.05pt;"> </font>and documents<font style="letter-spacing:2.2pt;"> </font>as<font style="letter-spacing:2.2pt;"> </font>may<font style="letter-spacing:1.95pt;"> </font>be<font style="letter-spacing:2.15pt;"> </font>necessary<font style="letter-spacing:1.85pt;"> </font>to<font style="letter-spacing:2.2pt;"> </font>effect<font style="letter-spacing:2.2pt;"> </font>the<font style="letter-spacing:2.15pt;"> </font>transfer<font style="letter-spacing:2.15pt;"> </font>of<font style="letter-spacing:2.15pt;"> </font>rights<font style="letter-spacing:2.25pt;"> </font>to<font style="letter-spacing:2.2pt;"> </font>such<font style="letter-spacing:2.45pt;"> </font>Terminated<font style="letter-spacing:2.15pt;"> </font>Products hereunder to Takeda.&nbsp;&nbsp;Each Party shall bear its own expenses under this Section<font style="letter-spacing:-0.65pt;"> </font>15.7(c)(iv);</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(v)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall transfer to Takeda any and all Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Documentation directly</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Terminated</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">INDs</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Product Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Approvals</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">request,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">available</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">other relevant information reasonably related to such Regulatory</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Documentation;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vi)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">effective on the date of termination, Ultragenyx, for itself and on behalf</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Affiliates,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">hereby</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">assigns</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">assignment</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">can</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">only</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">future hereby</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">agrees</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">assign)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">right,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">title</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">interest</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Product Improvements, Licensed Product Improvement Patents, Option Product Improvements,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and Option</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Improvement</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">foregoing</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Cover</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Terminated</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Product and are Controlled by Ultragenyx or its Affiliates. Ultragenyx will execute and</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">record assignments and other necessary documents consistent with such change in ownership;</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">assume</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">prosecution,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">maintenance,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and enforcement</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Covering</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Terminated Products. Ultragenyx will cooperate with Takeda and provide Takeda with reasonable</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">assistance and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">cooperation</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">prosecution,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">maintenance,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">enforcement</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to such</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Patents.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Effect of Termination on Ultragenyx&#8217;s Put Rights under the Common</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Stock Purchase Agreement</font><font style="font-size:10.5pt;">. Immediately upon (i) written notice of termination of this Agreement</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">in its</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">entirety</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">15.2,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">15.6,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Licensed Product</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">15.2,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">15.3,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">15.4,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">15.5,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">18.5</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">(iii)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">terminating</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">4.3(f),</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Ultragenyx&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the Common</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Stock</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Purchase</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">require</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">purchase</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Second</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Tranche</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Shares</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and Third</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Tranche</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Shares</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">(as</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">defined</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Common</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Stock</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Purchase</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Agreement) shall be suspended and such rights shall automatically terminate on the effective date of</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">such termination, provided, however, there shall be no suspension or termination of such</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights<font style="letter-spacing:1.7pt;"> </font>under<font style="letter-spacing:1.65pt;"> </font>the<font style="letter-spacing:1.75pt;"> </font>Common<font style="letter-spacing:1.65pt;"> </font>Stock<font style="letter-spacing:1.65pt;"> </font>Purchase<font style="letter-spacing:1.6pt;"> </font>Agreement<font style="letter-spacing:1.65pt;"> </font>to<font style="letter-spacing:1.7pt;"> </font>the<font style="letter-spacing:1.65pt;"> </font>extent<font style="letter-spacing:1.65pt;"> </font>Ultragenyx<font style="letter-spacing:1.9pt;"> </font>terminates<font style="letter-spacing:1.75pt;"> </font>the Agreement,<font style="letter-spacing:1.4pt;"> </font>a<font style="letter-spacing:1.4pt;"> </font>Licensed<font style="letter-spacing:1.4pt;"> </font>Product<font style="letter-spacing:1.35pt;"> </font>or<font style="letter-spacing:1.25pt;"> </font>Research<font style="letter-spacing:1.3pt;"> </font>Product<font style="letter-spacing:1.55pt;"> </font>pursuant<font style="letter-spacing:1.35pt;"> </font>to<font style="letter-spacing:1.35pt;"> </font>Section<font style="letter-spacing:1.4pt;"> </font>15.2.<font style="letter-spacing:2.75pt;"> </font>Where<font style="letter-spacing:1.25pt;"> </font>written notice<font style="letter-spacing:0.85pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>termination<font style="letter-spacing:0.85pt;"> </font>pursuant<font style="letter-spacing:0.85pt;"> </font>to<font style="letter-spacing:0.9pt;"> </font>Section<font style="letter-spacing:1.05pt;"> </font>15.2<font style="letter-spacing:1pt;"> </font>is<font style="letter-spacing:1.05pt;"> </font>provided<font style="letter-spacing:0.9pt;"> </font>by<font style="letter-spacing:0.65pt;"> </font>Takeda,<font style="letter-spacing:0.9pt;"> </font>and<font style="letter-spacing:1pt;"> </font>Ultragenyx<font style="letter-spacing:1.1pt;"> </font>cures<font style="letter-spacing:1pt;"> </font>all material breaches during the Cure Period, the suspension shall be removed on the effective<font style="letter-spacing:2pt;"> </font>date of such<font style="letter-spacing:-0.15pt;"> </font>cure.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.8</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark149"></a><font style="font-size:10.5pt;font-weight:bold;">Effect of</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Expiration</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Expiration of Collaboration Term. </font><font style="font-size:10.5pt;">Upon expiration of the Collaboration</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Term for a given Research</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">Product:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">All rights to such Research Product shall revert to Takeda except for</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">those rights, if any, granted to Ultragenyx under an Option Product License</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Agreement;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark150"></a>(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">As soon as reasonably practical after the effective date of expiration of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the Collaboration</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">given</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">shall,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">where</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">otherwise provided</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">contract</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">(1)</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Information,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">including copies</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Clinical</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Trial</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">data</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">results,</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">like</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">developed</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">benefit</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">relating</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">(2)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">documents</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">relating</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to such Research Product that are necessary for their continued Exploitation. Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">will cooperate with Takeda to provide a transfer of such material Information and documents.</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">At Takeda&#8217;s request, Ultragenyx shall assign to Takeda any and all Patents and agreements to</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">which Ultragenyx,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Affiliate,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">parties,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">govern</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">Exploitation activities conducted in connection with such Research Product prior to such expiration, or if</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">such assignment is not permitted under the relevant agreement: (i) grant to Takeda other rights</font><font style="font-size:10.5pt;letter-spacing:-1pt;"> </font><font style="font-size:10.5pt;">to provide to Takeda the benefit of such non-assignable agreement to the extent permitted under</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the terms</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">non-assignable</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">agreement;</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of such</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">non-assignable</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">agreement,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">discuss</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">alternative</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">solution</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to enable Takeda to receive the benefit of the terms of such non-assignable agreement. In </font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">addition to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">actions</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">contemplated</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">15.8(a)(ii),</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">take</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">actions and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">execute</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">instruments,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">assignments</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">documents</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">effect the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">transfer</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Takeda.</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">bear</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">own</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">under this Section</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">15.8(a)(ii);</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Ultragenyx shall transfer to Takeda any and all Regulatory</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Documentation directly</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Research</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">INDs</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Product Regulatory</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Approvals</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Takeda&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">request,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">make</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">available</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">other relevant information reasonably related to such Regulatory Documentation;</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">assume</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">prosecution,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">maintenance,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and enforcement</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Patents</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Covering</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Research Product. Ultragenyx will cooperate with Takeda and provide Takeda with reasonable</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">assistance and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">cooperation</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">prosecution,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">maintenance,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">enforcement</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">activities</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to such</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Patents.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Expiration of Licensed Product Royalty Term. </font><font style="font-size:10.5pt;">Upon the expiration of</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">the Licensed</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Royalty</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Term</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">country</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Territory, Ultragenyx shall have a non-exclusive, fully-paid up and irrevocable license under the</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Licensed [***]</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Technology</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">country</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Field for Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Products.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Expiration of Exercised Product License Agreement and Option</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Product License Agreement</font><font style="font-size:10.5pt;">. Each Exercised Product License Agreement and Option Product</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">License Agreement shall provide that, upon expiration of the applicable royalty term, Takeda shall have</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">a non-exclusive,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">fully-paid</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">up</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">irrevocable</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Exercised</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Products</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and Licensed Option Products,</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">respectively.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark151"></a>15.9<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Remedies. </font><font style="font-size:10.5pt;">Notwithstanding anything to the contrary in this Agreement, except</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">as otherwise</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">not relieve</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">liability</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">obligation</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">accrued</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">effective date of such termination or expiration, nor prejudice either Party&#8217;s right to obtain performance</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of any obligation. Each Party shall be free, pursuant to ARTICLE 16, to seek, without restriction</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">as to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">number</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">times</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">seek,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">damages,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">remedies</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">available</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">it under Applicable Laws or in equity and shall be entitled to offset the amount of any damages</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">and costs</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">obtained</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">against</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">determination</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">16.4,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">against</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">any amounts otherwise due to such other Party under this</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">Agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark152"></a>15.10<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Survival</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">provisions</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">survive</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">this Agreement</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">time</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">specified</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">therein</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">(or,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">period</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">specified, indefinitely): ARTICLE 1 (Definitions); ARTICLE 16 (Dispute Resolution); and ARTICLE 17 (Indemnification); and Sections 4.5 (Records; Disclosure of Data and Results), 6.6(b) (Research Materials Transfer), 11.9, 11.10, 11.11, 11.12, 11.13 (Payment, Taxes, Audit); 12.1</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">(Ownership of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Inventions);</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">14.1,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">14.2,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">14.3,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">14.4,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">14.5,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">14.6,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">14.7,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">14.8</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">(Confidentiality);</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">15.7,</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">15.8,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">15.9, 15.10 (Termination); 18.3, 18.7, 18.8, 18.9, 18.10, 18.14, 18.15, 18.16, and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">18.17 (Miscellaneous).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark154"></a><a name="_bookmark153"></a><a name="_bookmark153"></a>ARTICLE 16&nbsp;&nbsp;<font style="font-weight:normal;">&#8211; </font>DISPUTE<font style="letter-spacing:0.1pt;"> </font>RESOLUTION</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark155"></a>16.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Exclusive</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Dispute</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Resolution</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Mechanism.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">Except</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">disputes</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">has final</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">decision</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">authority</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Sections</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">2.1(b)(ii),</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">2.2(c)(ii) and 12.4, the Parties agree that the procedures set forth in this ARTICLE 16 shall&nbsp;&nbsp;be</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">the exclusive</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">mechanism</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">resolving</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">dispute,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">controversy,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">claim</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">between</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">that may arise from time to time pursuant to this Agreement relating to either Party&#8217;s rights</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">or obligations</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">(each,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;">&#8221;,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">collectively,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Disputes</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">resolved through good faith negotiation between the</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Parties.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark156"></a>16.2<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Resolution by Executive Officers. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In </font><font style="font-size:10.5pt;">the event of any Dispute, the Parties shall</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">first attempt in good faith to resolve such Dispute by negotiation and consultation</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">between themselves.</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">In</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">resolved</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">informal</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">basis</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">ten</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(10) Business</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Days</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">writing</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">may,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">by written</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">refer</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Senior</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Officers</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">for</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">attempted resolution by good faith negotiation within thirty (30) days after such notice<font style="letter-spacing:1.4pt;"> </font>is received. Except where exclusive decision-making authority rests with a Party under<font style="letter-spacing:1.45pt;"> </font>this Agreement (including Sections 2.1(b)(ii), 2.2(c)(ii) and 12.4), each Party may, in its<font style="letter-spacing:0.05pt;"> </font>sole discretion,<font style="letter-spacing:0.85pt;"> </font>seek<font style="letter-spacing:0.85pt;"> </font>resolution<font style="letter-spacing:0.9pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>any<font style="letter-spacing:0.65pt;"> </font>and<font style="letter-spacing:1pt;"> </font>all<font style="letter-spacing:0.9pt;"> </font>Disputes<font style="letter-spacing:0.9pt;"> </font>that<font style="letter-spacing:0.85pt;"> </font>are<font style="letter-spacing:0.8pt;"> </font>not<font style="letter-spacing:0.9pt;"> </font>resolved<font style="letter-spacing:0.85pt;"> </font>under<font style="letter-spacing:0.85pt;"> </font>this<font style="letter-spacing:0.9pt;"> </font>Section<font style="letter-spacing:1.25pt;"> </font>16.2 using (a) arbitration pursuant Section 16.3 where arbitration pursuant to Section 16.3<font style="letter-spacing:0.8pt;"> </font>is specifically provided for in this Agreement or (b) otherwise, pursuant to Section<font style="letter-spacing:-0.65pt;"> </font>16.4.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark157"></a>16.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Baseball Arbitration. </font><font style="font-size:10.5pt;">Any Dispute for which arbitration pursuant to this Section 16.3</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">is specifically</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">finally</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">decided</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">expedited</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">arbitration</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in accordance with the following abbreviated dispute resolution</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">procedures:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark158"></a>(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">resolved</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">thirty</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">(30)</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">days</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">referral</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s respective</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Senior</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Officers</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">16.2,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">send</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a written</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">wishes</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">resolve</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">using</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">neutral</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Third</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">who</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">an Expert with at least fifteen (15) years of experience in area of the Dispute (the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Neutral</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Expert</font><font style="font-size:10.5pt;">&#8221;). The date of the other Party&#8217;s receipt of such written notices shall be the &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Notice</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Date</font><font style="font-size:10.5pt;">.&#8221;</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark159"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Within fifteen (15) Business Days of the Notice Date, each Party shall notify</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">the other Party in writing of its appointed Expert (each, a &#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Representative Expert</font><font style="font-size:10.5pt;">&#8221;).</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">The Representative Experts for each Party shall jointly appoint the Neutral Expert within fifteen</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">(15) Business</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Days.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Within ten (10) Business Days after the appointment of the Neutral Expert,</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">each Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">submit</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Neutral</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Expert</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">summary</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">its position with respect to the Dispute. Contemporaneously with the submission of its</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">written summary</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">position,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">provide</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Neutral</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Expert with copies of all documents it relied upon in its written summary; provided that each Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">may redact any portion of such documents which are covered by an applicable privilege or do</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">not relate</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Agreement.</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Within</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">three</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(3)</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Business</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Days</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">receipt</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the other Party's written summary regarding its position, each Party may submit an</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">opposition statement of no more than five (5) pages in length (excluding exhibits and declarations).</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Neither Party</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">allowed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">discovery.</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">Neither</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">have</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">communications (either written or oral) with the other Party&#8217;s Representative Experts or the Neutral Expert</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">other than</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">sole</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">purpose</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">engaging</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">expert</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">panel</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">expressly</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Section 16.3; provided, that oral presentations and follow-up written submissions may be made to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the Neutral Expert at such Neutral Expert's request. The Neutral Expert may consult in writing</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">with the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Representative</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Experts</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">submissions</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">made</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party;</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">both Representative</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Experts</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">aware</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">consultation</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">opportunity</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">respond. Evaluating</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">submissions,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Neutral</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Expert</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">ten</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(10)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Business Days of receipt of the written opposition statement, select in total, either Takeda's submission</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or Ultragenyx&#8217;s submission. Such decision shall be final, binding and not</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">appealable.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">whose</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">submission</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">selected</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">solely</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the expenses</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">fees</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Neutral</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Expert</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">fees</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s Representative</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">Expert.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark160"></a>16.4<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Litigation.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">unresolved</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Dispute</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">was</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">16.2,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">brought exclusively</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">court</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">competent</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">jurisdiction,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">federal</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">state,</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">located</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">New</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">York,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">New York, and in no other jurisdiction. Each Party hereby consents to personal jurisdiction and</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">venue in, and agrees to service of process issued or authorized by, such</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">court.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Preliminary Injunctions. </font><font style="font-size:10.5pt;">Notwithstanding anything in this Agreement to the contrary,</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">a Party may seek a temporary restraining order or a preliminary injunction from any court</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of competent jurisdiction in order to prevent immediate and irreparable injury, loss, or damage on</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">a provisional basis, pending the decision of the arbitrator(s) on the ultimate merits of any</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">Dispute.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.6<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Patent and Trademark Disputes. </font><font style="font-size:10.5pt;">Notwithstanding anything in this Agreement to</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">the contrary, any and all issues regarding the scope, construction, validity, and enforceability of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">any Patent or trademark relating to a Product that is the subject of this Agreement shall </font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">be determined</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">court</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">tribunal,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">case</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">competent</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">jurisdiction</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the applicable patent or trademark laws of the country in which such Patent or trademark rights</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">were granted or</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">arose.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.7<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Confidentiality. </font><font style="font-size:10.5pt;">Any and all activities conducted under ARTICLE 16, including any</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">and all</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">proceedings</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">decisions</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">16.4,</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">deemed</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Confidential</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Information</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">of each of the Parties, and shall be subject to ARTICLE</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">14.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.8<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">WAIVER OF RIGHT TO JURY TRIAL</font><font style="font-size:10.5pt;">. In connection with the Parties&#8217; rights</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">under Section</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">16.4,</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">EACH</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">PARTY,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">TO</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">THE</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">EXTENT</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">PERMITTED</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">BY</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">APPLICABLE</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">LAWS, KNOWINGLY, VOLUNTARILY, AND INTENTIONALLY WAIVES ITS RIGHT TO</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">A TRIAL BY JURY </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">IN </font><font style="font-size:10.5pt;">ANY ACTION OR OTHER LEGAL PROCEEDING ARISING OUT</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">OF OR RELATING TO THIS AGREEMENT AND THE TRANSACTIONS</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">IT</font><font style="font-size:10.5pt;"> CONTEMPLATES. THIS WAIVER APPLIES TO ANY ACTION OR </font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">LEGAL PROCEEDING, WHETHER SOUNDING IN CONTRACT, TORT, OR</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">OTHERWISE.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark161"></a><a name="_bookmark162"></a><a name="_bookmark162"></a>ARTICLE 17&nbsp;&nbsp;<font style="font-weight:normal;">&#8211;</font><font style="font-weight:normal;letter-spacing:-0.05pt;"> </font>INDEMNIFICATION</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark163"></a>17.1<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Indemnification by Ultragenyx. </font><font style="font-size:10.5pt;">Ultragenyx hereby agrees to defend, indemnify</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">and hold harmless Takeda and its Affiliates, and each of their respective directors,</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">officers, employees, agents and representatives (each, a </font><font style="font-style:italic;font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Takeda Indemnitee</font><font style="font-size:10.5pt;">&#8221;) from and against any</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">and all claims, suits, actions, demands, liabilities, expenses and/or loss, including reasonable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">legal expense</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">attorneys&#8217;</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">fees</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">(collectively,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-style:italic;font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Losses</font><font style="font-size:10.5pt;">&#8221;),</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Indemnitee</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">may become subject as a result of any claim, demand, action or other proceeding by any Third</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">Party (each,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-style:italic;font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Claim</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Losses</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">arise</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">directly</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">indirectly</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">out</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">of:</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">practice</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx or its Affiliate of any license granted to it under ARTICLE 3; (ii) the Exploitation</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of a Compound or a Product by Ultragenyx, its Affiliates or its sublicensees on or after </font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">the Effective Date, including, for the avoidance of doubt, any Product Liabilities arising from the</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">use of</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Losses that may arise due to Ultragenyx, its Affiliates or its sublicensees continuing to Exploit</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">a Compound or Product in its territory or field that is the subject matter of a termination by</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Takeda pursuant to Section 15.3; (iii) the Exploitation of any Ultragenyx Pipeline&nbsp;&nbsp;Product</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">by Ultragenyx, its Affiliates or its licensees before the Effective Date, including, for the</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">avoidance</font></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of<font style="letter-spacing:0.7pt;"> </font>doubt,<font style="letter-spacing:0.8pt;"> </font>any<font style="letter-spacing:0.5pt;"> </font>Product<font style="letter-spacing:0.9pt;"> </font>Liabilities<font style="letter-spacing:0.75pt;"> </font>arising<font style="letter-spacing:0.65pt;"> </font>from<font style="letter-spacing:0.8pt;"> </font>the<font style="letter-spacing:0.85pt;"> </font>use<font style="letter-spacing:0.7pt;"> </font>of<font style="letter-spacing:0.7pt;"> </font>a<font style="letter-spacing:0.7pt;"> </font>Ultragenyx<font style="letter-spacing:0.85pt;"> </font>Pipeline<font style="letter-spacing:0.75pt;"> </font>Product;<font style="letter-spacing:0.8pt;"> </font>(iv)<font style="letter-spacing:-0.1pt;"> </font>the breach by Ultragenyx of any warranty, representation, covenant or agreement made by Ultragenyx in this Agreement; (v) the negligence, gross negligence or willful<font style="letter-spacing:2.55pt;"> </font>misconduct (including<font style="letter-spacing:1.55pt;"> </font>to<font style="letter-spacing:1.7pt;"> </font>the<font style="letter-spacing:1.65pt;"> </font>extent<font style="letter-spacing:1.55pt;"> </font>such<font style="letter-spacing:1.65pt;"> </font>negligence,<font style="letter-spacing:1.8pt;"> </font>gross<font style="letter-spacing:1.65pt;"> </font>negligence<font style="letter-spacing:1.6pt;"> </font>or<font style="letter-spacing:1.65pt;"> </font>willful<font style="letter-spacing:1.65pt;"> </font>misconduct<font style="letter-spacing:1.7pt;"> </font>gives<font style="letter-spacing:1.65pt;"> </font>rise<font style="letter-spacing:1.6pt;"> </font>to Product<font style="letter-spacing:0.85pt;"> </font>Liabilities<font style="letter-spacing:0.75pt;"> </font>under<font style="letter-spacing:0.85pt;"> </font>any<font style="letter-spacing:0.5pt;"> </font>legal<font style="letter-spacing:0.8pt;"> </font>theory)<font style="letter-spacing:0.7pt;"> </font>of<font style="letter-spacing:0.85pt;"> </font>Ultragenyx,<font style="letter-spacing:0.75pt;"> </font>its<font style="letter-spacing:0.75pt;"> </font>Affiliate<font style="letter-spacing:0.75pt;"> </font>or<font style="letter-spacing:0.7pt;"> </font>its<font style="letter-spacing:0.8pt;"> </font>sublicensee,<font style="letter-spacing:0.75pt;"> </font>or<font style="letter-spacing:0.7pt;"> </font>any officer, director, employee, agent or representative thereof; except, with respect to each<font style="letter-spacing:1.8pt;"> </font>of subsections<font style="letter-spacing:0.75pt;"> </font>(i)<font style="letter-spacing:0.7pt;"> </font>through<font style="letter-spacing:0.75pt;"> </font>(v)<font style="letter-spacing:0.7pt;"> </font>above,<font style="letter-spacing:0.75pt;"> </font>to<font style="letter-spacing:0.8pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>extent<font style="letter-spacing:0.75pt;"> </font>such<font style="letter-spacing:0.85pt;"> </font>Losses<font style="letter-spacing:0.75pt;"> </font>arise<font style="letter-spacing:0.7pt;"> </font>directly<font style="letter-spacing:0.65pt;"> </font>or<font style="letter-spacing:0.7pt;"> </font>indirectly<font style="letter-spacing:0.5pt;"> </font>from<font style="letter-spacing:0.8pt;"> </font>the negligence,<font style="letter-spacing:1.1pt;"> </font>gross<font style="letter-spacing:1pt;"> </font>negligence<font style="letter-spacing:0.95pt;"> </font>or<font style="letter-spacing:0.95pt;"> </font>willful<font style="letter-spacing:1pt;"> </font>misconduct<font style="letter-spacing:1pt;"> </font>of<font style="letter-spacing:0.95pt;"> </font>any<font style="letter-spacing:1pt;"> </font>Takeda<font style="letter-spacing:1.15pt;"> </font>Indemnitee<font style="letter-spacing:0.9pt;"> </font>or<font style="letter-spacing:0.95pt;"> </font>the<font style="letter-spacing:0.95pt;"> </font>breach<font style="letter-spacing:1pt;"> </font><font style="letter-spacing:0.15pt;">by</font> Takeda of any warranty, representation, covenant or agreement made by Takeda in<font style="letter-spacing:0.7pt;"> </font>this Agreement. Notwithstanding the foregoing, following the execution of an Exercised<font style="letter-spacing:1.5pt;"> </font>Product License Agreement or Option Product License Agreement, the terms of such license<font style="letter-spacing:0.2pt;"> </font>agreement shall<font style="letter-spacing:1.7pt;"> </font>govern<font style="letter-spacing:1.65pt;"> </font>the<font style="letter-spacing:1.65pt;"> </font>indemnification<font style="letter-spacing:1.65pt;"> </font>terms<font style="letter-spacing:1.7pt;"> </font>with<font style="letter-spacing:1.7pt;"> </font>respect<font style="letter-spacing:1.7pt;"> </font>to<font style="letter-spacing:1.7pt;"> </font>such<font style="letter-spacing:1.65pt;"> </font>Product(s)<font style="letter-spacing:1.65pt;"> </font>that<font style="letter-spacing:1.65pt;"> </font>are<font style="letter-spacing:1.6pt;"> </font>the<font style="letter-spacing:1.65pt;"> </font>subject<font style="letter-spacing:1.7pt;"> </font>of such license<font style="letter-spacing:-0.25pt;"> </font>agreement.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark164"></a>17.2<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Indemnification by Takeda. </font><font style="font-size:10.5pt;">Takeda hereby agrees to defend, indemnify and</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">hold harmless Ultragenyx and its Affiliates and each of their respective directors, officers,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">employees, agents and representatives (each, an </font><font style="font-style:italic;font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Ultragenyx Indemnitee</font><font style="font-size:10.5pt;">&#8221;) from and against any and</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">all Losses to which any Ultragenyx Indemnitee may become subject as a result of any Claim to</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the extent such Losses arise directly or indirectly out of: (i) the practice by Takeda or its Affiliate</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">license</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">granted</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">3;</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Exploitation</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">its Affiliates or its sublicensees on or after the Effective Date, including, for the avoidance of</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">doubt, any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Liabilities</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">arising</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Date</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">[***] Product</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Field</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Territory</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Losses</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">arise</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">due</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">its Affiliates or its sublicensees continuing to Exploit a Compound or Product in its territory or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">field that</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">termination</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:2.9pt;"> </font><font style="font-size:10.5pt;">15.3;</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">(iii)</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">the Exploitation</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Licensed</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Product,</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Candidate</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">its Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">licensees</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Date,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">including,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">avoidance</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">doubt,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">any Product Liabilities arising from the use of a Licensed [***] Product, [***] Product or</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">Candidate Product</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">licensees</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Date,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">(iv)</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">by Takeda of any warranty, representation, covenant or agreement made by Takeda in</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">this Agreement;</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(iv)</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">negligence,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">gross</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">negligence</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">willful</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">misconduct</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(including</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">extent such</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">negligence,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">gross</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">negligence</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">willful</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">misconduct</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">gives</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">rise</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">product</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">liability</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Claims under</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">legal</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">theory)</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Affiliate</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">licensee</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">(other</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">its Affiliate or sublicensee), or any officer, director, employee, agent or representative</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">thereof; except, with respect to each of subsections (i) through (iv) above, to the extent such Losses</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">arise directly or indirectly from the negligence, gross negligence or willful misconduct of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any Ultragenyx Indemnitee or the breach by Ultragenyx of any warranty, representation, covenant</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">or agreement made by Ultragenyx in this Agreement. Notwithstanding the foregoing, following</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">the execution of an Exercised Product License Agreement or Option Product&nbsp;&nbsp;License</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Agreement, the terms of such license agreement shall govern the indemnification terms with respect to</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">such Product(s) that are the subject of such license</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">agreement.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">17.3</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark165"></a><font style="font-size:10.5pt;font-weight:bold;">Indemnification</font><font style="font-size:10.5pt;letter-spacing:0.05pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Procedures</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark166"></a>(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Notice. </font><font style="font-size:10.5pt;">Promptly after a Takeda Indemnitee or an Ultragenyx Indemnitee</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(each, an</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-style:italic;font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Indemnitee</font><font style="font-size:10.5pt;">&#8221;)</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">receives</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">pending</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">threatened</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Claim,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Indemnitee</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">give written notice of the Claim to the Party from whom the Indemnitee is entitled to</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">receive indemnification</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">pursuant</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Sections</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">17.1</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">17.2,</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">(the</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">&#8220;</font><font style="text-decoration:underline;font-size:10.5pt;">Indemnifying</font><font style="text-decoration:underline;font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="text-decoration:underline;font-size:10.5pt;">Party</font><font style="font-size:10.5pt;">&#8221;). However, an Indemnitee&#8217;s delay in providing or failure to provide such notice will not relieve</font><font style="font-size:10.5pt;letter-spacing:-0.5pt;"> </font><font style="font-size:10.5pt;">the Indemnifying</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">indemnification</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">obligations,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">except</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">can</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">demonstrate prejudice due to the delay or lack of</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">notice.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Defense. </font><font style="font-size:10.5pt;">Upon receipt of notice under Section 17.3(a) from the Indemnitee,</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the Indemnifying Party will have the duty to either compromise or defend, at its own expense and</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">by counsel (reasonably satisfactory to Indemnitee), such Claim. The Indemnifying Party</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">will promptly (and in any event not more than twenty (20) days after receipt of the</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">Indemnitee&#8217;s original notice) notify the Indemnitee in writing that it acknowledges its obligation to</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">indemnify the Indemnitee with respect to the Claim pursuant to this ARTICLE 17 and of its intention</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">either to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">compromise</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">defend</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">Claim.</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Once</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Indemnifying</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">gives</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">notice</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the Indemnitee, the Indemnifying Party is not liable to the Indemnitee for the fees of other counsel</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">or any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">subsequently</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">incurred</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Indemnitee</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">connection</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">defense, other</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">than</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Indemnitee&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">reasonable</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">investigation</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">cooperation.</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">However,</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the Indemnitee will have the right to employ separate counsel and to control the defense of a</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Claim at its own</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">expense.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Cooperation. </font><font style="font-size:10.5pt;">The Indemnitee will cooperate fully with the Indemnifying</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Party and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">legal</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">representatives</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">investigation</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">defense</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Claim.</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Indemnifying Party will keep the Indemnitee informed on a reasonable and timely basis as to the status of</font><font style="font-size:10.5pt;letter-spacing:2.85pt;"> </font><font style="font-size:10.5pt;">such Claim</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">(to</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">Indemnitee</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">participating</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">defense</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Claim)</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">and conduct the defense of such Claim in a prudent</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">manner.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Settlement. </font><font style="font-size:10.5pt;">If an Indemnifying Party assumes the defense of a Claim,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">no compromise or settlement of such Claim may be effected by the Indemnifying Party without</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">the Indemnitee&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">consent</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">(which</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">consent</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">unreasonably</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">withheld,</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">conditioned</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or delayed),</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">unless:</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">there</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">no</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">finding</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">admission</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">violation</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">law</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">violation</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of the rights of any person and no effect on any other claims that may be made against</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">the Indemnitee; (ii) the sole relief provided is monetary damages that are paid in full by</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">the Indemnifying Party; and (iii) the Indemnitee&#8217;s rights under this Agreement are not</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">adversely affected. If the Indemnifying Party fails to assume defense of a Claim within a reasonable</font><font style="font-size:10.5pt;letter-spacing:2.45pt;"> </font><font style="font-size:10.5pt;">time, the Indemnitee may settle such Claim on such terms as it deems appropriate with the consent</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">or delayed), and the Indemnifying Party will be obligated to indemnify the Indemnitee for</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">such settlement as provided in this ARTICLE</font><font style="font-size:10.5pt;letter-spacing:0.1pt;"> </font><font style="font-size:10.5pt;">17.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.4<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Insurance. </font><font style="font-size:10.5pt;">Each Party shall, at its own expense, procure and maintain during the</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Term and for a period of five (5) years thereafter, insurance policy/policies, including product</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">liability insurance,</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">adequate</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">cover</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">consistent</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">normal business practices of prudent companies similarly situated. Such insurance shall not </font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">be construed</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">create</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">limit</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">liability</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">indemnification</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">obligations</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">under this ARTICLE 17. Each Party shall provide the other Party with written evidence of<font style="letter-spacing:2.25pt;"> </font>such insurance or self-insurance upon request. Each Party shall provide the other Party with<font style="letter-spacing:2.1pt;"> </font>prompt written notice of cancellation, non-renewal or material change in such insurance or<font style="letter-spacing:0.05pt;"> </font>self- insurance that could materially adversely affect the rights of such other Party hereunder,<font style="letter-spacing:2.4pt;"> </font>and shall<font style="letter-spacing:2.1pt;"> </font>provide<font style="letter-spacing:2.05pt;"> </font>such<font style="letter-spacing:2.05pt;"> </font>notice<font style="letter-spacing:2.05pt;"> </font>within<font style="letter-spacing:2.05pt;"> </font>thirty<font style="letter-spacing:1.7pt;"> </font>(30)<font style="letter-spacing:2pt;"> </font>days<font style="letter-spacing:2.1pt;"> </font>after<font style="letter-spacing:2.05pt;"> </font>any<font style="letter-spacing:1.7pt;"> </font>such<font style="letter-spacing:2.05pt;"> </font>cancellation,<font style="letter-spacing:2.05pt;"> </font>non-renewal<font style="letter-spacing:2.1pt;"> </font>or material<font style="letter-spacing:-0.2pt;"> </font>change.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.5<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Limitation of Liability. </font><font style="font-size:10.5pt;">EXCEPT FOR A PARTY&#8217;S OBLIGATIONS SET FORTH</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">IN THIS</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">17,</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">AND</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">ANY</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">BREACH</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">OF</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">ARTICLE</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">14</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">(CONFIDENTIALITY)</font><font style="font-weight:bold;font-size:10.5pt;">,</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">IN</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">NO EVENT</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">WILL</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">EITHER</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">PARTY</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">BE</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">LIABLE</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">TO</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">THE</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">OTHER</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">PARTY</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">(OR</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">THE</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">OTHER PARTY&#8217;S AFFILIATES OR SUBLICENSEES) </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">IN </font><font style="font-size:10.5pt;">CONNECTION WITH</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">THIS AGREEMENT FOR LOST REVENUE, LOST PROFITS, LOST SAVINGS, LOSS OF</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">USE, DAMAGE TO GOODWILL, OR ANY CONSEQUENTIAL, INCIDENTAL,</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">SPECIAL, EXEMPLARY, PUNITIVE OR INDIRECT DAMAGES UNDER ANY</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">THEORY, INCLUDING CONTRACT, NEGLIGENCE, OR STRICT LIABILITY, EVEN IF</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">THAT PARTY HAS BEEN PLACED ON NOTICE OF THE POSSIBILITY OF SUCH</font><font style="font-size:10.5pt;letter-spacing:-0.4pt;"> </font><font style="font-size:10.5pt;">DAMAGES.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:30.9%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark167"></a><a name="_bookmark167"></a>ARTICLE 18&nbsp;&nbsp;<font style="font-weight:normal;">&#8211;</font><font style="font-weight:normal;letter-spacing:0.1pt;"> </font>MISCELLANEOUS</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark168"></a>18.1<font style="margin-left:47pt;"></font><font style="font-size:10.5pt;">HSR Act.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Each of Ultragenyx and Takeda shall, within ten (10) Business Days</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">after Execution Date, file with the United States Federal Trade Commission and the Antitrust Division of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">United</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">States</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Department</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Justice,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Filing</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">it</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Act with respect to the subject matter of this Agreement, which forms shall specifically request</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">early termination of the initial HSR Act waiting period. The Parties will cooperate with one another</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">to the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">extent</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">necessary</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">preparation</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Filing.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">hereto</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">commit</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to instruct their respective counsel to cooperate with each other and use good faith, diligent</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">efforts to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">facilitate</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">expedite</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">identification</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">resolution</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">issues</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">consequently, the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">expiration</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Act</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">waiting</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">period,</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">faith</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">diligent</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">efforts</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">to include counsel&#8217;s undertaking: (i) to keep each other appropriately informed of</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">communications received</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">submitted</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">personnel</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">reviewing</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">antitrust</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">authority;</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">confer with</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">regarding</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">appropriate</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">contacts</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">response</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">personnel</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">United States Federal Trade Commission and the Antitrust Division of the United States Department</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">of Justice.</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Each</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">responsible</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">own</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">costs</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">expenses</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be responsible</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">filing</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">fees</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">associated</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Filing.</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">In</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Filing, each</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">will</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">good</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">faith,</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">diligent</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">efforts</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">eliminate</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">concern on the part of any court or governmental authority regarding the legality of the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">proposed transaction, including cooperating in good faith with any government investigation and</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the prompt</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">production</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">documents,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">information,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">witnesses</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">requested</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">course</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of any</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">investigation,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">those</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">contained</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Request</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Additional</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Information</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and Documentary Materials (as that term is defined in the HSR Act), and to cause the Effective</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Date of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">occur</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">soon</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">practical,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">18.1(b).</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Nothing</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">this Section shall require either Party to consent to the divestiture or other disposition of any of its</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or its</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">Affiliates&#8217;</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">assets</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">consent</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">structural</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">conduct</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">remedy,</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">and</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its Affiliates shall have no obligation to contest, administratively or in court, any ruling, order<font style="letter-spacing:0.7pt;"> </font>or other<font style="letter-spacing:1.3pt;"> </font>action<font style="letter-spacing:1.35pt;"> </font>of<font style="letter-spacing:1.3pt;"> </font>the<font style="letter-spacing:1.45pt;"> </font>United<font style="letter-spacing:1.35pt;"> </font>States<font style="letter-spacing:1.5pt;"> </font>Federal<font style="letter-spacing:1.4pt;"> </font>Trade<font style="letter-spacing:1.55pt;"> </font>Commission<font style="letter-spacing:1.4pt;"> </font>and<font style="letter-spacing:1.35pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>Antitrust<font style="letter-spacing:1.4pt;"> </font>Division<font style="letter-spacing:1.4pt;"> </font>of<font style="letter-spacing:1.3pt;"> </font>the United States Department of Justice or any Third Party respecting the transactions<font style="letter-spacing:1.85pt;"> </font>contemplated by this<font style="letter-spacing:-0.3pt;"> </font>Agreement.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark169"></a>(b)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Except for the specific provisions expressly identified in Section 18.1(c),</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">this Agreement</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">effective</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">until</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(i)</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">HSR</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Conditions</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">are</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">met</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">(ii)</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">earlier</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(A)<font style="letter-spacing:1.8pt;"> </font>the<font style="letter-spacing:1.9pt;"> </font>date<font style="letter-spacing:1.8pt;"> </font>on<font style="letter-spacing:1.95pt;"> </font>which<font style="letter-spacing:1.85pt;"> </font>the<font style="letter-spacing:1.8pt;"> </font>Tax<font style="letter-spacing:1.95pt;"> </font>Conditions<font style="letter-spacing:2.05pt;"> </font>are<font style="letter-spacing:1.85pt;"> </font>met,<font style="letter-spacing:1.85pt;"> </font>or<font style="letter-spacing:1.8pt;"> </font>(B)<font style="letter-spacing:1.8pt;"> </font>July<font style="letter-spacing:1.7pt;"> </font>18,<font style="letter-spacing:1.95pt;"> </font>2016,<font style="letter-spacing:1.85pt;"> </font>at<font style="letter-spacing:1.85pt;"> </font>which<font style="letter-spacing:1.85pt;"> </font>time<font style="letter-spacing:1.95pt;"> </font>this Agreement shall be effective automatically in its entirety (such date the &#8220;<font style="font-weight:bold;">Effective</font><font style="font-weight:bold;letter-spacing:-0.8pt;"> </font><font style="font-weight:bold;">Date</font>&#8221;).</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark170"></a>(c)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">Notwithstanding Section 18.1(b) and anything in this Agreement to the</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">contrary, the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">provisions</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">full</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">force</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">effect</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Execution Date: Sections 14.5 (Publicity) and 14.6 (Securities Filings), ARTICLE 1 (Definitions)</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">and ARTICLE 18 (other than Sections 18.2, 18.5 and 18.6)</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">(Miscellaneous).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:83pt;"></font><font style="font-size:10.5pt;">If the Effective Date has not occurred within one hundred eighty (180)</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">days following</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Execution</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Date,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">may</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">mutually</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">agree,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Agreement may be terminated by either Party on written notice to the</font><font style="font-size:10.5pt;letter-spacing:-0.8pt;"> </font><font style="font-size:10.5pt;">other.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18.2</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark171"></a><font style="font-size:10.5pt;font-weight:bold;">Exports and Restrictions on</font><font style="font-size:10.5pt;letter-spacing:0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Competition</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Exports</font><font style="font-size:10.5pt;">.</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Except</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">not,</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall cause its Affiliates and sublicensees not to, whether directly or indirectly through a Third</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Party, export, distribute or</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">sell:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">in the case of Ultragenyx, (A) Licensed [***] Products outside</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx Field or outside the Territory, (B) Licensed Analog Products outside the</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Licensed Field or outside the Territory, (C) Research Products unless and until an Option Product</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">License Agreement is executed for such Products and then only in accordance with such Option</font><font style="font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;">Product License</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Agreement;</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">provided</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">further</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">that,</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">has</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">been</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">exercised</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">given Product Ultragenyx may not export, distribute or sell such Product in the Takeda</font><font style="font-size:10.5pt;letter-spacing:-0.6pt;"> </font><font style="font-size:10.5pt;">Territory.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div style="width:100%;">
<div style="float:left;width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;text-indent:0%;font-size:10.5pt;letter-spacing:-0.05pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Territory.</p>
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="font-size:10.5pt;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a></font></p></td></tr></table></div>
<div style="float:right;width:86%;padding-left:1%">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap"></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:10.5pt;">In the case of Takeda, Ultragenyx Pipeline Products outside of the</font><font style="font-size:10.5pt;letter-spacing:2.7pt;"> </font><font style="font-size:10.5pt;">Takeda</font></p></td></tr></table></div></div>
<p style=" clear:both;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark172"></a>(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Non-Competition Obligations</font><font style="font-size:10.5pt;">.&nbsp;&nbsp;Ultragenyx shall not, and shall cause</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">its Affiliates not to, whether directly or indirectly through a Third Party (including any</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">sublicensee), (i) develop a Competing Product in the Territory at any time prior to the [***] of the Effective Date or (ii) commercialize a Competing Product in the Territory at any time prior to the [***] of the First Commercial Sale of a Product. Ultragenyx shall not be in breach of this Section 18.2(b) by acquiring, merging or consolidating with a Third Party which develops or commercializes a Competing Product; provided, however, that in the event Ultragenyx acquires such Competing Product, it must, unless Takeda agrees to the contrary, within [***] of such acquisition, either divest such Competing Product to a Third Party, discontinue the development or commercialization of such Competing Product, or, if applicable, terminate</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">this Agreement with respect to the Licensed Product that is the subject of competition<font style="letter-spacing:1.35pt;"> </font>in accordance with Section<font style="letter-spacing:-0.2pt;"> </font>15.4.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark173"></a>18.3<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Notice.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">Any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">notice,</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">request,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">communication</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">this Agreement shall be in writing, shall refer specifically to this Agreement and shall be</font><font style="font-size:10.5pt;letter-spacing:-0.55pt;"> </font><font style="font-size:10.5pt;">hand delivered or sent by a recognized overnight delivery service, costs prepaid, or by facsimile</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(with transmission</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">confirmed),</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">following</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">addresses</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">addresses</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">may designate by written notice in accordance with this Section</font><font style="font-size:10.5pt;letter-spacing:-0.3pt;"> </font><font style="font-size:10.5pt;">18.3:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:9.69%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to<font style="letter-spacing:-0.2pt;"> </font>Takeda:</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;margin-right:41.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Takeda Pharmaceutical Company<font style="letter-spacing:-0.55pt;"> </font>Limited 1-1, Doshomachi<font style="letter-spacing:-0.1pt;"> </font>4-chome,</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chuo-ku, Osaka<font style="letter-spacing:-0.15pt;"> </font>540-8645</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;margin-right:26.39%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Head of Global Business<font style="letter-spacing:-0.45pt;"> </font>Development Facsimile: (+81)<font style="letter-spacing:-0.25pt;"> </font>3-3278-2323</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:9.69%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Copy<font style="letter-spacing:-0.15pt;"> </font>to:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;margin-right:42.47%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Takeda Pharmaceuticals U.S.A.,<font style="letter-spacing:-0.4pt;"> </font>Inc. One Takeda<font style="letter-spacing:-0.1pt;"> </font>Parkway</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deerfield, IL<font style="letter-spacing:2.75pt;"> </font>60015</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;margin-right:26.39%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: General Counsel, Legal<font style="letter-spacing:-0.45pt;"> </font>Department Facsimile:<font style="letter-spacing:2.8pt;"> </font>224-554-7831</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:9.69%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to<font style="letter-spacing:-0.4pt;"> </font>Ultragenyx:</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;margin-right:49.28%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx Pharmaceutical<font style="letter-spacing:-0.5pt;"> </font>Inc. 60 Leveroni<font style="letter-spacing:-0.2pt;"> </font>Court</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Novato, CA<font style="letter-spacing:-0.1pt;"> </font>94949</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:9.69%;margin-right:1.24%;text-indent:7.42%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Chief Business<font style="letter-spacing:-0.3pt;"> </font>Officer</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:9.69%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Copy<font style="letter-spacing:-0.15pt;"> </font>to:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cooley<font style="letter-spacing:-0.25pt;"> </font>LLP</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:17.11%;margin-right:61.86%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3175 Hanover<font style="letter-spacing:-0.15pt;"> </font>Street Palo Alto, CA<font style="letter-spacing:-0.05pt;"> </font>94304 Attention: Glen<font style="letter-spacing:-0.05pt;"> </font>Sato Fax:<font style="letter-spacing:-0.15pt;"> </font>650-849-7400</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.4<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Designation of Affiliates</font><font style="font-size:10.5pt;">. Each Party may discharge any obligations and exercise</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">any rights hereunder through delegation of its obligations or rights to any of its&nbsp;&nbsp;Affiliates. </font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">Each Party</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">hereby</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">guarantees</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">performance</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">this Agreement,</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">comply</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">provisions</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in connection</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">performance.</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">Any</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">Affiliate</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Party&#8217;s obligations</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">deemed</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">Party</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may<font style="letter-spacing:1.9pt;"> </font>proceed<font style="letter-spacing:2pt;"> </font>directly<font style="letter-spacing:1.9pt;"> </font>against<font style="letter-spacing:2.05pt;"> </font>such<font style="letter-spacing:1.95pt;"> </font>Party<font style="letter-spacing:1.9pt;"> </font>without<font style="letter-spacing:2.05pt;"> </font>any<font style="letter-spacing:1.75pt;"> </font>obligation<font style="letter-spacing:2pt;"> </font>to<font style="letter-spacing:2.15pt;"> </font>first<font style="letter-spacing:2.15pt;"> </font>proceed<font style="letter-spacing:2.1pt;"> </font>against<font style="letter-spacing:2.05pt;"> </font>such Party&#8217;s<font style="letter-spacing:-0.35pt;"> </font>Affiliate.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:2.27%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.42%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18.5</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_bookmark174"></a><font style="font-size:10.5pt;font-weight:bold;">Change of Control of</font><font style="font-size:10.5pt;letter-spacing:0.1pt;font-weight:bold;"> </font><font style="font-size:10.5pt;font-weight:bold;">Ultragenyx</font><font style="font-size:10.5pt;">.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Notice</font><font style="font-size:10.5pt;">. Ultragenyx (or its successor) shall provide notice to Takeda&nbsp;&nbsp;of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">any Change</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Control</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Ultragenyx</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">within</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">[***]</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">Business</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">Days</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">after</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">upon</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the Ultragenyx Change of Control closes or otherwise becomes</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">effective.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:7.42%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:83pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Effects of Change of Control of Ultragenyx</font><font style="font-size:10.5pt;">. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In </font><font style="font-size:10.5pt;">the event of a&nbsp;&nbsp;Change</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">of Control of Ultragenyx, the following shall</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">apply:</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.24%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">The</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> Takeda Option Term</font><font style="font-size:10.5pt;"> applicable</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">event</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Change</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">Control of Ultragenyx shall</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">apply.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:14.85%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark175"></a>(ii)<font style="margin-left:119pt;"></font><font style="font-size:10.5pt;">On</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">before</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">date</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">one hundred eighty (180) days after the date upon which a Change of Control of Ultragenyx closes or otherwise becomes effective, Takeda may take or require that Ultragenyx, or its successor, take or perform, as applicable, any one or more of the following actions: (A) Ultragenyx and its successor shall adopt reasonable written procedures, approved by Takeda, to prevent disclosure of Takeda&#8217;s Confidential Information, (B) the definition of Licensed Analog Compounds shall be amended to be limited to those Compounds listed on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit </font><font style="font-size:10.5pt;">1.99 as of the effective date of the Ultragenyx Change of Control, provided that if Ultragenyx has paid costs in connection with the Development of a Licensed Analog Compound, such Licensed Analog Compound shall be listed on </font><font style="text-decoration:underline;font-size:10.5pt;">Exhibit </font><font style="font-size:10.5pt;">1.99, as amended, (C) Section 5.1 shall be amended to require Takeda&#8217;s written consent in order for Ultragenyx and its successor to exercise its rights to co-Commercialize and Co-Develop thereunder to the extent Ultragenyx has not previously exercised such right(s), and (D) Takeda may terminate, in its sole discretion, one or more of the ongoing Validation Research Plans and Research Plans, in which case any associated licenses to Ultragenyx and its successor under Section 6.5 shall terminate, and any Research Products designated by Takeda shall be deemed Terminated Products; provided that to the extent that Ultragenyx has paid costs in connection with the Development of a Research Product on or before such date, such Validation Research Plan or Research Plan, as applicable, and associated licenses to Ultragenyx or its successor shall continue in full force and effect and such Research Products shall not be deemed Terminated Products under this Section 18.5(b)(ii). For clarity, termination pursuant to this Section 18.5(b)(ii) shall not terminate the Collaboration Term for any purposes under this Agreement other than the foregoing clause (D).</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark176"></a>18.6<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Force Majeure. </font><font style="font-size:10.5pt;">Both Parties shall be excused from the performance of their</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">obligations under this Agreement to the extent that such performance is prevented by Force Majeure and</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the nonperforming Party promptly provides notice of the prevention to the other Party. Such</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">excuse shall be continued so long as the condition constituting Force Majeure continues and</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">the nonperforming Party takes reasonable efforts to remove the condition. Notwithstanding</font><font style="font-size:10.5pt;letter-spacing:-0.45pt;"> </font><font style="font-size:10.5pt;">the foregoing,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">excused</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">making</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">payments</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">owed</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">because</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">a Force Majeure affecting such Party. If a Force Majeure persists for more than ninety (90)</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">days,</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">then<font style="letter-spacing:0.6pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>Parties<font style="letter-spacing:0.6pt;"> </font>will<font style="letter-spacing:0.65pt;"> </font>discuss<font style="letter-spacing:0.65pt;"> </font>in<font style="letter-spacing:0.65pt;"> </font>good<font style="letter-spacing:0.65pt;"> </font>faith<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>modification<font style="letter-spacing:0.65pt;"> </font>of<font style="letter-spacing:0.6pt;"> </font>the<font style="letter-spacing:0.6pt;"> </font>Parties&#8217;<font style="letter-spacing:0.75pt;"> </font>obligations<font style="letter-spacing:0.65pt;"> </font>under<font style="letter-spacing:0.6pt;"> </font>this Agreement in order to mitigate the delays caused by such Force<font style="letter-spacing:-0.6pt;"> </font>Majeure.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark177"></a>18.7<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Assignment. </font><font style="font-size:10.5pt;">Prior to the Effective Date, neither Party may assign or transfer</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">this Agreement or any rights or obligations hereunder without the prior written consent of the</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">other. On or after the Effective Date, neither Party may assign or transfer this Agreement or any</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">rights or obligations hereunder without the prior written consent of the other; provided that no</font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">such consent</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">required</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">assignment</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">Affiliates</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">(b)</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">connection</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">sale</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">or substantially all of the assets to which this Agreement relates, whether in a merger, sale of</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">stock, sale of assets or any other transaction (subject, in the case of Ultragenyx, to Section 18.5).</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">Any successor</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">assignee</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">and/or</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">obligations</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">permitted</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">shall,</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">writing</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">the other</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">Party,</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">expressly</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">assume</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">performance</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">rights</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and/or</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">obligations.</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Any</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">permitted assignment shall be binding on the successors of the assigning Party. Any assignment</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">or attempted</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">assignment</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">either</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">violation</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">terms</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">Section</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">null,</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">void and of no legal</font><font style="font-size:10.5pt;letter-spacing:-0.1pt;"> </font><font style="font-size:10.5pt;">effect.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark178"></a>18.8<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Severability. </font><font style="font-size:10.5pt;">If any one or more of the provisions of this Agreement is held to be</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">invalid or unenforceable by any court of competent jurisdiction from which no appeal can be or is</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">taken, the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">provision</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">considered</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">severed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">from</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">serve</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">invalidate any remaining provisions hereof. The Parties shall make a good faith effort&nbsp;&nbsp;to&nbsp;&nbsp;replace</font><font style="font-size:10.5pt;letter-spacing:0.05pt;"> </font><font style="font-size:10.5pt;">any invalid</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">unenforceable</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">provision</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:2.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">valid</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">enforceable</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">objectives contemplated by the Parties when entering this Agreement may be</font><font style="font-size:10.5pt;letter-spacing:-0.7pt;"> </font><font style="font-size:10.5pt;">realized.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark179"></a>18.9<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">English</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Language.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">This</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">executed</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">in,</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.25pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">other communications</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">connection</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">English</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">language. Any</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">translation</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">into</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">language</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.45pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">official</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">version</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">thereof,</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">event of any conflict in interpretation between the English version and such translation, the</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">English version shall</font><font style="font-size:10.5pt;letter-spacing:-0.05pt;"> </font><font style="font-size:10.5pt;">control.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark180"></a>18.10<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Waiver and Non-Exclusion of Remedies.&nbsp;&nbsp;</font><font style="font-size:10.5pt;">Any term or condition of this </font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agreement may be waived at any time by the Party that is entitled to the benefit thereof, but no such</font><font style="font-size:10.5pt;letter-spacing:2.3pt;"> </font><font style="font-size:10.5pt;">waiver shall</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">effective</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">unless</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">written</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">instrument</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">duly</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">executed</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">behalf</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the Party waiving such term or condition. The waiver by either Party hereto of any right </font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">hereunder or of the failure to perform or of a breach by the other Party shall not be deemed a waiver of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">any other</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">right</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">hereunder</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">breach</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">failure</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">other</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">whether</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">similar nature or otherwise. The rights and remedies provided herein are cumulative and do not</font><font style="font-size:10.5pt;letter-spacing:0.25pt;"> </font><font style="font-size:10.5pt;">exclude any other right or remedy provided by Applicable Laws or otherwise available except</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">as expressly set forth</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">herein.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.11<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Further Assurance. </font><font style="font-size:10.5pt;">Each Party shall duly execute and deliver, or cause to be</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">duly executed</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">delivered,</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">further</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">instruments</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">do</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">cause</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">done</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">further</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">acts and things, including the filing of such assignments, agreements, documents, and instruments,</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">as may be necessary or as the other Party may reasonably request in connection with </font><font style="font-size:10.5pt;letter-spacing:0.2pt;"> </font><font style="font-size:10.5pt;">this Agreement or to carry out more effectively the provisions and purposes</font><font style="font-size:10.5pt;letter-spacing:-0.65pt;"> </font><font style="font-size:10.5pt;">hereof.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.12<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Relationship</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">of</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">the</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Parties.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:0.35pt;"> </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">It</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">is</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">expressly</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">agreed</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">Takeda,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">one</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">hand,</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">and Ultragenyx, on the other hand, shall be independent contractors and that the relationship</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">between the</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">two</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">not</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">constitute</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">a</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">partnership,</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">joint</font><font style="font-size:10.5pt;letter-spacing:1.15pt;"> </font><font style="font-size:10.5pt;">venture</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">agency.</font><font style="font-size:10.5pt;letter-spacing:2.35pt;"> </font><font style="font-size:10.5pt;">Neither</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Takeda</font><font style="font-size:10.5pt;letter-spacing:1.1pt;"> </font><font style="font-size:10.5pt;">nor Ultragenyx shall have the authority to make any statements, representations or commitments</font><font style="font-size:10.5pt;letter-spacing:0.5pt;"> </font><font style="font-size:10.5pt;">of any</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">kind,</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">take</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">action</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">which</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">binding</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">on</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">other,</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">without</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">prior</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">written consent of the other Party to do so. All persons employed by a Party shall be employees of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">that Party and not of the other Party and all costs and obligations incurred by reason of</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">such employment</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">for</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">account</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">expense</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Party.</font><font style="font-size:10.5pt;letter-spacing:2.95pt;"> </font><font style="font-size:10.5pt;">For</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">clarity,</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">(a)</font><font style="font-size:10.5pt;letter-spacing:2.55pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:2.5pt;"> </font><font style="font-size:10.5pt;">Takeda provides Research Support for an Ultragenyx Pipeline Product (other than Exercised Products)</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">or Licensed</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">(in</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">connection</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">an</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">Option</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Product</font><font style="font-size:10.5pt;letter-spacing:1.7pt;"> </font><font style="font-size:10.5pt;">License</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Agreement),</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Takeda shall be deemed an independent contractor in the performance of such Research Support and</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">(b) in no case shall Takeda provide Research Support with respect to a Licensed</font><font style="font-size:10.5pt;letter-spacing:-0.25pt;"> </font><font style="font-size:10.5pt;">Product.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.13<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Counterparts. </font><font style="font-size:10.5pt;">This Agreement may be executed in two (2) or more counterparts, </font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">each of which shall be deemed an original, but all of which together shall constitute one and the</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">same instrument. This Agreement may be executed by facsimile, .pdf or other</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">electronically transmitted</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">signatures</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">such</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">signatures</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">deemed</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">bind</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">each</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">Party</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">hereto</font><font style="font-size:10.5pt;letter-spacing:1.05pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:0.95pt;"> </font><font style="font-size:10.5pt;">if</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">they were the original</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">signatures.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark181"></a>18.14<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Construction. </font><font style="font-size:10.5pt;">Except where the context otherwise requires, wherever used, the</font><font style="font-size:10.5pt;letter-spacing:0.9pt;"> </font><font style="font-size:10.5pt;">singular shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">include</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">plural,</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">plural</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">singular,</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">use</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">gender</font><font style="font-size:10.5pt;letter-spacing:0.85pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">applicable</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to all genders. Whenever this Agreement refers to a number of days, such number refers </font><font style="font-size:10.5pt;letter-spacing:1.75pt;"> </font><font style="font-size:10.5pt;">to calendar days. The terms &#8220;including,&#8221; &#8220;include,&#8221; or &#8220;includes&#8221; as used herein shall</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">mean &#8220;including, but not limited to,&#8221; and shall not limit the generality of any description</font><font style="font-size:10.5pt;letter-spacing:2.65pt;"> </font><font style="font-size:10.5pt;">preceding such term. The language of this Agreement shall be deemed to be the language mutually</font><font style="font-size:10.5pt;letter-spacing:0.15pt;"> </font><font style="font-size:10.5pt;">chosen by the Parties and no rule of strict construction shall be applied against either Party hereto.</font><font style="font-size:10.5pt;letter-spacing:2.2pt;"> </font><font style="font-size:10.5pt;">Each Party represents that it has been represented </font><font style="font-size:10.5pt;letter-spacing:0.2pt;">by </font><font style="font-size:10.5pt;">legal counsel in connection with this</font><font style="font-size:10.5pt;letter-spacing:2.75pt;"> </font><font style="font-size:10.5pt;">Agreement and acknowledges that it has participated in the drafting hereof. </font><font style="font-size:10.5pt;letter-spacing:-0.15pt;">In </font><font style="font-size:10.5pt;">interpreting and applying</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">the terms and provisions of this Agreement, the Parties agree that no presumption will apply</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">against the Party which drafted such terms and</font><font style="font-size:10.5pt;letter-spacing:-0.2pt;"> </font><font style="font-size:10.5pt;">provision.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark182"></a>18.15<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Governing Laws. </font><font style="font-size:10.5pt;">This Agreement was prepared in the English language,</font><font style="font-size:10.5pt;letter-spacing:2.6pt;"> </font><font style="font-size:10.5pt;">which language shall govern the interpretation of, and any dispute regarding, the terms of</font><font style="font-size:10.5pt;letter-spacing:1.2pt;"> </font><font style="font-size:10.5pt;">this Agreement.</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">This</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">disputes</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">arising</font><font style="font-size:10.5pt;letter-spacing:0.55pt;"> </font><font style="font-size:10.5pt;">out</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.6pt;"> </font><font style="font-size:10.5pt;">related</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:0.8pt;"> </font><font style="font-size:10.5pt;">this</font><font style="font-size:10.5pt;letter-spacing:0.65pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:0.75pt;"> </font><font style="font-size:10.5pt;">or</font><font style="font-size:10.5pt;letter-spacing:0.7pt;"> </font><font style="font-size:10.5pt;">any breach</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">hereof</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">be</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">governed</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">by</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">construed</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">under</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">laws</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">State</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">New</font><font style="font-size:10.5pt;letter-spacing:1.8pt;"> </font><font style="font-size:10.5pt;">York, without</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">giving</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">effect</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">any</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">choice</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">law</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">principles</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">that</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">would</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">require</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">application</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">the laws of a different</font><font style="font-size:10.5pt;letter-spacing:-0.15pt;"> </font><font style="font-size:10.5pt;">state.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark183"></a>18.16<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Entire</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-weight:bold;font-size:10.5pt;">Agreement.</font><font style="font-weight:bold;font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">This</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Agreement,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">including</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">Exhibits</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">hereto,</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">Common Stock</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Purchase</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:2.15pt;"> </font><font style="font-size:10.5pt;">set</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">forth</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">complete,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">final</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">exclusive</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">agreement</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">all</font><font style="font-size:10.5pt;letter-spacing:2.05pt;"> </font><font style="font-size:10.5pt;">the covenants, promises, agreements, warranties, representations, conditions and</font><font style="font-size:10.5pt;letter-spacing:1.65pt;"> </font><font style="font-size:10.5pt;">understandings between</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">Parties</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">hereto</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">hereof</font><font style="font-size:10.5pt;letter-spacing:1.55pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">supersedes,</font><font style="font-size:10.5pt;letter-spacing:1.6pt;"> </font><font style="font-size:10.5pt;">as</font><font style="font-size:10.5pt;letter-spacing:1.5pt;"> </font><font style="font-size:10.5pt;">of</font><font style="font-size:10.5pt;letter-spacing:1.45pt;"> </font><font style="font-size:10.5pt;">the Execution Date, all prior and contemporaneous agreements and understandings between</font><font style="font-size:10.5pt;letter-spacing:-0.75pt;"> </font><font style="font-size:10.5pt;">the Parties</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">respect</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">to</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">subject</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">matter</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">hereof;</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">provided,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">that,</font><font style="font-size:10.5pt;letter-spacing:1.9pt;"> </font><font style="font-size:10.5pt;">until</font><font style="font-size:10.5pt;letter-spacing:1.95pt;"> </font><font style="font-size:10.5pt;">the</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Effective</font><font style="font-size:10.5pt;letter-spacing:1.85pt;"> </font><font style="font-size:10.5pt;">Date,</font><font style="font-size:10.5pt;letter-spacing:2pt;"> </font><font style="font-size:10.5pt;">the Confidentiality</font><font style="font-size:10.5pt;letter-spacing:1pt;"> </font><font style="font-size:10.5pt;">Agreement</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">shall</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">continue</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">full</font><font style="font-size:10.5pt;letter-spacing:1.25pt;"> </font><font style="font-size:10.5pt;">force</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">and</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">effect</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">in</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">accordance</font><font style="font-size:10.5pt;letter-spacing:1.3pt;"> </font><font style="font-size:10.5pt;">with</font><font style="font-size:10.5pt;letter-spacing:1.4pt;"> </font><font style="font-size:10.5pt;">its</font><font style="font-size:10.5pt;letter-spacing:1.35pt;"> </font><font style="font-size:10.5pt;">terms.</font></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:3pt;margin-bottom:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as provided in the Common Stock Purchase Agreement, there are no<font style="letter-spacing:2.95pt;"> </font>covenants, promises,<font style="letter-spacing:1.75pt;"> </font>agreements,<font style="letter-spacing:1.75pt;"> </font>warranties,<font style="letter-spacing:1.75pt;"> </font>representations,<font style="letter-spacing:1.75pt;"> </font>conditions<font style="letter-spacing:1.75pt;"> </font>or<font style="letter-spacing:1.7pt;"> </font>understandings,<font style="letter-spacing:1.75pt;"> </font>either<font style="letter-spacing:1.7pt;"> </font>oral<font style="letter-spacing:1.75pt;"> </font>or written, between the Parties other than as are set forth herein and therein. No<font style="letter-spacing:0.6pt;"> </font>subsequent alteration,<font style="letter-spacing:1.2pt;"> </font>amendment,<font style="letter-spacing:1.2pt;"> </font>change<font style="letter-spacing:1.15pt;"> </font>or<font style="letter-spacing:1.15pt;"> </font>addition<font style="letter-spacing:1.2pt;"> </font>to<font style="letter-spacing:1.2pt;"> </font>this<font style="letter-spacing:1.1pt;"> </font>Agreement<font style="letter-spacing:1.2pt;"> </font>shall<font style="letter-spacing:1.2pt;"> </font>be<font style="letter-spacing:1.15pt;"> </font>binding<font style="letter-spacing:1.05pt;"> </font>upon<font style="letter-spacing:1.2pt;"> </font>the<font style="letter-spacing:1.15pt;"> </font>Parties unless reduced to writing and signed by an authorized officer of each Party. In the event of<font style="letter-spacing:2.25pt;"> </font>any inconsistency between the body of this Agreement and the Exhibits to this Agreement,<font style="letter-spacing:1pt;"> </font>the Common Stock Purchase Agreement, or any subsequent agreements ancillary to this<font style="letter-spacing:2.2pt;"> </font>Agreement, unless otherwise expressly stated to the contrary in such Exhibit, Common Stock<font style="letter-spacing:-0.8pt;"> </font>Purchase Agreement or subsequent ancillary agreement, the terms contained in this Agreement<font style="letter-spacing:2.05pt;"> </font>shall control.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:2.27%;margin-right:1.03%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_bookmark184"></a>18.17<font style="margin-left:47pt;"></font><font style="font-weight:bold;font-size:10.5pt;">Headings. </font><font style="font-size:10.5pt;">The headings of each Article and Section in this Agreement have</font><font style="font-size:10.5pt;letter-spacing:2.8pt;"> </font><font style="font-size:10.5pt;">been inserted for convenience of reference only and are not intended to limit or expand&nbsp;&nbsp;on</font><font style="font-size:10.5pt;letter-spacing:0.4pt;"> </font><font style="font-size:10.5pt;">the meaning of the language contained in the particular Article or</font><font style="font-size:10.5pt;letter-spacing:-0.35pt;"> </font><font style="font-size:10.5pt;">Section.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.84%;margin-right:1.24%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURE PAGE<font style="letter-spacing:-0.05pt;"> </font>FOLLOWS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:8.14%;margin-right:7.01%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.2%;margin-right:16.08%;text-indent:0.04%;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THIS AGREEMENT is executed by the authorized representatives of the Parties as of<font style="letter-spacing:2.75pt;"> </font>the Execution<font style="letter-spacing:1.4pt;"> </font>Date.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:47.51%;"></td>
<td style="width:56.6%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ULTRAGENYX<font style="letter-spacing:1.6pt;"> </font>PHARMACEUTICAL <font style="letter-spacing:-2.75pt;"> &nbsp;&nbsp;</font>INC.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TAKEDA<font style="letter-spacing:0.4pt;"> </font>PHARMACEUTICAL<font style="letter-spacing:-2.75pt;"> </font>COMPANY<font style="letter-spacing:2.65pt;"> </font>LIMITED</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By<font style="text-decoration:underline;color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; /s/ Emil Kakkis&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By<font style="text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Misako Hamamura&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="color:#1D1D1D;letter-spacing:-7.65pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;</font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:&nbsp;&nbsp;Emil Kakkis</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:&nbsp;&nbsp;Misako Hamamura</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:&nbsp;&nbsp;CEO</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:&nbsp;&nbsp;Head of JP Strategy &amp; BD</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div style="width:100%;">
<div style="float:left;width:16%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.06%;text-indent:0%;font-weight:bold;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>&nbsp;</p>
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0.98%;text-indent:0%;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:0.98%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.93%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.93%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.93%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.93%;text-indent:0%;font-weight:bold;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.06%;margin-right:14.99%;text-indent:-0.05%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.93%;margin-right:14.99%;text-indent:0.04%;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;letter-spacing:-7.65pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="line-height:25pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.98%;text-indent:0%;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family:Calibri;color:#000000;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a></font></p></div>
<div style="float:left;width:20%;padding-left:1%">
<p style="line-height:25pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.98%;text-indent:0%;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Calibri;color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p></div>
<p style=" clear:both;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:22.11%;margin-right:14.26%;text-indent:0%;color:#1D1D1D;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">{Signature Page to License&nbsp;&nbsp;<font style="color:#363636;">and&nbsp;&nbsp;</font>Collaboration<font style="letter-spacing:1.3pt;"> </font>Agreement}</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:23.39%;margin-right:22.3%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<font style="letter-spacing:0.05pt;"> </font>1.6(i)</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:13.99%;margin-right:3.47%;text-indent:-8.57%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:314pt;margin-bottom:0pt;margin-top:0pt;margin-left:1.99%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:8pt;margin-bottom:0pt;margin-left:8.57%;margin-right:3.47%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chemical<font style="letter-spacing:-0.1pt;"> </font>Name:&nbsp;&nbsp;<font style="font-family:Times New Roman;">[***]</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.57%;margin-right:44.79%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Molecular Formula:<font style="letter-spacing:2.05pt;"> </font><font style="font-family:Times New Roman;">[***]</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.57%;margin-right:44.79%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Molecular Weight:<font style="letter-spacing:2.2pt;"> </font><font style="font-family:Times New Roman;">[***]</font></p>
<p style="text-align:center;margin-top:12pt; clear:both;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:23.39%;margin-right:22.3%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<font style="letter-spacing:-0.1pt;"> </font>1.6(iii)</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:23.39%;margin-right:22.3%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;margin-left:23.03%;margin-right:22.3%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<font style="letter-spacing:0.05pt;"> </font>1.82</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:23.03%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:23.03%;margin-right:22.12%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Initial <font style="font-weight:normal;">[***]</font> Development<font style="letter-spacing:-0.45pt;"> </font>Plan</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:17.28%;text-indent:-13.16%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:1.98%;margin-right:3.47%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Initial Development Plan</font><font style="text-decoration:underline;letter-spacing:-0.5pt;"> </font><font style="text-decoration:underline;">Framework</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:1.98%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.98%;margin-right:3.47%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Estimated</font><font style="text-decoration:underline;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;">Timeline</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.98%;margin-right:0.91%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.98%;margin-right:3.47%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Development Activities and</font><font style="text-decoration:underline;letter-spacing:-0.45pt;"> </font><font style="text-decoration:underline;">Budget</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:1.98%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-top:12pt; clear:both;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:36.28%;margin-right:35.28%;text-indent:0.05%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.91</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:36.28%;margin-right:35.28%;text-indent:0.05%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Knowledge<font style="letter-spacing:-0.25pt;"> </font>Group</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.98%;margin-right:3.47%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Ultragenyx Position</font><font style="text-decoration:underline;letter-spacing:-0.25pt;"> </font><font style="text-decoration:underline;">Titles</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.98%;margin-right:41.5%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tom Kassberg, SVP and Chief Business<font style="letter-spacing:-0.4pt;"> </font>Officer Shalini Sharp, SVP and Chief Financial<font style="letter-spacing:-0.4pt;"> </font>Officer Sunil Agarwal, SVP and Chief Medical<font style="letter-spacing:-0.4pt;"> </font>Officer Cori Leonard, VP,<font style="letter-spacing:-0.35pt;"> </font>Regulatory</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.98%;margin-right:13.71%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yael Weiss, Executive Director, Search and Evaluation, Business<font style="letter-spacing:-0.7pt;"> </font>Development Rob Anstey, Senior Director, Business<font style="letter-spacing:-0.25pt;"> </font>Development</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.98%;margin-right:3.47%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Takeda Position</font><font style="text-decoration:underline;letter-spacing:-0.2pt;"> </font><font style="text-decoration:underline;">Titles</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:1.98%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-top:12pt; clear:both;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:23.39%;margin-right:22.3%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<font style="letter-spacing:0.05pt;"> </font>1.94</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:23.39%;margin-right:22.3%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:72pt;margin-bottom:0pt;margin-top:0pt;margin-left:25.31%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.28%;white-space:nowrap">
<p style="margin-top:10pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.29%;white-space:nowrap">
<p style="margin-top:10pt;margin-bottom:0pt;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><font style="font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">&#178;</font></p></td>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;"><font style="font-size:10.5pt;font-family:Calibri;">Chemical Name:&nbsp;&nbsp;</font><font style="font-size:10.5pt;font-family:Times New Roman;">[***]</font></p></td>
<td valign="top" style="width:10.6%;white-space:nowrap">
<p style="margin-top:10pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.28%;white-space:nowrap">
<p style="line-height:17pt;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.29%;white-space:nowrap">
<p style="line-height:17pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><font style="font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">&#178;</font></p></td>
<td valign="top">
<p style="line-height:17pt;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;"><font style="font-size:10.5pt;font-family:Calibri;">Molecular Formula: &nbsp;&nbsp;</font><font style="font-size:10.5pt;font-family:Times New Roman;">[***]</font></p></td>
<td valign="top" style="width:3.47%;white-space:nowrap">
<p style="line-height:17pt;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;">&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.28%;white-space:nowrap">
<p style="line-height:14pt;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.29%;white-space:nowrap">
<p style="line-height:14pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><font style="font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">&#178;</font></p></td>
<td valign="top">
<p style="line-height:14pt;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;"><font style="font-size:10.5pt;font-family:Calibri;">Molecular Weight:  </font><font style="font-size:10.5pt;font-family:Times New Roman;">[***]</font></p></td>
<td valign="top" style="width:3.47%;white-space:nowrap">
<p style="line-height:14pt;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:12pt;">&nbsp;</p></td></tr></table></div>
<p style="line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:32.91%;margin-right:30.71%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.99</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:32.91%;margin-right:30.71%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Licensed Analog<font style="letter-spacing:-0.2pt;"> </font>Compounds</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:32.91%;margin-right:30.71%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:30.71%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:54pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:32.38%;margin-right:27.06%;text-indent:0.53%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.137</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:32.38%;margin-right:27.06%;text-indent:0.53%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preexisting Third Party<font style="letter-spacing:-0.15pt;"> </font>IP</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:33.73%;margin-right:31.26%;text-indent:0.53%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:38.41%;text-indent:1.08%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">3 pages omitted</font>]</p>
<p style="text-align:center;margin-top:12pt; clear:both;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:38.41%;margin-right:37.29%;text-indent:0.07%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.141</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:38.41%;margin-right:36.93%;text-indent:0.07%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Product<font style="letter-spacing:-0.25pt;"> </font>INDs</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:37.84%;margin-right:36.2%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.13%;text-indent:1.08%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:44.58%;margin-right:43.61%;text-indent:0.01%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a><font style="font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.168</font></p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:44.58%;margin-right:43.61%;text-indent:0.01%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Takeda<font style="letter-spacing:-0.3pt;"> </font>Patents</p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:1.68%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Licensed <font style="font-weight:normal;">[***]</font><font style="letter-spacing:-0.3pt;"> </font>Patent</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.81%;width:644.5pt;;">
<tr>
<td style="width:108.75pt;"></td>
<td style="width:117.05pt;"></td>
<td style="width:144pt;"></td>
<td style="width:153.25pt;"></td>
<td style="width:121.45pt;"></td>
</tr>
<tr style="height:22.45pt;">
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:8.15pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Patent /</font><font style="text-decoration:underline;letter-spacing:-0.45pt;"> </font><font style="text-decoration:underline;">Publication</font></p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:10.05pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Priority /</font><font style="text-decoration:underline;letter-spacing:-0.5pt;"> </font><font style="font-style:italic;text-decoration:underline;">Application</font></p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:15.7pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Inventor(s) /</font><font style="text-decoration:underline;letter-spacing:-0.55pt;"> </font><font style="text-decoration:underline;">Assignee(s)</font></p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:46.2pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Title /</font><font style="text-decoration:underline;letter-spacing:-0.45pt;"> </font><font style="text-decoration:underline;">Claims</font></p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;line-height:13pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Status</font></p></td>
</tr>
<tr style="height:358.05pt;">
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p></td>
<td valign="top"  style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">2 pages omitted</font>]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:39.93%;margin-right:46.81%;text-indent:0.01%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><font style="font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.188</font></p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:39.93%;margin-right:46.81%;text-indent:0.01%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx<font style="letter-spacing:-0.2pt;"> </font>Patents</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:1.55%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx <font style="font-weight:normal;">[***]</font><font style="letter-spacing:-0.2pt;"> </font>Patents</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.55%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.55%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx [***] Patents</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:1.55%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:1.55%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">3 pages omitted</font>]</p>
<p style="text-align:center;margin-top:12pt; clear:both;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:23.81%;margin-right:23.2%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<font style="letter-spacing:0.05pt;"> </font>1.195</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:23.81%;margin-right:22.66%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:29.31%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:26.75%;margin-right:25.51%;text-indent:0.12%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 6.1</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:26.75%;margin-right:25.51%;text-indent:0.12%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Listed<font style="letter-spacing:-0.25pt;"> </font>Compounds</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:26.75%;margin-right:25.51%;text-indent:0.12%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="line-height:73pt;margin-bottom:0pt;margin-top:0pt;margin-left:13.64%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:73pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:17.71%;margin-right:20.76%;text-indent:-0.05%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 6.3(a)</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:17.71%;margin-right:20.76%;text-indent:-0.05%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***] <font style="font-weight:bold;">Research</font><font style="font-weight:bold;letter-spacing:-0.3pt;"> P</font><font style="font-weight:bold;">lan</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:17.71%;margin-right:20.76%;text-indent:-0.05%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-top:12pt; clear:both;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:17.71%;margin-right:20.35%;text-indent:0%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 6.10(b)</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:17.71%;margin-right:20.49%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:17.71%;margin-right:20.49%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:17.71%;margin-right:20.49%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">4 pages omitted</font>]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:17.36%;margin-right:16.55%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 13.2(b)</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:17.36%;margin-right:16.55%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:17.36%;margin-right:16.55%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:17.36%;margin-right:16.55%;text-indent:0%;font-size:10.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-style:italic;">4 pages omitted</font>]</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:47pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:24.42%;margin-right:22.12%;text-indent:-0.12%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 14.5</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:24.42%;margin-right:22.12%;text-indent:-0.12%;font-size:10.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form of Press<font style="letter-spacing:-0.25pt;"> </font>Release</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="line-height:108pt;margin-bottom:0pt;margin-top:0pt;margin-left:0.2%;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g2016120919561763815184.jpg" title="" alt="" style="width:232px;height:144px;"><font style="font-size:10.5pt;font-family:Times New Roman;margin-left:381pt;"><img src="g2016120919561764015185.jpg" title="" alt="" style="width:192px;height:72px;"></font>&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:7.71%;margin-right:35.14%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contact Ultragenyx Pharmaceutical<font style="letter-spacing:-0.25pt;"> </font>Inc. Investors &amp;<font style="letter-spacing:-0.15pt;"> </font>Media</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.71%;margin-right:55.9%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ryan<font style="letter-spacing:-0.1pt;"> </font>Martins <font style="letter-spacing:-0.05pt;">844-758-7273</font></p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:7.71%;margin-right:35.14%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">For Takeda Pharmaceutical Company</font><font style="text-decoration:underline;letter-spacing:-0.5pt;"> </font><font style="text-decoration:underline;">Limited:</font> Tsuyoshi Tada &#8211;<font style="letter-spacing:-0.05pt;"> </font>Japan <font style="text-decoration:underline;color:#0000FF;">tsuyoshi.tada@takeda.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.71%;margin-right:24.56%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+81332782417</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.71%;margin-right:35.14%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Julia Ellwanger &#8211;<font style="letter-spacing:-0.1pt;"> </font>USA <font style="text-decoration:underline;color:#0000FF;letter-spacing:-0.05pt;">julia.ellwanger@takeda.com</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.71%;margin-right:24.56%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+1-224-554-7681</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:8.8%;margin-right:1.76%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Takeda<font style="letter-spacing:-0.2pt;"> </font>enter<font style="letter-spacing:-0.15pt;"> </font>into<font style="letter-spacing:-0.2pt;"> </font>a<font style="letter-spacing:-0.3pt;"> </font>Collaboration<font style="letter-spacing:-0.1pt;"> </font>to<font style="letter-spacing:-0.3pt;"> </font>Develop<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>Commercialize<font style="letter-spacing:-0.2pt;"> </font>Therapies<font style="letter-spacing:-0.15pt;"> </font>for<font style="letter-spacing:-0.15pt;"> </font>Rare Genetic<font style="letter-spacing:-0.3pt;"> </font>Diseases</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:15.53%;margin-right:8.55%;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Ultragenyx to license and develop one or more product candidates from<font style="letter-spacing:-1.15pt;"> </font>Takeda Takeda to make equity investment in Ultragenyx to fund<font style="letter-spacing:-1.05pt;"> </font>development</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.71%;margin-right:0.41%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">NOVATO, CA, June 7, 2016 and OSAKA, JAPAN, June 8, 2016 &#8211; <font style="font-weight:normal;">Ultragenyx Pharmaceutical Inc.</font><font style="letter-spacing:-1.2pt;font-weight:normal;"> </font><font style="font-weight:normal;">(NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and</font><font style="letter-spacing:-1pt;font-weight:normal;"> </font><font style="font-weight:normal;">ultra- rare genetic diseases, and Takeda Pharmaceutical Company Limited (</font><font style="text-decoration:underline;color:#0000FF;font-weight:normal;">TSE: 4502</font><font style="font-weight:normal;">), today announced</font><font style="letter-spacing:-1.1pt;font-weight:normal;"> </font><font style="font-weight:normal;">a strategic partnership to develop and commercialize therapies to treat rare genetic</font><font style="letter-spacing:-1.5pt;font-weight:normal;"> </font><font style="font-weight:normal;">diseases.</font></p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:7.71%;margin-right:0.41%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx will initially receive an exclusive license to one preclinical Takeda product candidate in a<font style="letter-spacing:-1.1pt;"> </font>pre- determined field of use, and will have an exclusive option to co-develop and co-commercialize<font style="letter-spacing:-1.1pt;"> </font>the product candidate in additional therapeutic areas. The companies have also established a<font style="letter-spacing:-0.75pt;"> </font>five-year research collaboration in which Ultragenyx will have the option to license up to five additional<font style="letter-spacing:-1.15pt;"> </font>Takeda</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:1.47%;margin-right:2.58%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">product candidates for rare diseases after the parties agree on and conduct initial validation<font style="letter-spacing:-1.5pt;"> </font>activities under the purview of a Joint Research<font style="letter-spacing:-0.6pt;"> </font>Committee.</p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;This broad collaboration provides Ultragenyx with a product opportunity that is approaching<font style="letter-spacing:-0.65pt;"> </font>clinical- stage development as well as a potential continued source of new product candidates that will help<font style="letter-spacing:-1.65pt;"> </font>us<font style="letter-spacing:-0.05pt;"> </font>achieve our goal of bringing a new therapy into the clinic every one to two years,&#8221; said Emil D.<font style="letter-spacing:-1.2pt;"> </font>Kakkis, MD, PhD, Chief Executive Officer of Ultragenyx. &#8220;Takeda has an impressive early pipeline of<font style="letter-spacing:-1.2pt;"> </font>therapies with potential across a number of rare genetic diseases, and we are pleased that Takeda has chosen<font style="letter-spacing:-1.15pt;"> </font>to partner with us to bring these therapies to patients with rare diseases that have few or no<font style="letter-spacing:-1.35pt;"> </font>treatment options.&#8221;</p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">"Ultragenyx is a rapidly emerging rare disease company, led by a highly experienced and<font style="letter-spacing:-1pt;"> </font>successful management team," said Andrew Plump, M.D., Ph.D., Chief Medical and Scientific Officer of<font style="letter-spacing:-0.35pt;"> </font>Takeda. &#8220;This partnership provides Takeda access to Ultragenyx&#8217;s strong patient-centric development<font style="letter-spacing:-0.4pt;"> </font>and regulatory capabilities in the rare disease space, and could create significant value for both companies<font style="letter-spacing:-1.4pt;"> </font>by<font style="letter-spacing:-0.05pt;"> </font>delivering important new therapies to<font style="letter-spacing:-0.3pt;"> </font>patients.&#8221;</p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:1.47%;margin-right:2.58%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Takeda will receive an exclusive option to commercialize any licensed products resulting from<font style="letter-spacing:-1.05pt;"> </font>the collaboration in Asia, including Japan. In addition, Takeda receives an option to exclusively license<font style="letter-spacing:-1.15pt;"> </font>one Ultragenyx pipeline product in Japan. Each company will receive potential development and<font style="letter-spacing:-1pt;"> </font>sales<font style="letter-spacing:-0.05pt;"> </font>milestone payments and royalties on net sales of licensed products by the other<font style="letter-spacing:-1.3pt;"> </font>party.</p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:1.47%;margin-right:2.58%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Takeda will invest up to $65 million in Ultragenyx in two tranches, the first of which will comprise<font style="letter-spacing:-1.2pt;"> </font>a</p>
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:1.47%;margin-right:2.58%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$25million stock purchase along with a $15 million cash premium at closing. This will be followed<font style="letter-spacing:-1.15pt;"> </font>at Ultragenyx&#8217;s option, within 12 months, by a second equity purchase of $25million with no<font style="letter-spacing:-0.8pt;"> </font>additional premium. A potential third equity investment by Takeda is contingent upon Ultragenyx achieving<font style="letter-spacing:-1.05pt;"> </font>a specific development milestone on a second asset. No additional financial details were<font style="letter-spacing:-1.3pt;"> </font>disclosed.</p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The completion of the transactions are subject to Hart-Scott-Rodino Antitrust Improvements Act of<font style="letter-spacing:-1.6pt;"> </font>1976 (HSR) review and the satisfaction of other customary closing<font style="letter-spacing:-1.1pt;"> </font>conditions.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.47%;margin-right:2.58%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">About<font style="letter-spacing:-0.25pt;"> </font>Ultragenyx</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.47%;margin-right:1.22%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market<font style="letter-spacing:-0.9pt;"> </font>novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating<font style="letter-spacing:-1.15pt;"> </font>genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates<font style="letter-spacing:-1.4pt;"> </font>with the potential to address diseases for which the unmet medical need is high, the biology for treatment<font style="letter-spacing:-1.55pt;"> </font>is clear, and for which there are no approved<font style="letter-spacing:-0.45pt;"> </font>therapies.</p>
<p style="margin-top:9pt;margin-bottom:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The company is led by a management team experienced in the development and commercialization<font style="letter-spacing:-1.25pt;"> </font>of rare disease therapeutics. Ultragenyx&#8217;s strategy is predicated upon time and cost-efficient<font style="letter-spacing:-0.55pt;"> </font>drug development, with the goal of delivering safe and effective therapies to patients with the<font style="letter-spacing:-1.05pt;"> </font>utmost urgency.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:1.47%;margin-right:2.58%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For more information on Ultragenyx, please visit the company&#8217;s website at<font style="letter-spacing:-1.15pt;"> </font><font style="text-decoration:underline;color:#0000FF;">www.ultragenyx.com</font>.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:1.47%;margin-right:2.58%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">About<font style="letter-spacing:-0.2pt;"> </font>Takeda</p>
<p style="margin-top:1pt;margin-bottom:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-size:10.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, R&amp;D-driven pharmaceutical<font style="letter-spacing:-1pt;"> </font>company committed to bringing better health and a brighter future to patients by translating science into<font style="letter-spacing:-1.15pt;"> </font>life- changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and<font style="letter-spacing:-0.9pt;"> </font>central nervous system therapeutic areas. It also has specific development programs in specialty<font style="letter-spacing:-0.8pt;"> </font>cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&amp;D both internally and<font style="letter-spacing:-1pt;"> </font>with partners to stay at the leading edge of innovation. <font style="letter-spacing:-0.1pt;">New </font>innovative products, especially in<font style="letter-spacing:-0.8pt;"> </font>oncology, central nervous system and gastroenterology, as well as its presence in emerging markets, fuel<font style="letter-spacing:-0.9pt;"> </font>the growth<font style="letter-spacing:-0.2pt;"> </font>of<font style="letter-spacing:-0.15pt;"> </font>Takeda.<font style="letter-spacing:-0.2pt;"> </font>More<font style="letter-spacing:-0.15pt;"> </font>than<font style="letter-spacing:-0.1pt;"> </font>30,000<font style="letter-spacing:-0.15pt;"> </font>Takeda<font style="letter-spacing:-0.2pt;"> </font>employees<font style="letter-spacing:-0.05pt;"> </font>are<font style="letter-spacing:-0.2pt;"> </font>committed<font style="letter-spacing:-0.1pt;"> </font>to improving<font style="letter-spacing:-0.1pt;"> </font>quality<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.05pt;"> </font>life<font style="letter-spacing:-0.05pt;"> </font>for patients, working with our partners in health care in more than 70 countries. For more information,<font style="letter-spacing:-1pt;"> </font>visit <font style="text-decoration:underline;color:#0000FF;">http://www.takeda.com/news</font>.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;margin-left:1.47%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Ultragenyx Forward-Looking<font style="letter-spacing:-0.5pt;"> </font>Statements</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Except<font style="letter-spacing:1.45pt;"> </font>for<font style="letter-spacing:1.45pt;"> </font>the<font style="letter-spacing:1.5pt;"> </font>historical<font style="letter-spacing:1.45pt;"> </font>information<font style="letter-spacing:1.4pt;"> </font>contained<font style="letter-spacing:1.55pt;"> </font>herein,<font style="letter-spacing:1.5pt;"> </font>the<font style="letter-spacing:1.5pt;"> </font>matters<font style="letter-spacing:1.45pt;"> </font>set<font style="letter-spacing:1.45pt;"> </font>forth<font style="letter-spacing:1.55pt;"> </font>in<font style="letter-spacing:1.4pt;"> </font>this<font style="letter-spacing:1.55pt;"> </font>press<font style="letter-spacing:1.4pt;"> </font>release, including statements regarding the potential to develop the licensed product candidate in<font style="letter-spacing:0.15pt;"> </font>additional therapeutic areas, as well as the potential to develop additional rare disease targets pursuant to<font style="letter-spacing:2.4pt;"> </font>the collaboration and the ability to bring new therapies to clinic, are forward-looking statements<font style="letter-spacing:0.65pt;"> </font>within the<font style="letter-spacing:0.65pt;"> </font>meaning<font style="letter-spacing:0.6pt;"> </font>of<font style="letter-spacing:0.65pt;"> </font>the<font style="letter-spacing:0.65pt;"> </font>"safe<font style="letter-spacing:0.75pt;"> </font>harbor"<font style="letter-spacing:0.6pt;"> </font>provisions<font style="letter-spacing:0.7pt;"> </font>of<font style="letter-spacing:0.55pt;"> </font>the<font style="letter-spacing:0.75pt;"> </font>Private<font style="letter-spacing:0.65pt;"> </font>Securities<font style="letter-spacing:0.6pt;"> </font>Litigation<font style="letter-spacing:0.6pt;"> </font>Reform<font style="letter-spacing:0.6pt;"> </font>Act<font style="letter-spacing:0.6pt;"> </font>of<font style="letter-spacing:0.55pt;"> </font>1995. Such<font style="letter-spacing:1.85pt;"> </font>forward-looking<font style="letter-spacing:1.8pt;"> </font>statements<font style="letter-spacing:1.8pt;"> </font>involve<font style="letter-spacing:1.85pt;"> </font>substantial<font style="letter-spacing:1.8pt;"> </font>risks<font style="letter-spacing:1.8pt;"> </font>and<font style="letter-spacing:1.8pt;"> </font>uncertainties<font style="letter-spacing:1.8pt;"> </font>that<font style="letter-spacing:1.8pt;"> </font>could<font style="letter-spacing:1.8pt;"> </font>cause<font style="letter-spacing:1.85pt;"> </font>our development programs, future results, performance or achievements to differ significantly<font style="letter-spacing:0.9pt;"> </font>from those expressed or implied by the forward-looking statements. Such risks and uncertainties<font style="letter-spacing:2.25pt;"> </font>include, among others, the satisfaction of the HSR requirements and the impact on the timing of the<font style="letter-spacing:2.05pt;"> </font>closing, whether<font style="letter-spacing:1.9pt;"> </font>any<font style="letter-spacing:1.8pt;"> </font>products<font style="letter-spacing:1.85pt;"> </font>will<font style="letter-spacing:1.9pt;"> </font>be<font style="letter-spacing:1.8pt;"> </font>successfully<font style="letter-spacing:1.85pt;"> </font>developed<font style="letter-spacing:1.85pt;"> </font>and<font style="letter-spacing:1.85pt;"> </font>commercialized<font style="letter-spacing:1.85pt;"> </font>from<font style="letter-spacing:1.85pt;"> </font>the<font style="letter-spacing:1.8pt;"> </font>collaboration, uncertainties inherent in the drug development process and other matters that could affect<font style="letter-spacing:1.2pt;"> </font>the potential for success of the collaboration, including the sufficiency of existing cash, cash<font style="letter-spacing:0.2pt;"> </font>equivalents and<font style="letter-spacing:1.2pt;"> </font>short-term<font style="letter-spacing:1.25pt;"> </font>investments<font style="letter-spacing:1.15pt;"> </font>to<font style="letter-spacing:1.2pt;"> </font>fund<font style="letter-spacing:1.2pt;"> </font>operations.<font style="letter-spacing:1.2pt;"> </font>Ultragenyx<font style="letter-spacing:1.25pt;"> </font>undertakes<font style="letter-spacing:1.2pt;"> </font>no<font style="letter-spacing:1.1pt;"> </font>obligation<font style="letter-spacing:1.2pt;"> </font>to<font style="letter-spacing:1.2pt;"> </font>update<font style="letter-spacing:1.2pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>revise<font style="letter-spacing:0.9pt;"> </font>any<font style="letter-spacing:0.85pt;"> </font>forward-looking<font style="letter-spacing:0.8pt;"> </font>statements.<font style="letter-spacing:0.85pt;"> </font>For<font style="letter-spacing:0.85pt;"> </font>a<font style="letter-spacing:0.8pt;"> </font>further<font style="letter-spacing:0.9pt;"> </font>description<font style="letter-spacing:0.8pt;"> </font>of<font style="letter-spacing:0.8pt;"> </font>the<font style="letter-spacing:0.9pt;"> </font>risks<font style="letter-spacing:0.95pt;"> </font>and<font style="letter-spacing:0.8pt;"> </font>uncertainties<font style="letter-spacing:0.8pt;"> </font>that could<font style="letter-spacing:1.4pt;"> </font>cause<font style="letter-spacing:1.5pt;"> </font>actual<font style="letter-spacing:1.45pt;"> </font>results<font style="letter-spacing:1.4pt;"> </font>to<font style="letter-spacing:1.4pt;"> </font>differ<font style="letter-spacing:1.45pt;"> </font>from<font style="letter-spacing:1.45pt;"> </font>those<font style="letter-spacing:1.5pt;"> </font>expressed<font style="letter-spacing:1.45pt;"> </font>in<font style="letter-spacing:1.4pt;"> </font>these<font style="letter-spacing:1.45pt;"> </font>forward-looking<font style="letter-spacing:1.4pt;"> </font>statements,<font style="letter-spacing:1.5pt;"> </font>as well as risks relating to the business of the company in general, see Ultragenyx's Quarterly Report<font style="letter-spacing:1pt;"> </font>on<font style="letter-spacing:-0.05pt;"> </font>Form 10-Q filed with the Securities and Exchange Commission on March 10 2016, and its<font style="letter-spacing:1.45pt;"> </font>subsequent periodic reports filed with the Securities and Exchange<font style="letter-spacing:-1.05pt;"> </font>Commission.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.47%;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Takeda Forward-Looking<font style="letter-spacing:-0.45pt;"> </font>Statements</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">This press release contains &#8220;forward-looking statements.&#8221; Forward-looking statements include<font style="letter-spacing:0.65pt;"> </font>all statements other than statements of historical fact, including plans, strategies and expectations<font style="letter-spacing:1pt;"> </font>for the future, statements regarding the expected timing of filings and approvals relating to<font style="letter-spacing:1.95pt;"> </font>the transaction,<font style="letter-spacing:1.35pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>expected<font style="letter-spacing:1.3pt;"> </font>timing<font style="letter-spacing:1.3pt;"> </font>of<font style="letter-spacing:1.25pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>completion<font style="letter-spacing:1.3pt;"> </font>of<font style="letter-spacing:1.25pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>transaction,<font style="letter-spacing:1.35pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>ability<font style="letter-spacing:1.35pt;"> </font>to<font style="letter-spacing:1.3pt;"> </font>complete<font style="letter-spacing:1.35pt;"> </font>the transaction<font style="letter-spacing:1.85pt;"> </font>or<font style="letter-spacing:1.9pt;"> </font>to<font style="letter-spacing:1.85pt;"> </font>satisfy<font style="letter-spacing:1.75pt;"> </font>the<font style="letter-spacing:1.9pt;"> </font>various<font style="letter-spacing:1.85pt;"> </font>closing<font style="letter-spacing:1.85pt;"> </font>conditions,<font style="letter-spacing:1.9pt;"> </font>future<font style="letter-spacing:1.9pt;"> </font>revenues<font style="letter-spacing:1.85pt;"> </font>and<font style="letter-spacing:1.85pt;"> </font>profitability<font style="letter-spacing:1.9pt;"> </font>from<font style="letter-spacing:1.9pt;"> </font>or</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.14%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">growth<font style="letter-spacing:0.95pt;"> </font>or<font style="letter-spacing:0.95pt;"> </font>any<font style="letter-spacing:1pt;"> </font>assumptions<font style="letter-spacing:0.95pt;"> </font>underlying<font style="letter-spacing:0.9pt;"> </font>any<font style="letter-spacing:1pt;"> </font>of<font style="letter-spacing:0.9pt;"> </font>the<font style="letter-spacing:1pt;"> </font>foregoing.<font style="letter-spacing:0.95pt;"> </font>Statements<font style="letter-spacing:0.95pt;"> </font>made<font style="letter-spacing:1pt;"> </font>in<font style="letter-spacing:0.95pt;"> </font>the<font style="letter-spacing:1pt;"> </font>future<font style="letter-spacing:1pt;"> </font>tense, and<font style="letter-spacing:0.8pt;"> </font>words<font style="letter-spacing:0.8pt;"> </font>such<font style="letter-spacing:0.95pt;"> </font>as<font style="letter-spacing:0.8pt;"> </font>&#8220;anticipate,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;expect,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;project,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;continue,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;believe,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;plan,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;estimate,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;pro forma,&#8221; &#8220;intend,&#8221; &#8220;potential,&#8221; &#8220;target,&#8221; &#8220;forecast,&#8221; &#8220;guidance,&#8221; &#8220;outlook,&#8221; &#8220;seek,&#8221; &#8220;assume,&#8221;<font style="letter-spacing:0.85pt;"> </font>&#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; and similar expressions are intended to qualify as forward-looking<font style="letter-spacing:2.15pt;"> </font>statements. Forward-looking<font style="letter-spacing:1.3pt;"> </font>statements<font style="letter-spacing:1.3pt;"> </font>are<font style="letter-spacing:1.35pt;"> </font>based<font style="letter-spacing:1.3pt;"> </font>on<font style="letter-spacing:1.25pt;"> </font>estimates<font style="letter-spacing:1.3pt;"> </font>and<font style="letter-spacing:1.3pt;"> </font>assumptions<font style="letter-spacing:1.3pt;"> </font>made<font style="letter-spacing:1.35pt;"> </font>by<font style="letter-spacing:1.35pt;"> </font>management<font style="letter-spacing:1.3pt;"> </font>that are believed to be reasonable, though they are inherently uncertain and difficult to predict.<font style="letter-spacing:1.65pt;"> </font>Investors and security holders are cautioned not to place undue reliance on these forward-looking<font style="letter-spacing:-1.2pt;"> </font>statements.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">Forward-looking statements involve risks and uncertainties that could cause actual results<font style="letter-spacing:1.1pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>experience<font style="letter-spacing:1.3pt;"> </font>to<font style="letter-spacing:1.15pt;"> </font>differ<font style="letter-spacing:1.35pt;"> </font>materially<font style="letter-spacing:1.3pt;"> </font>from<font style="letter-spacing:1.35pt;"> </font>that<font style="letter-spacing:1.3pt;"> </font>expressed<font style="letter-spacing:1.3pt;"> </font>or<font style="letter-spacing:1.35pt;"> </font>implied<font style="letter-spacing:1.3pt;"> </font>by<font style="letter-spacing:1.35pt;"> </font>the<font style="letter-spacing:1.35pt;"> </font>forward-looking<font style="letter-spacing:1.3pt;"> </font>statements. Some<font style="letter-spacing:0.75pt;"> </font>of<font style="letter-spacing:0.65pt;"> </font>these<font style="letter-spacing:0.7pt;"> </font>risks<font style="letter-spacing:0.7pt;"> </font>and<font style="letter-spacing:0.7pt;"> </font>uncertainties<font style="letter-spacing:0.7pt;"> </font>include,<font style="letter-spacing:0.75pt;"> </font>but<font style="letter-spacing:0.85pt;"> </font>are<font style="letter-spacing:0.75pt;"> </font>not<font style="letter-spacing:0.7pt;"> </font>limited<font style="letter-spacing:0.7pt;"> </font>to:<font style="letter-spacing:0.8pt;"> </font>required<font style="letter-spacing:0.7pt;"> </font>regulatory<font style="letter-spacing:0.75pt;"> </font>approvals for the transaction may not be obtained in a timely manner, if at all; the conditions to closing of<font style="letter-spacing:0.8pt;"> </font>the transaction may not be satisfied; competitive pressures and developments; applicable laws<font style="letter-spacing:-0.15pt;"> </font>and regulations; the success or failure of product development programs; actions of<font style="letter-spacing:1.85pt;"> </font>regulatory authorities and the timing thereof; changes in exchange rates; and claims or concerns regarding<font style="letter-spacing:1.2pt;"> </font>the safety or efficacy of marketed products or product candidates in<font style="letter-spacing:-1.05pt;"> </font>development.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:9pt;margin-bottom:0pt;margin-left:1.47%;margin-right:0.68%;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;">The forward-looking statements contained in this press release speak only as of the date of this<font style="letter-spacing:-1.05pt;"> </font>press release, and neither Ultragenyx nor Takeda undertakes any obligation to revise or update<font style="letter-spacing:1.75pt;"> </font>any forward-looking<font style="letter-spacing:1.95pt;"> </font>statements<font style="letter-spacing:1.95pt;"> </font>to<font style="letter-spacing:1.95pt;"> </font>reflect<font style="letter-spacing:2pt;"> </font>new<font style="letter-spacing:1.95pt;"> </font>information,<font style="letter-spacing:2.05pt;"> </font>future<font style="letter-spacing:2.05pt;"> </font>events<font style="letter-spacing:1.95pt;"> </font>or<font style="letter-spacing:2pt;"> </font>circumstances<font style="letter-spacing:2pt;"> </font>after<font style="letter-spacing:2.05pt;"> </font>the date<font style="letter-spacing:0.65pt;"> </font>of<font style="letter-spacing:0.6pt;"> </font>the<font style="letter-spacing:0.7pt;"> </font>forward-looking<font style="letter-spacing:0.65pt;"> </font>statement.<font style="letter-spacing:0.65pt;"> </font>If<font style="letter-spacing:0.6pt;"> </font>one<font style="letter-spacing:0.7pt;"> </font>or<font style="letter-spacing:0.65pt;"> </font>more<font style="letter-spacing:0.7pt;"> </font>of<font style="letter-spacing:0.6pt;"> </font>these<font style="letter-spacing:0.65pt;"> </font>statements<font style="letter-spacing:0.6pt;"> </font>is<font style="letter-spacing:0.65pt;"> </font>updated<font style="letter-spacing:0.65pt;"> </font>or<font style="letter-spacing:0.65pt;"> </font>corrected, investors and others should not conclude that additional updates or corrections will be<font style="letter-spacing:-1.25pt;"> </font>made.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:4.88%;text-indent:0%;font-weight:bold;font-style:italic;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">CONFIDENTIAL TREATMENT REQUESTED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:4.88%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.&nbsp;&nbsp;Confidential treatment has been requested with respect to omitted portions marked &#8220;***&#8221;.</p></body>
</html>
</TEXT>
</DOCUMENT>
